抗间皮素嵌合抗原受体(car)构建体及其用途
阅读说明:本技术 抗间皮素嵌合抗原受体(car)构建体及其用途 (Anti-mesothelin Chimeric Antigen Receptor (CAR) constructs and uses thereof ) 是由 戴晴 刘健 杨帅 蒋坤 彭园园 呼晨 武术 于 2019-08-29 设计创作,主要内容包括:本文描述了经工程改造以表达单独的嵌合抗原受体(CAR)诸如抗间皮素CAR或其与滤泡刺激素受体(FSHR)结合结构域和/或显性负性转化生长因子-β受体II(dnTGFβRII)的组合的T细胞,所述T细胞用于治疗与间皮素表达相关的疾病。还描述了经工程改造以表达修饰的T细胞受体(TCR)的T细胞。(Described herein are T cells engineered to express Chimeric Antigen Receptors (CARs) such as anti-mesothelin CARs alone or in combination with Follicle Stimulating Hormone Receptor (FSHR) binding domain and/or dominant negative transforming growth factor-beta receptor II (dnTGF β RII) for the treatment of diseases associated with mesothelin expression. T cells engineered to express a modified T Cell Receptor (TCR) are also described.)
相关申请的交叉引用
本申请要求于2018年8月29日提交的国际专利申请第PCT/CN2018/103050号和2019年4月23日提交的国际专利申请第PCT/CN2019/083918号的优先权权益,其内容通过引用整体并入本文。
对以电子方式提交的序列表的引用
本申请包含序列表,所述序列表作为ASCII格式的序列表经由EFS-Web以电子方式提交,文件名为“689296-13CN1序列表”且创建日期为2019年4月16日,并且大小为约727kb。经由EFS-Web提交的序列表是本说明书的一部分,并且通过引用整体并入本文。
技术领域
本发明一般涉及经工程改造以表达嵌合抗原受体(CAR)诸如抗间皮素CAR单独或与滤泡刺激素受体(FSHR)结合结构域和/或显性负性转化生长因子-β受体II(dnTGFβRII)组合的T细胞用于治疗与间皮素表达相关的疾病的用途。
背景技术
过继性T细胞免疫疗法已在治疗血液恶性肿瘤中显示巨大前景,在所述疗法中患者自身的T淋巴细胞经工程改造以表达嵌合抗原受体(CAR)。Gill S等人,Blood Rev.2016;30(3):157-167。CAR通常含有3个模块:胞外靶结合部分、将CAR锚定在细胞膜中的跨膜结构域(TM结构域)和传输激活信号的胞内信号传导结构域(ICD)。一旦结合到靶肿瘤抗原,CAR便可激活T细胞以便以主要组织相容性复合体(MHC)非依赖性方式发动特异性抗肿瘤反应。
间皮素(MSLN)最初由Ira Pastan和Mark Willingham于1992年在国家癌症研究所鉴别的肿瘤相关抗原。Chang K等人,Cancer Res.1992;52(1):181-186和Chang K等人,Proc Natl Acad Sci USA.1996;93(1):136-140。间皮素为糖基化磷脂酰肌醇(GPI)锚定的糖蛋白,其具有限于胸膜、腹膜和心包膜内衬的间皮细胞的正常表达,但在包括以下的许多恶性肿瘤中过度表达:恶性胸膜间皮瘤(MPM)、胰腺导管腺癌(PDA)、卵巢癌、肺腺癌、三阴性乳腺癌、子宫内膜癌、胆管癌、胃癌和小儿急性骨髓性白血病。
间皮素合成为71-kD前体蛋白且由内切蛋白酶furin裂解以释放所分泌的N端区域,称为巨核细胞增强因子(MPF),而41-kD成熟间皮素保持连接于膜上。Yamaguchi N等人,Biol Chem.1994;269:805-808。剩余GPI连接的成熟间皮素也可经由肿瘤坏死因子α-转化酶蛋白酶的作用自细胞脱落。Zhang Y等人,Cancer Res.2011;71:5915-5922。
脱落的间皮素的血清含量与疾病之间的相关性提示间皮素蛋白在癌症进展中的潜在作用。然而,对间皮素的生物功能并未充分了解。已知间皮素结合到卵巢癌抗原MUC16(癌抗原125),已显示所述癌抗原诱发细胞与细胞的黏附并且可能促进腹膜种植和转移扩散。Gubbels JA等人,Mol Cancer.2006;5:50。此外,间皮素剔除小鼠通常生长并繁殖并且没有可检测的表型。Bera TK等人,Mol Cell Biol.2000;20:2902-2906。
滤泡刺激素受体(FSHR)是见于卵巢表面上皮以及一些卵巢癌细胞系和组织中的G蛋白连接受体,其分布可限于生殖系统中。Zhang W等人,Am J Pathol.1996;148:47-53。滤泡刺激素(FSH)是由α链与β链组成的糖蛋白激素,并且已经鉴别出FSHβ链的氨基酸33至53以高亲和力结合到FSHR。Agris PF等人,J Protein Chem.1992;11:495-507。具体地讲,FSHβ33-53肽当共价连接到纳米颗粒时表现出功能,提供向表达FSHR的卵巢肿瘤的高选择性纳米颗粒递送。Zhang XY等人,Cancer Res.2009;69(16):6506-6514。已报告FSHR在50-70%卵巢癌组织中的表达以及其在以下广泛肿瘤的血管表面上的选择性表达:例如肾细胞癌、前列腺癌、乳腺癌、结肠癌、胰腺癌、膀胱癌、肾癌、肺癌、肝癌、胃癌、睾丸癌和卵巢癌(原发肿瘤和/或转移)(Radu等人,N Engl J Med 363:1621,2010;Siraj等人,BMC Cancer 13:246,2013;以及Renner等人,Histopathology 63:29,2013)。FSHR在恶性组织的细胞表面上的相对特异性表达使其成为FSHR肿瘤免疫疗法有吸引力的靶标。
转化生长因子-β1(TGFβ1)是多功能分泌型蛋白,其调控细胞增殖、分化和运动并且影响细胞外基质的产生、新血管形成和免疫功能。Derynck R等人,Nature.2003;425:577-584。已表明TGFβ1和其受体(TGFβ受体I型和TGFβ受体II型)的表达可在上皮性卵巢癌的增殖和进展中发挥关键作用。TGFβ还可能通过促进终末分化和凋亡而对肿瘤细胞本身产生不良影响。肿瘤可通过其TGFβ受体(TGFβRI和TGFβRII)的突变避免这种活性。Ebner R等人,Science.1993;260:1344-1348。在许多癌症中部分地归因于TGFβ信号传导的免疫抑制环境可通过使用显性负性TGFβRII而阻断,所述显性负性TGFβRII是截短的并且缺少下游信号传导所必需的胞内结构域。Wieser R等人,Molecular and cellular biology.1993;13:7239-7247。最近报道一项临床试验(NCT00368082),其测试dnTGFβRII受体在淋巴瘤的EBV特异性T细胞中的安全性与功效。Bollard CM等人,J Clin Oncol.2018;36:1128-1139。更近来,开始另一项临床试验,以评估涉及与dnTGFβRII共表达的前列腺特异性膜抗原(PSMA)的CAR-T细胞作为用于患有复发与难治性转移性前列腺癌的患者的方法(NCT03089203)。Christopher C等人,Molecular Therapy.2018;26:1855-1866。
T细胞受体(TCR)是含有通过二硫键连接的α链与β链或δ链与γ链的跨膜异源二聚体。TCR通常含有高度可变的α链与β链,表达为与不变的CD3链分子的复合体的一部分。α链与β链内的互补决定区(CDR)决定TCR将结合到的抗原,由此激活T细胞,造成免疫反应过剩。例如,抗原呈递细胞(APC)消化病原体并且在主要组织相容性复合体(MHC)分子上展示其片段。这种MHC/抗原复合体结合到TCR,而其他共刺激分子(例如CD28)受到激活,造成T细胞激活、增殖、分化、凋亡或细胞因子释放(参见,例如Samelson,2011,Cold Spring HarbPerspect Biol.,3(12):a011510)。TCR还可与以下其他分子相互作用,包括非肽抗原,诸如脂质(Mori和De Libero,2012,Immunol Res,53,191-199)、结合到MHC样分子MR1的代谢中间物(Reantragoon等人2012,J Exp Med,209:761-774.)等。TCR信号传导的起始需要共受体,诸如辅助T细胞的CD4和细胞毒性T细胞的CD8。这些共受体充当细胞黏附分子,其结合它们各自的MHC分子并且使T细胞与抗原呈递细胞的相互作用稳定。TCR还紧密地位于信号传导分子的复合体附近,这有助于介导T细胞激活。它们包括CD3蛋白家族(CD3δ、CD3ε和CD3γ)以及TCR zeta(ζ)链(图1)(Wucherpfennig等人,2010,Cold Spring Harb PerspectBiol,2:a005140)。
需要一种用于治疗某些癌症例如卵巢癌的更有针对性的抗原特异性免疫疗法。
发明内容
在一个通常方面中,本发明涉及经工程改造以表达嵌合抗原受体(CAR)的T细胞和其用于治疗某些癌症的用途。在另一通常方面中,本发明涉及经工程改造以表达修饰的T细胞受体(TCR)复合体的T细胞,所述TCR复合体含有滤泡刺激素受体(FSHR)结合结构域。在某些方面中,本发明涉及经工程改造以表达抗间皮素CAR与含有FSHR结合结构域和/或dnTGFβRII的修饰的TCR复合体组合的T细胞,其用于治疗与间皮素和/或FSHR表达相关的疾病。在某些方面中,本发明涉及经工程改造以表达CAR的T细胞及其用途,所述CAR包含FSHR结合结构域和特异性地结合到肿瘤抗原的抗原结合片段。在某些方面中,本发明涉及经工程改造以表达靶向间皮素和/或FSHR和/或显性负性转化生长因子-β受体II(dnTGFβRII)的CAR的T细胞,其用于治疗与间皮素表达相关的疾病。
本文提供一种分离的多核苷酸,其包含编码修饰的T细胞受体(TCR)复合体蛋白的核苷酸序列。所述蛋白自N端至C端包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽、以及选自由CD3-γ链、CD3-δ链和CD3-ε链组成的组中的CD3多肽的胞外结构域、跨膜结构域和胞内结构域。
在某些实施方案中,特异性结合到FSHR的第一多肽可例如包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列,并且所述蛋白还含有胞外结构域,其分别包含选自由SEQ ID NO:433至435组成的组中的氨基酸序列;跨膜结构域,其分别包含选自由SEQ IDNO:436至438组成的组中的氨基酸序列;和胞内结构域,其分别包含选自由SEQ ID NO:439至441组成的组中的氨基酸序列。在某些实施方案中,所述蛋白质还包含信号肽。在某些实施方案中,所述信号肽包含选自由SEQ ID NO:430至432组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸包含编码修饰的TCR复合体蛋白的核苷酸序列,所述修饰的TCR复合体蛋白包含选自由SEQ ID NO:442-444组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸还包含编码嵌合抗原受体(CAR)的第二核苷酸序列,其中所述CAR包含:(a)胞外结构域,其包含特异性结合到肿瘤抗原的抗原结合片段;(b)跨膜结构域;和(c)胞内信号传导结构域。第二核苷酸序列可编码任何合适的CAR。优选地,第二核苷酸序列编码本发明的CAR,诸如特异性结合到间皮素的CAR。CAR的实例包括但不限于本申请中所例示的CAR。优选地,编码修饰的TCR复合体蛋白的核苷酸序列经由2A肽编码序列连接到编码CAR的核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码具有选自由SEQ ID NO:454-456组成的组中的氨基酸序列的蛋白质的核苷酸序列。
在某些实施方案中,编码修饰的TCR复合体蛋白的核苷酸序列还包含第三核苷酸序列,所述第三核苷酸序列编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。免疫细胞的细胞介导免疫反应的抑制剂可为例如转化生长因子β(TGF-β)受体。抑制剂的显性负性形式可例如包含SEQ ID NO:347的氨基酸序列。在某些实施方案中,编码修饰的TCR复合体蛋白的核苷酸序列经由2A肽编码序列连接到第三核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码具有选自由SEQ ID NO:457-459组成的组中的氨基酸序列的蛋白质的核苷酸序列。
在某些实施方案中,分离的多核苷酸包含:第一核苷酸序列,其编码修饰的TCR复合体蛋白;第二核苷酸序列,其编码CAR;和第三核苷酸序列,其编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。在某些实施方案中,第一核苷酸序列、第二核苷酸序列和第三核苷酸序列经由2A肽编码序列连接。第一核苷酸序列、第二核苷酸序列和第三核苷酸序列在分离的多核苷酸中可以任何顺序排列。
在某些实施方案中,分离的多核苷酸包含编码具有选自由SEQ ID NO:469-471组成的组中的氨基酸序列的蛋白质的核苷酸序列。
本文还提供分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列。所述CAR可例如包含:(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽和特异性结合到肿瘤抗原的抗原结合片段;(b)跨膜结构域;和(c)胞内信号传导结构域。所述CAR可任选还包含在其氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
在某些实施方案中,特异性结合到FSHR的第一多肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。
在某些实施方案中,第一多肽经由接头连接到抗原结合片段的氨基端或羧基端。接头可例如选自由下列组成的组:G4S接头、(G4S)2接头、(G4S)3接头、(G4S)4接头和(G4S)5接头。
在某些实施方案中,肿瘤抗原选自由下列组成的组:间皮素、叶酸受体α、黏蛋白16(MUC16)、前列腺特异性膜抗原(PSMA)、人表皮生长因子受体2(HER2)、表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)。肿瘤抗原可为例如间皮素,优选为人间皮素。
在某些实施方案中,抗原结合片段包含Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)或骆驼抗体的可变结构域(VHH)。所述抗原结合片段可例如包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158,
或在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
在某些实施方案中,所述抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
在某些实施方案中,所述胞外结构域包含选自由SEQ ID NO:348-357组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
还提供分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列。所述CAR可例如包含(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;(b)跨膜结构域;和(c)胞内信号传导结构域。所述CAR可任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。所述抗原结合片段可例如包含
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158,
或在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
在某些实施方案中,所述抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个或三个氨基酸取代、缺失或插入,或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个或三个氨基酸取代、缺失或插入。
在某些实施方案中,多核苷酸还包含编码第二嵌合抗原受体(CAR)的第二核苷酸序列,其中所述第二CAR包含:
(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的多肽;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中所述第二CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
优选地,编码CAR的核苷酸序列经由2A肽编码序列连接到第二核苷酸序列。
特异性结合到FSHR的多肽可例如包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。
在某些实施方案中,所述CAR包含具有与SEQ ID NO:340至少90%相同的氨基酸序列的信号肽。在某些实施方案中,所述CAR包含具有与SEQ ID NO:341至少90%相同的氨基酸序列的铰链区。
在某些实施方案中,所述CAR包含选自由以下组成的组中的跨膜结构域:CD8α跨膜结构域、CD28跨膜结构域、CD4跨膜结构域、CD3ζ跨膜结构域、CD2跨膜结构域、4-1BB跨膜结构域、OX40跨膜结构域、ICOS跨膜结构域、CTLA-4跨膜结构域、PD-1跨膜结构域、LAG-3跨膜结构域、2B4跨膜结构域、BTLA跨膜结构域和GMCSFR跨膜结构域。
在某些实施方案中,所述CAR包含选自由以下组成的组中的胞内信号传导结构域:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ的信号传导结构域。
在某些实施方案中,所述CAR包含选自由以下一个或多个的共刺激结构域组成的组中的共刺激结构域:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
在某些实施方案中,分离的多核苷酸包含编码CAR的核苷酸序列,所述CAR包含选自由SEQ ID NO:370-379和SEQ ID NO:448-450组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸包含编码选自由SEQ ID NO:380-389和SEQID NO:451-453组成的组中的氨基酸序列的核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码CAR的核苷酸序列,所述CAR包含选自由SEQ ID NO:358-367和SEQ ID NO:445-447组成的组中的氨基酸序列。
在某些实施方案中,编码CAR的核苷酸序列还包含第三核苷酸序列,所述第三核苷酸序列编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。免疫细胞的细胞介导免疫反应的抑制剂可为例如转化生长因子β(TGF-β)受体。抑制剂的显性负性形式可例如包含SEQ ID NO:347的氨基酸序列。在某些实施方案中,编码CAR的核苷酸序列经由2A肽编码序列连接到第三核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码选自由SEQ ID NO:390-419和SEQID NO:460-468组成的组中的氨基酸序列的核苷酸序列。
还提供包含本发明的多核苷酸的载体。
还提供宿主细胞,其包含本发明的多核苷酸或本发明的载体。
还提供工程改造的免疫细胞,其表达由本发明的多核苷酸编码的CAR。工程改造的免疫细胞可例如选自由下列各细胞组成的组:细胞毒性T细胞、辅助T细胞、自然杀伤T细胞、γδT细胞和NK细胞。
还提供药物组合物。所述药物组合物可包含本发明的多核苷酸、本发明的载体、本发明的宿主细胞和/或本发明的工程改造的免疫细胞和药学上可接受的载剂。
还提供治疗有需要的受试者的癌症的方法。所述方法可例如包括向受试者施用治疗有效量的本发明的宿主细胞。所述方法可例如包括向受试者施用治疗有效量的本发明的药物组合物。在某些实施方案中,所述癌症选自由下列各病组成的组:卵巢癌、原发性腹膜癌、胰腺导管腺癌(PDA)、恶性胸膜间皮瘤(MPM)、肺腺癌、三阴性乳腺癌、子宫内膜癌、胆管癌、胃癌和小儿急性骨髓性白血病。
还提供工程改造免疫细胞的方法。所述方法包括将本发明的多核苷酸引入免疫细胞中,其中所述多核苷酸可操作地连接到启动子。
还提供产生药物组合物的方法。所述方法包括将本发明的多核苷酸、本发明的载体、本发明的宿主细胞和/或本发明的工程改造的免疫细胞与药学上可接受的载剂组合以获得药物组合物。
还提供用于诱导免疫细胞和/或靶细胞的活性的系统。所述系统可例如包含本发明的嵌合抗原受体(CAR)。
还提供分离的抗体或抗原结合片段,其特异性结合间皮素、优选人间皮素。分离的抗体或抗原结合片段可例如选自由下列组成的组:Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)和骆驼抗体的可变结构域(VHH)。
在某些实施方案中,分离的抗体或抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体;
其中分离的抗体或其抗原结合片段特异性结合间皮素、优选人间皮素。
在某些实施方案中,所述抗体或抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含与选自由SEQID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
在某些实施方案中,所述抗体或其抗原结合片段为嵌合的。在某些实施方案中,所述抗体或其抗原结合片段为人或人源化的。
还提供分离的核酸,其编码本发明的分离的抗体或其抗原结合片段。还提供包含本发明的分离的核酸的载体。还提供宿主细胞,其包含本发明的分离的核酸和/或载体。
还提供药物组合物,其包含本发明的分离的抗体或其抗原结合片段和药学上可接受的载剂。
还提供治疗有需要的受试者的癌症的方法。所述方法包括向所述受试者施用药物组合物,所述药物组合物包含本发明的分离的抗体或其抗原结合片段和药学上可接受的载剂。
还提供产生本发明的抗体或其抗原结合片段的方法。所述方法包括在产生所述抗体或其抗原结合片段的条件下培养包含编码所述抗体或其抗原结合片段的核酸的细胞,和自所述细胞或培养物中回收所述抗体或其抗原结合片段。
还提供产生药物组合物的方法,所述药物组合物包含本发明的抗体或其抗原结合片段。所述方法包括将所述抗体或其抗原结合片段与药学上可接受的载剂组合以获得药物组合物。
附图说明
在结合附图阅读时,将更好地理解上述发明内容以及本申请的优选实施方案的以下详细说明。然而,应理解本申请不限于附图中所示的确切实施方案。
图1A为抗间皮素CAR构建体的示意图;且图1B显示锚定于T细胞膜中的CAR构建体。
图2A为FSHR TCR构建体的示意图;且图2B显示锚定于T细胞膜中的TCR构建体。
图3A-图3D展示FSHR/间皮素串联CAR构建体的实施方案的示意图和锚定于T细胞膜中的构建体的图解。
图4A-图4B展示间皮素/FSHR双重CAR构建体的示意图和锚定于T细胞膜中的构建体的图解。
图5A-图5B展示间皮素/FSHR CAR/TCR构建体的示意图和锚定于T细胞膜中的构建体的图解。
图6A-图6L展示根据本申请的实施方案的dnTGFβRII铠装的CAR和/或TCR构建体的示意图和锚定于T细胞膜中的构建体的图解。
图7-图8为表明根据本发明的实施方案的抗间皮素CAR-T诱导针对OVCAR-8细胞的杀伤的图。在每个图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图9-图10为展示用根据本申请的实施方案的各种CAR构建体转导的T细胞的上清液中的IFNγ的水平的图。在每个图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图11展示表明根据本申请的实施方案的抗间皮素CAR-T通过重复刺激造成长期扩增的图。
图12展示表明在OVCAR-8异种移植模型中根据本申请的实施方案的抗间皮素CAR-T的抗肿瘤功效的图。
图13展示经由流式细胞测定在卵巢癌细胞系上的FSHR的表达。
图14展示表明根据本发明的实施方案的FSHR/间皮素串联CAR-T诱导针对OVCAR-8细胞的杀伤的图。在图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图15展示表明根据本申请的实施方案的间皮素/FSHR双重CAR-T和间皮素/FSHRCAR/TCR-T诱导针对OVCAR-8细胞的杀伤的图。在图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图16-图17展示表明根据本申请的实施方案的dnTGFβRII铠装的CAR-T和裸CAR-T诱导针对OVCAR-8细胞的杀伤的图。在每个图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图18-图19展示表明在施用根据本申请的实施方案的CAR和/或TCR构建体后检测的IFNg和TNFa释放水平的图。在每个图中,CAR的结果按照右侧图例中所示的顺序进行描述。
图20-图21展示表明在OVCAR-8异种移植模型中根据本申请的实施方案的抗间皮素CAR-T和间皮素/FSHR双重CAR-T的抗肿瘤功效的图。
图22展示表明在OVCAR-8异种移植模型中根据本申请的实施方案的dnTGFβRII铠装的CAR-T和裸CAR-T的抗肿瘤功效的图。
具体实施方式
各种出版物、文章和专利在本说明书的背景和通篇中引用或描述;这些参考文献各自通过引用整体并入本文。包括在本说明书中的对于文件、动作、材料、装置、物品或其类似物的论述仅为了提供本发明的背景。这些论述并非承认任何或所有这些事宜皆为关于任何所公开或要求保护的发明的现有技术的一部分。
除非另外定义,否则本文所用的所有技术和科学术语皆具有本领域的技术人员通常理解的相同含义。另外,本文所用的某些术语具有如说明书中所阐述的含义。
除非文中另外清楚指出,否则必须指出如本文和所附权利要求书中所用,单数形式“一个(种)”和“所述”包括多个参考。
除非另有说明,否则任何数值,诸如本文所述的浓度或浓度范围应理解为在所有情况下均由术语“约”修饰。因此,数值通常包括列举值±10%。例如,1mg/mL的浓度包括0.9mg/mL至1.1mg/mL。同样,1%至10%(w/v)的浓度范围包括0.9%(w/v)至11%(w/v)。除非上下文另外清楚指明,否则如本文所用的数值范围的使用明确地包括所有可能的子范围、所述范围内的所有个别数值,包括所述范围内的整数和这些值的分数。
除非另外指明,否则在一系列要素之前的术语“至少”应理解为是指所述系列中的每个要素。本领域技术人员将认识到或能够仅利用常规实验便可确定本文所述的本发明的特定实施方案的许多等效方案。这些等效方案旨在由本发明所涵盖。
如本文所用,术语“包含(comprises)”、“包含(comprising)”、“包括(includes)”、“包括(including)”、“具有(has)”、“具有(having)”、“含有(contains)”或“含有(containing)”或其任何其他变型应理解为包含指定的整数或整数群,而不排除任何其他整数或整数群且旨在为非排他性或开放性的。例如,包含要素清单的组合物、混合物、工艺、方法、物品或设备不一定仅限于那些要素,而还可包括未明确列出的或这些组合物、混合物、工艺、方法、物品或设备所固有的其他要素。此外,除非明确地相反规定,否则“或”是指包含性或而非排他性或。例如,条件A或B由以下任一项满足:A为真(或存在)且B为假(或不存在),A为假(或不存在)且B为真(或存在),以及A与B两者皆为真(或存在)。
如本文所用,多个所列要素之间的连接术语“和/或”应理解为涵盖个别选项和组合选项两者。例如,当两个要素由“和/或”连接时,第一选项是指在无第二要素的情况下应用第一要素。第二选项是指在无第一要素的情况下应用第二要素。第三选项是指一起应用第一要素与第二要素。这些选项中的任一个应理解为落在所述含义内,并且因此满足如本文所用的术语“和/或”的要求。不止一种选项的同时应用还应理解为落在所述含义内,并且因此满足术语“和/或”的要求。
如本文所用,术语“由...组成(consists of)”或如本说明书和权利要求书通篇所用的变型诸如“由...组成(consist of)”或“由...组成(consisting of)”指明包括任何所列整数或整数群,而未将额外的整数或整数群添加到指定方法、结构或组合物中。
如本文所用,术语“基本上由...组成(consists essentially of)”或如本说明书和权利要求书通篇中所用的变型诸如“基本上由...组成(consist essentially of)”或“基本上由...组成(consisting essentially of)”指明包括任何所列整数或整数群,并且任选包括任何所列整数或整数群,所述整数或整数群实质上不改变所示方法、结构或组合物的基本或新型性质。参见M.P.E.P.§2111.03。
如本文所用,“受试者”意指任何动物,优选哺乳动物,最优选人。如本文所用,术语“哺乳动物”涵盖任何哺乳动物。哺乳动物的实例包括但不限于奶牛、马、绵羊、猪、猫、狗、小鼠、大鼠、兔、豚鼠、猴、人等,更优选为人。
还应理解本文所用的术语“约”、“大致”、“一般”、“实质上”和其类似术语当关于优选发明的组分的尺寸或特征时指明所述尺寸/特征并非严格的边界或参数并且不排除在功能上相同或相似的由此的较小变化,如本领域的普通技术人员所理解。至少,包括数值参数的这些引用将包括使用本领域中接受的数学和工业原理(例如,四舍五入、测量或其他系统误差、制造公差等)不会改变最小有效位的变化。
术语“相同”或“同一性”百分比在两种或更多种核酸或多肽序列(例如,CAR多肽和编码其的CAR多核苷酸;抗间皮素抗体和其抗原结合片段和编码其的多核苷酸;FSHR肽和编码其的多核苷酸;dnTGFβRII肽和编码其的多核苷酸)的情形下是指两个或更多个序列或子序列当使用以下序列比较算法中的一种或通过目视检查所测量来比较和比对最大一致性时,为相同的或具有所示百分比的相同氨基酸残基或核苷酸。
对于序列比较,通常一个序列用作参照序列,将测试序列与参照序列相比较。当使用序列比较算法时,将测试序列和参照序列皆输入计算机中,若需要,则设定子序列坐标,接着设定序列算法程序参数。随后,序列比较算法基于设定的程序参数计算一个或多个测试序列相对于参照序列的序列同一性百分比。
可通过以下方法进行用于比较的最佳序列比对:例如Smith&Waterman,Adv.Appl.Math.2:482(1981)的局部同源性算法;Needleman和Wunsch,J.Mol.Biol.48:443(1970)的同源性比对算法;Pearson&Lipman,Proc.Nat’l.Acad.Sci.USA 85:2444(1988)的搜索相似性法;这些算法的电脑化实施(在Wisconsin Genetics Software Package中的GAP、BESTFIT、FASTA和TFASTA,Genetics Computer Group,575Science Dr.,Madison,WI);或目测检查(一般参见,Current Protocols in Molecular Biology,F.M.Ausubel等人编,Current Protocols,Greene Publishing Associates,Inc.和John Wiley&Sons,Inc.之间的合资企业,(1995增刊)(Ausubel))。
适用于测定序列同一性百分比和序列相似性的算法的实例为BLAST和BLAST 2.0算法,其分别描述于Altschul等人(1990)J.Mol.Biol.215:403-410和Altschul等人(1997)Nucleic Acids Res.25:3389-3402中。用于执行BLAST分析的软件可经由国家生物技术信息中心(National Center for Biotechnology Information)公开获得。这种算法涉及首先通过在查询序列中鉴别长度W的短字来确定高计分序列对(HSP),当短字与数据库序列中的相同长度的字比对时,匹配或符合某个正值阈值计分T。T称为邻近字计分阈值(Altschul等人,同上)。这些原始邻近字命中充当开始搜索以发现含有它们的更长HSP的种子。所述字命中接着在沿着每个序列的两个方向上延伸直至累积比对计分可增加为止。
对于核苷酸序列,使用参数M(一对匹配残基的奖分;总是>0)和N(错配残基的罚分;总是<0)计算累积计分。对于氨基酸序列,使用评分矩阵来计算累积计分。当满足以下条件时,在每个方向上的字命中的延伸停止:累积比对计分自其最大获得值降低了量X;由于一个或多个负分值残基比对的累积,累积计分趋向零或更低值;或者达到任一序列的末端。BLAST算法参数W、T和X决定比对的灵敏度和速度。BLASTN程序(对于核苷酸序列)使用如下默认值:字长(W)为11、期望值(E)为10、M=5、N=-4以及两条链的比较。对于氨基酸序列,BLASTP程序使用如下默认值:字长(W)为3、期望值(E)为10以及BLOSUM62计分矩阵(参见Henikoff&Henikoff,Proc.Natl.Acad.Sci.USA 89:10915(1989))。
除计算序列同一性百分比之外,BLAST算法还执行两个序列之间的相似性统计分析(参见,例如Karlin&Altschul,Proc.Nat’l.Acad.Sci.USA 90:5873-5787(1993))。BLAST算法所提供的一种相似性量度为最小总和概率(P(N)),其提供两个核苷酸或氨基酸序列之间将偶然出现匹配的概率指标。例如,若在比较测试核酸与参照核酸时发现最小总和概率小于约0.1、更优选小于约0.01、且最优选小于约0.001,则认为核酸与参照序列相似。
两个核酸序列或多肽实质上相同的另一指征是由第一核酸编码的多肽与由第二核酸编码的多肽在免疫上交叉反应,如下所述。因此,多肽通常与第二多肽实质上相同,例如,其中两条肽仅因保守取代而不同。两个核酸序列实质上相同的另一指征是两个分子在严格条件下彼此杂交。
如本文所用,术语“分离的”意指已经实质上分离、自生物体的其他生物组分中产生或自其中纯化的生物组分(诸如核酸、肽或蛋白质),所述组分天然存在于所述生物体中,即其他染色体和染色体外DNA和RNA以及蛋白质。已“分离”的核酸、肽和蛋白质因此包括通过标准纯化方法纯化的核酸和蛋白质。“分离的”核酸、肽和蛋白质可为组合物的一部分,并且若组合物并非核酸、肽或蛋白质的自然环境的一部分,则仍分离。所述术语还包括通过在宿主细胞中重组表达所制备的核酸、肽和蛋白质以及化学合成的核酸。
如本文所用,术语“多核苷酸”,同义地称为“核酸分子”、“核苷酸”或“核酸”,是指任何多核糖核苷酸或聚去氧核苷酸,其可为未修饰的RNA或DNA或修饰的RNA或DNA。“多核苷酸”包括但不限于单链DNA和双链DNA、单链区与双链区的混合物的DNA、单链RNA和双链RNA、以及单链区与双链区的混合物的RNA、包含DNA与RNA的杂交分子,它们可为单链或更通常双链或单链区与双链区的混合物。另外,“多核苷酸”是指包含RNA或DNA或RNA与DNA两者的三链区。术语多核苷酸还包括含有一个或多个修饰的碱基的DNA或RNA和具有为了稳定性或其他原因而修饰的主链的DNA或RNA。“修饰的”碱基包括例如三酰化碱基和不寻常碱基,诸如肌苷。可对DNA和RNA做出多种修饰;因此,“多核苷酸”包括如通常在自然界中发现的化学、酶或代谢修饰形式的多核苷酸以及病毒与细胞所特有的化学形式的DNA和RNA。“多核苷酸”还包括相对较短的核酸链,常称为寡核苷酸。
如本文所用,术语“载体”为其中另一核酸区段可经可操作地插入以便实现所述区段的复制或表达的复制子。
如本文所用,术语“宿主细胞”是指包含本发明的核酸分子的细胞。“宿主细胞”可为任何类型的细胞,例如,原代细胞、培养的细胞或来自细胞系的细胞。在一个实施方案中,“宿主细胞”为用本发明的核酸分子转染的细胞。在另一实施方案中,“宿主细胞”为这样的转染的细胞的子代或潜在子代。细胞的子代可与亲本细胞相同或不同,例如,由于可能发生在核酸分子的后续生成或向宿主细胞基因组中的整合的突变或环境影响。
如本文所用的术语“表达”是指基因产物的生物合成。所述术语涵盖基因向RNA的转录。所述术语还涵盖RNA翻译成一种或多种多肽,并且还涵盖所有天然存在的转录后和翻译后修饰。所表达的CAR可在宿主细胞的胞质内、在胞外环境诸如细胞培养物的生长培养基中、或锚定于细胞膜上。
如本文所用,术语“免疫细胞”或“免疫效应细胞”是指参与免疫反应、例如促进免疫效应反应的细胞。免疫细胞的实例包括T细胞、B细胞、自然杀伤(NK)细胞、肥大细胞和骨髓来源的吞噬细胞。根据具体实施方案,工程改造的免疫细胞为T细胞,并且称为CAR-T细胞,因为它们经工程改造以表达本发明的CAR。
如本文所用,术语“工程改造的免疫细胞”是指免疫细胞,也称为免疫效应细胞,其已通过添加呈DNA或RNA形式的额外遗传物质至细胞的总遗传物质中而经基因修饰。根据本文的实施方案,工程改造的免疫细胞已经基因修饰以表达根据本发明的CAR构建体。
如本文所用,术语“信号肽”是指在初生蛋白的氨基端(N端)处的前导序列,其将初生蛋白共翻译或翻译后导向内质网且随后进行表面表达。
如本文所用,术语“胞外抗原结合结构域”、“胞外结构域”或“胞外配体结合结构域”是指位于细胞膜之外且能够结合到抗原、靶标或配体的蛋白质的部分。
如本文所用,术语“铰链区”是指连接蛋白质的两个相邻结构域(例如,胞外结构域与跨膜结构域)的蛋白质的部分。
如本文所用,术语“跨膜结构域”是指跨细胞膜延伸并将蛋白质锚定于细胞膜上的蛋白质的部分。
T细胞受体(TCR)复合体和嵌合抗原受体(CAR)
TCR为二硫键连接的膜锚定的异源二聚蛋白,通常包含高度可变的alpha(α)链和beta(β)链,表达为与不变CD3链分子的复合体。表达这些类型的TCR的T细胞称为α∶β(或αβ)T细胞。少数T细胞表达包含可变gamma(γ)链和delta(δ)链的替代TCR且称为γδT细胞。TCR由于其短的胞质尾而不能自身介导信号传导,因此TCR仍需要CD3和ξ以在其原位进行信号传导。TCR受体复合体为可变TCR受体α和β链的八聚复合体,其具有三个二聚信号模块CD3δ/ε、CD3γ/ε和CD247ζ/ζ或ζ/η。
根据本申请的实施方案,合适的TCR特异性结合到癌细胞表面上的主要组织相容性复合体(MHC),所述MHC展示肿瘤抗原的肽片段。MHC是一组细胞表面蛋白,其允许获得性免疫系统识别“外来”分子。蛋白质在细胞内降解并且由MHC呈递于细胞表面上。展示“外来”肽诸如病毒或癌症相关肽的MHC由具有适当TCR的T细胞识别,促进细胞破坏途径。癌细胞表面上的MHC可展示肿瘤抗原的肽片段,即存在于癌细胞而非相应非癌细胞上的抗原。识别这些肽片段的T细胞可对癌细胞发挥细胞毒性作用。
例如,T细胞可经修饰以表达异种TCR,其特异性结合到MHC,所述MHC展示由特定癌症患者中的癌细胞表达的肿瘤抗原的肽片段。可使用标准技术鉴别由癌症患者中的癌细胞表达的肿瘤抗原。根据本发明的一个实施方案,异种TCR特异性结合到FSHR。例如,特异性结合到FSHR的多肽诸如FSH片段融合至CD3ε链、CD3γ链或CD3δ链。融合蛋白经由CD3与TCRα/β链的相互作用在T细胞上形成TCR复合体。TCR复合体经由FSH片段特异性结合到肿瘤细胞上的FSHR,并且所述结合起始针对肿瘤细胞的TCR信号传导。根据本发明的又一个实施方案,异种TCR与特异性结合到间皮素的CAR一起表达。异种TCR可包括αβTCR异源二聚体。
TCR可经工程改造以提高其与肿瘤抗原的亲和力或亲合力(即,亲和力增强的TCR)。亲和力增强的TCR相对于天然存在的TCR可包含一个或多个突变,例如,在TCRα和β链的可变区的高变互补决定区(CDR)中的一个或多个突变。这些突变提高TCR对MHC的亲和力,所述MHC展示由癌细胞表达的肿瘤抗原的肽片段。生成亲和力增强的TCR的合适方法包括使用噬菌体或酵母展示筛选TCR突变体文库且所述方法为本领域中熟知的(参见,例如Robbins等人,J Immunol(2008)180(9):6116;San Miguel等人(2015)Cancer Cell 28(3)281-283;Schmitt等人,(2013)Blood 122 348-256;Jiang等人,(2015)Cancer Discovery5 901)。
异种抗原受体诸如异种TCR或CAR的表达可改变T细胞的免疫原性特异性,使得它们识别或展示对于在一种或多种肿瘤抗原的改进的识别,所述一种或多种肿瘤抗原存在于患有癌症的个体的癌细胞表面上。
在一些实施方案中,T细胞在异种抗原受体不存在下可展示与癌细胞的减少的结合或不结合。例如,异种抗原受体(诸如工程改造的CAR和/或TCR)的表达可提高癌细胞相对于未修饰的T细胞结合修饰的T细胞的亲和力和/或特异性。
在一些实施方案中,CAR和/或TCR的个别组分(例如scFv或sdAb、FSH片段、CD3ε链、CD3γ链或CD3δ链、或TCRα链和TCRβ链)的编码序列可通过编码裂解识别序列的序列而分离。这允许构建体的组分表达为单一融合物,其经历胞内裂解以生成两种或更多种单独的蛋白质。合适的裂解识别序列为本领域中熟知的并且包括但不限于2A-furin序列,例如P2A。
术语“异种”是指具体生物系统诸如宿主细胞外来的且并非天然存在于所述系统中的多肽或核酸。可通过人工手段,例如使用重组技术将异种多肽或核酸引入生物系统中。例如,编码多肽的异种核酸可插入合适的表达构建体中,其又用于转化宿主细胞以产生多肽。异种多肽或核酸可为合成的或人工的或者可存在于不同生物系统,诸如不同物种或细胞类型。内源性多肽或核酸为具体生物系统诸如宿主细胞所固有的,并且天然地存在于所述系统中。重组多肽由异种核酸表达,已通过人工手段,例如使用重组技术将所述异种核酸引入细胞中。重组多肽可与天然地存在于细胞中的多肽相同或可与天然地存在于所述细胞中的多肽不同。
在一个通常方面中,提供一种分离的多核苷酸,其包含编码修饰的T细胞受体(TCR)复合体蛋白的核苷酸序列。所述蛋白自N端至C端包含任选的信号肽、特异性结合到滤泡刺激素受体(FSHR)的第一多肽、以及选自由CD3-γ链、CD3-δ链和CD3-ε链组成的组中的CD3多肽的胞外结构域、跨膜结构域和胞内结构域。
在某些实施方案中,所述蛋白质含有:信号肽,其包含选自由分别与SEQ ID NO:430至432至少90%相同的氨基酸序列组成的组中的氨基酸序列;第一多肽,其特异性结合到包含选自由分别与SEQ ID NO:319-331至少90%相同的氨基酸序列组成的组中的氨基酸序列的FSHR;胞外结构域,其包含选自由分别与SEQ ID NO:433至435至少90%相同的氨基酸序列组成的组中的氨基酸序列;跨膜结构域,其包含选自由分别与SEQ ID NO:436至438至少90%相同的氨基酸序列组成的组中的氨基酸序列;以及胞内结构域,其包含选自由分别与SEQ ID NO:439至441至少90%相同的氨基酸序列组成的组中的氨基酸序列。
在某些实施方案中,所述蛋白质含有:信号肽,其包含选自由SEQ ID NO:430至432组成的组中的氨基酸序列;第一多肽,其特异性结合到包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列的FSHR;胞外结构域,其包含分别选自由SEQ ID NO:433至435组成的组中的氨基酸序列;跨膜结构域,其包含分别选自由SEQ ID NO:436至438组成的组中的氨基酸序列;以及胞内结构域,其包含分别选自由SEQ ID NO:439至441组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸包含编码修饰的TCR复合体蛋白的核苷酸序列,所述修饰的TCR复合体蛋白包含SEQ ID NO:442-444的氨基酸序列或其变异体。优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
在某些实施方案中,包含编码修饰的TCR蛋白的核苷酸序列的分离的多核苷酸还包含第三核苷酸序列,所述第三核苷酸序列编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。免疫细胞的细胞介导免疫反应的抑制剂可为例如转化生长因子β(TGF-β)受体(例如TGFβRII)。在某些实施方案中,抑制剂的显性负性形式包含SEQ ID NO:347的氨基酸序列。在某些实施方案中,编码修饰的TCR复合体蛋白的核苷酸序列经由2A肽编码序列连接到第三核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码蛋白质的核苷酸序列,所述蛋白质随后裂解以产生修饰的TCR蛋白和免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。优选地,所述蛋白包含选自由SEQ ID NO:457-459组成的组中的氨基酸序列。
在某些实施方案中,编码修饰的TCR蛋白的分离的多核苷酸还包含编码嵌合抗原受体(CAR)的第二核苷酸序列,其中所述CAR包含:(a)胞外结构域,其包含特异性结合到肿瘤抗原的抗原结合片段;(b)跨膜结构域;和(c)胞内信号传导结构域。优选地,编码修饰的TCR复合体蛋白的核苷酸序列经由2A肽编码序列连接到编码CAR的核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码蛋白质的核苷酸序列,所述蛋白质随后裂解以产生修饰的TCR蛋白和CAR蛋白。优选地,所述蛋白包含选自由SEQ ID NO:454-456组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸包含编码蛋白质的核苷酸序列,所述蛋白质随后裂解以产生修饰的TCR蛋白、CAR蛋白和免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。优选地,所述蛋白包含选自由SEQ ID NO:469-471组成的组中的氨基酸序列。
如本文所用,术语“嵌合抗原受体”(CAR)是指经重组工程改造以包含特异性结合到抗原或靶标的至少一个胞外结构域、跨膜结构域和胞内T细胞受体激活信号传导结构域的人工受体。CAR的胞外结构域与靶细胞表面上的靶抗原的接合造成CAR群集并将激活刺激递送至含CAR的细胞。CAR重定向免疫效应细胞的特异性并触发增殖、细胞因子产生、吞噬和/或可以主要组织相容性复合物(MHC)非依赖性方式介导表达靶抗原的细胞的细胞死亡的分子的产生。
CAR可例如包含融合至TCR CD3跨膜区和内结构域的scFv或肽配体。scFv为免疫球蛋白经由大约10至25个氨基酸的短接头肽连接的重链(VH)与轻链(VL)的可变区的融合蛋白(Huston J.S.等人,Proc Natl Acad Sci USA 1988;85(16):5879-5883)。接头可为富甘氨酸的,以利于柔性,且可为富丝氨酸或苏氨酸的,以利于溶解性。接头肽可将VH的N端连接到VL的C端,或反之亦然。肽配体可为特异性结合到目标受体的任何肽。scFv或肽配体可放在信号肽之前以将蛋白质导向内质网,然后导向T细胞表面。在CAR中,scFv或肽配体可融合到TCR跨膜和内结构域。柔性间隔区可包括在scFv与TCR跨膜结构域之间以允许可变定向和抗原结合。内结构域为受体的功能性信号传输结构域。CAR的内结构域可包含例如胞内信号传导结构域,其来自CD3ζ-链或来自受体诸如CD28、41BB或ICOS。CAR可包含多个信号传导结构域,例如但不限于CD3z-CD28-41BB或CD3z-CD28-OX40。
所述CAR可特异性结合到由癌细胞表达的肿瘤特异性抗原。例如,T细胞可经修饰以表达CAR,所述CAR特异性结合到由特定癌症患者中的癌细胞表达的肿瘤抗原。可使用标准技术鉴别由癌症患者中的癌细胞表达的肿瘤抗原。根据本发明的一个实施方案,CAR特异性结合到间皮素。根据本发明的另一实施方案,CAR特异性结合到FSHR。根据本发明的又一个实施方案,CAR特异性结合到间皮素和FSHR。
在某些通常方面中,本发明涉及一种分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列。所述CAR包含:
(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽和特异性结合到肿瘤抗原的抗原结合片段;
(b)跨膜结构域;和
(c)胞内结构域,
其中所述CAR任选还包含在其氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
在某些实施方案中,特异性结合到FSHR的第一多肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。在某些实施方案中,所述第一多肽包含SEQ ID NO:319的氨基酸序列。
在某些实施方案中,第一多肽经由接头连接到抗原结合片段的氨基端或羧基端。接头可例如选自由下列组成的组:G4S接头、(G4S)2接头、(G4S)3接头、(G4S)4接头和(G4S)5接头。
在某些实施方案中,肿瘤抗原选自由下列组成的组:间皮素、叶酸受体α、黏蛋白16(MUC16)、前列腺特异性膜抗原(PSMA)、人表皮生长因子受体2(HER2)、表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)。肿瘤抗原可为例如间皮素,优选为人间皮素。
在某些实施方案中,所述抗原结合片段为Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)或骆驼抗体的可变结构域(VHH)。
在其他通常方面中,所述CAR包含:
(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区,并且其中所述抗原结合片段为(i)单结构域抗体(sdAb)或(ii)单链可变片段(scFv)。在某些实施方案中,CAR还包含特异性结合到滤泡刺激素受体(FSHR)的多肽。特异性结合到FSHR的多肽可例如包含选自由分别与SEQ ID NO:319-331至少90%相同的氨基酸序列组成的组中的氨基酸序列。在某些实施方案中,特异性结合到FSHR的多肽可包含SEQ ID NO:319的氨基酸序列。
在某些实施方案中,CAR的胞外结构域放在氨基端处的信号肽之前。任何合适的信号肽可用于本发明中。信号肽可例如来源于自然、合成、半合成或重组来源。根据一个实施方案,信号肽为人CD8α信号肽、人CD3δ信号肽、人CD3ζ信号肽、人GMCSFR信号肽、人4-1BB信号肽或其衍生物。根据具体实施方案,信号肽为人CD8α信号肽。人CD8α信号肽包含与SEQ IDNO:340至少90%相同的氨基酸序列,优选包含SEQ ID NO:340的氨基酸序列。信号肽可在CAR易位完成期间或之后由信号肽酶裂解以生成不含信号肽的成熟CAR。
在某些实施方案中,CAR还可包含连接胞外结构域与跨膜结构域的铰链区。铰链区用于使胞外结构域移动远离工程改造的免疫细胞的表面以使得能实现适当的细胞/细胞接触、结合到靶标或抗原以及激活(Patel等人,Gene Therapy 6:412-9(1999))。任何合适的铰链区可用于本发明的CAR中。铰链区可来源于自然、合成、半合成或重组来源。根据具体实施方案,CAR的铰链区为来自CD8α肽的铰链区。在具体实施方案中,铰链区包含与SEQ IDNO:341至少90%相同的氨基酸序列,优选包含SEQ ID NO:341的氨基酸序列。
本发明的CAR包含跨膜结构域。任何合适的跨膜结构域可用于本发明的CAR中。跨膜结构域可来源于自然、合成、半合成或重组来源。根据一些实施方案,跨膜结构域为来自选自由以下组成的组中的肽的跨膜结构域:CD8α肽、CD28肽、CD4肽、CD3ζ肽、CD2肽、4-1BB肽、OX40肽、ICOS肽、CTLA-4肽、PD-1肽、LAG-3肽、2B4肽、BTLA肽、GMCSFR肽和其类似物。在具体实施方案中,跨膜结构域为CD8α跨膜结构域。CD8α跨膜结构域可包含与SEQ ID NO:342至少90%相同的氨基酸序列,优选包含SEQ ID NO:342的氨基酸序列。
本发明的CAR包含胞内信号传导结构域。任何合适的胞内结构域可用于本发明的CAR中。在具体实施方案中,使用整个胞内信号传导结构域。在其他具体实施方案中,使用转导效应物或信号的信号传导结构域的截短部分。根据本发明的实施方案,胞内信号传导结构域产生信号,所述信号促进含CAR的细胞(例如CAR-T细胞)的免疫效应功能,包括但不限于增殖、激活和/或分化。在具体实施方案中,所述信号促进CAR-T细胞的例如细胞溶解活性、辅助活性和/或细胞因子分泌。根据一些实施方案,CAR的胞内信号传导结构域包含以下各物的信号传导结构域:Fcγ受体(FcγR)、Fcε受体(FcεR)、Fcα受体(FcαR)、新生Fc受体(FcRn)、CD3、CD3ζ、CD3γ、CD3δ、CD3ε、CD4、CD5、CD8、CD21、CD22、CD28、CD32、CD40L(CD154)、CD45、CD66δ、CD79α、CD79β、CD80、CD86、CD278(也称为ICOS)、CD247ζ、CD247η、DAP10、DAP12、FYN、LAT、Lck、MAPK、MHC复合体、NFAT、NF-κB、PLC-γ、iC3b、C3dg、C3d和Zap70。根据一些实施方案,胞内信号传导结构域选自由下列的信号传导结构域组成的组:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ。
根据具体实施方案,胞内信号传导结构域还包含一个或多个共刺激信号传导结构域。共刺激结构域可例如包含选自以下的肽的信号传导结构域:2B4/CD244/SLAMF4、4-1BB/TNFSF9/CD137、B7-1/CD80、B7-2/CD86、B7-H1/PD-L1、B7-H2、B7-H3、B7-H4、B7-H6、B7-H7、BAFF-R/TNFRSF13C、BAFF/BLyS/TNFSF13B、BLAME/SLAMF8、BTLA/CD272、CD100(SEMA4D)、CD103、CD11a、CD11b、CD11c、CD11d、CD150、CD160(BY55)、CD18、CD19、CD2、CD200、CD229/SLAMF3、CD27配体/TNFSF7、CD27/TNFRSF7、CD28、CD29、CD2F-10/SLAMF9、CD30配体/TNFSF8、CD30/TNFRSF8、CD300a/LMIR1、CD4、CD40配体/TNFSF5、CD40/TNFRSF5、CD48/SLAMF2、CD49a、CD49D、CD49f、CD53、CD58/LFA-3、CD69、CD7、CD8α、CD8β、CD82/Kai-1、CD84/SLAMF5、CD90/Thy1、CD96、CDS、CEACAM1、CRACC/SLAMF7、CRTAM、CTLA-4、DAP12、Dectin-1/CLEC7A、DNAM1(CD226)、DPPIV/CD26、DR3/TNFRSF25、EphB6、GADS、Gi24/VISTA/B7-H5、GITR配体/TNFSF18、GITR/TNFRSF18、I类HLA、HLA-DR、HVEM/TNFRSF14、IA4、ICAM-1、ICOS/CD278、Ikaros、IL2Rβ、IL2Rγ、IL7Rα、整合素α4/CD49d、整合素α4β1、整合素α4β7/LPAM-1、IPO-3、ITGA4、ITGA6、ITGAD、ITGAE、ITGAL、ITGAM、ITGAX、ITGB1、ITGB2、ITGB7、KIRDS2、LAG-3、LAT、LIGHT/TNFSF14、LTBR、Ly108、Ly9(CD229)、淋巴细胞功能相关抗原-1(LFA-1)、淋巴毒素-α/TNF-β、NKG2C、NKG2D、NKp30、NKp44、NKp46、NKp80(KLRF1)、NTB-A/SLAMF6、OX40配体/TNFSF4、OX40/TNFRSF4、PAG/Cbp、PD-1、PDCD6、PD-L2/B7-DC、PSGL1、RELT/TNFRSF19L、SELPLG(CD162)、SLAM(SLAMF1)、SLAM/CD150、SLAMF4(CD244)、SLAMF6(NTB-A)、SLAMF7、SLP-76、TACI/TNFRSF13B、TCL1A、TCL1B、TIM-1/KIM-1/HAVCR、TIM-4、TL1A/TNFSF15、TNF RII/TNFRSF1B、TNF-α、TRANCE/RANKL、TSLP、TSLP R、VLA1和VLA-6。在某些实施方案中,共刺激结构域选自由以下一种或多种的共刺激结构域组成的组:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
在某些实施方案中,所述CAR为特异性结合到FSHR和间皮素的串联CAR。优选地,所述CAR包含选自由SEQ ID NO:370-379和SEQ ID NO:448-450组成的组中的氨基酸序列。
在某些实施方案中,所述CAR特异性结合到间皮素。优选地,所述CAR包含选自由SEQ ID NO:358-367和SEQ ID NO:445-447组成的组中的氨基酸序列。
在某些实施方案中,分离的多核苷酸包含编码蛋白质的核苷酸序列,所述蛋白质随后裂解产生双重CAR,所述双重CAR含有特异性结合到FSHR的第一CAR和特异性结合到间皮素的第二CAR。优选地,所述蛋白质包含选自由SEQ ID NO:380-389和SEQ ID NO:451-453组成的组中的氨基酸序列。
根据具体方面,包含编码CAR的核苷酸序列的分离的多核苷酸还包含第三核苷酸序列。第三核苷酸序列可例如编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。免疫细胞的细胞介导免疫反应的抑制剂可为例如转化生长因子β(TGF-β)受体(例如,TGFβRII)。在某些实施方案中,抑制剂的显性负性形式包含SEQ ID NO:347的氨基酸序列。
编码CAR的核苷酸序列可例如经由2A肽编码序列连接到编码细胞介导免疫反应的抑制剂的显性负性形式的第三核苷酸序列。
在某些实施方案中,分离的多核苷酸包含编码蛋白质的核苷酸序列,所述蛋白质随后裂解以产生一种或多种CAR和免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。优选地,所述蛋白质包含选自由SEQ ID NO:390-419和SEQ ID NO:460-468组成的组中的氨基酸序列。
免疫细胞
根据具体方面,本发明提供细胞,所述细胞为免疫细胞,其包含分离的多核苷酸或包含分离的多核苷酸的载体,所述分离的多核苷酸包含编码本文所提供的CAR的核苷酸序列。包含本发明的分离的多核苷酸和/或载体的免疫细胞可称为“工程改造的免疫细胞”。优选地,工程改造的免疫细胞来源于人(在进行重组之前具有人来源)。
工程改造的免疫细胞可为例如淋巴谱系的细胞。淋巴谱系的细胞的非限制性实例可包括T细胞和自然杀伤(NK)细胞。T细胞表达T细胞受体(TCR),其中大多数细胞表达α链和β链且较小群体表达γ链和δ链。可用作本发明的工程改造的免疫细胞的T细胞可为CD4+或CD8+并且可包括但不限于T辅助细胞(CD4+)、细胞毒性T细胞(也称为细胞毒性T淋巴细胞,CTL;CD8+细胞)和记忆T细胞,包括中央记忆T细胞、干细胞样记忆T细胞和效应物记忆T细胞、自然杀伤T细胞、黏膜相关不变T细胞和γδT细胞。其他例示性免疫细胞包括但不限于巨噬细胞、抗原呈递细胞(APC)或表达细胞介导免疫反应的抑制剂的任何免疫细胞,所述抑制剂为例如免疫检查点抑制剂途径受体(例如PD-1)。可根据本发明使用的免疫细胞的前体细胞包括造血干细胞和/或祖细胞。造血干细胞和/或祖细胞可通过本领域中已知的方法衍生自骨髓、脐带血、细胞因子动员之后的成人外周血和其类似物。免疫细胞经工程改造以重组表达本发明的CAR。
免疫细胞和其前体细胞可通过本领域中已知的方法分离,所述方法包括市售的方法(参见,例如Rowland Jones等人,Lymphocytes:A Practical Approach,OxfordUniversity Press,NY(1999))。免疫细胞或其前体的来源包括但不限于外周血、脐带血、骨髓或造血细胞的其他来源。各种技术皆可用于将细胞分离成分离或富集的所需免疫细胞。例如,负选择方法可用于移除并非所需免疫细胞的细胞。另外,正选择方法可用于分离或富集所需免疫细胞或其前体,或者可采用负选择方法与正选择方法的组合。若有待分离一种具体类型的细胞,例如具体的T细胞,则各种细胞表面标记或标记(例如CD3、CD4、CD8、CD34)的组合可用于分离所述细胞。
免疫细胞或其前体细胞对于在本发明的治疗方法中施用所述细胞的受试者可为自体或非自体的。将自体细胞自有待施用重组表达CAR的工程改造的免疫细胞的受试者中分离。任选地,所述细胞可通过白细胞去除术获得,其中将白血球自抽出的血液中选择性地移除,进行重组,接着回输至供体中。或者,可使用来自并非受试者的非自体供体的同种异体细胞。在非自体供体的情况下,细胞经分型并与人白血球抗原(HLA)相匹配以确定适当的相容性水平。对于自体细胞和非自体细胞两者,细胞可任选经低温保存直至备用为止。
用于分离可用于重组表达本发明的CAR的免疫细胞的各种方法先前已经描述并且可使用,包括但不限于使用外周供体淋巴细胞(Sadelain等人,Nat.Rev.Cancer 3:35-45(2003);Morgan等人,Science314∶126-9(2006))、使用衍生自肿瘤活检中的肿瘤浸润淋巴细胞(TIL)的淋巴细胞培养物(Panelli等人,J.Immunol.164:495-504(2000);Panelli等人,J.Immunol.164:4382-92(2000))、以及使用采用人工抗原呈递细胞(AAPC)或树突细胞的选择性体外扩增的抗原特异性外周血白血球(Dupont等人,Cancer Res.65:5417-427(2005);Papanicolaou等人,Blood 102:2498-505(2003))。在使用干细胞的情况下,细胞可通过本领域中熟知的方法分离(参见,例如Klug等人,Hematopoietic Stem CellProtocols,Humana Press,NJ(2002);Freshney等人,Culture of Human Stem Cells,JohnWiley&Sons(2007))。
根据具体实施方案,制备工程改造的免疫细胞的方法包括转染或转导自个体分离的免疫效应细胞以使得所述免疫效应细胞表达根据本发明的实施方案的一种或多种CAR。制备用于免疫疗法的免疫细胞的方法描述于例如WO2014/130635、WO2013/176916和WO2013/176915中,这些专利以引用的方式并入本文中。可用于制备工程改造的免疫细胞的个别步骤公开于例如WO2014/039523、WO2014/184741、WO2014/191128、WO2014/184744和WO2014/184143中,这些专利以引用的方式并入本文中。
在一个具体实施方案中,免疫效应细胞诸如T细胞经本发明的CAR基因修饰(例如,用包含编码CAR的核酸的病毒载体转导),接着经激活并在体外扩增。在各种实施方案中,T细胞可在基因修饰之前或之后使用如例如US6352694、US6534055、US6905680、US6692964、US5858358、US6887466、US6905681、US7144575、US7067318、US7172869、US7232566、US7175843、US5883223、US6905874、US6797514、US6867041、US2006/121005中所述的方法激活并扩增以表达CAR,这些专利以引用的方式并入本文中。T细胞可在体外或体内扩增。一般而言,本发明的T细胞可通过与其上附着有刺激CD3/TCR复合体相关信号的剂和刺激T细胞表面上的共刺激分子的配体的表面接触而扩增。作为非限制性实例,T细胞群可如本文所述经刺激,诸如通过与抗CD3抗体或其抗原结合片段、或固定于表面上的抗CD2抗体接触;或通过与蛋白激酶C激动剂(例如苔藓虫素)连同钙离子载体一起接触;或通过激活CAR本身。对于T细胞表面上的辅助分子的共刺激,使用结合辅助分子的配体。例如,T细胞群可在适于刺激T细胞增殖的条件下与抗CD3抗体和抗CD28抗体接触。适于T细胞培养的条件包括例如适当的培养基(例如,最低必需培养基或RPMI培养基1640或X-vivo 15(Lonza)),其可含有增殖和生存所必需的因子,包括血清(例如,胎牛或人血清)、细胞因子,诸如IL-2、IL-7、IL-15和/或IL-21、胰岛素、IFN-g、GM-CSF、TGFβ和/或熟练技术人员已知的用于细胞生长的任何其他添加剂。在其他实施方案中,可使用诸如US6040177、US5827642和WO2012129514中所述的方法激活并刺激T细胞以便与喂养细胞和适当抗体与细胞因子一起增殖,这些专利以引用的方式并入本文中。
抗原结合片段
抗体
本发明一般涉及包含抗原结合片段的CAR构建体。所述抗原结合片段可为例如特异性结合肿瘤抗原的抗体或其抗原结合片段。在某些方面中,本发明涉及一种分离的抗体或抗原结合片段,其特异性结合肿瘤抗原。本发明一般还涉及分离的抗间皮素抗体、编码所述抗体的核酸和表达载体、含有所述载体的重组细胞、包含所述抗体的组合物、制备所述抗体的方法以及使用所述抗体治疗包括癌症的疾病的方法。本发明的抗体具有一种或多种所需功能性质,包括但不限于与肿瘤抗原(例如间皮素)的高亲和力结合、对肿瘤抗原(例如间皮素)的高特异性、刺激补体依赖性细胞毒性(CDC)的能力、抗体依赖性吞噬(ADPC)和/或针对表达肿瘤抗原(例如间皮素)的细胞的抗体依赖性细胞介导的细胞毒性(ADCC)以及当单独或与其他抗癌疗法组合施用时在有需要的受试者中和在动物模型中抑制肿瘤生长的能力。
所述抗原结合片段可为例如特异性结合肿瘤抗原的抗体或其抗原结合片段。由抗体或抗原结合片段所结合的任何合适的肿瘤抗原可基于有待治疗的受试者所展现出的肿瘤和/或癌症类型进行选择。合适的抗原包括但不限于间皮素(MSLN)、前列腺特异性膜抗原(PSMA)、前列腺干细胞抗原(PCSA)、碳酸酐酶IX(CAIX)、癌胚抗原(CEA)、CD5、CD7、CD10、CD19、CD20、CD22、CD30、CD33、CD34、CD38、CD41、CD44、CD49f、CD56、CD74、CD123、CD133、CD138、上皮糖蛋白-2(EGP 2)、上皮糖蛋白-40(EGP-40)、上皮黏附分子(EpCAM)、叶酸结合蛋白(FBP)、胎儿乙酰胆碱受体(AChR)、叶酸受体α和β(FRα和β)、神经节苷脂G2(GD2)、神经节苷脂G3(GD3)、人表皮生长因子受体2(HER-2/ERB2)、表皮生长因子受体(EGFR)、表皮生长因子受体vIII(EGFRvIII)、ERB3、ERB4、人端粒酶逆转录酶(hTERT)、白细胞介素-13受体亚基α-2(IL-13Rα2)、k-轻链、激酶插入结构域受体(KDR)、Lewis A(CA19.9)、Lewis Y(LeY)、L1细胞黏附分子(LICAM)、黑色素瘤结合抗原1(黑色素瘤抗原家族A1,MAGE-A1)、黏蛋白-16(Muc-16)、黏蛋白1(Muc癌)、NKG2D配体、癌症-睾丸抗原NY-ESO-1、癌胚抗原(h5T4)、肿瘤相关糖蛋白72(TAG-72)、血管内皮生长因子受体(VEGFR)、血管内皮生长因子R2(VEGF-R2)、威尔姆氏肿瘤蛋白(WT-1)、1型酪氨酸蛋白激酶跨膜受体(ROR1)、B7-H3(CD276)、B7-H6(Nkp30)、硫酸软骨素蛋白多糖-4(CSPG4)、DNAX辅助分子(DNAM-1)、肝配蛋白A型受体2(EpHA2)、成纤维细胞相关蛋白(FAP)、Gp100/HLA-A2、磷脂酰肌醇蛋白聚糖3(GPC3)、HA-1H、HERK-V、IL-11Rα、潜伏膜蛋白(LMP1)、神经细胞黏附分子(N-CAM/CD56)和trail受体(TRAILR)。合适的抗原优选选自由下列组成的组:间皮素、叶酸受体α、黏蛋白16、前列腺特异性膜抗原(PSMA)、人表皮生长因子受体2(HER2)、表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)。
在一个通常方面中,本发明涉及包含结合间皮素的抗体或其抗原结合片段的CAR构建体和/或结合间皮素的抗体或其抗原结合片段。
如本文所用,术语“抗体”是以广义使用并且包括免疫球蛋白或抗体分子,包括人抗体、人源化抗体、复合抗体和嵌合抗体以及抗体片段,其为单克隆或多克隆的。一般而言,抗体为展现与特定抗原的结合特异性的蛋白质或肽链。抗体结构为熟知的。视重链恒定结构域氨基酸序列而定,免疫球蛋白可分为5种主要类别(即IgA、IgD、IgE、IgG和IgM)。IgA和IgG进一步细分为同种型IgA1、IgA2、IgG1、IgG2、IgG3和IgG4。因此,本发明的抗体可为5种主要类别或相应子类中的任一种。优选地,本发明的抗体为IgG1、IgG2、IgG3或IgG4。脊椎动物物种的抗体轻链基于其恒定结构域的氨基酸序列可归入两种明显不同类型即κ和λ的一种中。因此,本发明的抗体可含有κ或λ轻链恒定结构域。根据具体实施方案,本发明的抗体包含来自大鼠或人抗体的重链恒定区和/或轻链恒定区。除重链恒定结构域和轻链恒定结构域之外,抗体还含有由轻链可变区与重链可变区构成的抗原结合区,所述可变区各自含有三个结构域(即,互补决定区1-3;CDR1、CDR2和CDR3)。轻链可变区结构域替代地被称为LCDR1、LCDR2和LCDR3,并且重链可变区结构域替代地被称为HCDR1、HCDR2和HCDR3。
如本文所用,术语“分离的抗体”是指实质上不含具有不同抗原特异性的其他抗体的抗体(例如,特异性结合到间皮素的分离的抗体实质上不含不结合到间皮素的抗体)。另外,分离的抗体实质上不含其他细胞物质和/或化学物质。
如本文所用,术语“单克隆抗体”是指自实质上均质性的抗体群获得的抗体,即,除可以微量存在的可能天然存在的突变之外群相同的单独抗体。本发明的单克隆抗体可通过融合瘤方法、噬菌体展示技术、单淋巴细胞基因克隆技术或通过重组DNA方法制成。例如,单克隆抗体可由包括自转基因非人动物诸如转基因小鼠或大鼠获得的B细胞的融合瘤产生,所述转基因非人动物具有包含人重链转基因与轻链转基因的基因组。
如本文所用,术语“抗原结合片段”是指抗体片段,诸如双抗体、Fab、Fab'、F(ab')2、Fv片段、二硫键稳定的Fv片段(dsFv)、(dsFv)2、双特异性dsFv(dsFv-dsFv')、二硫键稳定的双抗体(ds双抗体)、单链抗体分子(scFv)、单结构域抗体(sdAb)、scFv二聚体(二价双抗体)、由包含一个或多个CDR的抗体的一部分形成的多特异性抗体、骆驼源化单结构域抗体、微抗体、纳米抗体、结构域抗体、二价结构域抗体、轻链可变结构域(VL)、骆驼抗体的可变结构域(VHH)或结合到抗原但不包含完整抗体结构的任何其他抗体片段。抗原结合片段能够结合到亲本抗体或亲本抗体片段所结合的相同抗原。
如本文所用,术语“单链抗体”是指本领域中的常规单链抗体,其包含经由约15至约20个氨基酸的短肽(例如接头肽)连接的重链可变区与轻链可变区。
如本文所用,术语“单结构域抗体”是指本领域中的常规单结构域抗体,其包含重链可变区与重链恒定区或其仅包含重链可变区。
如本文所用,术语“人抗体”是指使用本领域中已知的任何技术由人产生的抗体或具有对应于由人产生的抗体的氨基酸序列的抗体。人抗体的这种定义包括完整或全长抗体、其片段和/或包含至少一条人重链和/或轻链多肽的抗体。
如本文所用,术语“人源化抗体”是指经修饰以提高与人抗体的序列同源性以使得抗体的抗原结合性质保留但其在人体中的抗原性降低的非人抗体。
如本文所用,术语“嵌合抗体”是指其中免疫球蛋白分子的氨基酸序列来源于两种或更多种物种的抗体。轻链与重链两者的可变区常对应于衍生自具有所需特异性、亲和力和能力的哺乳动物的一个物种(例如小鼠、大鼠、兔等)的抗体的可变区,而恒定区对应于衍生自哺乳动物的另一物种(例如人)的抗体的序列以避免在那些物种中引发免疫反应。
如本文所用,术语“多特异性抗体”是指包含多个免疫球蛋白可变结构域序列的抗体,其中所述多个序列的第一免疫球蛋白可变结构域序列具有针对第一表位的结合特异性且所述多个序列的第二免疫球蛋白可变结构域序列具有针对第二表位的结合特异性。在一个实施方案中,第一表位与第二表位在相同抗原例如相同蛋白质(或多聚蛋白的亚基)上。在一个实施方案中,第一表位与第二表位重叠或实质上重叠。在一个实施方案中,第一表位与第二表位不重叠或实质上不重叠。在一个实施方案中,第一表位与第二表位在不同抗原,例如不同蛋白质(或多聚蛋白的不同亚基)上。在一个实施方案中,多特异性抗体包含第三免疫球蛋白可变结构域、第四免疫球蛋白可变结构域或第五免疫球蛋白可变结构域。在一个实施方案中,多特异性抗体为双特异性抗体分子、三特异性抗体分子或四特异性抗体分子。
如本文所用,术语“双特异性抗体”是指结合不超过两个表位或两种抗原的多特异性抗体。双特异性抗体的特征为对第一表位具有结合特异性的第一免疫球蛋白可变结构域序列和对第二表位具有结合特异性的第二免疫球蛋白可变结构域序列。在一个实施方案中,第一表位与第二表位在相同抗原,例如相同蛋白质(或多聚蛋白的亚基)上。在一个实施方案中,第一表位与第二表位重叠或实质上重叠。在一个实施方案中,第一表位与第二表位在不同抗原,例如不同蛋白质(或多聚蛋白的不同亚基)上。在一个实施方案中,双特异性抗体包含对第一表位具有结合特异性的重链可变结构域序列与轻链可变结构域序列和对第二表位具有结合特异性的重链可变结构域序列与轻链可变结构域序列。在一个实施方案中,双特异性抗体包含对第一表位具有结合特异性的半抗体或其片段和对第二表位具有结合特异性的半抗体或其片段。在一个实施方案中,双特异性抗体包含对第一表位具有结合特异性的scFv或其片段和对第二表位具有结合特异性的scFv或其片段。在一个实施方案中,第一表位位于间皮素上且第二表位位于PD-1、PD-L1、CTLA-4、EGFR、HER-2、CD19、CD20、CD33、CD3和/或其他肿瘤相关免疫抑制因子或表面抗原上。
如本文所用,术语“间皮素”是指71-kD前体蛋白,其由内切蛋白酶furin裂解以释放分泌的N端区,称为巨核细胞增强因子(MPF)。41-kD成熟间皮素(即MPF)保持附着于膜上(Yamaguchi N等人,Biol Chem.1994;269:805-808)。剩余的GPI连接的成熟间皮素还可经由肿瘤坏死因子α-转化酶蛋白酶的作用自细胞上脱落(Zhang Y等人,Cancer Res.2011;71:5915-5922)。脱落的间皮素的血清含量与疾病之间的相关性提示间皮素蛋白在癌症进展中的潜在作用。然而,对间皮素的生物功能并未充分了解。已知间皮素结合到卵巢癌抗原MUC16(癌抗原125),已显示所述癌抗原诱发细胞与细胞的黏附并且可能促进腹膜种植和转移扩散(Gubbels JA等人,Mol Cancer.2006;5∶50)。此外,间皮素剔除小鼠通常生长并繁殖并且没有可检测的表型。Bera TK等人,Mol Cell Biol.2000;20:2902-2906。人间皮素的全长序列由SEQ ID NO:315提供,并且人41-kD成熟间皮素的序列由SEQ ID NO:318提供。
如本文所用,“特异性结合到间皮素”的抗体是指以如下KD结合到间皮素、优选人间皮素的抗体:1×10-7M或更小、优选1×10-8M或更小、更优选5×10-9M或更小、1×10-9M或更小、5×10-10M或更小、或1×10-10M或更小。术语“KD”是指解离常数,其由Kd与Ka的比率(即Kd/Ka)获得且表示为摩尔浓度(M)。鉴于本公开,可使用本领域中的方法确定抗体的KD值。例如,抗体的KD可通过使用表面等离子体共振,诸如通过使用生物传感器系统,例如系统;或通过使用生物层干涉测量技术,诸如Octet RED96系统测定。
抗体的KD值越小,抗体结合到靶抗原的亲和力越高。
根据具体方面,本发明涉及一种包含抗原结合片段的CAR构建体,其中所述抗原结合片段为特异性结合肿瘤抗原的抗体或抗原结合片段和/或特异性结合肿瘤抗原的分离的抗体或抗原结合片段。抗体或抗原结合片段可为例如Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)或骆驼抗体的可变结构域(VHH)。
在某些实施方案中,抗体或抗原结合片段为包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;
ll.分别为SEQ ID NO:68、136和204;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体;
其中所述单结构域抗体特异性结合到间皮素、优选人间皮素。在某些实施方案中,单结构域抗体包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的氨基酸序列。在某些实施方案中,单结构域抗体包含选自由SEQ ID NO:221-258和SEQ IDNO:420-428组成的组中的氨基酸序列或其变异体。优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:31、99和167的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:221至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:221的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:32、100和168的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:222至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:222的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:33、101和169的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:223至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:223的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:34、102和170的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:224、420、421或422至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:224、420、421或422的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:35、103和171的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:225至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:225的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:36、104和172的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:226至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:226的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:37、105和173的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:227至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:227的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:38、106和174的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:228至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:228的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:39、107和175的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:229至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:229的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:40、108和176的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:230至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:230的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:41、109和177的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:231至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:231的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:42、110和178的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:232至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:232的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:43、111和179的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:233至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:233的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:44、112和180的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:234至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:234的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:45、113和181的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:235至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:235的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:46、114和182的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:236至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:236的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:47、115和183的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:237至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:237的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:48、116和184的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:238至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:238的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:49、117和185的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:239至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:239的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:50、118和186的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:240至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:240的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:51、119和187的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:241至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:241的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:52、120和188的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:242至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:242的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:53、121和189的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:243至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:243的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:54、122和190的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:244至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:244的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:55、123和191的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:245至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:245的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:56、124和192的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:246至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:246的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:57、125和193的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:247至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:247的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:58、126和194的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:248至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:248的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:59、127和195的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:249至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:249的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:60、128和196的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:250至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:250的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:61、129和197的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:251至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:251的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:62、130和198的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:252至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:252的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:63、131和199的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:253至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:253的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:64、132和200的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:254至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:254的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:65、133和201的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:255至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:255的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:66、134和202的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:256、426、427或428至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:256、426、427或428的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:67、135和203的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:257、423、424或425至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:257、423、424或425的多肽序列。
在一个实施方案中,本发明涉及一种包含单结构域抗体或分离的单结构域抗体的CAR构建体,所述单结构域抗体包含CDR1、CDR2和CDR3,它们分别具有SEQ ID NO:68、136和204的多肽序列。在另一实施方案中,包含单结构域抗体(sdAb)或分离的sdAb的CAR构建体包含与SEQ ID NO:258至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含sdAb或分离的sdAb的CAR构建体包含SEQ ID NO:258的多肽序列。
在某些实施方案中,所述抗体或其抗原结合片段为包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体;
其中所述scFv特异性结合到间皮素、优选人间皮素。在某些实施方案中,scFv包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的氨基酸序列。
在某些实施方案中,所述抗体或其抗原结合片段为包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158,或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体,
其中所述scFv特异性结合到间皮素、优选人间皮素。在某些实施方案中,scFv包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的氨基酸序列。在某些实施方案中,单结构域抗体包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体。优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:1、69、137、2、70和138的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:205或206至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:205或206的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:3、71、139、4、72和140的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:207至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ IDNO:207的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:5、73、141、6、74和142的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:208至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ IDNO:208的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:7、75、143、8、76和144的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:209至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ IDNO:209的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:9、77、145、10、78和146的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:210至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ IDNO:210的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:11、79、147、12、80和148的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:211至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:211的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:13、81、149、14、82和150的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:212至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:212的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:15、83、151、16、84和152的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:213.至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:213的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:17、85、153、18、86和154的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:214至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:214的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:19、87、155、20、88和156的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:215至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:215的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:21、89、157、22、90和158的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:216至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:216的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:23、91、159、24、92和160的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:217至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:217的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:25、93、161、26、94和162的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:218至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:218的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:27、95、163、28、96和164的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:219至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:219的多肽序列。
在一个实施方案中,本发明涉及一种包含单链可变片段(scFv)或分离的scFv的CAR构建体,其包含HCDR1、HCDR2、HCDR3、LCDR1、LCDR2和LCDR3,它们分别具有SEQ ID NO:29、97、165、30、98和166的多肽序列。在另一实施方案中,包含scFv和/或分离的scFv的CAR构建体包含与SEQ ID NO:220至少85%、优选90%、更优选95%或更多,诸如95%、96%、97%、98%或99%相同的多肽序列。优选地,包含scFv和/或分离的scFv的CAR构建体包含SEQ ID NO:220的多肽序列。
在另一通常方面中,本发明涉及一种产生本发明的修饰的TCR复合体、CAR构建体或抗体或其抗原结合片段的方法,所述方法包括在产生本发明的修饰的TCR复合体、CAR构建体或抗体或其抗原结合片段的条件下培养包含编码以下蛋白质的核酸的细胞:修饰的TCR复合体、CAR构建体或抗体或其抗原结合片段。任选地,所述方法还包括自细胞或细胞培养物(例如自上清液)中回收修饰的TCR复合体、CAR构建体或抗体或其抗原结合片段。所表达的抗体或其抗原结合片段可自细胞中收获并且根据本领域中已知和如本文所述的常规技术纯化。
滤泡刺激素受体(FSHR)结合肽
如本文所用,术语“FSHR结合结构域”或“FSHR结合肽”是指特异性结合到滤泡刺激素受体(FSHR)的肽结构域或多肽。在某些实施方案中,FSHR结合结构域可包含滤泡刺激素(FSH)或其片段、FSHR拮抗剂或其片段、特异性结合到FSHR的抗原结合片段和/或抗FSHR激动剂或其片段。
如本文所用,术语“FSHR激动剂”是指对FSHR具有亲和力的分子或其片段。FSHR拮抗剂对FSHR的活性位点(即与FSH相似或相同的结合位点)具有亲和力。FSHR拮抗剂对FSHR的结合亲和力可为可逆的或不可逆的。
在某些方面中,本文提供CAR,其中所述CAR包含胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽。第一多肽可为例如FSHR结合肽。FSHR结合肽可为例如FSH或其片段、FSHR拮抗剂或其片段、抗FSHR抗体或其片段或抗FSHR激动剂或其片段。
在某些实施方案中,FSHR结合肽可包含来源于FSH分子的氨基酸序列。FSHR结合肽包括来源于FSH分子的片段、肽或多肽序列。在一个实施方案中,FSHR结合肽包含FSHβ33-53肽。在另一实施方案中,FSHR结合肽包含FSHβ51-65肽。在另一实施方案中,FSHR结合肽包含FSHβ81-95肽。
FSHR结合肽可包含任何片段或FSH分子。在某些实施方案中,FSHR结合肽包含FSH分子的至少10个氨基酸。FSHR结合肽可包含FSH分子的至少约6、7、8、9、10、11、12、13、14、15、16、17、18、19、20、21、22、23、24、25、26、27、28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、45、46、47、48、49、50个或更多个氨基酸。在某些实施方案中,FSHR结合肽可为FSH分子的约6个至约50个氨基酸、约10个至约45个氨基酸、约15个至约40个氨基酸、约20个至约35个氨基酸、或约25个至约30个氨基酸。FSHR结合肽保留结合到FSHR的能力。
在某些实施方案中,FSHR结合肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。在某些实施方案中,FSHR结合肽与选自由SEQ ID NO:319-331组成的组中的氨基酸序列具有80%、81%、82%、83%、84%、85%、86%、87%、88%、89%、90%、91%、92%、93%、94%、95%、96%、97%、98%或99%同一性。在某些实施方案中,FSHR结合肽具有选自由SEQ ID NO:319-331组成的组中的氨基酸序列或其变异体,所述变异体包含至多约5(诸如,约1、2、3、4或5中的任一者)个氨基酸取代。
细胞介导免疫反应的抑制剂的显性负性形式
免疫细胞或其前体细胞的细胞介导免疫反应的抑制剂是指用于抑制或遏止由免疫细胞或其前体细胞实现的免疫反应的分子。在某些实施方案中,细胞介导免疫反应的抑制剂可为例如免疫检查点抑制剂。
在某些方面中,本文提供表达CAR的工程改造的免疫细胞,所述CAR包含免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。作为非限制性实例,抑制剂的显性负性形式可为在免疫检查点抑制剂途径中发挥作用的受体。免疫检查点途径可遏止免疫细胞的免疫反应。所述途径可将负信号传递至免疫细胞并且削弱TCR介导的信号,由此可造成细胞增殖减少、细胞因子产生减少和细胞周期进展减慢(Pardoll,Nat.Rev.12:252-64(2012);Wu等人,Int.J.Biol.Sci.8:1420-30(2012))。免疫检查点抑制剂途径受体的实例可包括但不限于PD-1、CTLA-4、BTLA、TIM-3、LAG-3、CD160、TIGIT、LAIR1、2B4和其类似物(Chen等人,Nat.Rev.Immunol.13(4):227-42(2013))。用于这些受体的相应配体包括例如PD-L1(用于PD-1);PD-L2(用于PD-1);CD80、CD86(用于CTLA-4);HVEM(用于BTLA);半乳糖凝集素-9、HMGB1(用于TIM-3);MHCII(用于LAG-3);HVEM(用于CD160);CD155、CD112、CD113(用于TIGIT);C1q、胶原蛋白(用于LAIR1);CD48(用于2B4)和其类似物(Chen等人,Nat.Rev.Immunol.13(4):227-42(2013))。显性负性形式在免疫细胞中的表达提供细胞所固有的检查点抑制剂途径的抑制。
在某些实施方案中,免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式为显性负性转化生长因子-β受体II型(dnTGFβRII)。TGF-β受体II型可具有对应于GenBank第NP_001020018.1号的氨基酸序列或其片段。TGFβRII的结构域包括信号肽(氨基酸1-22)、胞外结构域(氨基酸23-191)、跨膜结构域(氨基酸192-212)和胞内结构域(氨基酸213-592)(参见,例如GenBank第NP_001020018.1号)。
在某些实施方案中,CAR包含显性负性形式的TGFβRII(dnTGFβRII)。在一个实施方案中,dnTGFβRII包含TGFβRII的胞外配体结合结构域。在一个实施方案中,dnTGFβRII包含胞外配体结合结构域和跨膜结构域。在另一实施方案中,dnTGFβRII包含TGFβRII的胞外配体结合结构域、跨膜结构域和信号肽。
先前已描述dnTGFβRII形式(参见,例如Bottinger等人,EMBO J 16:2621-33(1997);Foster等人,J.Immunother.31:500-5(2008);Bollard等人,Blood 99:3179-87(2002);Wieser等人,Mol.Cell.Biol.13:7239-47(1993))。在某些实施方案中,dnTGFβRII包含SEQ ID NO:347的氨基酸序列。
包含编码CAR的第一核苷酸序列和编码dnTGFβRII的第三核苷酸序列的分离的多核苷酸可例如具有经由编码2A肽的第三核苷酸序列连接到第三核苷酸序列上的第一核苷酸序列。2A肽通常为按序排列的16-20个氨基酸,例如P2A。当2A肽在多顺反子mRNA中的两个开放阅读框之间编码时,其造成核糖体在翻译多肽时在2A肽的羧基端处停止,由此导致来源于每个开放阅读框的多肽的分离。分离点处于2A肽的羧基端处,其中下游开放阅读框的第一个氨基酸为脯氨酸。2A肽例如描述于国际专利公布第WO2017/040815号中。
多核苷酸、载体和宿主细胞
在另一通常方面中,本发明涉及一种分离的核酸,其编码本发明的嵌合抗原受体(CAR)和/或抗体或其抗原结合片段。本领域技术人员应理解,蛋白质的编码序列可变化(例如置换、缺失、插入等),而不会改变蛋白质的氨基酸序列。因此,本领域技术人员应理解,编码本发明的CARs和/或抗体或其抗原结合片段的核酸序列可变更,而不会改变蛋白质的氨基酸序列。
在另一通常方面中,本发明涉及一种载体,其包含CAR和/或编码本发明的抗体或其抗原结合片段的分离的核酸。可使用本领域技术人员鉴于本公开已知的任何载体,诸如质粒、粘粒、噬菌体载体或病毒载体。在一些实施方案中,载体为重组表达载体,诸如质粒。载体可包括建立表达载体的常规功能的任何元件,例如,启动子、核糖体结合元件、终止子、增强子、选择标记和复制起点。启动子可为组成型、诱导型或阻抑型启动子。能够将核酸递送至细胞的许多表达载体是本领域中已知的且可在本文中用于在细胞中产生CAR和/或抗体或其抗原结合片段。常规克隆技术或人工基因合成可用于生成根据本发明的实施方案的重组表达载体。
在另一通常方面中,本发明涉及一种宿主细胞,其包含本发明的载体和/或编码本发明的CAR和/或抗体或其抗原结合片段的分离的核酸。本领域技术人员鉴于本公开已知的任何宿主细胞均可用于本发明的CAR和/或抗体或其抗原结合片段的重组表达。合适的宿主细胞包括原核生物、酵母、哺乳动物细胞或细菌细胞。在一些实施方案中,宿主细胞为大肠杆菌TG1或BL21细胞(关于例如CAR、scFv或sdAb的表达)、CHO-DG44或CHO-K1细胞或HEK293细胞(关于例如全长IgG抗体的表达)。根据具体实施方案,通过常规方法诸如化学转染、热休克或电穿孔将重组表达载体转化到宿主细胞中,其中将所述重组表达载体稳定地整合到宿主细胞基因组中以便有效地表达重组核酸。
药物组合物
在另一通常方面中,本发明涉及一种药物组合物,其包含本发明的分离的多核苷酸、本发明的分离的多肽、本发明的宿主细胞、本发明的工程改造的免疫细胞和/或本发明的抗体或其抗原结合片段和药学上可接受的载剂。如本文所用,术语“药物组合物”意指一种产物,其包含本发明的分离的多核苷酸、本发明的分离的多肽、本发明的宿主细胞和/或本发明的工程改造的免疫细胞以及药学上可接受的载剂。本发明的多核苷酸、多肽、宿主细胞、工程改造的免疫细胞和/或抗体或抗原结合片段以及包含它们的组合物还可用于制造供本文提及的治疗应用的药剂。
如本文所用,术语“载剂”是指任何赋形剂、稀释剂、填充剂、盐、缓冲剂、稳定剂、增溶剂、油、脂质、含脂质的囊泡、微球体、脂质体封装或本领域中熟知用于药物制剂中的其他材料。应理解,载剂、赋形剂或稀释剂的特征将视针对具体应用的施用途径而定。如本文所用,术语“药学上可接受的载剂”是指不干扰根据本发明的组合物的效果或根据本发明的组合物的生物活性的无毒材料。根据具体实施方案,鉴于本公开,适用于多核苷酸、多肽、宿主细胞、工程改造的免疫细胞和/或抗体药物组合物中的任何药学上可接受的载剂均可用于本发明。
药物活性成分与药学上可接受的载剂的制剂为本领域中已知的,例如Remington:The Science and Practice of Pharmacy(例如,第21版(2005)和任何后续版本)。额外成分的非限制性实例包括:缓冲剂、稀释剂、溶剂、张力调节剂、防腐剂、稳定剂和螯合剂。一种或多种药学上可接受的载剂可用于配制本发明的药物组合物。
使用方法
在另一通常方面中,本发明涉及一种治疗有需要的受试者的癌症的方法。所述方法包括向有需要的受试者施用治疗有效量的本发明的分离的多核苷酸、分离的多肽、宿主细胞、工程改造的免疫细胞、抗体或其抗原结合片段和/或药物组合物。所述癌症可例如选自卵巢癌、原发性腹膜癌、胰腺导管腺癌(PDA)、恶性胸膜间皮瘤(MPM)、肺腺癌、三阴性乳腺癌、子宫内膜癌、胆管癌、胃癌或小儿急性骨髓性白血病。
根据本发明的实施方案,所述药物组合物包含治疗有效量的分离的多核苷酸、分离的多肽、宿主细胞、工程改造的免疫细胞和/或抗体或抗原结合片段。如本文所用,术语“药学上有效量”是指活性成分或组分引发受试者中的所需生物或药物反应的量。治疗有效量可凭经验且以常规方式确定,而与所述目的有关。
如本文所用,关于本发明的分离的多核苷酸、分离的多肽、宿主细胞、工程改造的免疫细胞、抗体或抗原结合片段和/或药物组合物,治疗有效量意指所述分离的多核苷酸、分离的多肽、宿主细胞、工程改造的免疫细胞、抗体或抗原结合片段和/或药物组合物调节有需要的受试者中的免疫反应的量。
根据具体实施方案,治疗有效量是指足以达成以下效果中的一个、二个、三个、四个或更多个的疗法的量:(i)降低或改善有待治疗的疾病、病症或病状或与此相关的症状的严重程度;(ii)缩短有待治疗的疾病、病症或病状或与此相关的症状的持续时间;(iii)预防有待治疗的疾病、病症或病状或与此相关的症状的进展;(iv)致使有待治疗的疾病、病症或病状或与此相关的症状消退;(v)预防有待治疗的疾病、病症或病状或与此相关的症状的发展或发作;(vi)预防有待治疗的疾病、病症或病状或与此相关的症状的复发;(vii)减少患有有待治疗的疾病、病症或病状或与此相关的症状的受试者的住院;(viii)缩短患有有待治疗的疾病、病症或病状或与此相关的症状的受试者的住院时间;(ix)延长患有有待治疗的疾病、病症或病状或与此相关的症状的受试者的存活期;(x)抑制或减轻有待治疗的疾病、病症或病状或与此相关的症状;和/或(xi)增强或改进另一疗法的一种或多种预防或治疗效果。
治疗有效量或剂量可根据以下各种因素而变,诸如有待治疗的疾病、病症或病状、施用方式、靶位点、受试者的生理状态(包括例如年龄、体重、健康情况)、受试者为人或动物、施用的其他药物以及治疗为预防性的或治疗性的。治疗剂量经最佳滴定以优化安全性和功效。
根据具体实施方案,本文所述的组合物经配制以适于向受试者的预定施用途径。例如,本文所述的组合物可经配制以适于静脉内、皮下或肌内施用。
本发明的细胞可以本领域技术人员已知的任何便利的方式施用。例如,本发明的细胞可通过气溶胶吸入、注射、摄取、输注、植入和/或移植向受试者施用。包含本发明的细胞的组合物可经动脉、皮下、皮内、肿瘤内、结节内、髓内、肌内、胸膜内、通过静脉内(i.v.)注射或腹膜内施用。在某些实施方案中,本发明的细胞可在有或没有受试者的淋巴细胞清除的情况下施用。
包含表达本发明的CAR的本发明细胞的药物组合物可以无菌液体制剂,通常具有细胞悬浮液的等渗水溶液提供,或任选呈乳液、分散液或其类似物,其通常经缓冲至选定的pH值。所述组合物可包含载剂,例如水、盐水、磷酸盐缓冲盐水和其类似物,其适于细胞的完整性和生存力,并且适于施用细胞组合物。
无菌可注射溶液可通过将本发明的细胞并入适量的适当溶剂中来制备,其视需要具有各种其他成分。这样的组合物可包括药学上可接受的载剂、稀释剂或赋形剂,诸如无菌水、生理盐水、葡萄糖、右旋糖或其类似物,其适于与细胞组合物一起使用且适于向受试者诸如人施用。用于提供细胞组合物的合适缓冲剂是本领域中熟知的。所用的任何媒介物、稀释剂或添加剂与保持本发明细胞的完整性和生存力相容。
本发明的细胞可于任何生理上可接受的媒介物中施用。包含本发明的细胞的细胞群可包含纯化的细胞群。本领域技术人员可容易地使用各种熟知方法确定细胞群中的细胞。包含本发明的基因修饰的细胞的细胞群中的纯度范围可为约50%至约55%、约55%至约60%、约60%至约65%、约65%至约70%、约70%至约75%、约75%至约80%、约80%至约85%、约85%至约90%、约90%至约95%、或约95%至约100%。剂量可容易由本领域技术人员调整,例如,纯度的降低可能需要剂量的增加。
本发明的细胞一般以基于每千克施用细胞的受试者的体重的细胞数(细胞/千克)的剂量来施用。一般而言,细胞剂量在约104个细胞/千克体重至约1010个细胞/千克体重,例如约105个细胞/千克体重至约109个细胞/千克体重、约105个细胞/千克体重至约108个细胞/千克体重、约105个细胞/千克体重至约107个细胞/千克体重、或约105个细胞/千克体重至约106个细胞/千克体重的范围内,视施用模式和位置而定。一般而言,就全身施用而言,与局部施用相比,使用更高的剂量,在局部施用时本发明的免疫细胞在肿瘤和/或癌症的区域处施用。另外,可调整剂量,以说明是否正在施用单一剂量或是否正在施用多个剂量。对将被视为有效剂量的精确确定可基于每个受试者的具体因素而定。
如本文所用,术语“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”均旨在指改善或逆转至少一个与癌症有关的可测量的身体参数,其并不一定在受试者中可辨别,但可以在受试者中可辨别。术语“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”还可指引起疾病、病症或病状的消退、预防进展或至少减慢进展。在一个具体实施方案中,“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”是指减轻一种或多种与疾病、病症或病状(诸如肿瘤或更优选癌症)相关的症状、预防其发展或发作或缩短其持续时间。在一个具体实施方案中,“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”是指预防疾病、病症或病状的复发。在一个具体实施方案中,“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”是指延长患有疾病、病症或病状的受试者的存活期。在一个具体实施方案中,“治疗(treat)”、“治疗(treating)”和“治疗(treatment)”是指消除受试者的疾病、病症或病状。
实施方案
本发明提供以下非限制性实施方案。
实施方案1.一种分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽和特异性结合到肿瘤抗原的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中所述CAR任选还包含在其氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
实施方案1a为实施方案1的分离的多核苷酸,其中所述第一多肽为特异性结合到FSHR、优选人FSHR的抗原结合片段。
实施方案1b为实施方案1a的分离的多核苷酸,其中特异性结合到FSHR的所述第一多肽包含Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)、仅重链的抗体或骆驼抗体的可变结构域(VHH)。
实施方案2为实施方案1的分离的多核苷酸,其中所述第一多肽包含选自由SEQ IDNO:319-331组成的组中的氨基酸序列。
实施方案3为实施方案1至2中任一项的分离的多核苷酸,其中所述第一多肽经由接头连接到所述抗原结合片段的氨基端。
实施方案3a为实施方案1或2的分离的多核苷酸,其中所述第一多肽经由接头连接到所述抗原结合片段的羧基端。
实施方案4为实施方案1至3a中任一项的分离的多核苷酸,其中所述肿瘤抗原选自由下列组成的组:间皮素、叶酸受体α、黏蛋白16(MUC16)、前列腺特异性膜抗原(PSMA)、人表皮生长因子受体2(HER2)、表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)。
实施方案5为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为间皮素,优选为人间皮素。
实施方案5a为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为MUC16,优选为人MUC16。
实施方案5b为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为PSMA,优选为人PSMA。
实施方案5c为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为HER2,优选为人HER2。
实施方案5d为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为EGFR,优选为人EGFR。
实施方案5e为实施方案4的分离的多核苷酸,其中所述肿瘤抗原为VEGFR,优选为人VEGFR。
实施方案6为实施方案5至5e中任一项的分离的多核苷酸,其中所述抗原结合片段为Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)、仅重链的抗体或骆驼抗体的可变结构域(VHH)。
实施方案6a为实施方案6的分离的多核苷酸,其中所述抗原结合片段为Fab。
实施方案6b为实施方案6的分离的多核苷酸,其中所述抗原结合片段为Fab’。
实施方案6c为实施方案6的分离的多核苷酸,其中所述抗原结合片段为F(ab’)2。
实施方案6d为实施方案6的分离的多核苷酸,其中所述抗原结合片段为Fv。
实施方案6e为实施方案6的分离的多核苷酸,其中所述抗原结合片段为scFv。
实施方案6f为实施方案6的分离的多核苷酸,其中所述抗原结合片段为微抗体。
实施方案6g为实施方案6的分离的多核苷酸,其中所述抗原结合片段为双抗体。
实施方案6h为实施方案6的分离的多核苷酸,其中所述抗原结合片段为sdAb。
实施方案6i为实施方案6的分离的多核苷酸,其中所述抗原结合片段为VL。
实施方案6j为实施方案6的分离的多核苷酸,其中所述抗原结合片段为仅重链的抗体。
实施方案6k为实施方案6的分离的多核苷酸,其中所述抗原结合片段为骆驼抗体的VHH。
实施方案7为实施方案6至6k中任一项的分离的多核苷酸,其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158,或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
实施方案7a为实施方案6至6k中任一项的分离的多核苷酸,其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158。
实施方案8为实施方案7或7a的分离的多核苷酸,其中所述抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案8a为实施方案7或7a的分离的多核苷酸,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列或其变异体,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案8b为实施方案7或7a的分离的多核苷酸,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列。
实施方案9为实施方案1至8b中任一项的分离的多核苷酸,其中所述胞外结构域包含选自由SEQ ID NO:348-357组成的组中的氨基酸序列。
实施方案10为一种分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区,并且其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158,或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
实施方案10a为一种分离的多核苷酸,其包含编码嵌合抗原受体(CAR)的核苷酸序列,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区,并且其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158。
实施方案11为实施方案10或10a的分离的多核苷酸,其中所述抗原结合片段为
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入,或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案11a为实施方案10或10a的分离的多核苷酸,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列或其变异体,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案11b为实施方案10或10a的分离的多核苷酸,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列。
实施方案12为实施方案10至11b中任一项的分离的多核苷酸,其中所述多核苷酸还包含编码第二嵌合抗原受体(CAR)的第二核苷酸序列,其中所述第二CAR包含:
(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的多肽;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中所述第二CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
实施方案12a为实施方案12的分离的多核苷酸,其中编码CAR的核苷酸序列经由2A肽编码序列连接到第二核苷酸序列。
实施方案12b为实施方案12或12a的分离的多核苷酸,其中编码CAR的核苷酸序列的3’-端连接到第二核苷酸序列的5’-端。
实施方案12c为实施方案12或12a的分离的多核苷酸,其中第二核苷酸序列的3’-端连接到编码CAR的核苷酸序列的5’-端。
实施方案12d为实施方案12至12c中任一项的分离的多核苷酸,其中特异性结合到FSHR的多肽为特异性结合到FSHR、优选人FSHR的抗原结合片段。
实施方案12e为实施方案12d的分离的多核苷酸,其中特异性结合到FSHR的抗原结合片段为Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)、仅重链的抗体或骆驼抗体的可变结构域(VHH)。
实施方案13为实施方案12至12d中任一项的分离的多核苷酸,其中特异性结合到FSHR的多肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。
实施方案14为实施方案1-13中任一项的分离的多核苷酸,其中所述CAR包含具有与SEQ ID NO:340至少90%相同的氨基酸序列的信号肽。
实施方案14a为实施方案12-14中任一项的分离的多核苷酸,其中所述第二CAR包含具有与SEQ ID NO:340至少90%相同的氨基酸序列的信号肽。
实施方案14b为实施方案14或14a的分离的多核苷酸,其中所述CAR与所述第二CAR包含相同信号序列。
实施方案14c为实施方案14或14a的分离的多核苷酸,其中所述CAR与所述第二CAR包含不同信号序列。
实施方案15为实施方案1-14c中任一项的分离的多核苷酸,其中所述CAR包含具有与SEQ ID NO:341至少90%相同的氨基酸序列的铰链区。
实施方案15a为实施方案12-15中任一项的分离的多核苷酸,其中所述第二CAR包含具有与SEQ ID NO:341至少90%相同的氨基酸序列的铰链区。
实施方案15b为实施方案15或15a的分离的多核苷酸,其中所述CAR与所述第二CAR包含相同铰链区。
实施方案15c为实施方案15或15a的分离的多核苷酸,其中所述CAR与所述第二CAR包含不同铰链区。
实施方案16为实施方案1-15c中任一项的分离的多核苷酸,其中所述CAR包含选自由以下组成的组中的跨膜结构域:CD8α跨膜结构域、CD28跨膜结构域、CD4跨膜结构域、CD3ζ跨膜结构域、CD2跨膜结构域、4-1BB跨膜结构域、OX40跨膜结构域、ICOS跨膜结构域、CTLA-4跨膜结构域、PD-1跨膜结构域、LAG-3跨膜结构域、2B4跨膜结构域、BTLA跨膜结构域和GMCSFR跨膜结构域。
实施方案16a为实施方案12-16中任一项的分离的多核苷酸,其中所述第二CAR包含选自由以下组成的组中的跨膜结构域:CD8α跨膜结构域、CD28跨膜结构域、CD4跨膜结构域、CD3ζ跨膜结构域、CD2跨膜结构域、4-1BB跨膜结构域、OX40跨膜结构域、ICOS跨膜结构域、CTLA-4跨膜结构域、PD-1跨膜结构域、LAG-3跨膜结构域、2B4跨膜结构域、BTLA跨膜结构域和GMCSFR跨膜结构域。
实施方案16b为实施方案16或16a的分离的多核苷酸,其中所述CAR与所述第二CAR包含相同跨膜结构域。
实施方案16c为实施方案16或16a的分离的多核苷酸,其中所述CAR与所述第二CAR包含不同跨膜结构域。
实施方案17为实施方案1-16c中任一项的分离的多核苷酸,其中所述CAR包含选自由以下组成的组中的胞内信号传导结构域:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ的信号传导结构域。
实施方案17a为实施方案12-17中任一项的分离的多核苷酸,其中所述第二CAR包含选自由以下组成的组中的胞内信号传导结构域:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ的信号传导结构域。
实施方案17b为实施方案17或17a的分离的多核苷酸,其中所述CAR与所述第二CAR包含相同胞内信号传导结构域。
实施方案17c为实施方案17或17a的分离的多核苷酸,其中所述CAR与所述第二CAR包含不同胞内信号传导结构域。
实施方案18为实施方案17的分离的多核苷酸,其中所述CAR包含选自由以下一个或多个的共刺激结构域组成的组中的共刺激结构域:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
实施方案18a为实施方案12-17中任一项的分离的多核苷酸,其中所述第二CAR包含选自由以下一个或多个的共刺激结构域组成的组中的共刺激结构域:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
实施方案18b为实施方案18或18a的分离的多核苷酸,其中所述CAR与所述第二CAR包含相同共刺激结构域。
实施方案18c为实施方案18或18a的分离的多核苷酸,其中所述CAR与所述第二CAR包含不同共刺激结构域。
实施方案19为实施方案1的分离的多核苷酸,其中所述CAR包含选自由SEQ ID NO:370-379和SEQ ID NO:448-450组成的组中的氨基酸序列。
实施方案20为实施方案10的分离的多核苷酸,其中所述CAR包含选自由SEQ IDNO:358-367和SEQ ID NO:445-447组成的组中的氨基酸序列。
实施方案20为实施方案10的分离的多核苷酸,其编码具有选自由SEQ ID NO:380-389和SEQ ID NO:451-453组成的组中的氨基酸序列的蛋白质。
实施方案21为实施方案1-20中任一项的分离的多核苷酸,还包含第三核苷酸序列,其编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。
实施方案22为实施方案21的分离的多核苷酸,其中所述免疫细胞的细胞介导免疫反应的抑制剂为转化生长因子β(TGF-β)受体。
实施方案23为实施方案22的分离的多核苷酸,其中抑制剂的显性负性形式包含SEQ ID NO:347的氨基酸序列。
实施方案24为实施方案21-23中任一项的分离的多核苷酸,其中编码所述CAR的核苷酸序列经由2A肽编码序列连接到所述第三核苷酸序列。
实施方案24a为实施方案24的分离的多核苷酸,其中编码所述CAR的核苷酸序列的3’端连接到所述第三核苷酸序列的5’端。
实施方案24b为实施方案24的分离的多核苷酸,其中所述第三核苷酸序列的3’端连接到编码所述CAR的核苷酸序列的5’端。
实施方案24c为实施方案24的分离的多核苷酸,其中所述第二核苷酸序列的3’端连接到所述第三核苷酸序列的5’端。
实施方案24d为实施方案24的分离的多核苷酸,其中所述第三核苷酸序列的3’端连接到所述第二核苷酸序列的5’端。
实施方案25为实施方案24至24d中任一项的分离的多核苷酸,其中所述CAR包含选自由SEQ ID NO:390-419和SEQ ID NO:460-468组成的组中的氨基酸序列。
实施方案26为一种载体,其包含实施方案1-25和72-80中任一项的多核苷酸。
实施方案27为一种宿主细胞,其包含如实施方案1-25和72-80中任一项所述的多核苷酸或实施方案26的载体。
实施方案28为一种治疗有需要的受试者的癌症的方法,所述方法包括向所述受试者施用治疗有效量的实施方案27的宿主细胞。
实施方案29为一种工程改造的免疫细胞,其表达由实施方案1-25中任一项的多核苷酸编码的CAR或包含融合蛋白的修饰的TCR,所述融合蛋白由实施方案72-80中任一项的多肽编码。
实施方案30为实施方案29的工程改造的免疫细胞,其中所述工程改造的免疫细胞选自由下列组成的组:细胞毒性T细胞、辅助T细胞、自然杀伤细胞、γδT细胞和NKT细胞。
实施方案31为一种药物组合物,其包含实施方案29或30的工程改造的免疫细胞和药学上可接受的载剂。
实施方案32为一种治疗有需要的受试者的癌症的方法,所述方法包括向所述受试者施用治疗有效量的实施方案31的药物组合物。
实施方案32a为实施方案32的方法,其中所述工程改造的免疫细胞为自体的。
实施方案32b为实施方案32的方法,其中所述工程改造的免疫细胞为同种异体的。
实施方案32c为实施方案32的方法,其中所述工程改造的免疫细胞为同基因的。
实施方案33为实施方案28和32-32c中任一项的方法,其中所述癌症选自卵巢癌、原发性腹膜癌、胰腺导管腺癌(PDA)、恶性胸膜间皮瘤(MPM)、肺腺癌、三阴性乳腺癌、子宫内膜癌、胆管癌、胃癌或小儿急性骨髓性白血病,优选为卵巢癌。
实施方案34为一种工程改造免疫细胞的方法,所述方法包括将可操作连接到启动子的实施方案1-25和72-80中任一项的多核苷酸引入所述免疫细胞中。
实施方案35为一种产生药物组合物的方法,所述方法包括将实施方案29或30的工程改造的免疫细胞与药学上可接受的载剂组合以获得所述药物组合物。
实施方案36为一种用于诱导免疫细胞和/或靶细胞的活性的系统,所述系统包含含有嵌合抗原受体(CAR)的工程改造的细胞,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽和特异性结合到肿瘤抗原的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中所述CAR任选还包含在其氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区。
实施方案37为实施方案36的系统,其中所述第一多肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。
实施方案38为实施方案36或37的系统,其中所述第一多肽经由接头连接到抗原结合片段的氨基端或羧基端。
实施方案39为实施方案36至38中任一项的系统,其中所述肿瘤抗原选自由下列组成的组:间皮素、叶酸受体α、黏蛋白16(MUC16)、前列腺特异性膜抗原(PSMA)、人表皮生长因子受体2(HER2)、表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)。
实施方案40为实施方案36至39中任一项的系统,其中所述肿瘤抗原为间皮素,优选为人间皮素。
实施方案41为实施方案40的系统,其中所述抗原结合片段为Fab、Fab’、F(ab’)2、Fv、单链可变片段(scFv)、微抗体、双抗体、单结构域抗体(sdAb)、轻链可变结构域(VL)或骆驼抗体的可变结构域(VHH)。
实施方案42为实施方案41的系统,其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
实施方案42a为实施方案41的系统,其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158。
实施方案43为实施方案42或42a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入,或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案43a为实施方案42或42a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列或其变异体,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案43b为实施方案42或42a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列。
实施方案44为实施方案36至43b中任一项的系统,其中所述胞外结构域包含选自由SEQ ID NO:348-357组成的组中的氨基酸序列。
实施方案45为一种用于诱导免疫细胞和/或靶细胞的活性的系统,所述系统包含含有嵌合抗原受体(CAR)的工程改造的细胞,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区,并且
其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体。
实施方案45a为一种用于诱导免疫细胞和/或靶细胞的活性的系统,所述系统包含含有嵌合抗原受体(CAR)的工程改造的细胞,其中所述CAR包含:
(a)胞外结构域,其包含特异性结合到间皮素、优选人间皮素的抗原结合片段;
(b)跨膜结构域;和
(c)胞内信号传导结构域,
其中CAR任选还包含在氨基端处的信号肽和连接胞外结构域与跨膜结构域的铰链区,并且
其中所述抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158。
实施方案46为实施方案45或45a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入,或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案46a为实施方案45或45a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列或其变异体,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案46b为实施方案45或45a的系统,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列。
实施方案47为实施方案45至46b中任一项的系统,其中所述CAR还包含特异性结合到滤泡刺激素受体(FSHR)的多肽。
实施方案48为实施方案47的系统,其中特异性结合到FSHR的多肽包含选自由SEQID NO:319-331组成的组中的氨基酸序列。
实施方案49为实施方案36-47中任一项的系统,其中所述CAR包含具有与SEQ IDNO:340至少90%相同的氨基酸序列的信号肽。
实施方案50为实施方案36-49中任一项的系统,其中所述CAR包含具有与SEQ IDNO:341至少90%相同的氨基酸序列的铰链区。
实施方案51为实施方案36-50中任一项的系统,其中所述CAR包含选自由以下组成的组中的跨膜结构域:CD8α跨膜结构域、CD28跨膜结构域、CD4跨膜结构域、CD3ζ跨膜结构域、CD2跨膜结构域、4-1BB跨膜结构域、OX40跨膜结构域、ICOS跨膜结构域、CTLA-4跨膜结构域、PD-1跨膜结构域、LAG-3跨膜结构域、2B4跨膜结构域、BTLA跨膜结构域和GMCSFR跨膜结构域。
实施方案52为实施方案36-51中任一项的系统,其中所述CAR包含选自由以下组成的组中的胞内信号传导结构域:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ的信号传导结构域。
实施方案53为实施方案52的系统,其中所述CAR包含选自由以下一个或多个的共刺激结构域组成的组中的共刺激结构域:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
实施方案54为实施方案36的系统,其中所述CAR包含选自由SEQ ID NO:370-379和SEQ ID NO:448-450组成的组中的氨基酸序列。
实施方案55为实施方案45的系统,其中所述CAR包含选自由SEQ ID NO:358-367和SEQ ID NO:445-447组成的组中的氨基酸序列。
实施方案56为实施方案36-55中任一项的系统,其中所述CAR还包含免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式。
实施方案57为实施方案56的系统,其中所述免疫细胞的细胞介导免疫反应的抑制剂为转化生长因子β(TGF-β)受体。
实施方案58为实施方案57的系统,其中抑制剂的显性负性形式包含SEQ ID NO:347的氨基酸序列。
实施方案59为实施方案56至58中任一项的系统,其中所述CAR经由2A肽编码序列连接到所述抑制剂的显性负性形式。
实施方案60为实施方案59的系统,其中所述CAR包含选自由SEQ ID NO:390-419和SEQ ID NO:460-468组成的组中的氨基酸序列。
实施方案61为一种分离的抗体或抗原结合片段,其中所述分离的抗体或抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;
o.分别为SEQ ID NO:21、89、157、22、90和158;或
在CDR区中包含至多约3(诸如约1、2或3中的任一者)个氨基酸取代的其变异体,
其中分离的抗体或其抗原结合片段特异性结合间皮素、优选人间皮素。
实施方案61a为一种分离的抗体或抗原结合片段,其中所述分离的抗体或抗原结合片段包含:
i.包含互补决定区1(CDR1)、CDR2和CDR3的单结构域抗体(sdAb),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:34、102和170;
b.分别为SEQ ID NO:54、122和190;
c.分别为SEQ ID NO:55、123和191;
d.分别为SEQ ID NO:61、129和197;
e.分别为SEQ ID NO:31、99和167;
f.分别为SEQ ID NO:32、100和168;
g.分别为SEQ ID NO:33、101和169;
h.分别为SEQ ID NO:35、103和171;
i.分别为SEQ ID NO:36、104和172;
j.分别为SEQ ID NO:37、105和173;
k.分别为SEQ ID NO:38、106和174;
l.分别为SEQ ID NO:39、107和175;
m.分别为SEQ ID NO:40、108和176;
n.分别为SEQ ID NO:41、109和177;
o.分别为SEQ ID NO:42、110和178;
p.分别为SEQ ID NO:43、111和179;
q.分别为SEQ ID NO:44、112和180;
r.分别为SEQ ID NO:45、113和181;
s.分别为SEQ ID NO:46、114和182;
t.分别为SEQ ID NO:47、115和183;
u.分别为SEQ ID NO:48、116和184;
v.分别为SEQ ID NO:49、117和185;
w.分别为SEQ ID NO:50、118和186;
x.分别为SEQ ID NO:51、119和187;
y.分别为SEQ ID NO:52、120和188;
z.分别为SEQ ID NO:53、121和189;
aa.分别为SEQ ID NO:56、124和192;
bb.分别为SEQ ID NO:57、125和193;
cc.分别为SEQ ID NO:58、126和194;
dd.分别为SEQ ID NO:59、127和195;
ee.分别为SEQ ID NO:60、128和196;
ff.分别为SEQ ID NO:62、130和198;
gg.分别为SEQ ID NO:63、131和199;
hh.分别为SEQ ID NO:64、132和200;
ii.分别为SEQ ID NO:65、133和201;
jj.分别为SEQ ID NO:66、134和202;
kk.分别为SEQ ID NO:67、135和203;或
ll.分别为SEQ ID NO:68、136和204;或
ii.包含重链互补决定区1(HCDR1)、HCDR2、HCDR3、轻链互补决定区1(LCDR1)、LCDR2和LCDR3的单链可变片段(scFv),所述互补决定区具有以下多肽序列:
a.分别为SEQ ID NO:1、69、137、2、70和138;
b.分别为SEQ ID NO:19、87、155、20、88和156;
c.分别为SEQ ID NO:23、91、159、24、92和160;
d.分别为SEQ ID NO:25、93、161、26、94和162;
e.分别为SEQ ID NO:27、95、163、28、96和164;
f.分别为SEQ ID NO:29、97、165、30、98和166;
g.分别为SEQ ID NO:3、71、139、4、72和140;
h.分别为SEQ ID NO:5、73、141、6、74和142;
i.分别为SEQ ID NO:7、75、143、8、76和144;
j.分别为SEQ ID NO:9、77、145、10、78和146;
k.分别为SEQ ID NO:11、79、147、12、80和148;
l.分别为SEQ ID NO:13、81、149、14、82和150;
m.分别为SEQ ID NO:15、83、151、16、84和152;
n.分别为SEQ ID NO:17、85、153、18、86和154;或
o.分别为SEQ ID NO:21、89、157、22、90和158,
其中分离的抗体或其抗原结合片段特异性结合间皮素、优选人间皮素。
实施方案62为实施方案61或61a的分离的抗体或抗原结合片段,其中所述抗体或抗原结合片段包含:
i.单结构域抗体,其包含与选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入,或
ii.单链可变片段,其包含与选自由SEQ ID NO:205-220组成的组中的氨基酸序列至少95%相同的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案62a为实施方案61或61a的分离的抗体或抗原结合片段,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列或其变异体,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列或其变异体,优选地,所述变异体包含一个、两个、三个或更多个氨基酸取代、缺失和/或插入。
实施方案62b为实施方案61或61a的分离的抗体或抗原结合片段,其中所述抗原结合片段包含:
i.单结构域抗体,其包含选自由SEQ ID NO:221-258和SEQ ID NO:420-428组成的组中的氨基酸序列;或
ii.单链可变片段,其包含选自由SEQ ID NO:205-220组成的组中的氨基酸序列。
实施方案63为实施方案61至62b中任一项的分离的抗体或抗原结合片段,其中所述抗体或其抗原结合片段为嵌合的。
实施方案64为实施方案61至62b中任一项的分离的抗体或抗原结合片段,其中所述抗体或其抗原结合片段为人或人源化的。
实施方案65为一种分离的核酸,其编码实施方案61至64中任一项的分离的抗体或其抗原结合片段。
实施方案66为一种载体,其包含实施方案65的分离的核酸。
实施方案67为一种宿主细胞,其包含实施方案66的载体。
实施方案68为一种药物组合物,其包含实施方案61至64中任一项的分离的抗体或其抗原结合片段和药学上可接受的载剂。
实施方案69为一种治疗有需要的受试者的癌症的方法,所述方法包括向所述受试者施用实施方案68的药物组合物。
实施方案70为一种产生实施方案61至64中任一项的抗体或其抗原结合片段的方法,所述方法包括在产生所述抗体或其抗原结合片段的条件下培养包含编码所述抗体或其抗原结合片段的核酸的细胞,和自所述细胞或培养物中回收所述抗体或其抗原结合片段。
实施方案71为一种产生药物组合物的方法,所述药物组合物包含实施方案61至64中任一项的抗体或其抗原结合片段,所述方法包括将所述抗体或其抗原结合片段与药学上可接受的载剂组合以获得药物组合物。
实施方案72为一种分离的多核苷酸,其包含编码融合蛋白的第一核苷酸序列,其中所述融合蛋白自N端至C端包含特异性结合到滤泡刺激素受体(FSHR)的第一多肽、以及选自由CD3-γ链、CD3-δ链和CD3-ε链组成的组中的CD3多肽的胞外结构域、跨膜结构域和胞内结构域。
实施方案73为实施方案72的分离的多核苷酸,其中所述CD3多肽的胞外结构域包含分别选自由SEQ ID NO:433至435组成的组中的氨基酸序列;所述跨膜结构域包含分别选自由SEQ ID NO:436至438组成的组中的氨基酸序列;并且所述胞内结构域包含分别选自由SEQ ID NO:439至441组成的组中的氨基酸序列。
实施方案74为实施方案72或73的分离的多核苷酸,其中所述第一多肽包含选自由SEQ ID NO:319-331组成的组中的氨基酸序列。
实施方案74a为实施方案74的分离的多核苷酸,其中所述融合蛋白包含选自由SEQID NO:442-444组成的组中的氨基酸序列。
实施方案75为实施方案72至74a中任一项的分离的多核苷酸,还包含编码嵌合抗原受体(CAR)的第二核苷酸序列,其中所述CAR包含:(a)胞外结构域,其包含特异性结合到肿瘤抗原的抗原结合片段;(b)跨膜结构域;和(c)胞内信号传导结构域。
实施方案76为实施方案75的分离的多核苷酸,其中所述CAR为实施方案10-11a和20中任一项的CAR。
实施方案76a为实施方案76的分离的多核苷酸,其中所述CAR包含选自由以下组成的组中的跨膜结构域:CD8α跨膜结构域、CD28跨膜结构域、CD4跨膜结构域、CD3ζ跨膜结构域、CD2跨膜结构域、4-1BB跨膜结构域、OX40跨膜结构域、ICOS跨膜结构域、CTLA-4跨膜结构域、PD-1跨膜结构域、LAG-3跨膜结构域、2B4跨膜结构域、BTLA跨膜结构域和GMCSFR跨膜结构域。
实施方案76b为实施方案76的分离的多核苷酸,其中所述CAR包含选自由以下组成的组中的胞内信号传导结构域:CD3ζ、FcRγ、FcRβ、CD3γ、CD3δ、CD3ε、CD5、CD22、CD79α、CD79β和CD66δ的信号传导结构域。
实施方案76c为实施方案76的分离的多核苷酸,其中所述CAR包含选自由以下一个或多个的共刺激结构域组成的组中的共刺激结构域:CD28、4-1BB(CD137)、CD27、OX40、CD27、CD40、PD-1、ICOS、淋巴细胞功能相关抗原-1(LFA-1)、CD2、CD7、LIGHT、NKG2C、B7-H3、TNFRSF9、TNFRSF4、TNFRSF8、CD40LG、ITGB2、KLRC2、TNFRSF18、TNFRSF14、HAVCR1、LGALS9、CD83和与CD83特异性结合的配体。
实施方案77为实施方案76的分离的多核苷酸,其编码具有选自由SEQ ID NO:454-456组成的组中的氨基酸序列的蛋白质。
实施方案78为实施方案72至77中任一项的分离的多核苷酸,其还包含第三核苷酸序列,所述第三核苷酸序列编码免疫细胞的细胞介导免疫反应的抑制剂的显性负性形式,优选为转化生长因子β(TGF-β)受体的显性负性形式。
实施方案78a为实施方案78的分离的多核苷酸,其中所述抑制剂的显性负性形式包含SEQ ID NO:347的氨基酸序列。
实施方案79为实施方案78或78a的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和/或第三核苷酸序列经由2A肽编码序列彼此连接。
实施方案79a为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第一核苷酸序列、第二核苷酸序列和第三核苷酸序列的顺序连接。
实施方案79b为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第二核苷酸序列、第一核苷酸序列和第三核苷酸序列的顺序连接。
实施方案79c为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第三核苷酸序列、第一核苷酸序列和第二核苷酸序列的顺序连接。
实施方案79d为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第三核苷酸序列、第二核苷酸序列和第一核苷酸序列的顺序连接。
实施方案79e为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第二核苷酸序列、第三核苷酸序列和第一核苷酸序列的顺序连接。
实施方案79f为实施方案79的分离的多核苷酸,其中第一核苷酸序列、第二核苷酸序列和第三核苷酸序列自N端至C端以第一核苷酸序列、第三核苷酸序列和第二核苷酸序列的顺序连接。
实施方案80为实施方案79的分离的多核苷酸,其编码包含选自由SEQ ID NO:469-471组成的组中的氨基酸序列的蛋白质。
实施方案81为一种用于诱导免疫细胞和/或靶细胞的活性的系统,所述系统包含工程改造的细胞,所述细胞包含修饰的TCR复合体,所述复合体包含由实施方案72-80的多核苷酸编码的融合蛋白。
实施例
除非另有规定,否则以下提供的实施例仅用于例示的目的,而不旨在限制。因此,本发明决不应被视为限于以下实施例,而应解释为涵盖将由本文所提供的教导变得显而易见的任何和所有变型。
实施例1:抗间皮素抗体的选择
有待用于CAR构建体中的间皮素结合结构域衍生自噬菌体文库的淘选。用于CAR构建体中的间皮素结合结构域可涵盖scFv或sdAb。
动物免疫
将包含具有C端6-His标签的重组人间皮素蛋白(R&D Systems,目录号3265-MS;Minneapolis,MN)的免疫原与佐剂或PBS混合,然后注射到小鼠或骆驼中。通常,以1周至2周的时间间隔对动物进行免疫2-4次。在多轮免疫之后,通过经由酶联免疫吸附测定(ELISA)和流式细胞测定两者进行血清滴定来评估针对靶抗原的免疫反应。
噬菌体展示文库构建
根据制造商的协议,使用试剂,自免疫小鼠或免疫骆驼的淋巴细胞中提取总RNA。根据制造商的协议,使用PRIMESCRIPTTM第一链cDNA合成试剂盒,基于具有寡(dT)20引物的RNA模板合成cDNA。自小鼠cDNA扩增VH与VL以生成scFv噬菌体文库。自骆驼cDNA扩增VHH以生成VHH噬菌体文库。
抗间皮素抗体的生物淘选和分离
将构建的scFv噬菌体文库和VHH噬菌体文库分别针对人间皮素蛋白和表达间皮素的肿瘤细胞进行淘选。将经由淘选获得的输出噬菌体颗粒用于感染指数生长的大肠杆菌TG1细胞以生成用于筛选的单一克隆。关于对间皮素的结合力随机挑选和筛选单独的克隆。选择特定的结合物并定序以鉴别独特的抗间皮素scFv或sdAb克隆。
实施例2:抗间皮素抗体的人源化
选择3个抗间皮素骆驼sdAb克隆:AS65233、AS80444和AS80533用于人源化。简言之,应用CDR移植方法:将sdAb的3个CDR插入人框架中,然后在框架区中插入若干回复突变以维持抗体的结构与结合性质。将3种人源化sdAb变异体(VH4、VH5、VH6)分别针对AS65233、AS80444和AS80533(SEQ ID NO:420-428)进行设计。为了证实sdAb的结合亲和力,表达具有人IgG1Fc的骆驼sdAb与人源化sdAb融合物并利用真核表达系统来纯化。执行表面等离子体共振(SPR)以测定纯化的骆驼sdAb与人源化sdAb对人间皮素的亲和力。如表1中所示,骆驼sdAb与人源化sdAb之间的亲和力差距小于3倍。
表1:通过SPR测定的抗间皮素sdAb的亲和力
实施例3:抗间皮素CAR构建体的制备
抗间皮素scFv和sdAb片段的互补决定区(CDR)的氨基酸序列提供于表2中,并且全长抗间皮素scFV和sdAb氨基酸序列提供于表3中。使用具有用于生成全CAR构建体的额外序列的表2的scFv或sdAb片段生成全CAR构建体。SS1 scFv(SEQ ID NO:313)为小鼠抗间皮素scFv,其用于生成CAR构建体作为参照(SS1 CAR)。M5 scFv(SEQ ID NO:314)为人抗间皮素scFv,其用于生成CAR构建体作为参照(M5 CAR)。TC-210为先前描述的非常规CAR构建体,其包含融合至CD3ε链(SEQ ID:429)的人源化抗间皮素sdAb,TC-210还用作参照。全长抗间皮素CAR构建体自N端至C端含有:CD8α信号肽(SEQ ID NO:340)、间皮素结合结构域scFv或sdAb(SEQ ID NO:205-258和SEQ ID NO:420-428)、CD8α铰链结构域(SEQ ID NO:341)、CD8α跨膜结构域(SEQ ID NO:342)、CD137胞内结构域(SEQ ID NO:343)和CD3ζ胞内结构域(SEQID NO:345)。抗间皮素CAR构建体的示意图示于图1A-1B中。接着使用用于表达的人EF1α启动子(SEQ ID NO:339)将CAR片段克隆至慢病毒载体中以产生在单编码框架中的全长抗间皮素CAR构建体。将所得CAR主链载体命名为“PLLV-hEF1α-间皮素CAR”。
表2:抗间皮素scFV和sdAb CDR氨基酸序列
表3:抗间皮素scFV和sdAb氨基酸序列
实施例4:抗间皮素CAR-T的生成
慢病毒的制备
将包含pCMV-△R-8.47和pMD2.G(Addgene,目录号12259;Cambridge,MA)的慢病毒包装质粒混合物与载体PLLV-hEF1α-间皮素以与聚乙烯亚胺的预优化比率预混合,然后添加HEK293细胞。过夜孵育之后收集上清液。将含病毒的上清液经由0.45μm PES过滤器过滤,然后进行超离心以使慢病毒浓缩。将病毒沉淀块用预冷却的DPBS冲洗。将病毒适当地等分,接着立即储存于-80℃下。经由流式细胞测定,通过测量supT1细胞系的转导效率来确定病毒滴度。
T淋巴细胞的收集与转导
通过分离术自健康供体处收集白血球。根据制造商的协议,使用FICOLL-PAQUETMPLUS介质分离外周血单核细胞(PBMC)。根据制造商的协议,使用Pan T细胞分离试剂盒(Miltenyi,目录号130-096-535;Bergisch Gladbach,Germany)自PBMC中纯化人T细胞。随后根据制造商的协议,用人T细胞激活/扩增试剂盒(Miltenyi,目录号130-091-441)预激活纯化的T细胞持续48小时,其中以1:2的珠粒:细胞比率添加抗CD3/CD28 MACSiBead颗粒。在7μg/ml凝聚胺存在下用慢病毒储备液转导预激活的T细胞。接着将转导的细胞转移到细胞培养孵育器中以便在合适条件下进行转基因表达。
实施例5:抗间皮素CAR-T的体外活性的评价
体外细胞毒性测定
OVCAR-8细胞是表达间皮素与FSHR两者的人卵巢癌细胞系,其在以下研究中用作靶细胞以评价CAR-T的活性。在转导后第5天或第9天,收获转导的T细胞并且与比率为7.5:1的效应细胞(CAR-T)与靶细胞(OVCAR-8)共孵育20小时。SS1 CAR-T、M5 CAR-T和TC-210用作对照。对照SS1 CAR-T和M5 CAR-T在所有测定中用于比较测定变异和/或充当对照。未转导的T细胞(UnT)用作阴性对照。
通过乳酸脱氢酶(LDH)测定测定细胞毒性。结果表明,M5CAR-T、AS51674 CAR-T、AS60676 CAR-T、TC-210、AS65233CAR-T、AS65691 CAR-T、AS80444 CAR-T和AS80533 CAR-T展现针对OVCAR-8细胞的体外强抗肿瘤活性,而SS1 CAR-T展示次等体外活性,UnT则没有杀伤效果(图7和图8)。
IFNγ释放测定
另外,自体外细胞毒性测定收集上清液以评估CAR诱导的细胞因子释放,例如干扰素γ(IFNγ)释放。如图9和图10中所示,M5CAR-T、AS51674 CAR-T、AS60702 CAR-T、AS91156CAR-T、AS91189 CAR-T、AS92110 CAR-T、AS65233 CAR-T、AS65271 CAR-T和AS80533 CAR-T由OVCAR-8刺激以产生IFNγ,而SS1 CAR-T产生较少IFNγ,UnT则几乎不产生IFNγ。
通过重复刺激进行的长期扩增测定
第0天(转导后4天),将2×105个OVCAR-8细胞涂于6孔板中以建立单层。第1天,计数T细胞并将1×106个活的CAR+T细胞在细胞因子不存在下涂于新鲜培养基中的OVCAR-8细胞的顶部。第3天,将新的2×105个OVCAR-8细胞单层如第0天中一样涂板。第4天,计数活的CAR-T细胞。第4天,将来自扩增(具有至少此数量的细胞)的孔的1×106个CAR+T细胞如第1天中一样重新涂板于新的单层上。重复过程历时3-4次重复刺激。将每次刺激之后的倍数扩增计算为[第4天的活CAR+T细胞]/1×106,即在每次刺激的第1天涂板的CAR-T细胞的量。为了针对每次新刺激时丢弃的细胞进行归一化,通过[(倍数扩增)×(倍数扩增+1)……]确定累积倍数扩增。如图11中所示,在与靶细胞的3轮共培养之后,AS51674 CAR-T、AS80444CAR-T、AS80533 CAR-T、AS80533VH4 CAR-T和AS60702 CAR-T展现比M5 CAR-T和TC-210更佳的扩增能力。
实施例6:在体内小鼠模型中抗间皮素CAR-T的评价
在OVCAR-8异种移植模型中体内评估抗间皮素CAR-T的抗肿瘤活性。在第0天,将10×106个OVCAR-8细胞皮下植入NOD scidγ(NSG)小鼠中。一旦肿瘤达到150-200mm3,便将小鼠随机分到治疗组中。以200μl剂量静脉内施用0.33×106个CAR阳性T细胞(M5CAR-T、TC-210、抗间皮素CAR-T、UnT)。在肿瘤细胞植入后监测小鼠和肿瘤持续约60天。
如图12中所示,AS80533VH4 CAR-T有效地根除小鼠中的肿瘤并导致无肿瘤。AS80444 CAR-T还在体内显著消退肿瘤。然而,M5CAR-T将肿瘤生长抑制了约50%,而TC-210几乎不能抑制肿瘤生长。通过输注UnT未观察到肿瘤抑制效果。CAR-T输注之后65天,10×106个OVCAR-8细胞在AS80533VH4 CAR-T治愈的小鼠中皮下重新激发。肿瘤保持在初次治疗的小鼠中生长,而重新激发的肿瘤在AS80533VH4治愈的小鼠中则根除。这些结果表明AS80533VH4CAR-T以相对较低的剂量(0.33×106个CAR阳性T细胞)根除肿瘤并且提供体内长期保护(大于100天)。
实施例7:滤泡刺激素受体(FSHR)于卵巢肿瘤细胞系上的表达的检测
将FSHβ33-53肽(SEQ ID NO:319)与人IgG的Fc区在C端处融合,接着瞬时产生并自HEK293F细胞中纯化。用标准方法执行HEK293F细胞中的瞬时表达和纯化。简言之,用100μg质粒和300μg聚乙烯亚胺转染100ml浓度为3×106个细胞/ml的HEK293F细胞。将细胞在37℃下用8%CO2孵育并在80rpm下旋转。6天之后,通过在3500×g下离心20分钟收获细胞。通过使Fc融合FSHβ33-53肽结合到蛋白A琼脂糖珠粒来纯化上清液。将所述蛋白质用柠檬酸盐缓冲液洗脱并且针对磷酸盐缓冲盐水(PBS)透析。
为了证实FSHR于卵巢肿瘤细胞系上的表达,经由流式细胞测定测试Fc融合FSHβ33-53肽(SEQ ID NO:332)对于OVCAR-3细胞、OVCAR-8细胞和HEK293F细胞(阴性对照)的结合力。荧光激活细胞分选(FACS)数据(图13)展示,Fc融合FSHβ33-53肽特异性结合到OVCAR-3细胞和OVCAR-8细胞,并且不结合到HEK293对照细胞,表明FSHR在卵巢肿瘤细胞系上表达。
实施例8:FSHR TCR复合体的制备
将FSHβ33-53肽融合至CD3ε链、γ链或δ链以便以FSHR依赖性和MHC非依赖性方式进行TCR/CD3复合体信号传导。将这种TCR复合体命名为FSHR TCR复合体。因此,FSHR TCR复合体包含融合蛋白,所述融合蛋白自N端至C端包含CD3ε、CD3γ或CD3δ信号肽(SEQ ID NO:430-432);FSHβ33-53肽(SEQ ID NO:319);接头;CD3ε、CD3γ或CD3δ胞外结构域(SEQ IDNO:433-435);CD3ε、CD3γ或CD3δ跨膜结构域(SEQ ID NO:436-438);以及CD3ε、CD3γ或CD3δ胞内结构域(SEQ ID NO:439-441)。包含融合构建体的FSHR TCR复合体的示意图示于图2A-图2B中,所述融合构建体具有融合至CD3ε胞外结构域的FSHβ33-53肽。还可制备相似的FSHR TCR复合体,其具有融合至CD3γ或CD3δ胞外结构域的FSHβ33-53肽。接着将所述融合蛋白的编码序列克隆至慢病毒载体中以便在单编码框架中产生FSHR TCR构建体,使用人EF1α启动子用于表达。将所得CAR主链载体命名为“PLLV-hEF1α-FSHR TCR”。
实施例9:FSHR/间皮素串联CAR构建体的制备
将FSHβ33-53肽融合至抗间皮素CAR的CD8α信号肽与抗间皮素scFv或sdAb片段之间以生成含有间皮素和FSHR结合结构域的串联CAR构建体。接头序列(选自SEQ ID NO:334-338)用于将FSHβ33-53肽的C端连接到抗间皮素scFv或sdAb片段的N端。因此,全长FSHR/间皮素串联CAR自N端至C端含有:CD8α信号肽、FSHβ33-53肽、接头、间皮素结合结构域scFv或sdAb、CD8α铰链结构域、CD8α跨膜结构域、CD137胞内结构域和CD3ζ胞内结构域。串联CAR构建体的示意图示于图3A-3D中。接着将CAR片段克隆至慢病毒载体中以便在单编码框架中产生串联CAR构建体,使用人EF1α启动子用于表达。将所得的CAR主链载体命名为“PLLV-hEF1α-串联”。
实施例10:间皮素/FSHR双重CAR构建体的制备
FSHβ33-53肽用于生成包含CD28胞内结构域和CD3ζ胞内结构域的第二代CAR构建体。接着将靶向FSHR的CAR经由2A元件(SEQ ID NO:346)在C端连接到抗间皮素CAR。因此,全长间皮素/FSHR双重CAR自N端至C端含有:CD8α信号肽(SEQ ID NO:340)、间皮素结合结构域scFv或sdAb(SEQ ID NO:205-258和SEQ ID NO:420-428)、CD8α铰链结构域(SEQ ID NO:341)、CD8α跨膜结构域(SEQ ID NO:342)、CD137胞内结构域(SEQ ID NO:343)、CD3ζ胞内结构域(SEQ ID NO:345)、2A元件(SEQ ID NO:346)、CD8α信号肽(SEQ ID NO:340)、FSHβ33-53肽(SEQ ID NO:319)、CD8α铰链结构域(SEQ ID NO:341)、CD8α跨膜结构域(SEQ ID NO:342)、CD28胞内结构域(SEQ ID NO:344)和CD3ζ胞内结构域(SEQ ID NO:345)。双重CAR构建体的示意图示于图4A-图4B中。接着将CAR片段克隆至慢病毒载体中以便在单编码框架中产生双重CAR构建体,使用人EF1α启动子用于表达。将所得CAR主链载体命名为“PLLV-hEF1α-双重”。
实施例11:间皮素/FSHR CAR/TCR构建体的制备
接着将FSHR TCR经由2A元件(SEQ ID NO:346)在C端连接到抗间皮素CAR。因此,全长间皮素/FSHR CAR/TCR自N端至C端含有:CD8α信号肽(SEQ ID NO:340)、间皮素结合结构域scFv或sdAb(SEQ ID NO:205-258和SEQ ID NO:420-428)、CD8α铰链结构域(SEQ ID NO:341)、CD8α跨膜结构域(SEQ ID NO:342)、CD137胞内结构域(SEQ ID NO:343)、CD3ζ胞内结构域(SEQ ID NO:345)、2A元件(SEQ ID NO:346)、CD3ε信号肽(SEQ ID NO:430)、FSHβ33-53肽(SEQ ID NO:319)、接头、CD3ε胞外结构域(SEQ ID NO:433)、CD3ε跨膜结构域(SEQ IDNO:436)和CD3ε胞内结构域(SEQ ID NO:439)。CAR/TCR构建体的示意图示于图5A-图5B中。接着将CAR片段克隆至慢病毒载体中以便在单编码框架中产生CAR/TCR构建体,使用人EF1α启动子用于表达。将所得CAR主链载体命名为“PLLV-hEF1α-CAR/TCR”。
使用类似方法,还可制备含有FSHR TCR复合体的间皮素/FSHR CAR/TCR构建体,所述复合体具有融合至CD3γ或CD3δ胞外结构域的FSHβ33-53肽。
实施例12:用dnTGFβRII铠装的CAR构建体的制备
通过截短人TGFβRII以移除如最初报告的残基199处的胞内激酶结构域(SEQ IDNO:347)来构建显性负性TGFβRII(dnTGFβRII)(Wieser R等人,Molecular and cellularbiology.1993;13∶7239-7247)。dnTGFβRII经由P2A元件在N端或C端处连接到CAR或TCR复合体的组分。分别制备dnTGFβRII铠装的抗间皮素CAR、dnTGFβRII铠装的FSHR TCR、dnTGFβRII铠装的FSHR/间皮素串联CAR、dnTGFβRII铠装的间皮素/FSHR双重CAR、dnTGFβRII铠装的间皮素/FSHR CAR/TCR。dnTGFβRII铠装的CAR和/或TCR构建体的示意图示于图6A-图6L中。接着将编码CAR和/或TCR构建体的核酸克隆至慢病毒载体中以便在单编码框架中产生具有dnTGFβRII的CAR构建体,使用人EF1α启动子用于表达。将所得CAR主链载体命名为“PLLV-hEF1α-dnTGFβRII铠装的CAR”。
实施例13:不同CAR/TCR构建体的体外活性的评价
如上所述制备含有不同CAR/TCR构建体的转基因的慢病毒。通过将慢病毒转导至原代T细胞中分别生成具有不同模式(抗间皮素CAR、FSHR TCR、FSHR/间皮素串联CAR、间皮素/FSHR双重CAR、间皮素/FSHR CAR/TCR、dnTGFβRII铠装的CAR)的CAR-T细胞。
抗间皮素CAR和FSHR/间皮素串联CAR的体外活性
通过LDH测定评价AS51674 CAR-T和基于AS51674的FSHR/间皮素串联CAR-T的体外细胞毒性。FSHβ33-53肽经由短接头或长接头在N端或C端处连接到AS51674,然后与分别对应于以下各物的第二代CAR构建体合并:FSH33-53+AS51674-SL、AS51674+FSH33-53-SL、FSH33-53+AS51674-LL、51674+FSH33-53-LL。结果指明FSHR/间皮素串联CAR具有与抗间皮素CAR相当的针对OVCAR-8细胞的杀伤功效,而UnT则没有杀伤效果(图14)。
抗间皮素CAR、间皮素/FSHR双重CAR和间皮素/FSHR CAR/TCR的体外活性
通过LDH测定评价AS51674 CAR-T、基于AS51674的间皮素/FSHR双重CAR-T、AS80533VH4 CAR-T、基于AS80533VH4的间皮素/FSHR双重CAR-T和基于AS80533VH4的间皮素/FSHR CAR/TCR-T的体外细胞毒性。结果指明基于AS51674的间皮素/FSHR双重CAR-T具有与AS51674 CAR-T相当的针对OVCAR-8细胞的杀伤功效,基于AS80533VH4的间皮素/FSHR双重CAR-T、基于AS80533VH4的间皮素/FSHR CAR/TCR-T具有与AS80533VH4CAR-T相当的针对OVCAR-8细胞的杀伤功效,而UnT则没有杀伤效果(图15)。
裸(未dnTGFβRII铠装)CAR和dnTGFβRII铠装的CAR的体外活性
如先前所述,dnTGFβRII在N端(dnTGFβRII+CAR)或C端(CAR+dnTGFβRII)处连接到CAR构建体。通过LDH测定评价AS51674CAR-T和dnTGFβRII铠装的AS51674 CAR-T的体外细胞毒性。结果指明dnTGFβRII铠装的AS51674 CAR-T具有比AS51674 CAR-T更佳的针对OVCAR-8细胞的杀伤功效,而UnT则没有杀伤效果(图16)。
除此之外,通过LDH测定评价基于AS80533VH4的间皮素/FSHR双重CAR-T、基于AS80533的间皮素/FSHR CAR/TCR-T和相应的dnTGFβRII铠装的CAR-T的体外细胞毒性。结果表明dnTGFβRII铠装的CAR-T具有与裸CAR-T相当的针对OVCAR-8细胞的杀伤功效,而UnT则没有杀伤效果(图17)。
另外,自体外细胞毒性测定收集上清液以评估CAR诱导的细胞因子释放,例如,干扰素γ(IFNγ)和肿瘤坏死因子α(TNFα)释放。如图18和图19中所示,基于AS80533VH4的间皮素/FSHR双重CAR-T、基于AS80533的间皮素/FSHR CAR/TCR-T和相应的dnTGFβRII铠装的CAR-T由OVCAR-8刺激以产生相当的IFNγ和TNFα水平,而UnT则几乎不产生IFNγ和TNFα。
实施例14:抗间皮素CAR与间皮素/FSHR双重CAR的体内功效比较
在OVCAR-8异种移植模型中体内评估AS51674 CAR-T和基于AS51674的间皮素/FSHR双重CAR-T的抗肿瘤活性。第0天,将10×106个OVCAR-8细胞皮下植入NSG小鼠中。一旦肿瘤达到150-200mm3,便将小鼠随机分到治疗组中。以200μl剂量静脉内施用0.33×106个CAR阳性T细胞。如图20中所示,基于AS51674的间皮素/FSHR双重CAR-T有效地根除小鼠中的肿瘤,而AS51674CAR-T几乎不抑制肿瘤生长。通过输注UnT未观察到肿瘤抑制效果。
此外,还在OVCAR-8异种移植模型中体内评估AS80533VH4CAR-T和基于AS80533VH4的间皮素/FSHR双重CAR-T的抗肿瘤活性。类似地,当肿瘤达到150-200mm3时,以200μl剂量将0.11×106个CAR阳性T细胞静脉内施用至携带肿瘤的NSG小鼠中。如图21中所示,间皮素/FHSR双重CAR-T有效地根除所有4只小鼠中的肿瘤且导致无肿瘤,而抗间皮素CAR-T仅消退4只小鼠的3只中的肿瘤。通过输注UnT未观察到肿瘤抑制效果。这些结果表明间皮素/FSHR双重CAR-T比抗间皮素CAR-T具有更有效的体内抗肿瘤功效。
实施例15:裸CAR和dnTGFβRII铠装的CAR的体内功效比较
在OVCAR-8异种移植模型中体内评价基于AS80533VH4的间皮素/FSHR双重CAR-T、基于AS80533的间皮素/FSHR CAR/TCR-T和相应的dnTGFβRII铠装的CAR-T的抗肿瘤活性。类似地,当肿瘤达到150-200mm3时,以200μl剂量将0.1×106个CAR阳性T细胞静脉内施用至携带肿瘤的NSG小鼠中。如图22中所示,dnTGFβRII铠装的CAR-T比相应的裸CAR-T更有效地抑制肿瘤生长,对于间皮素/FSHR双重CAR和间皮素/FSHR CAR/TCR两者而言。此外,间皮素/FSHR CAR/TCR比间皮素/FSHR双重CAR在体内更有效一点。通过输注UnT未观察到肿瘤抑制效果。这些结果表明dnTGFβRII铠装可增强CAR-T的体内功效。
本领域技术人员应理解可在不偏离广泛的发明概念的情况下对如上所述的实施方案进行改变。因此,应理解本发明不限于所公开的具体实施方案,但旨在涵盖如本说明书中所定义的本发明的精神和范畴内的修改。
根据本发明的实施方案的例示性构建体的序列:
SEQ ID NO:205(AD58126 scFv氨基酸序列;CDR加下划线)
QVQLKQSGAELAKPGASVEMSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSTGHTDYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGKPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPLTFGSGTRLEIK
SEQ ID NO:206(AD58126VH3VL1 scFv氨基酸序列;CDR加下划线)
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIK
SEQ ID NO:207(AD58116 scFv氨基酸序列;CDR加下划线)
QVQLKESGPELVKPGASVKISCKTSGYTFTEYTMNWVRQSHGKSLEWIGGIIPNNGDTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCAGRFAYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQAPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWFLQRPGQSPKRLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQ GTHFPFTFGSGTKLEIK
SEQ ID NO:208(AD58117 scFv氨基酸序列;CDR加下划线)
QVQLQQSGPELKKPGETVKISCKASFYTFTAYSMHWVKQAPGKGLKWMGWINTETGEPTYADDFKGRFAFSLETSATTAYLQINNLKNEDTATFFCARGLRRFAYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPTSLAVSLGQRATISCRASESVDSYGNSFMNWYQQKPGQPPKLLIYLASYLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPYTFGGGTRLEIK
SEQ ID NO:209(AD58127 scFv氨基酸序列;CDR加下划线)
QVQLQQSGAELVRPGASVTLSCKASGYTFTDYEIHWVKQTPVHGLEWIGGIDPETGGAAYTQKFKGKATLTADKSSSTAYMELRSLTSEDSAVYYCTTYGNYPLDSWGQGTTLTVSSGGGGSGGGGSGGGGSGIVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPLTFGAGTRLEIK
SEQ ID NO:210(AD58143 scFv氨基酸序列;CDR加下划线)
QVQLKQSGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGGIDPETGGAAYTQKFKGKATPTADKSSSTAYMELRSLTSEDSAVYYCTTYGNYPLDSWGQGTTVTVSSGGGGSGGGGSGGGGSDIQMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISGVEAEDLGVYFCSQSTHVPLTFGAGTKLELK
SEQ ID NO:211(AD58159 scFv氨基酸序列;CDR加下划线)
QVQLKQSGAELVRPGTSVKISCKASGYTITNYWLGWVKQRPGHGLEWIGDIYPGGGYTNYNEKFKGKATLTADTSSITAYMQLSSLTSEDSAVYFCARGGSSYWYFDVWGAGTSVTVSSGGGGSGGGGSGGGGSDIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQ QYSKVPYTFGGGTKLELK
SEQ ID NO:212(AD58115 scFv氨基酸序列;CDR加下划线)
QVQLKQSGPELVKPGASVKISCKTSGYTFTEYTMNWVKQSHGKSLEWIGGIIPNNGDTSYKQEFKGKATLTVDKSSSTAYMELRSLTSDDSAVYYCAGRFAYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWFLQRPGQSPKRLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCWQ GTHFPFTFGSGTKLEIK
SEQ ID NO:213(AD58123 scFv氨基酸序列;CDR加下划线)
EVQLQQSGPGLVAPSQSLSITCTVSGFSLSRYSVHWVRQPPGKGLEWLGMIWGGGNTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARSLGWYFDIWGAGTTVTVSSGGGGSGGGGSGGGGSDIVMTQSPSSLAVSAGEKVTMSCKSSQSVLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSWTFGGGTKLEIK
SEQ ID NO:214(AD58145 scFv氨基酸序列;CDR加下划线)
EVQLQQSGAELAKPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSTGYTDYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPLTFGAGTKLELK
SEQ ID NO:215(AS51489 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQ GFSYYPITFGQGTKVEIK
SEQ ID NO:216(AS51491 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNLYSYSMHWVRQAPGKGLEWVAYIYPYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQSYY WLFTFGQGTKVEIK
SEQ ID NO:217(AS92110 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASS GYHYLITFGQGTKVEIK
SEQ ID NO:218(AS91156 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPY YHPITFGQGTKVEIK
SEQ ID NO:219(AS91189 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYW YYPITFGQGTKVEIK
SEQ ID NO:220(AS51674 scFv氨基酸序列;CDR加下划线)
EVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIK
SEQ ID NO:221(AS66073 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGDSVQAGGSLTLACTGRKYSSLYCMAWFRQAPGKAREGVAVISSGGFTNYADSVKGRFTISRDNSKNTLYLAMNGLKPEDTAMYYCAAGLSYCHSSTATATYRGQGTQVTVSS
SEQ ID NO:222(AS66439 sdAb氨基酸序列;CDR加下划线)
QMQLVESGGGSVQAGGSLRLSCTAPGFTSSDCDMDWYRQAAGNQREWVSSLLSTDGSTSYADSVRGRFTISKDPAKDTVYLQMNSLKPEDTAMYFCRCVVAEWGGMDYWGKGTLVTVSS
SEQ ID NO:223(AS65955 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCAASGDRVSTGCMGWFRQGPGEEREGLAQIHNYNIAKYADSVKGRFTISKDNAKNILYLQMNSLKPEDTGLYICTAPVDCSWSMFLQDPLALSPPRGQGTQVTVSS
SEQ ID NO:224(AS65233 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSS
SEQ ID NO:225(AS65926 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLRLSCAASGNLYNNMCMGWFRQAPGKEREGVASIYIGGGYTNYADSVKGRFTISPISRDNAKSTLYLQMNSLKPEDTAMYYCAAVSIALTREFCAPIVSRYNYWGQGTQVTVSS
SEQ ID NO:226(AS66159 sdAb氨基酸序列;CDR加下划线)
QVRLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSS
SEQ ID NO:227(AS66416 sdAb氨基酸序列;CDR加下划线)
QVQLAESGGGSVQAGGSLRLSCAASGNLYNNMCMGWFRQAPGKEREGVGSIYIGGGYTNYSESVRGRFTISLDNAKKTLNLQMNSLKPEDTAMYYCAAIPIALTRAFCAPIVSRYTYWGQGTQVTVSS
SEQ ID NO:228(AS65850 sdAb氨基酸序列;CDR加下划线)
EVQLMESGGGSVQAGGSLRLSCAASGFSYSNICMGWFRQAPGKEREGVAAIYSNGSTIYADSVKGRFTVSKEFAKNTQYLQMNSLKPEDTAMYYCAAGRCGGPNYWGQGTQVTVSS
SEQ ID NO:229(AS65183 sdAb氨基酸序列;CDR加下划线)
EVQLAESGGGSAQAGGSLRLSCASNGYYNRRYCMAWFRQAPGKEREGVATMTTTSGRTYYADAVKGRFTVSQDNAKSTLYLQMSSLKPEDTAMYYCAAHLPSSWVTSTDYCDNLQAGFYNSWGQGTQVTVSS
SEQ ID NO:230(AS65062 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCAASGVSVVNFAMRWYRQAPGNEREFVSAMYRSGSTSYADSVRGRFTISRDSALNTVFLQMSGLKPEDTATYYCQATSPMGDTYWGQGTQVTVSS
SEQ ID NO:231(AS65065 sdAb氨基酸序列;CDR加下划线)
EVQLAESGGGSVQAGGSLRLSCAASGYSYCRSTMRWYRQAPGNVREFVSAIYSDGTTSYTDSVKGRFTISQDNAKNTVYLQMNSLQPEDTAMYYCRIDLVGCNVAGGSPYWGQGTQVTVSS
SEQ ID NO:232(AS65556 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQVGGSLRLSCAASGYNASICRMSWYRQAPGTEREFVSSSYRDGSQSYADSVKGRFTTSRDSAKNTVFLQMNSLKPSDTAMYYCNAACPWRAYWGQGTQVTVSS
SEQ ID NO:233(AS65069 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCVASGDTGYQPTMRWYRQAPGKEREFVSAIYSDQTTSYADSVKGRFTISQDNARKTVYLQMASLKPEDTAMYYCKLTTRRGSEYWGQGTQVTVSS
SEQ ID NO:234(AS65691 sdAb氨基酸序列;CDR加下划线)
QMQLVESGGGSVQAGGSLRLSCTVSGYTDYRLVLRWYRQALGKEREFISAIYSDGVTSYSDSVKGRFTISRDNAKNTAYLQMNSLKSEDTAMYYCKATGSGGVAYWGQGTQVTVSS
SEQ ID NO:235(AS65064 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLKLSCAVSGDTVQTNCMAWFRQAPGKEREAVASILSLYSSGGKTVYADSVKGRFTISPDNAQNTVSLQMNNLKPEDTAMYYCATVRVTVTWAEKLRRCTGFSGMDYWGKGTLVTVSS
SEQ ID NO:236(AS65081 sdAb氨基酸序列;CDR加下划线)
QVHLMESGGGSVQAGGSLRLSCAASGVPASSYCMGWFRQAPGKEREGVAGIVSDTTTTYADSVKGRFTISKDNAKNTLYLQMNSLKPEDTATYYCAASHFLLCARKPRWDDLIKYEYWGQGTQVTVSS
SEQ ID NO:237(AS65115 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLRLSCAASGYIYGCMGWFRRAPGKAREEVATIYRDGTAYYANSVEGRFTASRNNAENTLSLEMNSLNAEDTAMYYCAARTTGCNWDISGVYWGQGTQVTVSS
SEQ ID NO:238(AS65271 sdAb氨基酸序列;CDR加下划线)
QMQLVESGGGSVQAGGSLTLSCAASGKTYGRCMAWFRQAPGKERELVAATYISGGRPYVADSVKGRFTISRDNAKSTMSLQMNSLRPDDSAMYYCAAGSAGRGPCDRFDQNQYTFWGQGTQVTVSS
SEQ ID NO:239(AS65166 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLRLSCTASEDLSIYGYNCMGWFRQAPGKEREAVAAIYTGRGTTYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCASKYCAVVADFGNSRLVRYWGQGTQVTVSS
SEQ ID NO:240(AS65450 sdAb氨基酸序列;CDR加下划线)
QVRLVESGGGSVQAGGSLRLSCAASGDMNGYKCMGWFRQAPGKEREAVAGIYTGRGTTYYADSVKDRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAAKYCAVVAEFGGPRLVRYWGQGTQVTVSS
SEQ ID NO:241(AS65454 sdAb氨基酸序列;CDR加下划线)
QVRLVESGGGSVQAGGSLRLSCAASGDMNGYKCMGWFRQAPGKEREAVAGIYTGRNTTYYADSVKDLFTISQDNAQNTVFLQMNSLKPEDTAMYYCASYCAVVAEFRGPRLDRYWGYGTQVTVTS
SEQ ID NO:242(AS65131 sdAb氨基酸序列;CDR加下划线)
EVQLAESGGGSVQAGGSLTLSCTASEYVTHLGWFRQAPGKEREGVAIESFRIGYTYYADSVKGRFTISHDNAKNTLYLQMNSLKPEDTAIYYCAARQDRSGASMVNRDSYNYWGKGTQVTVSS
SEQ ID NO:243(AS65182 sdAb氨基酸序列;CDR加下划线)
QVKLVESGGGSVQAGGSLRLSCAASGYTYSYGYMGWFRQAPGKEREGVAKIYNGDGSTYYADSVKGRFTISQDRRNNTLYLQMNSLAPEDTGMYYCATNRLPNSDVDLVLPRFGRFGYWGQGTQVTVSS
SEQ ID NO:244(AS60685 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSS
SEQ ID NO:245(AS60702 sdAb氨基酸序列;CDR加下划线)
QVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSS
SEQ ID NO:246(AS60705 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQSGGSLRLSCAASGYAYSGSCMMAWFRQAPGKEREGVAVSVRRTGSAFYADSVKARFTISRDNAKNTLYLQMNNLKVEDTAMYYCAADFTCRTWTLNKNYNHWGQGTQVTVSS
SEQ ID NO:247(AS60660 sdAb氨基酸序列;CDR加下划线)
QVHLMESGGGSVQAGGSLRLSCVASGDTGYQPTMRWYRQAPGKEREFVSAIYSDQTTSYADSVKGRFTISQDNARKTVYLQMASLKPEDTAMYYCKLTTRRGSEYWGQGTQVTVSS
SEQ ID NO:248(AS60662 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCVASGYRNCRSTMRWYRQGPGQVRDWVSSIYTDGTTSYTDSVKGRFTIAQDKGKNTVYLQMNSLQPEDTAMYYCRIDLVGCNVAGGSPYWGHGTQVTVSS
SEQ ID NO:249(AS60664 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLTLSCAASGKTYGRCMAWFRQAPGKERELVAATYISGGRPYVADSVKGRFTISRDNAKSTMSLQMNSLRPDDSAMYYCAAGSAGRGPCDRFDQNQYTFWGQGTQVTVSS
SEQ ID NO:250(AS60668 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCAASGDMNGYKCMGWFRQAPGKEREAVAGIYTGRNTTYYADSVKDRFTISQDNAKNTVFLQMNSLKPEDTAMYYCASKYCAVVAEFGGPRLVRYWGQGTQVTVSS
SEQ ID NO:251(AS60676 sdAb氨基酸序列;CDR加下划线)
QVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSS
SEQ ID NO:252(AS60678 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQAGGSLRLSCAVSGYTSSRGCMSWFRQAPGKERERVAYINMRVLTTIYAASVKDRFAISRDNAKNTVDLQMNNLKPEDTAMYYCAAGYNGQWCEHASDVTAWGQGTQVTVSS
SEQ ID NO:253(AS60679 sdAb氨基酸序列;CDR加下划线)
QVHLMESGGGSVQAGGSLRLSCARSGVTYCRLTMRWYRQAPGSEREFVSAIYSDGSTAYADSVKGRFTMSQDDAKNTVYLQMNSVKPEDTAMYYCKLNCASGLTAWGQGTQVTVSS
SEQ ID NO:254(AS81326 sdAb氨基酸序列;CDR加下划线)
EVQLVESGGGSVQAGGSLTLSCAASESRDCMAWFRQAPGKAREGVASIYAPDGSTTYADTVKGRFTISQDNAKNTLYLQMNSLQPEDAAMYHCAIGGLSRNTCGYLRGGYFAYFGRGTQVTVSS
SEQ ID NO:255(AS81187 sdAb氨基酸序列;CDR加下划线)
QVRLVESGGGSVQAGGSLRLSCAASGYTYSSYSSNCLGWFRQAPGKEREAVARIYPNSGSTYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAVAVGVGDNWCASGAAYFGYWGQGTQVTVSS
SEQ ID NO:256(AS80533 sdAb氨基酸序列;CDR加下划线)
QVHLVESGGGSVQTGGSLRLSCTASGLSFSTYTVAWFRQAPGKEREGVAAIPYTSQHMVYTDSVKGRFTISRDNTKNMVYLQMNSLKPEDTAMYYCATDRRPGTSMLAINGYNRWGQGTQVTVSS
SEQ ID NO:257(AS80444 sdAb氨基酸序列;CDR加下划线)
EVQLAESGGGSVQAGGSLRLSCAASGFTFSRNTMGWFRQAPGKEREGVAAIPYTSTGIVYSDSVGGRFTISRDNTKNMVYLQMNNLEPEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTQVTVSS
SEQ ID NO:258(AS81487 sdAb氨基酸序列;CDR加下划线)
QVRLVESGGGSVQAGGSLRVSCLVSKLTAWRSCVGWFRQAPGKEREGVAAIYSGTGSTYYADSVKGRFTIAQDYAKNMVYLQMNSLKPEDTAMYYCAGTSIRSSCGLVRDEYAYWGQGTQVTVSS
SEQ ID NO:259(AD58126 scFv核酸序列)
CAGGTGCAGCTGAAGCAGTCTGGGGCTGAACTGGCAAAACCTGGGGCCTCAGTGGAGATGTCCTGCAAGGCTTCTGGCTACACCTTTACTAGCTACTGGATGCACTGGGTAAAACAGAGGCCTGGACAGGGTCTGGAATGGATTGGATACATTAATCCTAGTACTGGTCATACTGACTACAATCAGAAGTTCAAGGACAAGGCCACATTGACTGCAGACAAATCCTCCAGCACAGCCTACATGCAACTGAGCAGCCTGACATCTGAGGACTCTGCAGTCTATTACTGTGCAAGATCCAACTGGGCCTGGTTTCCTTACTGGGGCCAAGGGACTCTGGTCACTGTCTCGAGCggtggaggcggttcaggcggaggtggctctggcggtggcgggtcgGACATTGTGATGACTCAGTCTCCATCCTCCCTGACTGTGACAGCAGGAGAGAAGGTCACTATGAGCTGCAAGTCCAGTCAGAGTCTGTTAAACAGTGGAAATCAAAAGAACTACTTGACCTGGTACCAGCAGAAACCAGGGAAGCCTCCTAAACTGTTGATCTACTGGGCATCCACTAGGGAATCTGGGGTCCCTGATCGCTTCACAGGCAGTGGATCTGGAACAGATTTCACTCTCACCATCAGCAGTGTGCAGGCTGAAGACCTGGCAGTTTATTACTGTCAGAATGATTATAGTTATCCGCTCACGTTCGGTTCTGGGACCAGACTGGAAATAAAA
SEQ ID NO:260(AD58126VH3VL1 scFv核酸序列)
CAGGTGCAGCTGGTGCAGTCCGGAGCAGAGGTGAAGAAGCCAGGAGCCAGCGTGAAGGTGTCCTGCAAGGCCTCTGGCTACACCTTCACAAGCTATTGGATGCACTGGGTGAAGCAGGCACCAGGACAGGGACTGGAGTGGATCGGCTACATCAATCCCTCCACAGGCCACACCGACTATAACCAGAAGTTTAAGGATCGGGCCACCCTGACAGCCGACACCTCTACAAGCACCGTGTACATGGAGCTGAGCTCCCTGAGGTCCGAGGATACAGCCGTGTACTATTGCGCCCGCTCTAATTGGGCCTGGTTCCCCTATTGGGGCCAGGGCACACTGGTGACCGTGTCTAGCGGAGGAGGAGGATCCGGAGGAGGAGGATCTGGCGGCGGCGGCAGCGATATCGTGATGACACAGTCCCCTGACTCTCTGGCCGTGTCTCTGGGAGAGAGGGCAACCATCAACTGTAAGTCCTCTCAGAGCCTGCTGAACTCCGGCAATCAGAAGAACTACCTGACCTGGTATCAGCAGAAGCCTGGCCAGCCCCCTAAGCTGCTGATCTACTGGGCATCTACAAGGGAGAGCGGAGTGCCAGATAGATTCTCCGGCTCTGGCAGCGGCACCGACTTTACACTGACCATCAGCTCCCTGCAGGCCGAGGATGTGGCCGTGTACTATTGTCAGAATGACTACAGCTATCCCCTGACATTTGGCGGCGGCACCAAGCTGGAGATCAAG
SEQ ID NO:261(AD58116 scFv核酸序列)
CAGGTGCAGCTGAAGGAGTCTGGACCTGAGCTGGTGAAGCCTGGGGCTTCAGTGAAGATATCCTGCAAGACTTCTGGATACACATTCACTGAATACACCATGAACTGGGTGAGGCAGAGCCATGGAAAGAGCCTTGAGTGGATTGGAGGTATTATTCCTAACAATGGTGATACTAGCTACAACCAGAAGTTCAAGGGCAAGGCCACATTGACTGTAGACAAGTCCTCCAGCACAGCCTACATGGAACTCCGCAGCCTGACATCTGAGGATTCTGCAGTCTATTACTGTGCAGGGCGGTTTGCTTACTGGGGCCAAGGGACTCTGGTCACTGTCTCGAGCggtggaggcggttcaggcggaggtggctctggcggtggcgggtcgGATATTGTGATGACCCAGGCTCCACTCACTTTGTCGGTTACCATTGGACAACCAGCCTCCATCTCTTGCAAGTCAAGTCAGAGCCTCTTAGATAGTGATGGAAAGACATATTTGAATTGGTTCTTACAGAGGCCAGGCCAGTCTCCAAAGCGCCTAATCTATCTGGTGTCTAAACTGGACTCTGGAGTCCCTGACAGGTTCACTGGCAGTGGATCAGGGACAGATTTCACACTGAAAATCAGCAGAGTGGAGGCTGAGGATTTGGGAGTTTATTATTGCTGGCAAGGTACACATTTTCCATTCACGTTCGGCTCGGGCACAAAGTTGGAAATAAAA
SEQ ID NO:262(AD58-1-17scFv核酸序列)
CAGGTCCAGCTGCAGCAGTCTGGACCTGAGCTGAAGAAGCCTGGAGAGACCGTCAAGATCTCCTGCAAGGCTTCTTTTTATACCTTCACAGCCTATTCAATGCACTGGGTGAAGCAGGCTCCAGGAAAGGGTTTAAAGTGGATGGGCTGGATAAACACTGAGACTGGTGAGCCAACATATGCAGATGACTTCAAGGGACGGTTTGCCTTCTCTTTGGAAACCTCTGCCACCACTGCCTATTTGCAGATCAACAACCTCAAAAATGAGGACACGGCTACATTTTTCTGTGCTAGGGGACTACGGCGGTTTGCTTACTGGGGCCAGGGGACTCTGGTCACTGTCTCGAGCggtggaggcggttcaggcggaggtggctctggcggtggcgggtcgGACATTGTGATGACACAGTCTCCAACTTCTTTGGCTGTGTCTCTAGGGCAGAGGGCCACCATATCCTGCAGAGCCAGTGAAAGTGTTGATAGTTATGGCAATAGTTTTATGAATTGGTACCAGCAGAAACCAGGACAGCCACCCAAACTCCTCATCTATCTTGCATCCTACCTAGAATCTGGGGTCCCTGCCAGGTTCAGTGGCAGTGGGTCTAGGACAGACTTCACCCTCACCATTGATCCTGTGGAGGCTGATGATGCTGCAACCTATTACTGTCAGCAAAATAATGAGGATCCGTACACGTTCGGAGGGGGGACCAGACTGGAAATAAAA
SEQ ID NO:263(AD58127 scFv核酸序列)
CAGGTTCAGCTGCAGCAGTCTGGGGCTGAACTGGTGAGGCCTGGGGCTTCAGTGACGCTGTCCTGCAAGGCTTCGGGCTACACATTTACTGACTATGAAATTCACTGGGTGAAGCAGACACCTGTGCATGGCCTGGAATGGATTGGAGGTATTGATCCTGAAACTGGTGGTGCTGCCTACACTCAGAAGTTCAAGGGCAAGGCCACACTGACTGCAGACAAATCCTCCAGCACAGCCTACATGGAGCTCCGCAGCCTGACATCTGAGGACTCTGCCGTCTATTACTGTACAACTTATGGTAACTACCCCCTTGACTCCTGGGGCCAAGGCACCACTCTCACAGTCTCGAGCggtggaggcggttcaggcggaggtggctctggcggtggcgggtcgGGTATTGTGATGACCCAGACTCCACTCTCCCTGCCTGTCAGTCTTGGAGATCAAGCCTCCATCTCTTGCAGATCTAGTCAGAGCCTTGTACACAGTAATGGAAACACCTATTTACATTGGTACCTGCAGAAGCCAGGCCAGTCTCCAAAGCTCCTGATCTACAAAGTTTCCAACCGATTTTCTGGGGTCCCAGACAGGTTCAGTGGCAGTGGATCAGGGACAGATTTCACACTCAAGATCAGCAGAGTGGAGGCTGAGGATCTGGGAGTTTATTTCTGCTCTCAAAGTACACATGTTCCGCTCACGTTCGGTGCTGGGACCAGACTGGAAATAAAA
SEQ ID NO:264(AD58143 scFv核酸序列)
CAGGTGCAACTGAAGCAGTCTGGGGCTGAACTGGTGAGGCCTGGGGCTTCAGTGACGCTGTCCTGCAAGGCTTCGGGCTACACATTTACTGACTATGAAATGCACTGGGTGAAGCAGACACCTGTGCATGGCCTGGAATGGATCGGAGGTATTGATCCTGAAACTGGTGGTGCTGCCTACACTCAGAAGTTCAAGGGCAAGGCCACACCGACTGCAGACAAATCCTCCAGCACAGCCTACATGGAGCTCCGCAGCCTGACATCTGAGGACTCTGCCGTCTATTACTGTACAACTTATGGTAACTACCCCCTTGACTCCTGGGGCCAAGGCACCACGGTCACCGTCTCGAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGATATCCAGATGACACAGACTCCACTCTCCCTGCCTGTCAGTCTTGGAGATCAAGCCTCCATCTCTTGCAGATCTAGTCAGAGCCTTGTACACAGTAATGGAAACACCTATTTACATTGGTACCTGCAGAAGCCAGGCCAGTCTCCAAAGCTCCTGATCTACAAAGTTTCCAACCGATTTTCTGGGGTCCCAGACAGGTTCAGTGGCAGTGGATCAGGGACAGATTTCACACTCAAGATCAGCGGAGTGGAGGCTGAGGATCTGGGAGTTTATTTCTGCTCTCAAAGTACACATGTTCCGCTCACGTTCGGTGCTGGGACCAAGCTGGAGCTGAAA
SEQ ID NO:265(AD58159 scFv核酸序列)
CAGGTGCAACTGAAGCAGTCTGGAGCTGAGCTGGTAAGGCCTGGGACTTCAGTGAAGATATCCTGCAAGGCTTCTGGCTACACCATCACTAACTACTGGCTAGGTTGGGTAAAGCAGAGGCCAGGACATGGACTTGAGTGGATTGGAGATATTTACCCTGGAGGTGGTTATACTAACTACAATGAGAAGTTCAAGGGCAAGGCCACACTGACTGCAGACACATCCTCCATCACTGCCTACATGCAGCTCAGTAGCCTGACATCTGAGGACTCTGCTGTCTATTTCTGTGCAAGAGGCGGTAGTAGCTACTGGTACTTCGATGTCTGGGGCGCAGGGACCTCAGTCACCGTCTCGAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGATATCCAGATGACACAGACTACATCCTCCCTGTCTGCCTCTCTGGGAGACAGAGTCACCATCAGTTGCAGTGCAAGTCAGGACATTAGCAATTATTTAAACTGGTATCAGCAGAAACCAGATGGAACTGTTAAACTCCTGATCTATTACACATCAAGTTTACACTCAGGAGTCCCATCAAGGTTCAGTGGCAGTGGGTCTGGGACAGATTATTCTCTCACCATCAGCAACCTGGAACCTGAAGATATTGCCACTTACTATTGTCAGCAGTATAGTAAGGTTCCGTACACGTTCGGAGGGGGGACCAAGCTGGAGCTGAAA
SEQ ID NO:266(AD58115 scFv核酸序列)
CAGGTGCAGCTGAAGCAGTCTGGACCTGAGCTGGTGAAGCCTGGGGCTTCAGTGAAGATATCCTGCAAGACTTCTGGATACACATTCACTGAATACACCATGAACTGGGTGAAGCAGAGCCATGGAAAGAGCCTTGAGTGGATTGGAGGAATTATTCCTAACAATGGTGATACTAGCTACAAACAGGAGTTCAAGGGCAAGGCCACATTGACTGTAGACAAGTCCTCCAGCACAGCCTACATGGAGCTCCGCAGCCTGACATCTGACGATTCTGCAGTCTATTACTGTGCAGGGCGGTTTGCTTACTGGGGCCAAGGGACTCTGGTCACTGTCTCGAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGATATTGTGATGACCCAGACTCCACTCACTTTGTCGGTTACCATTGGACAACCAGCCTCCATCTCTTGCAAGTCAAGTCAGAGCCTCTTAGATAGTGATGGAAAGACATATTTGAATTGGTTCTTACAGAGGCCAGGCCAGTCTCCAAAGCGCCTAATCTATCTGGTGTCTAAACTGGACTCTGGAGTCCCTGACAGGTTCACTGGCAGTGGATCAGGGACAGATTTCACACTGAAAATCAGCAGAGTGGAGGCTGAGGATTTGGGAGTTTATTATTGCTGGCAAGGTACACATTTTCCATTCACGTTCGGCTCGGGCACAAAGTTGGAAATAAAA
SEQ ID NO:267(AD58123 scFv核酸序列)
GAGGTCCAGCTGCAGCAGTCAGGACCTGGCCTGGTGGCACCCTCACAGAGCCTGTCCATCACATGCACTGTCTCTGGGTTCTCATTATCCAGATATAGTGTACACTGGGTTCGCCAGCCTCCAGGAAAGGGTCTGGAGTGGCTGGGAATGATATGGGGTGGTGGAAACACAGACTATAATTCAGCTCTCAAATCCAGACTGAGCATCAGCAAGGACAACTCCAAGAGCCAAGTTTTCTTAAAAATGAACAGTCTGCAAACTGATGACACAGCCATGTACTACTGTGCCAGAAGCCTGGGCTGGTACTTCGATATCTGGGGCGCAGGGACCACGGTCACCGTCTCGAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATTGTGATGACACAGTCGCCATCATCTCTGGCTGTGTCTGCAGGAGAAAAGGTCACTATGAGCTGTAAGTCCAGTCAAAGTGTTTTATACAGTTCAAATCAGAAGAACTACTTGGCCTGGTACCAGCAGAAACCAGGGCAGTCTCCTAAACTGCTGATCTACTGGGCATCCACTAGGGAATCTGGTGTCCCTGATCGCTTCACAGGCAGTGGATCTGGGACAGATTTTACTCTTACCATCAGCAGTGTACAAGCTGAAGACCTGGCAGTTTATTACTGTCATCAATACCTCTCCTCGTGGACGTTCGGTGGAGGCACAAAGCTGGAAATCAAA
SEQ ID NO:268(AD58145 scFv核酸序列)
GAGGTTCAGCTGCAACAGTCTGGGGCTGAACTGGCAAAACCTGGGGCCTCAGTGAAGATGTCCTGCAAGGCTTCTGGCTACACCTTTACTAGCTACTGGATGCACTGGGTAAAACAGAGGCCTGGACAGGGTCTGGAATGGATTGGATACATTAATCCTAGCACTGGTTATACTGACTACAATCAGAAGTTCAAGGACAAGGCCACATTGACTGCAGACAAATCCTCCAGCACAGCCTACATGCAACTGAGCAGCCTGACATCTGAGGACTCTGCAGTCTATTACTGTGCAAGATCCAACTGGGCCTGGTTTCCTTACTGGGGCCAAGGGACTCTGGTCACTGTCTCGAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACACAGTCTCCATCCTCCCTGACTGTGACAGCAGGAGAGAAGGTCACTATGAGCTGCAAGTCCAGTCAGAGTCTGTTAAACAGTGGAAATCAAAAGAACTACTTGACCTGGTACCAGCAGAAACCAGGGCAGCCTCCTAAACTGTTGATCTACTGGGCATCCACTAGGGAATCTGGGGTCCCTGATCGCTTCACAGGCAGTGGATCTGGAACAGATTTCACTCTCACCATCAGCAGTGTGCAGGCTGAAGACCTGGCAGTTTATTACTGTCAGAATGATTATAGTTATCCGCTCACGTTCGGTGCTGGGACCAAGCTGGAGCTGAAA
SEQ ID NO:269(AS51489 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACCTCTATTATTATTCTATCCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATATATTTCTTCTTCTTCTAGCTATACTTATTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCTACTACCCGTACTACGGTATGGACTACTGGGGTCAAGGCACCCTGGTTACCGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAAGGTTTCTCTTACTACCCGATCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:270(AS51491 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACCTCTATTCTTATTCTATGCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATATATTTATCCTTATTCTGGCTCTACTTATTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCGGTTACGGTATGGACTACTGGGGTCAAGGCACCCTGGTTACCGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAATCTTACTACTGGCTGTTCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:271(AS92110 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACATCTATTATTCTTCTATGCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATATATTTATCCTTATTATAGCTATACTTATTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCGGTTACGCTTTGGACTACTGGGGTCAAGGCACCCTGGTTACCGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAAGCTTCTTCTGGTTACCATTACCTGATCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:272(AS91156 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACATCTATTCTTCTTCTATCCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATCTATTTCTTCTTATTCTAGCTATACTTCTTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCTACTACGCTATGGACTACTGGGGTCAAGGCACCCTGGTTACCGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAAGGTCCGTACTACCATCCGATCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:273(AS91189 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACCTCTCTTATTCTTCTATCCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATCTATTTATTCTTATTCTGGCTCTACTTATTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCTACTGGGGTATGGACTACTGGGGTCAAGGCACCCTGGTTACCGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAATACTACTGGTACTACCCGATCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:274(AS51674 scFv核酸序列)
GAGGTTCAACTGGTGGAGAGCGGTGGTGGTCTGGTTCAGCCGGGTGGTAGCCTGCGTCTGAGCTGCGCAGCTTCTGGCTTCAACCTCTATTCTTATTATATGCACTGGGTGCGTCAGGCGCCGGGTAAAGGCCTGGAATGGGTTGCATCTATTTATTCTTATTCTAGCTATACTTCTTATGCCGATAGCGTCAAGGGCCGTTTCACCATCAGCGCGGATACCAGCAAAAACACCGCATACCTGCAAATGAACAGCCTGCGTGCGGAAGATACCGCCGTCTATTATTGTGCTCGCCCGTTCGGTTGGGGTTACGCTGGTATGGACTACTGGGGTCAAGGCACCCTGGTTACTGTGAGCAGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGGTCGGACATCCAGATGACCCAGAGCCCGAGCAGCCTGAGCGCGAGCGTTGGTGACCGTGTTACCATTACCTGCCGTGCGAGCCAGAGCGTTAGCAGCGCGGTGGCGTGGTACCAGCAAAAGCCGGGTAAAGCGCCGAAGCTGCTGATCTATAGCGCGAGCAGCCTGTATAGCGGCGTTCCGAGCCGTTTCAGCGGTAGCCGTAGCGGCACCGACTTTACCCTGACCATTAGCAGCCTGCAGCCGGAAGATTTCGCAACTTATTACTGTCAGCAAGGTTACGCTCCGATCACGTTCGGACAGGGCACCAAAGTTGAGATTAAA
SEQ ID NO:275(AS66073 sdAb核酸序列)
CAGGTTCAGCTGGTGGAGTCTGGGGGAGACTCGGTGCAGGCTGGGGGGTCTCTGACACTCGCCTGTACAGGGCGTAAATACAGCAGTCTATACTGCATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGCGCGCGAGGGGGTCGCAGTTATTAGCAGTGGCGGCTTCACAAATTACGCTGACTCCGTAAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATCTGGCAATGAACGGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAGGCCTATCCTATTGCCATTCAAGCACAGCAACCGCCACGTACCGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:276(AS66439 sdAb核酸序列)
CAGATGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGGGGGTCTCTGAGACTCTCCTGCACAGCCCCTGGATTCACCTCCAGTGACTGCGACATGGACTGGTACCGCCAGGCTGCAGGGAATCAGCGCGAATGGGTCTCATCTCTTCTTAGTACTGACGGTAGCACAAGCTATGCGGACTCCGTGAGGGGCCGATTCACCATCTCCAAAGACCCAGCCAAGGACACGGTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACGGCCATGTATTTCTGTAGGTGTGTCGTGGCTGAGTGGGGCGGCATGGACTACTGGGGCAAAGGAACCCTGGTCACCGTCTCCTCA
SEQ ID NO:277(AS65955 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGCGACCGCGTCAGTACTGGCTGTATGGGCTGGTTCCGCCAGGGTCCAGGCGAGGAGCGCGAGGGGCTCGCACAAATTCACAATTATAATATCGCAAAGTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAAAGACAACGCCAAGAACATTCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGGCTTGTACATCTGTACGGCTCCTGTAGATTGTAGCTGGAGCATGTTTCTGCAAGACCCACTTGCGTTGTCTCCACCTAGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:278(AS65233 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGAATTCACGTACAGTATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGCGTCGCACATATTTACACTCGTGGTGGTACCACGGTCTATGCCGACTCCGTGAAGGGCCGATTCGTCCTCTCCCGATACAACGCCAAGAGCATAATGTATCTACAAATGAACAGCGTGAAACTTGAGGACACTGCCATGTATTACTGTGCGGCCCGGACCATATTCGAAGGTAGCTGGTCGTCCCCATCCTCGTTTGACTTCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:279(AS65926 sdAb核酸序列)
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGAAACCTCTACAATAACATGTGCATGGGCTGGTTCCGGCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAAGTATTTATATTGGTGGTGGTTACACCAACTATGCCGACTCCGTGAAGGGCCGATTCACCATCTCCCCCATCTCCCGAGACAACGCCAAGAGCACGCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAGTCTCCATCGCGCTTACGAGGGAATTCTGCGCCCCGATCGTTTCTCGGTATAATTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:280(AS66159 sdAb核酸序列)
CAGGTGAGGTTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCATGTGCAGCCTCTGGAAACGTCTACAATAACATGTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAAGTATCTATGTTGGTGGTGGTTACACCAACTATGCCGACTCCGTGAGGGGCCGATTCACCATCTCCCAAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAATTACCGTCGCGCTTACGAGGGCTTTCTGCGCCCCGATCCCTTCTCGGTATACCAACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:281(AS66416 sdAb核酸序列)
CAGGTGCAGCTGGCGGAGTCTGGGGGAGGTTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGAAACCTCTACAATAACATGTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGGAAGTATTTATATTGGTGGTGGTTACACCAACTATTCCGAATCCGTGAGGGGCCGATTCACCATCTCCCTAGACAACGCCAAGAAGACGCTGAATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAATCCCCATCGCGCTTACGAGGGCTTTCTGCGCCCCGATCGTTTCTCGGTATACGTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:282(AS65850 sdAb核酸序列)
GAGGTGCAGCTGATGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCTCCTACAGTAACATCTGTATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCGGCTATTTATAGTAATGGTAGCACAATCTACGCAGACTCCGTGAAGGGCCGATTCACCGTCTCCAAAGAATTCGCCAAGAACACTCAGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAGGCCGGTGTGGGGGCCCTAACTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:283(AS65183 sdAb核酸序列)
GAGGTGCAACTGGCGGAGTCTGGGGGAGGCTCGGCGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAAGCAATGGGTACTACAACCGTCGCTATTGTATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCGACTATGACTACTACTAGTGGTCGCACATACTATGCCGACGCCGTGAAGGGCCGATTCACCGTCTCCCAAGACAACGCCAAGTCCACGCTGTATCTGCAAATGAGCAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCGCACCTTCCCAGTTCTTGGGTGACGTCGACTGATTACTGCGACAACTTGCAAGCCGGCTTTTATAACTCCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:284(AS65062 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGAGTCAGCGTGGTTAACTTCGCCATGAGGTGGTACCGCCAGGCTCCAGGGAACGAGCGCGAGTTCGTCTCAGCGATGTACCGTTCTGGTAGCACGTCTTACGCTGACTCCGTGAGGGGCCGATTCACCATCTCCCGAGACAGCGCCTTGAACACGGTGTTTCTTCAAATGAGCGGCCTGAAACCTGAGGACACGGCCACGTATTACTGTCAAGCGACATCACCTATGGGCGACACCTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:285(AS65065 sdAb核酸序列)
GAGGTGCAACTGGCGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATACAGCTACTGTAGGTCCACCATGCGCTGGTACCGCCAGGCTCCAGGGAACGTGCGCGAATTTGTCTCAGCTATCTATAGTGATGGTACCACAAGCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCCAAGACAACGCCAAGAACACTGTGTATCTACAAATGAACAGCCTGCAACCTGAAGACACGGCCATGTATTACTGTCGGATAGATCTTGTCGGATGCAACGTAGCTGGTGGCAGTCCTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:286(AS65556 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGTTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATACAACGCCTCTATCTGCCGCATGAGCTGGTACCGCCAGGCTCCCGGGACTGAGCGCGAGTTCGTCTCATCGTCTTACAGGGATGGTAGCCAAAGCTACGCAGACTCCGTGAAGGGGCGATTCACCACATCCCGAGACTCCGCCAAGAACACGGTGTTTCTGCAAATGAACAGCCTGAAACCTTCGGACACGGCCATGTATTACTGTAACGCAGCTTGCCCCTGGCGGGCCTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:287(AS65069 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGTAGCCTCTGGAGACACCGGCTACCAACCTACGATGAGGTGGTACCGCCAGGCTCCAGGGAAGGAGCGCGAGTTCGTCTCCGCTATTTATAGTGATCAGACCACAAGCTATGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCCAAGACAACGCCAGAAAAACGGTGTATCTGCAAATGGCTAGCCTGAAACCTGAGGACACGGCCATGTATTACTGTAAACTCACTACTCGCAGGGGGTCTGAGTACTGGGGCCAGGGGACACAGGTCACCGTCTCCTCA
SEQ ID NO:288(AS65691 sdAb核酸序列)
CAGATGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTACAGTCTCTGGATACACCGACTATAGGCTCGTACTGAGGTGGTACCGCCAGGCTCTAGGGAAGGAGCGCGAGTTCATCTCAGCTATTTATAGTGATGGAGTCACAAGCTACTCAGACTCCGTGAAGGGCCGATTCACCATCTCCCGAGACAACGCCAAGAACACGGCGTATCTGCAAATGAACAGCCTGAAATCTGAGGACACGGCCATGTATTACTGTAAAGCAACCGGGTCCGGTGGCGTTGCCTACTGGGGCCAGGGAACCCAGGTCACCGTCTCCTCA
SEQ ID NO:289(AS65064 sdAb核酸序列)
CAGGTTCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAAACTCTCCTGTGCAGTCTCTGGAGACACCGTCCAGACTAACTGTATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGCGGTCGCCAGCATTTTGAGTCTTTATTCTAGTGGAGGTAAGACAGTCTATGCCGACTCCGTGAAGGGCCGATTCACCATCTCCCCAGACAACGCCCAGAACACGGTGTCGCTGCAAATGAACAATTTGAAACCTGAGGACACTGCCATGTACTACTGTGCGACTGTCCGCGTGACCGTCACTTGGGCCGAAAAGTTGAGGCGTTGTACCGGATTCAGCGGCATGGACTACTGGGGCAAAGGAACCCTGGTCACCGTCTCCTCA
SEQ ID NO:290(AS65081 sdAb核酸序列)
CAGGTGCACCTGATGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGAGTCCCCGCTAGTAGCTACTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAGGTATTGTCAGTGATACTACCACAACCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAAAGACAACGCCAAGAACACTCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCACGTACTACTGTGCGGCCTCCCATTTTCTATTGTGCGCCAGAAAACCCCGCTGGGATGACCTCATTAAATATGAGTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:291(AS65115 sdAb核酸序列)
CAGGTTCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGCGACTCTCCTGTGCAGCCTCTGGATACATTTACGGCTGCATGGGCTGGTTCCGCCGGGCTCCAGGGAAGGCGCGCGAGGAGGTTGCGACTATTTACCGCGATGGTACAGCATACTACGCAAACTCCGTAGAGGGCCGATTCACCGCCTCCAGAAACAACGCCGAGAACACTCTGTCTCTGGAGATGAACAGTCTGAACGCTGAGGACACTGCCATGTACTACTGTGCGGCAAGAACAACTGGTTGTAACTGGGACATATCTGGGGTTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:292(AS65271 sdAb核酸序列)
CAGATGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGACACTCTCCTGTGCAGCCTCTGGAAAAACCTACGGACGCTGCATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGTTAGTCGCTGCTACTTATATTAGTGGTGGGCGACCCTACGTTGCCGACTCCGTGAAGGGCCGATTCACCATTTCCCGGGACAACGCCAAGAGTACGATGTCTCTGCAAATGAACAGCCTGAGACCTGACGACAGCGCCATGTACTACTGTGCGGCGGGTTCGGCGGGTCGGGGACCTTGTGATCGCTTCGACCAAAATCAATATACCTTCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:293(AS65166 sdAb核酸序列)
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTACAGCCTCTGAAGACTTATCTATTTACGGTTACAATTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGCGGTCGCAGCTATTTATACTGGCCGTGGTACCACATACTATGCCGACTCCGTGAAGGGCCGATTCACCATCTCCCAAGACAACGCCAAGAACACTGTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGTCAAAATACTGTGCGGTGGTAGCTGATTTCGGGAATTCTCGACTCGTTCGTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:294(AS65450 sdAb核酸序列)
CAGGTGAGGTTAGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGAGACATGAACGGTTACAAGTGCATGGGGTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGCGGTCGCAGGTATTTATACTGGCCGTGGGACCACATACTATGCCGACTCCGTGAAGGACCGATTCACCATCTCCCAAGACAACGCCAAGAACACTGTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCAGCAAAATACTGTGCGGTGGTAGCTGAATTCGGGGGTCCTCGACTCGTTCGTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:295(AS65454 sdAb核酸序列)
CAGGTGAGGTTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTGTCCTGTGCAGCCTCTGGAGACATGAACGGTTACAAGTGCATGGGGTGGTTCCGCCAGGCTCCAGGGAAGGAGCGAGAGGCGGTCGCAGGTATTTATACTGGCCGTAATACTACATACTATGCCGACTCCGTGAAGGACCTATTCACCATCTCCCAAGACAACGCCTAGAACACTGTGTTTCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGTCATAATACTGTGCGGTGGTAGCTGAATTCCGGGGTCCTCGACTCGATCGTTACTGGGGCTATGGGACCCAGGTCACCGTCACCTCA
SEQ ID NO:296(AS65131 sdAb核酸序列)
GAGGTGCAGCTGGCGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGACACTCTCCTGTACAGCCTCTGAATACGTCACACACTTGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAATCGAAAGTTTTCGTATTGGTTATACATACTATGCCGACTCCGTGAAGGGTCGATTCACCATCTCCCACGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATATACTACTGTGCGGCTCGGCAGGACCGATCGGGGGCTTCCATGGTAAATCGAGATTCATATAATTACTGGGGCAAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:297(AS65182 sdAb核酸序列)
CAGGTGAAGTTAGTGGAGTCAGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCGTCTGGATACACGTACAGTTACGGCTACATGGGCTGGTTCCGGCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAAAGATTTATAATGGTGACGGTAGTACATACTATGCCGACTCCGTGAAGGGCCGATTCACCATCTCCCAAGACCGCCGCAACAACACGCTGTATCTGCAAATGAACAGTCTGGCACCTGAGGACACTGGCATGTACTACTGTGCGACAAACCGACTCCCAAATAGCGACGTTGACTTGGTCCTTCCCCGGTTCGGCCGTTTTGGTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:298(AS60685 sdAb核酸序列)
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGTAATGTCTACAATAACATGTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAAGTATGTATGTTGGTGGTGGTTACACCTACTATGACGACTCCGTGAAGGGCCGATTCACCATCTCCCGAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAAACCTGAAGACACTGCCATGTACTACTGTGCGGCAATCTCCATCGCGCTTACGAGGGAATTCTGCGCCCCGATCGTTTCTCGGTATAATTATTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:299(AS60702 sdAb核酸序列)
CAGGTGAAGTTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCATGTGCAGCCTCTGGAAACGTCTACAATAACATGTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAAGTATCTATGTTGGTGGTGGTTACACCAACTATGCCGACTCCGTGAGGGGCCGATTCACCATCTCCCAAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGCAATTACCGTCGCGCTTACGAGGGCTTTCTGCGCCCCGATCCCTTCTCGGTATACCAACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:300(AS60705 sdAb核酸序列)
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGTCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATACGCCTACAGTGGGTCTTGCATGATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAGTTAGCGTTCGTCGTACGGGAAGCGCATTCTATGCCGACTCCGTGAAGGCCCGATTCACCATCTCCCGCGACAATGCCAAGAACACGCTGTATCTGCAAATGAATAACCTGAAAGTTGAGGACACTGCCATGTACTACTGTGCGGCAGATTTTACTTGTCGTACGTGGACTCTCAATAAAAATTACAACCACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:301(AS60660 sdAb核酸序列)
CAGGTGCACCTGATGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGTAGCCTCTGGAGACACCGGCTACCAACCTACGATGAGGTGGTACCGCCAGGCTCCAGGGAAGGAGCGCGAGTTCGTCTCCGCTATTTATAGTGATCAGACCACAAGCTATGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCCAAGACAACGCCAGAAAAACGGTGTATCTGCAAATGGCTAGCCTGAAACCTGAGGACACGGCCATGTATTACTGTAAACTCACTACTCGCAGGGGGTCTGAGTACTGGGGCCAGGGGACACAGGTCACCGTCTCCTCA
SEQ ID NO:302(AS60662 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGTAGCCTCTGGATACAGGAACTGTAGGTCCACCATGCGCTGGTACCGCCAGGGTCCAGGACAGGTGCGAGACTGGGTCTCAAGTATCTATACTGATGGTACCACAAGCTACACAGACTCCGTGAAGGGCCGATTCACCATCGCCCAAGACAAAGGCAAGAACACGGTGTATCTACAAATGAACAGCCTGCAACCTGAAGACACGGCCATGTATTACTGTCGGATAGATCTTGTCGGATGCAATGTAGCTGGTGGCAGTCCTTACTGGGGCCATGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:303(AS60664 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGACACTCTCCTGTGCAGCCTCTGGAAAAACCTACGGACGCTGCATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGTTAGTCGCTGCTACTTATATTAGTGGTGGGCGACCCTACGTTGCCGACTCCGTGAAGGGCCGATTCACCATTTCCCGGGACAACGCCAAGAGTACGATGTCTCTGCAAATGAACAGCCTGAGACCTGACGACAGCGCCATGTACTACTGTGCGGCGGGTTCGGCGGGTCGGGGACCTTGTGATCGCTTCGACCAAAATCAATATACCTTCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:304(AS60668 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTGTCCTGTGCAGCCTCTGGAGACATGAACGGTTACAAGTGCATGGGGTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGCGGTCGCAGGTATTTATACTGGCCGTAATACTACATACTATGCCGACTCCGTGAAGGACCGATTCACCATCTCCCAAGACAACGCCAAGAACACTGTGTTTCTGCAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGTCAAAATACTGTGCGGTGGTAGCTGAATTCGGGGGTCCTCGACTCGTTCGTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:305(AS60676 sdAb核酸序列)
CAGGTGCAGCTGGTGGAGTCTGGGGGAGGGTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGCGCAGCCTCTGGATACACCGTCAGTAGCGGCTGCATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGCGGGTCGCACAGATTGGTCGTGATGCTACCACGACCTACGCAGACTCCGTGAAGGGCCGATTCACCATCGCCAGAGACGACGCCGAGAACACTCTGTATCTGCAAATGAACAGCCTGAAACCTGAAGACACTGCCATGTACAGCTGTACGGCCTATTGGGGTGTATACTGTTTATCTCCAGGACGCTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:306(AS60678 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGTCTCTGGATACACCTCCAGTCGCGGTTGCATGAGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGAGGGTCGCATACATTAATATGCGTGTCCTAACCACAATCTATGCCGCCTCCGTGAAGGACCGATTCGCCATCTCCAGAGACAACGCCAAGAACACGGTGGATCTGCAAATGAACAACCTGAAACCTGAGGACACTGCCATGTACTACTGCGCGGCGGGGTACAATGGACAATGGTGCGAACATGCTAGTGACGTTACTGCCTGGGGTCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:307(AS60679 sdAb核酸序列)
CAGGTGCACCTGATGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCACGCTCTGGAGTCACCTATTGTAGGTTGACCATGAGGTGGTACCGCCAGGCTCCAGGGAGCGAGCGCGAGTTCGTCTCCGCTATTTATAGTGATGGTAGCACAGCCTACGCAGACTCCGTGAAGGGTCGATTCACCATGTCCCAAGACGACGCCAAGAACACGGTGTATCTGCAAATGAACAGCGTGAAACCTGAGGACACGGCCATGTATTATTGTAAATTGAATTGTGCGTCCGGCTTGACTGCCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:308(AS81326 sdAb核酸序列)
GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGACACTCTCCTGTGCAGCCTCCGAGAGTAGGGATTGTATGGCCTGGTTCCGCCAGGCTCCAGGGAAGGCGCGCGAGGGGGTCGCATCTATTTATGCTCCGGATGGTAGCACAACCTATGCCGACACCGTGAAGGGCCGATTCACCATCTCCCAAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGCAACCTGAGGACGCTGCCATGTACCACTGTGCGATCGGGGGGCTGTCACGCAATACTTGTGGTTACCTCAGAGGCGGATACTTTGCTTACTTTGGCCGGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:309(AS81187 sdAb核酸序列)
CAGGTGAGGTTGGTGGAGTCTGGGGGCGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATACACCTACAGCAGCTACAGTAGCAACTGCCTGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGCAGTCGCACGTATCTATCCTAACAGTGGTAGCACATACTATGCCGACTCCGTGAAGGGCCGCTTCACCATCTCCCAAGACAACGCCAAGAACACGGTGTATCTACAAATGAACAGCCTGAAACCTGAGGACACTGCCATGTACTACTGTGCGGTAGCAGTGGGAGTCGGTGATAATTGGTGTGCGTCAGGGGCCGCATACTTTGGTTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:310(AS80533 sdAb核酸序列)
CAGGTGCACCTGGTGGAGTCTGGGGGAGGCTCGGTGCAGACTGGAGGGTCTCTAAGACTCTCCTGTACAGCCTCTGGACTCAGCTTCAGTACCTACACGGTGGCCTGGTTCCGCCAGGCTCCAGGAAAGGAGCGCGAGGGGGTCGCGGCTATTCCATATACTAGTCAACACATGGTCTATACCGACTCCGTGAAGGGCCGATTCACCATCTCCCGAGACAACACAAAGAACATGGTGTATCTGCAAATGAACAGCCTGAAACCGGAGGACACCGCCATGTACTACTGTGCGACAGATCGGCGCCCTGGAACGAGTATGTTGGCTATAAATGGGTATAACCGCTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:311(AS80444 sdAb核酸序列)
GAGGTGCAGCTGGCGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCGCAACACGATGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCGGCTATTCCATATACTAGTACTGGCATAGTCTATTCCGACTCCGTGGGCGGCCGATTCACCATCTCCCGAGACAACACAAAGAACATGGTGTATCTGCAAATGAACAACCTGGAACCGGAGGACACTGCCATGTACTACTGTGCGACAGATCGGCGCCCTGGAACGACTATGTTGGCGGTAAATGGGTATAACCACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:312(AS81487 sdAb核酸序列)
CAGGTGAGGTTGGTGGAGTCTGGGGGAGGCTCGGTGCAGGCTGGAGGGTCTCTGAGAGTCTCCTGTTTAGTCTCTAAACTCACCGCATGGCGCAGCTGCGTGGGCTGGTTCCGCCAGGCTCCAGGGAAGGAGCGCGAGGGGGTCGCAGCTATATATTCTGGTACTGGTAGTACATACTATGCCGACTCCGTGAAGGGCCGATTCACCATCGCCCAAGACTACGCCAAGAACATGGTGTACTTGCAAATGAACAGCCTGAAACCTGAAGACACTGCCATGTACTACTGTGCGGGCACGTCGATACGCAGCAGTTGTGGCTTAGTGCGCGATGAATACGCCTACTGGGGCCAGGGGACCCAGGTCACCGTCTCCTCA
SEQ ID NO:313(SS1 scFv氨基酸序列;CDR加下划线)
QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGQGTTVTVSSGGGGSGGGGSGGGGSDIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQ WSGYPLTFGAGTKLEI
SEQ ID NO:314(M5 scFv氨基酸序列;CDR加下划线)
QVQLVQSGAEVEKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCASGWDFDYWGQGTLVTVSSGGGGSGGGGSGGGGSGGGGSDIVMTQSPSSLSASVGDRVTITCRASQSIRYYLSWYQQKPGKAPKLLIYTASILQNGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQTYTTPDFGPGTKVEIK
SEQ ID NO:315(人间皮素氨基酸序列)
MALPTARPLLGSCGTPALGSLLFLLFSLGWVQPSRTLAGETGQEAAPLDGVLANPPNISSLSPRQLLGFPCAEVSGLSTERVRELAVALAQKNVKLSTEQLRCLAHRLSEPPEDLDALPLDLLLFLNPDAFSGPQACTRFFSRITKANVDLLPRGAPERQRLLPAALACWGVRGSLLSEADVRALGGLACDLPGRFVAESAEVLLPRLVSCPGPLDQDQQEAARAALQGGGPPYGPPSTWSVSTMDALRGLLPVLGQPIIRSIPQGIVAAWRQRSSRDPSWRQPERTILRPRFRREVEKTACPSGKKAREIDESLIFYKKWELEACVDAALLATQMDRVNAIPFTYEQLDVLKHKLDELYPQGYPESVIQHLGYLFLKMSPEDIRKWNVTSLETLKALLEVNKGHEMSPQVATLIDRFVKGRGQLDKDTLDTLTAFYPGYLCSLSPEELSSVPPSSIWAVRPQDLDTCDPRQLDVLYPKARLAFQNMNGSEYFVKIQSFLGGAPTEDLKALSQQNVSMDLATFMKLRTDAVLPLTVAEVQKLLGPHVEGLKAEERHRPVRDWILRQRQDDLDTLGLGLQGGIPNGYLVLDLSMQEALSGTPCLLGPGPVLTVLALLLASTLA
SEQ ID NO:316(食蟹猴间皮素氨基酸序列)
MALPMARPLSGSCGTPALGSLLFLLFSLGWVQPSRVLAGETRQVRSPLGKPGRVFSLSPRQLLGFTCVEVSGLSTELVQELAVALGQKNVKLSAEQLRCLAHQLSEPPEDLDALPLDLLLFLNPDAFSGPQACTHFFSRVAKANVDLLPRGAPERQRLLPAALTCWGVRGSLLSEADVRALGGLACDLPGRFVAESAEVVLPRLVRCLGPLDQDQQEAARAALQRGGPPYGPPSTWSISTLDDLQSLLPVLGQPVIHSIPQGILAAWRQRSSRDPSWQQPEQTVLRPRFRRDVERTTCPPEKEVHEIDESLIFYKKRELEACVDPALLAAQMDRVDAIPFTYEQLDVLKHKLDELYPQGYPESVIRHLGHLFLKMSPEDIRKWNVTSLETLKALLKVSKGHEMSAQWPVPQVATLIDRVVVGRGQLDKDTVDTLTAFCPGCLCSLSPERLSSVPPSVIGAVRPQDLDTCGPRQLDVLYPKARLAFQNMSGSEYFVKIRPFLGGAPTEDVKALSQQNVSMDLATFMKLRREAVLPLTVAEVQKLLGPHVEGLKVEEQHSPVRDWILKQRQDDLDTLGLGLQGGIPNGYLILDLSVREALSGTPCLLGPGPVLTVLALLLASTLA
SEQ ID NO:317(巨核细胞增强因子氨基酸序列)
MALPTARPLLGSCGTPALGSLLFLLFSLGWVQPSRTLAGETGQEAAPLDGVLANPPNISSLSPRQLLGFPCAEVSGLSTERVRELAVALAQKNVKLSTEQLRCLAHRLSEPPEDLDALPLDLLLFLNPDAFSGPQACTRFFSRITKANVDLLPRGAPERQRLLPAALACWGVRGSLLSEADVRALGGLACDLPGRFVAESAEVLLPRLVSCPGPLDQDQQEAARAALQGGGPPYGPPSTWSVSTMDALRGLLPVLGQPIIRSIPQGIVAAWRQRSSRDPSWRQPERTILRPRFRR
SEQ ID NO:318(成熟间皮氨基酸序列)
EVEKTACPSGKKAREIDESLIFYKKWELEACVDAALLATQMDRVNAIPFTYEQLDVLKHKLDELYPQGYPESVIQHLGYLFLKMSPEDIRKWNVTSLETLKALLEVNKGHEMSPQVATLIDRFVKGRGQLDKDTLDTLTAFYPGYLCSLSPEELSSVPPSSIWAVRPQDLDTCDPRQLDVLYPKARLAFQNMNGSEYFVKIQSFLGGAPTEDLKALSQQNVSMDLATFMKLRTDAVLPLTVAEVQKLLGPHVEGLKAEERHRPVRDWILRQRQDDLDTLGLGLQGGIPNGYLVLDLSMQEALSGTPCLLGPGPVLTVLALLLASTLA
SEQ ID NO:319(FSHβ33-53氨基酸序列)
YTRDLVYKDPARPKIQKTCTF
SEQ ID NO:320(FSHβ51-65氨基酸序列)
CTFKELVYETVRVPGC
SEQ ID NO:321(FSHβ81-95氨基酸序列)
QCHCGKCDSDSTDCT
SEQ ID NO:322(FSHβ87-94+FSHβ25-42氨基酸序列)
CDSDSTDCILQCMGCCFSRAYPTPLR
SEQ ID NO:323(FSHβ87-94+FSHβ25-42+FSHβ27-45氨基酸序列)
CDSDSTDCILQCMGCCFSRAYPTPLRWCAGYCYCYTRDVKDPARP
SEQ ID NO:324(抗FSHR肽33-53氨基酸序列)
YTRDLVYKDPARPKIQKTC
SEQ ID NO:325(抗FSHR肽51-65氨基酸序列)
KTCTFKELVYETVRV
SEQ ID NO:326(抗FSHR肽81-95氨基酸序列)
GSQCHCGKCDSDSTDCTAS
SEQ ID NO:327(抗FSHR拮抗剂A氨基酸序列)
GSCDSDSTDCILQCMGCCFSRAYPTPLRAS
SEQ ID NO:328(抗FSHR拮抗剂B氨基酸序列)
GSRLPTPYARSFCCGMCQLICDTSDSDCAS
SEQ ID NO:329(抗FSHR激动剂A氨基酸序列)
GSCDSDSTDCILQCMGCCFSRAYPTPLRWCAGYCYCYTRDLVKDPARPA S
SEQ ID NO:330(抗FSHR激动剂B氨基酸序列)
PRAPDKVLDRTYCYCYGACWRLPTPYARSFCCGMCQLICDTSDSDC
SEQ ID NO:331(抗FSHR肽α+β链氨基酸序列)
GSNSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKEAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKSAS
SEQ ID NO:332(Fc融合FSHβ33-53氨基酸序列)
YTRDLVYKDPARPKIQKTCTFEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
SEQ ID NO:333(Fc融合FSHβ33-53核酸序列)
TACACCCGGGACCTGGTGTATAAGGATCCCGCCAGACCTAAGATCCAGAAGACCTGCACATTCGAGCCCAAGTCCTGTGATAAGACCCACACATGCCCCCCTTGTCCTGCTCCAGAGCTGCTGGGCGGCCCTAGCGTGTTCCTGTTTCCACCCAAGCCTAAGGACACCCTGATGATCTCTCGGACCCCAGAGGTGACATGCGTGGTGGTGGACGTGAGCCACGAGGATCCCGAGGTGAAGTTTAACTGGTATGTGGATGGCGTGGAGGTGCACAATGCCAAGACCAAGCCCAGAGAGGAGCAGTACAACTCCACCTATAGGGTGGTGTCTGTGCTGACAGTGCTGCACCAGGACTGGCTCAACGGCAAGGAGTATAAGTGCAAGGTGTCCAATAAGGCCCTGCCCGCCCCTATCGAGAAGACCATCTCTAAGGCCAAGGGCCAGCCTCGGGAGCCACAGGTGTACACACTGCCTCCATCCAGAGACGAGCTGACCAAGAACCAGGTGTCTCTGACATGTCTGGTCAAGGGCTTCTATCCCTCTGATATCGCCGTGGAGTGGGAGAGCAATGGCCAGCCTGAGAACAATTACAAGACCACACCCCCTGTGCTGGACTCCGATGGCTCTTTCTTTCTGTATAGCAAGCTGACCGTGGATAAGTCCCGGTGGCAGCAGGGCAACGTGTTCAGCTGTTCCGTGATGCACGAGGCACTGCACAACCATTACACCCAGAAGTCACTGTCACTGTCCCCAGGCAAG
SEQ ID NO:334(接头氨基酸序列)
GGGGS
SEQ ID NO:335(接头氨基酸序列)
GGGGSGGGGS
SEQ ID NO:336(接头氨基酸序列)
GGGGSGGGGSGGGGS
SEQ ID NO:337(接头氨基酸序列)
GGGGSGGGGSGGGGSGGGGS
SEQ ID NO:338(接头氨基酸序列)
GGGGSGGGGSGGGGSGGGGSGGGGS
SEQ ID NO:339(EF1α启动子核酸序列)
GAGTAATTCATACAAAAGGACTCGCCCCTGCCTTGGGGAATCCCAGGGACCGTCGTTAAACTCCCACTAACGTAGAACCCAGAGATCGCTGCGTTCCCGCCCCCTCACCCGCCCGCTCTCGTCATCACTGAGGTGGAGAAGAGCATGCGTGAGGCTCCGGTGCCCGTCAGTGGGCAGAGCGCACATCGCCCACAGTCCCCGAGAAGTTGGGGGGAGGGGTCGGCAATTGAACCGGTGCCTAGAGAAGGTGGCGCGGGGTAAACTGGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAACCGTATATAAGTGCAGTAGTCGCCGTGAACGTTCTTTTTCGCAACGGGTTTGCCGCCAGAACACAGGTAAGTGCCGTGTGTGGTTCCCGCGGGCCTGGCCTCTTTACGGGTTATGGCCCTTGCGTGCCTTGAATTACTTCCACGCCCCTGGCTGCAGTACGTGATTCTTGATCCCGAGCTTCGGGTTGGAAGTGGGTGGGAGAGTTCGAGGCCTTGCGCTTAAGGAGCCCCTTCGCCTCGTGCTTGAGTTGAGGCCTGGCTTGGGCGCTGGGGCCGCCGCGTGCGAATCTGGTGGCACCTTCGCGCCTGTCTCGCTGCTTTCGATAAGTCTCTAGCCATTTAAAATTTTTGATGACCTGCTGCGACGCTTTTTTTCTGGCAAGATAGTCTTGTAAATGCGGGCCAAGATCTGCACACTGGTATTTCGGTTTTTGGGGCCGCGGGCGGCGACGGGGCCCGTGCGTCCCAGCGCACATGTTCGGCGAGGCGGGGCCTGCGAGCGCGGCCACCGAGAATCGGACGGGGGTAGTCTCAAGCTGGCCGGCCTGCTCTGGTGCCTGGCCTCGCGCCGCCGTGTATCGCCCCGCCCTGGGCGGCAAGGCTGGCCCGGTCGGCACCAGTTGCGTGAGCGGAAAGATGGCCGCTTCCCGGCCCTGCTGCAGGGAGCTCAAAATGGAGGACGCGGCGCTCGGGAGAGCGGGCGGGTGAGTCACCCACACAAAGGAAAAGGGCCTTTCCGTCCTCAGCCGTCGCTTCATGTGACTCCACGGAGTACCGGGCGCCGTCCAGGCACCTCGATTAGTTCTCGAGCTTTTGGAGTACGTCGTCTTTAGGTTGGGGGGAGGGGTTTTATGCGATGGAGTTTCCCCACACTGAGTGGGTGGAGACTGAAGTTAGGCCAGCTTGGCACTTGATGTAATTCTCCTTGGAATTTGCCCTTTTTGAGTTTGGATCTTGGTTCATTCTCAAGCCTCAGACAGTGGTTCAAAGTTTTTTTCTTCCATTTCAGGTGTCGTGA
SEQ ID NO:340(CD8α信号肽氨基酸序列)
MALPVTALLLPLALLLHAARP
SEQ ID NO:341(CD8α铰链氨基酸序列)
TTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACD
SEQ ID NO:342(CD8α跨膜结构域氨基酸序列)
IYIWAPLAGTCGVLLLSLVITLYC
SEQ ID NO:343(CD137胞内结构域氨基酸序列)
KRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCEL
SEQ ID NO:344(CD28胞内结构域氨基酸序列)
RSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRS
SEQ ID NO:345(CD3ζ胞内结构域氨基酸序列)
RVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:346(P2A元件氨基酸序列)
GSGATNFSLLKQAGDVEENPGP
SEQ ID NO:347(dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:348(FSHβ33-53+AD58-1-26VH3VL1 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIK
SEQ ID NO:349(FSHβ33-53+AS51489 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIK
SEQ ID NO:350(FSHβ33-53+AS92110 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIK
SEQ ID NO:351(FSHβ33-53+AS91156 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIK
SEQ ID NO:352(FSHβ33-53+AS91189 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIK
SEQ ID NO:353(FSHβ33-53+AS51674 scFv串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIK
SEQ ID NO:354(FSHβ33-53+AS65233 sdAb串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSS
SEQ ID NO:355(FSHβ33-53+AS60685 sdAb串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSS
SEQ ID NO:356(FSHβ33-53+AS60702 sdAb串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSS
SEQ ID NO:357(FSHβ33-53+AS60676 sdAb串联氨基酸序列)
YTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSS
SEQ ID NO:358(AD58126VH3VL1 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:359(AS51489 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:360(AS92110 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:361(AS91156 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:362(AS91189 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:363(AS51674 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:364(AS65233 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:365(AS60685 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:366(AS60702 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:367(AS60676 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:368(SS1 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGQGTTVTVSSGGGGSGGGGSGGGGSDIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSGYPLTFGAGTKLEITTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:369(M5 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVQSGAEVEKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCASGWDFDYWGQGTLVTVSSGGGGSGGGGSGGGGSGGGGSDIVMTQSPSSLSASVGDRVTITCRASQSIRYYLSWYQQKPGKAPKLLIYTASILQNGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQTYTTPDFGPGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:370(FSHβ33-53+AD58-1-26VH3VL1串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:371(FSHβ33-53+AS51489串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:372(FSHβ33-53+AS92110串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:373(FSHβ33-53+AS91156串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:374(FSHβ33-53+AS91189串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:375(FSHβ33-53+AS51674串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:376(FSHβ33-53+AS65233串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:377(FSHβ33-53+AS60685串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:378(FSHβ33-53+AS60702串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:379(FSHβ33-53+AS60676串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:380(AD58126VH3VL1+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:381(AS51489+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:382(AS92110+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:383(AS91156+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:384(AS91189+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:385(AS51674+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:386(AS65233+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:387(AS60685+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:388(AS60702+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:389(AS60676+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:390(AD58-1-26VH3VL1 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:391(AS51489 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:392(AS92110 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:393(AS91156 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:394(AS91189 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:395(AS51674 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:396(AS65233 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:397(AS60685 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:398(AS60702 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:399(AS60676 CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:400(FSHβ33-53+AD58126VH3VL1串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:401(FSHβ33-53+AS51489串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:402(FSHβ33-53+AS92110串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:403(FSHβ33-53+AS91156串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:404(FSHβ33-53+AS91189串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:405(FSHβ33-53+AS51674串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:406(FSHβ33-53+AS65233串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:407(FSHβ33-53+AS60685串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:408(FSHβ33-53+AS60702串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:409(FSHβ33-53+AS60676串联CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:410(AD58-1-26VH3VL1+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVKQAPGQGLEWIGYINPSTGHTDYNQKFKDRATLTADTSTSTVYMELSSLRSEDTAVYYCARSNWAWFPYWGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPLTFGGGTKLEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:411(AS51489+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYYYSIHWVRQAPGKGLEWVAYISSSSSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYPYYGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGFSYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:412(AS92110+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYYSSMHWVRQAPGKGLEWVAYIYPYYSYTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGYALDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQASSGYHYLITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:413(AS91156+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNIYSSSIHWVRQAPGKGLEWVASISSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYYAMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGPYYHPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:414(AS91189+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLSYSSIHWVRQAPGKGLEWVASIYSYSGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYWGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYYWYYPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:415(AS51674+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFNLYSYYMHWVRQAPGKGLEWVASIYSYSSYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARPFGWGYAGMDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQGYAPITFGQGTKVEIKTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:416(AS65233+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVHLVESGGGSVQAGGSLRLSCAASEFTYSMGWFRQAPGKEREGVAHIYTRGGTTVYADSVKGRFVLSRYNAKSIMYLQMNSVKLEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:417(AS60685+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASMYVGGGYTYYDDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAISIALTREFCAPIVSRYNYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:418(AS60702+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVKLVESGGGSVQAGGSLRLSCAASGNVYNNMCMGWFRQAPGKEREGVASIYVGGGYTNYADSVRGRFTISQDNAKNTLYLQMNSLKPEDTAMYYCAAITVALTRAFCAPIPSRYTNWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ ID NO:419(AS60676+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGSVQAGGSLRLSCAASGYTVSSGCMGWFRQAPGKERERVAQIGRDATTTYADSVKGRFTIARDDAENTLYLQMNSLKPEDTAMYSCTAYWGVYCLSPGRYWGQGTQVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSS
SEQ NO:420(AS65233VH4)
EVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVSHIYTRGGTTVYADSVKGRFVLSRDNSKNTLYLQMNSLRAEDTAVYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSS
SEQ NO:421(AS65233VH5)
EVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSS
SEQ NO:422(AS65233VH6)
EVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGREGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSS
SEQ NO:423(AS80444VH4)
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSS
SEQ NO:424(AS80444VH5)
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSS
SEQ NO:425(AS80444VH6)
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGREGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSS
SEQ NO:426(AS80533VH4)
QVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSS
SEQ NO:427(AS80533VH5)
QVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTSMLAINGYNRWGQGTTVTVSS
SEQ NO:428(AS80533VH6)
QVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGREGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTSMLAINGYNRWGQGTTVTVSS
SEQ NO:429(TC-210)
MQSGTHWRVLGLCLLSVGVWGQEVQLVESGGGLVQPGGSLRLSCAASGGDWSANFMYWYRQAPGKQRELVARISGRGVVDYVESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAVASYWGQGTLVTVSSGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ NO:430(CD3ε信号肽)
MQSGTHWRVLGLCLLSVGVWGQ
SEQ NO:431(CD3γ信号肽)
MEQGKGLAVLILAIILLQGTLA
SEQ NO:432(CD3δ信号肽)
MEHSTFLSGLVLATLLSQVSP
SEQ NO:433(CD3ε胞外结构域)
DGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMD
SEQ NO:434(CD3γ胞外结构域)
QSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATIS
SEQ NO:435(CD3δ胞外结构域)
FKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNGTDIYKDKESTVQVHYRMCQSCVELDPATVA
SEQ NO:436(CD3ε跨膜结构域)
VMSVATIVIVDICITGGLLLLVYYWS
SEQ NO:437(CD3γ跨膜结构域)
GFLFAEIVSIFVLAVGVYFIA
SEQ NO:438(CD3δ跨膜结构域)
GIIVTDVIATLLLALGVFCFA
SEQ NO:439(CD3ε胞内结构域)
KNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ NO:440(CD3γ胞内结构域)
GQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN
SEQ NO:441(CD3δ胞内结构域)
GHETGRLSGAADTQALLRNDQVYQPLRDRDDAQYSHLGGNWARNK
SEQ NO:442(FSHβ33-53εTCR氨基酸序列)
MQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ NO:443(FSHβ33-53γTCR氨基酸序列)
MEQGKGLAVLILAIILLQGTLAYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATISGFLFAEIVSIFVLAVGVYFIAGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN
SEQ NO:444(FSHβ33-53δTCR氨基酸序列)
MEHSTFLSGLVLATLLSQVSPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSFKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNGTDIYKDKESTVQVHYRMCQSCVELDPATVAGIIVTDVIATLLLALGVFCFAGHETGRLSGAADTQALLRNDQVYQPLRDRDDAQYSHLGGNWARNK
SEQ ID NO:445(AS65233VH5 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:446(AS80444VH5 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:447(AS80533VH4 CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:448(FSHβ33-53+AS65233VH5串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:449(FSHβ33-53+AS80444VH5串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:450(FSHβ33-53+AS80533VH4串联CAR氨基酸序列)
MALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:451(AS65233VH5+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:452(AS80444VH5+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:453(AS80533VH4+FSHβ33-53双重CAR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:454(AS65233VH5 CAR+FSHβ33-53εTCR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ ID NO:455(AS80444VH5 CAR+FSHβ33-53εTCR氨基酸序列)
MALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ ID NO:456(AS80533VH4 CAR+FSHβ33-53εTCR氨基酸序列)
MALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ NO:457(FSHβ33-53εTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ NO:458(FSHβ33-53γTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMEQGKGLAVLILAIILLQGTLAYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATISGFLFAEIVSIFVLAVGVYFIAGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN
SEQ NO:459(FSHβ33-53δTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMEHSTFLSGLVLATLLSQVSPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSFKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNGTDIYKDKESTVQVHYRMCQSCVELDPATVAGIIVTDVIATLLLALGVFCFAGHETGRLSGAADTQALLRNDQVYQPLRDRDDAQYSHLGGNWARNK
SEQ NO:460(AS65233VH5 CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ NO:461(AS80444VH5 CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ NO:462(AS80533VH4 CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:463(FSHβ33-53+AS65233VH5串联CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:464(FSHβ33-53+AS80444VH5串联CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:465(FSHβ33-53+AS80533VH4串联CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:466(AS65233VH5+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:467(AS80444VH5+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:468(AS80533VH4+FSHβ33-53双重CAR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPYTRDLVYKDPARPKIQKTCTFTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRSRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR
SEQ ID NO:469(AS65233VH5 CAR+FSHβ33-53εTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASEFTYSMGWFRQAPGKGLEGVAHIYTRGGTTVYADSVKGRFVLSRDNSKNTMYLQMNSLRAEDTAMYYCAARTIFEGSWSSPSSFDFWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ ID NO:470(AS80444VH5 CAR+FSHβ33-53εTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPEVQLVESGGGLVQPGGSLRLSCAASGFTFSRNTMGWFRQAPGKGLEGVSAIPYTSTGIVYSDSVGGRFTISRDNSKNTVYLQMNSLRAEDTAMYYCATDRRPGTTMLAVNGYNHWGQGTLVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
SEQ ID NO:471(AS80533VH4 CAR+FSHβ33-53εTCR,具有dnTGFβRII氨基酸序列)
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSGSGATNFSLLKQAGDVEENPGPMALPVTALLLPLALLLHAARPQVQLVESGGGVVQPGGSLRLSCAASGLSFSTYTVAWFRQAPGKGLEGVAAIPYTSQHMVYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATDRRPGTSMLAINGYNRWGQGTTVTVSSTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCELRVKFSRSADAPAYKQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPRGSGATNFSLLKQAGDVEENPGPMQSGTHWRVLGLCLLSVGVWGQYTRDLVYKDPARPKIQKTCTFGGGGSGGGGSGGGGSDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI
序列表
<110> 南京传奇生物科技有限公司
<120> 抗间皮素嵌合抗原受体(CAR)构建体及其用途
<130> 689296.13CN1
<160> 471
<170> PatentIn version 3.5
<210> 1
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VH CDR1
<400> 1
Gly Tyr Thr Phe Thr Ser Tyr Trp Met His
1 5 10
<210> 2
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VL CDR1
<400> 2
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
1 5 10 15
Thr
<210> 3
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VH CDR1
<400> 3
Gly Tyr Thr Phe Thr Glu Tyr Thr Met Asn
1 5 10
<210> 4
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VL CDR1
<400> 4
Lys Ser Ser Gln Ser Leu Leu Asp Ser Asp Gly Lys Thr Tyr Leu Asn
1 5 10 15
<210> 5
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VH CDR1
<400> 5
Phe Tyr Thr Phe Thr Ala Tyr Ser Met His
1 5 10
<210> 6
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VL CDR1
<400> 6
Arg Ala Ser Glu Ser Val Asp Ser Tyr Gly Asn Ser Phe Met Asn
1 5 10 15
<210> 7
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VH CDR1
<400> 7
Gly Tyr Thr Phe Thr Asp Tyr Glu Ile His
1 5 10
<210> 8
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VL CDR1
<400> 8
Arg Ser Ser Gln Ser Leu Val His Ser Asn Gly Asn Thr Tyr Leu His
1 5 10 15
<210> 9
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VH CDR1
<400> 9
Gly Tyr Thr Phe Thr Asp Tyr Glu Met His
1 5 10
<210> 10
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VL CDR1
<400> 10
Arg Ser Ser Gln Ser Leu Val His Ser Asn Gly Asn Thr Tyr Leu His
1 5 10 15
<210> 11
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VH CDR1
<400> 11
Gly Tyr Thr Ile Thr Asn Tyr Trp Leu Gly
1 5 10
<210> 12
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VL CDR1
<400> 12
Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn
1 5 10
<210> 13
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VH CDR1
<400> 13
Gly Tyr Thr Phe Thr Glu Tyr Thr Met Asn
1 5 10
<210> 14
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VL CDR1
<400> 14
Lys Ser Ser Gln Ser Leu Leu Asp Ser Asp Gly Lys Thr Tyr Leu Asn
1 5 10 15
<210> 15
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VH CDR1
<400> 15
Gly Phe Ser Leu Ser Arg Tyr Ser Val His
1 5 10
<210> 16
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VL CDR1
<400> 16
Lys Ser Ser Gln Ser Val Leu Tyr Ser Ser Asn Gln Lys Asn Tyr Leu
1 5 10 15
Ala
<210> 17
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VH CDR1
<400> 17
Gly Tyr Thr Phe Thr Ser Tyr Trp Met His
1 5 10
<210> 18
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VL CDR1
<400> 18
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
1 5 10 15
Thr
<210> 19
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VH CDR1
<400> 19
Gly Phe Asn Leu Tyr Tyr Tyr Ser Ile His
1 5 10
<210> 20
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VL CDR1
<400> 20
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 21
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VH CDR1
<400> 21
Gly Phe Asn Leu Tyr Ser Tyr Ser Met His
1 5 10
<210> 22
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VL CDR1
<400> 22
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 23
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VH CDR1
<400> 23
Gly Phe Asn Ile Tyr Tyr Ser Ser Met His
1 5 10
<210> 24
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VL CDR1
<400> 24
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 25
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VH CDR1
<400> 25
Gly Phe Asn Ile Tyr Ser Ser Ser Ile His
1 5 10
<210> 26
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VL CDR1
<400> 26
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 27
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VH CDR1
<400> 27
Gly Phe Asn Leu Ser Tyr Ser Ser Ile His
1 5 10
<210> 28
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VL CDR1
<400> 28
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 29
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VH CDR1
<400> 29
Gly Phe Asn Leu Tyr Ser Tyr Tyr Met His
1 5 10
<210> 30
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VL CDR1
<400> 30
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
1 5 10
<210> 31
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66073 CDR1
<400> 31
Lys Tyr Ser Ser Leu Tyr Cys Met Ala
1 5
<210> 32
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66439 CDR1
<400> 32
Gly Phe Thr Ser Ser Asp Cys Asp Met Asp
1 5 10
<210> 33
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65955 CDR1
<400> 33
Gly Asp Arg Val Ser Thr Gly Cys Met Gly
1 5 10
<210> 34
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 CDR1
<400> 34
Glu Phe Thr Tyr Ser Met Gly
1 5
<210> 35
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65926 CDR1
<400> 35
Gly Asn Leu Tyr Asn Asn Met Cys Met Gly
1 5 10
<210> 36
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66159 CDR1
<400> 36
Gly Asn Val Tyr Asn Asn Met Cys Met Gly
1 5 10
<210> 37
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66416 CDR1
<400> 37
Gly Asn Leu Tyr Asn Asn Met Cys Met Gly
1 5 10
<210> 38
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65850 CDR1
<400> 38
Gly Phe Ser Tyr Ser Asn Ile Cys Met Gly
1 5 10
<210> 39
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65183 CDR1
<400> 39
Asn Gly Tyr Tyr Asn Arg Arg Tyr Cys Met Ala
1 5 10
<210> 40
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65062 CDR1
<400> 40
Gly Val Ser Val Val Asn Phe Ala Met Arg
1 5 10
<210> 41
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65065 CDR1
<400> 41
Gly Tyr Ser Tyr Cys Arg Ser Thr Met Arg
1 5 10
<210> 42
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65556 CDR1
<400> 42
Gly Tyr Asn Ala Ser Ile Cys Arg Met Ser
1 5 10
<210> 43
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65069 CDR1
<400> 43
Gly Asp Thr Gly Tyr Gln Pro Thr Met Arg
1 5 10
<210> 44
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65691 CDR1
<400> 44
Gly Tyr Thr Asp Tyr Arg Leu Val Leu Arg
1 5 10
<210> 45
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65064 CDR1
<400> 45
Gly Asp Thr Val Gln Thr Asn Cys Met Ala
1 5 10
<210> 46
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65081 CDR1
<400> 46
Gly Val Pro Ala Ser Ser Tyr Cys Met Gly
1 5 10
<210> 47
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65115 CDR1
<400> 47
Gly Tyr Ile Tyr Gly Cys Met Gly
1 5
<210> 48
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65271 CDR1
<400> 48
Gly Lys Thr Tyr Gly Arg Cys Met Ala
1 5
<210> 49
<211> 12
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65166 CDR1
<400> 49
Glu Asp Leu Ser Ile Tyr Gly Tyr Asn Cys Met Gly
1 5 10
<210> 50
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65450 CDR1
<400> 50
Gly Asp Met Asn Gly Tyr Lys Cys Met Gly
1 5 10
<210> 51
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65454 CDR1
<400> 51
Gly Asp Met Asn Gly Tyr Lys Cys Met Gly
1 5 10
<210> 52
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65131 CDR1
<400> 52
Glu Tyr Val Thr His Leu Gly
1 5
<210> 53
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65182 CDR1
<400> 53
Gly Tyr Thr Tyr Ser Tyr Gly Tyr Met Gly
1 5 10
<210> 54
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 CDR1
<400> 54
Gly Asn Val Tyr Asn Asn Met Cys Met Gly
1 5 10
<210> 55
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 CDR1
<400> 55
Gly Asn Val Tyr Asn Asn Met Cys Met Gly
1 5 10
<210> 56
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60705 CDR1
<400> 56
Gly Tyr Ala Tyr Ser Gly Ser Cys Met Met Ala
1 5 10
<210> 57
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60660 CDR1
<400> 57
Gly Asp Thr Gly Tyr Gln Pro Thr Met Arg
1 5 10
<210> 58
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60662 CDR1
<400> 58
Gly Tyr Arg Asn Cys Arg Ser Thr Met Arg
1 5 10
<210> 59
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60664 CDR1
<400> 59
Gly Lys Thr Tyr Gly Arg Cys Met Ala
1 5
<210> 60
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60668 CDR1
<400> 60
Gly Asp Met Asn Gly Tyr Lys Cys Met Gly
1 5 10
<210> 61
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 CDR1
<400> 61
Gly Tyr Thr Val Ser Ser Gly Cys Met Gly
1 5 10
<210> 62
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60678 CDR1
<400> 62
Gly Tyr Thr Ser Ser Arg Gly Cys Met Ser
1 5 10
<210> 63
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60679 CDR1
<400> 63
Gly Val Thr Tyr Cys Arg Leu Thr Met Arg
1 5 10
<210> 64
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81326 CDR1
<400> 64
Glu Ser Arg Asp Cys Met Ala
1 5
<210> 65
<211> 13
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81187 CDR1
<400> 65
Gly Tyr Thr Tyr Ser Ser Tyr Ser Ser Asn Cys Leu Gly
1 5 10
<210> 66
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533 CDR1
<400> 66
Gly Leu Ser Phe Ser Thr Tyr Thr Val Ala
1 5 10
<210> 67
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444 CDR1
<400> 67
Gly Phe Thr Phe Ser Arg Asn Thr Met Gly
1 5 10
<210> 68
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81487 CDR1
<400> 68
Lys Leu Thr Ala Trp Arg Ser Cys Val Gly
1 5 10
<210> 69
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VH CDR2
<400> 69
Tyr Ile Asn Pro Ser Thr Gly His Thr Asp Tyr Asn Gln Lys Phe Lys
1 5 10 15
Asp
<210> 70
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VL CDR2
<400> 70
Trp Ala Ser Thr Arg Glu Ser
1 5
<210> 71
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VH CDR2
<400> 71
Gly Ile Ile Pro Asn Asn Gly Asp Thr Ser Tyr Asn Gln Lys Phe Lys
1 5 10 15
Gly
<210> 72
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VL CDR2
<400> 72
Leu Val Ser Lys Leu Asp Ser
1 5
<210> 73
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VH CDR2
<400> 73
Trp Ile Asn Thr Glu Thr Gly Glu Pro Thr Tyr Ala Asp Asp Phe Lys
1 5 10 15
Gly
<210> 74
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VL CDR2
<400> 74
Leu Ala Ser Tyr Leu Glu Ser
1 5
<210> 75
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VH CDR2
<400> 75
Gly Ile Asp Pro Glu Thr Gly Gly Ala Ala Tyr Thr Gln Lys Phe Lys
1 5 10 15
Gly
<210> 76
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VL CDR2
<400> 76
Lys Val Ser Asn Arg Phe Ser
1 5
<210> 77
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VH CDR2
<400> 77
Gly Ile Asp Pro Glu Thr Gly Gly Ala Ala Tyr Thr Gln Lys Phe Lys
1 5 10 15
Gly
<210> 78
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VL CDR2
<400> 78
Lys Val Ser Asn Arg Phe Ser
1 5
<210> 79
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VH CDR2
<400> 79
Asp Ile Tyr Pro Gly Gly Gly Tyr Thr Asn Tyr Asn Glu Lys Phe Lys
1 5 10 15
Gly
<210> 80
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VL CDR2
<400> 80
Tyr Thr Ser Ser Leu His Ser
1 5
<210> 81
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VH CDR2
<400> 81
Gly Ile Ile Pro Asn Asn Gly Asp Thr Ser Tyr Lys Gln Glu Phe Lys
1 5 10 15
Gly
<210> 82
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VL CDR2
<400> 82
Leu Val Ser Lys Leu Asp Ser
1 5
<210> 83
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VH CDR2
<400> 83
Met Ile Trp Gly Gly Gly Asn Thr Asp Tyr Asn Ser Ala Leu Lys Ser
1 5 10 15
<210> 84
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VL CDR2
<400> 84
Trp Ala Ser Thr Arg Glu Ser
1 5
<210> 85
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VH CDR2
<400> 85
Tyr Ile Asn Pro Ser Thr Gly Tyr Thr Asp Tyr Asn Gln Lys Phe Lys
1 5 10 15
Asp
<210> 86
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VL CDR2
<400> 86
Trp Ala Ser Thr Arg Glu Ser
1 5
<210> 87
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VH CDR2
<400> 87
Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 88
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VL CDR2
<400> 88
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 89
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VH CDR2
<400> 89
Tyr Ile Tyr Pro Tyr Ser Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 90
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VL CDR2
<400> 90
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 91
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VH CDR2
<400> 91
Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 92
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VL CDR2
<400> 92
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 93
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VH CDR2
<400> 93
Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 94
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VL CDR2
<400> 94
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 95
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VH CDR2
<400> 95
Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 96
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VL CDR2
<400> 96
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 97
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VH CDR2
<400> 97
Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 98
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VL CDR2
<400> 98
Ser Ala Ser Ser Leu Tyr Ser
1 5
<210> 99
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66073 CDR2
<400> 99
Val Ile Ser Ser Gly Gly Phe Thr Asn Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 100
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66439 CDR2
<400> 100
Ser Leu Leu Ser Thr Asp Gly Ser Thr Ser Tyr Ala Asp Ser Val Arg
1 5 10 15
Gly
<210> 101
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65955 CDR2
<400> 101
Gln Ile His Asn Tyr Asn Ile Ala Lys Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 102
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 CDR2
<400> 102
His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 103
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65926 CDR2
<400> 103
Ser Ile Tyr Ile Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 104
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66159 CDR2
<400> 104
Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val Arg
1 5 10 15
Gly
<210> 105
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66416 CDR2
<400> 105
Ser Ile Tyr Ile Gly Gly Gly Tyr Thr Asn Tyr Ser Glu Ser Val Arg
1 5 10 15
Gly
<210> 106
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65850 CDR2
<400> 106
Ala Ile Tyr Ser Asn Gly Ser Thr Ile Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 107
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65183 CDR2
<400> 107
Thr Met Thr Thr Thr Ser Gly Arg Thr Tyr Tyr Ala Asp Ala Val Lys
1 5 10 15
Gly
<210> 108
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65062 CDR2
<400> 108
Ala Met Tyr Arg Ser Gly Ser Thr Ser Tyr Ala Asp Ser Val Arg Gly
1 5 10 15
<210> 109
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65065 CDR2
<400> 109
Ala Ile Tyr Ser Asp Gly Thr Thr Ser Tyr Thr Asp Ser Val Lys Gly
1 5 10 15
<210> 110
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65556 CDR2
<400> 110
Ser Ser Tyr Arg Asp Gly Ser Gln Ser Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 111
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65069 CDR2
<400> 111
Ala Ile Tyr Ser Asp Gln Thr Thr Ser Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 112
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65691 CDR2
<400> 112
Ala Ile Tyr Ser Asp Gly Val Thr Ser Tyr Ser Asp Ser Val Lys Gly
1 5 10 15
<210> 113
<211> 20
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65064 CDR2
<400> 113
Ser Ile Leu Ser Leu Tyr Ser Ser Gly Gly Lys Thr Val Tyr Ala Asp
1 5 10 15
Ser Val Lys Gly
20
<210> 114
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65081 CDR2
<400> 114
Gly Ile Val Ser Asp Thr Thr Thr Thr Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 115
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65115 CDR2
<400> 115
Thr Ile Tyr Arg Asp Gly Thr Ala Tyr Tyr Ala Asn Ser Val Glu Gly
1 5 10 15
<210> 116
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65271 CDR2
<400> 116
Ala Thr Tyr Ile Ser Gly Gly Arg Pro Tyr Val Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 117
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65166 CDR2
<400> 117
Ala Ile Tyr Thr Gly Arg Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 118
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65450 CDR2
<400> 118
Gly Ile Tyr Thr Gly Arg Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Asp
<210> 119
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65454 CDR2
<400> 119
Gly Ile Tyr Thr Gly Arg Asn Thr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Asp
<210> 120
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65131 CDR2
<400> 120
Ile Glu Ser Phe Arg Ile Gly Tyr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 121
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65182 CDR2
<400> 121
Lys Ile Tyr Asn Gly Asp Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 122
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 CDR2
<400> 122
Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr Tyr Asp Asp Ser Val Lys
1 5 10 15
Gly
<210> 123
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 CDR2
<400> 123
Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val Arg
1 5 10 15
Gly
<210> 124
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60705 CDR2
<400> 124
Val Ser Val Arg Arg Thr Gly Ser Ala Phe Tyr Ala Asp Ser Val Lys
1 5 10 15
Ala
<210> 125
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60660 CDR2
<400> 125
Ala Ile Tyr Ser Asp Gln Thr Thr Ser Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 126
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60662 CDR2
<400> 126
Ser Ile Tyr Thr Asp Gly Thr Thr Ser Tyr Thr Asp Ser Val Lys Gly
1 5 10 15
<210> 127
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60664 CDR2
<400> 127
Ala Thr Tyr Ile Ser Gly Gly Arg Pro Tyr Val Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 128
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60668 CDR2
<400> 128
Gly Ile Tyr Thr Gly Arg Asn Thr Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Asp
<210> 129
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 CDR2
<400> 129
Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 130
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60678 CDR2
<400> 130
Tyr Ile Asn Met Arg Val Leu Thr Thr Ile Tyr Ala Ala Ser Val Lys
1 5 10 15
Asp
<210> 131
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60679 CDR2
<400> 131
Ala Ile Tyr Ser Asp Gly Ser Thr Ala Tyr Ala Asp Ser Val Lys Gly
1 5 10 15
<210> 132
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81326 CDR2
<400> 132
Ser Ile Tyr Ala Pro Asp Gly Ser Thr Thr Tyr Ala Asp Thr Val Lys
1 5 10 15
Gly
<210> 133
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81187 CDR2
<400> 133
Arg Ile Tyr Pro Asn Ser Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 134
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533 CDR2
<400> 134
Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp Ser Val Lys
1 5 10 15
Gly
<210> 135
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444 CDR2
<400> 135
Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp Ser Val Gly
1 5 10 15
Gly
<210> 136
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81487 CDR2
<400> 136
Ala Ile Tyr Ser Gly Thr Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210> 137
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VH CDR3
<400> 137
Ser Asn Trp Ala Trp Phe Pro Tyr
1 5
<210> 138
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126-VL CDR3
<400> 138
Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
1 5
<210> 139
<211> 4
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VH CDR3
<400> 139
Arg Phe Ala Tyr
1
<210> 140
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116-VL CDR3
<400> 140
Trp Gln Gly Thr His Phe Pro Phe Thr
1 5
<210> 141
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VH CDR3
<400> 141
Gly Leu Arg Arg Phe Ala Tyr
1 5
<210> 142
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117-VL CDR3
<400> 142
Gln Gln Asn Asn Glu Asp Pro Tyr Thr
1 5
<210> 143
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VH CDR3
<400> 143
Tyr Gly Asn Tyr Pro Leu Asp Ser
1 5
<210> 144
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127-VL CDR3
<400> 144
Ser Gln Ser Thr His Val Pro Leu Thr
1 5
<210> 145
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VH CDR3
<400> 145
Tyr Gly Asn Tyr Pro Leu Asp Ser
1 5
<210> 146
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143-VL CDR3
<400> 146
Ser Gln Ser Thr His Val Pro Leu Thr
1 5
<210> 147
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VH CDR3
<400> 147
Gly Gly Ser Ser Tyr Trp Tyr Phe Asp Val
1 5 10
<210> 148
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159-VL CDR3
<400> 148
Gln Gln Tyr Ser Lys Val Pro Tyr Thr
1 5
<210> 149
<211> 4
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VH CDR3
<400> 149
Arg Phe Ala Tyr
1
<210> 150
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115-VL CDR3
<400> 150
Trp Gln Gly Thr His Phe Pro Phe Thr
1 5
<210> 151
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VH CDR3
<400> 151
Ser Leu Gly Trp Tyr Phe Asp Ile
1 5
<210> 152
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123-VL CDR3
<400> 152
His Gln Tyr Leu Ser Ser Trp Thr
1 5
<210> 153
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VH CDR3
<400> 153
Ser Asn Trp Ala Trp Phe Pro Tyr
1 5
<210> 154
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145-VL CDR3
<400> 154
Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
1 5
<210> 155
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VH CDR3
<400> 155
Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr
1 5
<210> 156
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489-VL CDR3
<400> 156
Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr
1 5 10
<210> 157
<211> 6
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VH CDR3
<400> 157
Gly Tyr Gly Met Asp Tyr
1 5
<210> 158
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491-VL CDR3
<400> 158
Gln Gln Ser Tyr Tyr Trp Leu Phe Thr
1 5
<210> 159
<211> 6
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VH CDR3
<400> 159
Gly Tyr Ala Leu Asp Tyr
1 5
<210> 160
<211> 12
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110-VL CDR3
<400> 160
Gln Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr
1 5 10
<210> 161
<211> 6
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VH CDR3
<400> 161
Tyr Tyr Ala Met Asp Tyr
1 5
<210> 162
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156-VL CDR3
<400> 162
Gln Gln Gly Pro Tyr Tyr His Pro Ile Thr
1 5 10
<210> 163
<211> 6
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VH CDR3
<400> 163
Tyr Trp Gly Met Asp Tyr
1 5
<210> 164
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189-VL CDR3
<400> 164
Gln Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr
1 5 10
<210> 165
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VH CDR3
<400> 165
Pro Phe Gly Trp Gly Tyr Ala Gly Met Asp Tyr
1 5 10
<210> 166
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674-VL CDR3
<400> 166
Gln Gln Gly Tyr Ala Pro Ile Thr
1 5
<210> 167
<211> 14
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66073 CDR3
<400> 167
Gly Leu Ser Tyr Cys His Ser Ser Thr Ala Thr Ala Thr Tyr
1 5 10
<210> 168
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66439 CDR3
<400> 168
Ala Glu Trp Gly Gly Met Asp Tyr
1 5
<210> 169
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65955 CDR3
<400> 169
Pro Val Asp Cys Ser Trp Ser Met Phe Leu Gln Asp Pro Leu Ala Leu
1 5 10 15
Ser Pro Pro
<210> 170
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 CDR3
<400> 170
Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp Phe
1 5 10 15
<210> 171
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65926 CDR3
<400> 171
Val Ser Ile Ala Leu Thr Arg Glu Phe Cys Ala Pro Ile Val Ser Arg
1 5 10 15
Tyr Asn Tyr
<210> 172
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66159 CDR3
<400> 172
Ile Thr Val Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Pro Ser Arg
1 5 10 15
Tyr Thr Asn
<210> 173
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66416 CDR3
<400> 173
Ile Pro Ile Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Val Ser Arg
1 5 10 15
Tyr Thr Tyr
<210> 174
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65850 CDR3
<400> 174
Gly Arg Cys Gly Gly Pro Asn Tyr
1 5
<210> 175
<211> 23
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65183 CDR3
<400> 175
His Leu Pro Ser Ser Trp Val Thr Ser Thr Asp Tyr Cys Asp Asn Leu
1 5 10 15
Gln Ala Gly Phe Tyr Asn Ser
20
<210> 176
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65062 CDR3
<400> 176
Thr Ser Pro Met Gly Asp Thr Tyr
1 5
<210> 177
<211> 13
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65065 CDR3
<400> 177
Asp Leu Val Gly Cys Asn Val Ala Gly Gly Ser Pro Tyr
1 5 10
<210> 178
<211> 7
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65556 CDR3
<400> 178
Ala Cys Pro Trp Arg Ala Tyr
1 5
<210> 179
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65069 CDR3
<400> 179
Thr Thr Arg Arg Gly Ser Glu Tyr
1 5
<210> 180
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65691 CDR3
<400> 180
Thr Gly Ser Gly Gly Val Ala Tyr
1 5
<210> 181
<211> 22
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65064 CDR3
<400> 181
Val Arg Val Thr Val Thr Trp Ala Glu Lys Leu Arg Arg Cys Thr Gly
1 5 10 15
Phe Ser Gly Met Asp Tyr
20
<210> 182
<211> 20
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65081 CDR3
<400> 182
Ser His Phe Leu Leu Cys Ala Arg Lys Pro Arg Trp Asp Asp Leu Ile
1 5 10 15
Lys Tyr Glu Tyr
20
<210> 183
<211> 13
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65115 CDR3
<400> 183
Arg Thr Thr Gly Cys Asn Trp Asp Ile Ser Gly Val Tyr
1 5 10
<210> 184
<211> 18
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65271 CDR3
<400> 184
Gly Ser Ala Gly Arg Gly Pro Cys Asp Arg Phe Asp Gln Asn Gln Tyr
1 5 10 15
Thr Phe
<210> 185
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65166 CDR3
<400> 185
Lys Tyr Cys Ala Val Val Ala Asp Phe Gly Asn Ser Arg Leu Val Arg
1 5 10 15
Tyr
<210> 186
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65450 CDR3
<400> 186
Lys Tyr Cys Ala Val Val Ala Glu Phe Gly Gly Pro Arg Leu Val Arg
1 5 10 15
Tyr
<210> 187
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65454 CDR3
<400> 187
Tyr Cys Ala Val Val Ala Glu Phe Arg Gly Pro Arg Leu Asp Arg Tyr
1 5 10 15
<210> 188
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65131 CDR3
<400> 188
Arg Gln Asp Arg Ser Gly Ala Ser Met Val Asn Arg Asp Ser Tyr Asn
1 5 10 15
Tyr
<210> 189
<211> 20
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65182 CDR3
<400> 189
Asn Arg Leu Pro Asn Ser Asp Val Asp Leu Val Leu Pro Arg Phe Gly
1 5 10 15
Arg Phe Gly Tyr
20
<210> 190
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 CDR3
<400> 190
Ile Ser Ile Ala Leu Thr Arg Glu Phe Cys Ala Pro Ile Val Ser Arg
1 5 10 15
Tyr Asn Tyr
<210> 191
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 CDR3
<400> 191
Ile Thr Val Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Pro Ser Arg
1 5 10 15
Tyr Thr Asn
<210> 192
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60705 CDR3
<400> 192
Asp Phe Thr Cys Arg Thr Trp Thr Leu Asn Lys Asn Tyr Asn His
1 5 10 15
<210> 193
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60660 CDR3
<400> 193
Thr Thr Arg Arg Gly Ser Glu Tyr
1 5
<210> 194
<211> 13
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60662 CDR3
<400> 194
Asp Leu Val Gly Cys Asn Val Ala Gly Gly Ser Pro Tyr
1 5 10
<210> 195
<211> 18
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60664 CDR3
<400> 195
Gly Ser Ala Gly Arg Gly Pro Cys Asp Arg Phe Asp Gln Asn Gln Tyr
1 5 10 15
Thr Phe
<210> 196
<211> 17
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60668 CDR3
<400> 196
Lys Tyr Cys Ala Val Val Ala Glu Phe Gly Gly Pro Arg Leu Val Arg
1 5 10 15
Tyr
<210> 197
<211> 12
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 CDR3
<400> 197
Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly Arg Tyr
1 5 10
<210> 198
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60678 CDR3
<400> 198
Gly Tyr Asn Gly Gln Trp Cys Glu His Ala Ser Asp Val Thr Ala
1 5 10 15
<210> 199
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60679 CDR3
<400> 199
Asn Cys Ala Ser Gly Leu Thr Ala
1 5
<210> 200
<211> 18
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81326 CDR3
<400> 200
Gly Gly Leu Ser Arg Asn Thr Cys Gly Tyr Leu Arg Gly Gly Tyr Phe
1 5 10 15
Ala Tyr
<210> 201
<211> 18
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81187 CDR3
<400> 201
Ala Val Gly Val Gly Asp Asn Trp Cys Ala Ser Gly Ala Ala Tyr Phe
1 5 10 15
Gly Tyr
<210> 202
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533 CDR3
<400> 202
Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn Gly Tyr Asn Arg
1 5 10 15
<210> 203
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444 CDR3
<400> 203
Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn Gly Tyr Asn His
1 5 10 15
<210> 204
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81487 CDR3
<400> 204
Thr Ser Ile Arg Ser Ser Cys Gly Leu Val Arg Asp Glu Tyr Ala Tyr
1 5 10 15
<210> 205
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126 scFv
<400> 205
Gln Val Gln Leu Lys Gln Ser Gly Ala Glu Leu Ala Lys Pro Gly Ala
1 5 10 15
Ser Val Glu Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp Tyr Asn Gln Lys Phe
50 55 60
Lys Asp Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
115 120 125
Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro Ser Ser Leu Thr
130 135 140
Val Thr Ala Gly Glu Lys Val Thr Met Ser Cys Lys Ser Ser Gln Ser
145 150 155 160
Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu Thr Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Lys Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg
180 185 190
Glu Ser Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Thr Ile Ser Ser Val Gln Ala Glu Asp Leu Ala Val Tyr
210 215 220
Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr Phe Gly Ser Gly Thr
225 230 235 240
Arg Leu Glu Ile Lys
245
<210> 206
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 scFv
<400> 206
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Trp Met His Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp Tyr Asn Gln Lys Phe
50 55 60
Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser Thr Ser Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
115 120 125
Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala
130 135 140
Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser
145 150 155 160
Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu Thr Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg
180 185 190
Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr
210 215 220
Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
Lys Leu Glu Ile Lys
245
<210> 207
<211> 240
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116 scFv
<400> 207
Gln Val Gln Leu Lys Glu Ser Gly Pro Glu Leu Val Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Thr Ser Gly Tyr Thr Phe Thr Glu Tyr
20 25 30
Thr Met Asn Trp Val Arg Gln Ser His Gly Lys Ser Leu Glu Trp Ile
35 40 45
Gly Gly Ile Ile Pro Asn Asn Gly Asp Thr Ser Tyr Asn Gln Lys Phe
50 55 60
Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Ala Gly Arg Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
100 105 110
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Asp Ile Val Met Thr Gln Ala Pro Leu Thr Leu Ser Val Thr Ile Gly
130 135 140
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser
145 150 155 160
Asp Gly Lys Thr Tyr Leu Asn Trp Phe Leu Gln Arg Pro Gly Gln Ser
165 170 175
Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro
180 185 190
Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
195 200 205
Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Trp Gln Gly
210 215 220
Thr His Phe Pro Phe Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys
225 230 235 240
<210> 208
<211> 242
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117 scFv
<400> 208
Gln Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Lys Lys Pro Gly Glu
1 5 10 15
Thr Val Lys Ile Ser Cys Lys Ala Ser Phe Tyr Thr Phe Thr Ala Tyr
20 25 30
Ser Met His Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys Trp Met
35 40 45
Gly Trp Ile Asn Thr Glu Thr Gly Glu Pro Thr Tyr Ala Asp Asp Phe
50 55 60
Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Thr Thr Ala Tyr
65 70 75 80
Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Phe Phe Cys
85 90 95
Ala Arg Gly Leu Arg Arg Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val
100 105 110
Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
115 120 125
Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro Thr Ser Leu Ala Val
130 135 140
Ser Leu Gly Gln Arg Ala Thr Ile Ser Cys Arg Ala Ser Glu Ser Val
145 150 155 160
Asp Ser Tyr Gly Asn Ser Phe Met Asn Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Gln Pro Pro Lys Leu Leu Ile Tyr Leu Ala Ser Tyr Leu Glu Ser Gly
180 185 190
Val Pro Ala Arg Phe Ser Gly Ser Gly Ser Arg Thr Asp Phe Thr Leu
195 200 205
Thr Ile Asp Pro Val Glu Ala Asp Asp Ala Ala Thr Tyr Tyr Cys Gln
210 215 220
Gln Asn Asn Glu Asp Pro Tyr Thr Phe Gly Gly Gly Thr Arg Leu Glu
225 230 235 240
Ile Lys
<210> 209
<211> 244
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127 scFv
<400> 209
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala
1 5 10 15
Ser Val Thr Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr
20 25 30
Glu Ile His Trp Val Lys Gln Thr Pro Val His Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asp Pro Glu Thr Gly Gly Ala Ala Tyr Thr Gln Lys Phe
50 55 60
Lys Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Thr Thr Tyr Gly Asn Tyr Pro Leu Asp Ser Trp Gly Gln Gly Thr Thr
100 105 110
Leu Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
115 120 125
Gly Gly Gly Ser Gly Ile Val Met Thr Gln Thr Pro Leu Ser Leu Pro
130 135 140
Val Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser
145 150 155 160
Leu Val His Ser Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys
165 170 175
Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe
180 185 190
Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe
210 215 220
Cys Ser Gln Ser Thr His Val Pro Leu Thr Phe Gly Ala Gly Thr Arg
225 230 235 240
Leu Glu Ile Lys
<210> 210
<211> 244
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143 scFv
<400> 210
Gln Val Gln Leu Lys Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala
1 5 10 15
Ser Val Thr Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr
20 25 30
Glu Met His Trp Val Lys Gln Thr Pro Val His Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asp Pro Glu Thr Gly Gly Ala Ala Tyr Thr Gln Lys Phe
50 55 60
Lys Gly Lys Ala Thr Pro Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Thr Thr Tyr Gly Asn Tyr Pro Leu Asp Ser Trp Gly Gln Gly Thr Thr
100 105 110
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
115 120 125
Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Thr Pro Leu Ser Leu Pro
130 135 140
Val Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser
145 150 155 160
Leu Val His Ser Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys
165 170 175
Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe
180 185 190
Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Lys Ile Ser Gly Val Glu Ala Glu Asp Leu Gly Val Tyr Phe
210 215 220
Cys Ser Gln Ser Thr His Val Pro Leu Thr Phe Gly Ala Gly Thr Lys
225 230 235 240
Leu Glu Leu Lys
<210> 211
<211> 241
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159 scFv
<400> 211
Gln Val Gln Leu Lys Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Thr
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Ile Thr Asn Tyr
20 25 30
Trp Leu Gly Trp Val Lys Gln Arg Pro Gly His Gly Leu Glu Trp Ile
35 40 45
Gly Asp Ile Tyr Pro Gly Gly Gly Tyr Thr Asn Tyr Asn Glu Lys Phe
50 55 60
Lys Gly Lys Ala Thr Leu Thr Ala Asp Thr Ser Ser Ile Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Gly Ser Ser Tyr Trp Tyr Phe Asp Val Trp Gly Ala Gly
100 105 110
Thr Ser Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Thr Thr Ser Ser
130 135 140
Leu Ser Ala Ser Leu Gly Asp Arg Val Thr Ile Ser Cys Ser Ala Ser
145 150 155 160
Gln Asp Ile Ser Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Asp Gly
165 170 175
Thr Val Lys Leu Leu Ile Tyr Tyr Thr Ser Ser Leu His Ser Gly Val
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Ser Leu Thr
195 200 205
Ile Ser Asn Leu Glu Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln
210 215 220
Tyr Ser Lys Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Leu
225 230 235 240
Lys
<210> 212
<211> 240
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115 scFv
<400> 212
Gln Val Gln Leu Lys Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Thr Ser Gly Tyr Thr Phe Thr Glu Tyr
20 25 30
Thr Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile
35 40 45
Gly Gly Ile Ile Pro Asn Asn Gly Asp Thr Ser Tyr Lys Gln Glu Phe
50 55 60
Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Ala Gly Arg Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
100 105 110
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Asp Ile Val Met Thr Gln Thr Pro Leu Thr Leu Ser Val Thr Ile Gly
130 135 140
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser
145 150 155 160
Asp Gly Lys Thr Tyr Leu Asn Trp Phe Leu Gln Arg Pro Gly Gln Ser
165 170 175
Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro
180 185 190
Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
195 200 205
Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Trp Gln Gly
210 215 220
Thr His Phe Pro Phe Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys
225 230 235 240
<210> 213
<211> 243
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123 scFv
<400> 213
Glu Val Gln Leu Gln Gln Ser Gly Pro Gly Leu Val Ala Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Arg Tyr
20 25 30
Ser Val His Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Met Ile Trp Gly Gly Gly Asn Thr Asp Tyr Asn Ser Ala Leu Lys
50 55 60
Ser Arg Leu Ser Ile Ser Lys Asp Asn Ser Lys Ser Gln Val Phe Leu
65 70 75 80
Lys Met Asn Ser Leu Gln Thr Asp Asp Thr Ala Met Tyr Tyr Cys Ala
85 90 95
Arg Ser Leu Gly Trp Tyr Phe Asp Ile Trp Gly Ala Gly Thr Thr Val
100 105 110
Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
115 120 125
Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro Ser Ser Leu Ala Val
130 135 140
Ser Ala Gly Glu Lys Val Thr Met Ser Cys Lys Ser Ser Gln Ser Val
145 150 155 160
Leu Tyr Ser Ser Asn Gln Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu
180 185 190
Ser Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Thr Ile Ser Ser Val Gln Ala Glu Asp Leu Ala Val Tyr Tyr
210 215 220
Cys His Gln Tyr Leu Ser Ser Trp Thr Phe Gly Gly Gly Thr Lys Leu
225 230 235 240
Glu Ile Lys
<210> 214
<211> 245
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145 scFv
<400> 214
Glu Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Ala Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Thr Gly Tyr Thr Asp Tyr Asn Gln Lys Phe
50 55 60
Lys Asp Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
115 120 125
Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Thr
130 135 140
Val Thr Ala Gly Glu Lys Val Thr Met Ser Cys Lys Ser Ser Gln Ser
145 150 155 160
Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu Thr Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg
180 185 190
Glu Ser Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Thr Ile Ser Ser Val Gln Ala Glu Asp Leu Ala Val Tyr
210 215 220
Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr Phe Gly Ala Gly Thr
225 230 235 240
Lys Leu Glu Leu Lys
245
<210> 215
<211> 241
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 scFv
<400> 215
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Leu Tyr Tyr Tyr
20 25 30
Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr Trp Gly Gln Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu
130 135 140
Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln
145 150 155 160
Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala
165 170 175
Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly
210 215 220
Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
225 230 235 240
Lys
<210> 216
<211> 237
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491 scFv
<400> 216
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Leu Tyr Ser Tyr
20 25 30
Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Tyr Ile Tyr Pro Tyr Ser Gly Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Tyr Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
100 105 110
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser
130 135 140
Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser
145 150 155 160
Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu
165 170 175
Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe
180 185 190
Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu
195 200 205
Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Tyr Trp
210 215 220
Leu Phe Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
225 230 235
<210> 217
<211> 240
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 scFv
<400> 217
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Tyr Tyr Ser
20 25 30
Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
100 105 110
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser
130 135 140
Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser
145 150 155 160
Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu
165 170 175
Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe
180 185 190
Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu
195 200 205
Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Ser Ser Gly
210 215 220
Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
225 230 235 240
<210> 218
<211> 238
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 scFv
<400> 218
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Tyr Ser Ser
20 25 30
Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
100 105 110
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser
130 135 140
Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser
145 150 155 160
Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu
165 170 175
Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe
180 185 190
Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu
195 200 205
Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Pro Tyr Tyr
210 215 220
His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
225 230 235
<210> 219
<211> 238
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 scFv
<400> 219
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Leu Ser Tyr Ser
20 25 30
Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
100 105 110
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser
130 135 140
Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser
145 150 155 160
Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu
165 170 175
Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe
180 185 190
Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu
195 200 205
Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Trp Tyr
210 215 220
Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
225 230 235
<210> 220
<211> 241
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 scFv
<400> 220
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Leu Tyr Ser Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
130 135 140
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
145 150 155 160
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
180 185 190
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
195 200 205
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
210 215 220
Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
225 230 235 240
Lys
<210> 221
<211> 121
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66073 sdAb
<400> 221
Gln Val Gln Leu Val Glu Ser Gly Gly Asp Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Thr Leu Ala Cys Thr Gly Arg Lys Tyr Ser Ser Leu Tyr Cys
20 25 30
Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Ala Arg Glu Gly Val Ala
35 40 45
Val Ile Ser Ser Gly Gly Phe Thr Asn Tyr Ala Asp Ser Val Lys Gly
50 55 60
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Ala
65 70 75 80
Met Asn Gly Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala
85 90 95
Gly Leu Ser Tyr Cys His Ser Ser Thr Ala Thr Ala Thr Tyr Arg Gly
100 105 110
Gln Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 222
<211> 119
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66439 sdAb
<400> 222
Gln Met Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Pro Gly Phe Thr Ser Ser Asp Cys
20 25 30
Asp Met Asp Trp Tyr Arg Gln Ala Ala Gly Asn Gln Arg Glu Trp Val
35 40 45
Ser Ser Leu Leu Ser Thr Asp Gly Ser Thr Ser Tyr Ala Asp Ser Val
50 55 60
Arg Gly Arg Phe Thr Ile Ser Lys Asp Pro Ala Lys Asp Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Phe Cys
85 90 95
Arg Cys Val Val Ala Glu Trp Gly Gly Met Asp Tyr Trp Gly Lys Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 223
<211> 127
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65955 sdAb
<400> 223
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asp Arg Val Ser Thr Gly
20 25 30
Cys Met Gly Trp Phe Arg Gln Gly Pro Gly Glu Glu Arg Glu Gly Leu
35 40 45
Ala Gln Ile His Asn Tyr Asn Ile Ala Lys Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Lys Asp Asn Ala Lys Asn Ile Leu Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Gly Leu Tyr Ile Cys Thr
85 90 95
Ala Pro Val Asp Cys Ser Trp Ser Met Phe Leu Gln Asp Pro Leu Ala
100 105 110
Leu Ser Pro Pro Arg Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 224
<211> 122
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 sdAb
<400> 224
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser Met Gly
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val Ala His Ile
35 40 45
Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys Gly Arg
50 55 60
Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile Met Tyr Leu Gln Met
65 70 75 80
Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Arg
85 90 95
Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp Phe Trp
100 105 110
Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 225
<211> 131
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65926 sdAb
<400> 225
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Leu Tyr Asn Asn Met
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ser Ile Tyr Ile Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Pro Ile Ser Arg Asp Asn Ala Lys Ser
65 70 75 80
Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met
85 90 95
Tyr Tyr Cys Ala Ala Val Ser Ile Ala Leu Thr Arg Glu Phe Cys Ala
100 105 110
Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln Val Thr
115 120 125
Val Ser Ser
130
<210> 226
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66159 sdAb
<400> 226
Gln Val Arg Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Val Tyr Asn Asn Met
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val
50 55 60
Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Pro
100 105 110
Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 227
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66416 sdAb
<400> 227
Gln Val Gln Leu Ala Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Leu Tyr Asn Asn Met
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Gly Ser Ile Tyr Ile Gly Gly Gly Tyr Thr Asn Tyr Ser Glu Ser Val
50 55 60
Arg Gly Arg Phe Thr Ile Ser Leu Asp Asn Ala Lys Lys Thr Leu Asn
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Ile Pro Ile Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Val
100 105 110
Ser Arg Tyr Thr Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 228
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65850 sdAb
<400> 228
Glu Val Gln Leu Met Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Tyr Ser Asn Ile
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ala Ile Tyr Ser Asn Gly Ser Thr Ile Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Val Ser Lys Glu Phe Ala Lys Asn Thr Gln Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala
85 90 95
Ala Gly Arg Cys Gly Gly Pro Asn Tyr Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 229
<211> 132
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65183 sdAb
<400> 229
Glu Val Gln Leu Ala Glu Ser Gly Gly Gly Ser Ala Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ser Asn Gly Tyr Tyr Asn Arg Arg Tyr
20 25 30
Cys Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Thr Met Thr Thr Thr Ser Gly Arg Thr Tyr Tyr Ala Asp Ala Val
50 55 60
Lys Gly Arg Phe Thr Val Ser Gln Asp Asn Ala Lys Ser Thr Leu Tyr
65 70 75 80
Leu Gln Met Ser Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala His Leu Pro Ser Ser Trp Val Thr Ser Thr Asp Tyr Cys Asp
100 105 110
Asn Leu Gln Ala Gly Phe Tyr Asn Ser Trp Gly Gln Gly Thr Gln Val
115 120 125
Thr Val Ser Ser
130
<210> 230
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65062 sdAb
<400> 230
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Val Ser Val Val Asn Phe
20 25 30
Ala Met Arg Trp Tyr Arg Gln Ala Pro Gly Asn Glu Arg Glu Phe Val
35 40 45
Ser Ala Met Tyr Arg Ser Gly Ser Thr Ser Tyr Ala Asp Ser Val Arg
50 55 60
Gly Arg Phe Thr Ile Ser Arg Asp Ser Ala Leu Asn Thr Val Phe Leu
65 70 75 80
Gln Met Ser Gly Leu Lys Pro Glu Asp Thr Ala Thr Tyr Tyr Cys Gln
85 90 95
Ala Thr Ser Pro Met Gly Asp Thr Tyr Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 231
<211> 121
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65065 sdAb
<400> 231
Glu Val Gln Leu Ala Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Tyr Cys Arg Ser
20 25 30
Thr Met Arg Trp Tyr Arg Gln Ala Pro Gly Asn Val Arg Glu Phe Val
35 40 45
Ser Ala Ile Tyr Ser Asp Gly Thr Thr Ser Tyr Thr Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Val Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Gln Pro Glu Asp Thr Ala Met Tyr Tyr Cys Arg
85 90 95
Ile Asp Leu Val Gly Cys Asn Val Ala Gly Gly Ser Pro Tyr Trp Gly
100 105 110
Gln Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 232
<211> 115
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65556 sdAb
<400> 232
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Val Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Asn Ala Ser Ile Cys
20 25 30
Arg Met Ser Trp Tyr Arg Gln Ala Pro Gly Thr Glu Arg Glu Phe Val
35 40 45
Ser Ser Ser Tyr Arg Asp Gly Ser Gln Ser Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Thr Ser Arg Asp Ser Ala Lys Asn Thr Val Phe Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Pro Ser Asp Thr Ala Met Tyr Tyr Cys Asn
85 90 95
Ala Ala Cys Pro Trp Arg Ala Tyr Trp Gly Gln Gly Thr Gln Val Thr
100 105 110
Val Ser Ser
115
<210> 233
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65069 sdAb
<400> 233
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Asp Thr Gly Tyr Gln Pro
20 25 30
Thr Met Arg Trp Tyr Arg Gln Ala Pro Gly Lys Glu Arg Glu Phe Val
35 40 45
Ser Ala Ile Tyr Ser Asp Gln Thr Thr Ser Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Arg Lys Thr Val Tyr Leu
65 70 75 80
Gln Met Ala Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys Lys
85 90 95
Leu Thr Thr Arg Arg Gly Ser Glu Tyr Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 234
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65691 sdAb
<400> 234
Gln Met Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Val Ser Gly Tyr Thr Asp Tyr Arg Leu
20 25 30
Val Leu Arg Trp Tyr Arg Gln Ala Leu Gly Lys Glu Arg Glu Phe Ile
35 40 45
Ser Ala Ile Tyr Ser Asp Gly Val Thr Ser Tyr Ser Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Ala Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Ser Glu Asp Thr Ala Met Tyr Tyr Cys Lys
85 90 95
Ala Thr Gly Ser Gly Gly Val Ala Tyr Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 235
<211> 134
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65064 sdAb
<400> 235
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Lys Leu Ser Cys Ala Val Ser Gly Asp Thr Val Gln Thr Asn
20 25 30
Cys Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ala Val
35 40 45
Ala Ser Ile Leu Ser Leu Tyr Ser Ser Gly Gly Lys Thr Val Tyr Ala
50 55 60
Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Pro Asp Asn Ala Gln Asn
65 70 75 80
Thr Val Ser Leu Gln Met Asn Asn Leu Lys Pro Glu Asp Thr Ala Met
85 90 95
Tyr Tyr Cys Ala Thr Val Arg Val Thr Val Thr Trp Ala Glu Lys Leu
100 105 110
Arg Arg Cys Thr Gly Phe Ser Gly Met Asp Tyr Trp Gly Lys Gly Thr
115 120 125
Leu Val Thr Val Ser Ser
130
<210> 236
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65081 sdAb
<400> 236
Gln Val His Leu Met Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Val Pro Ala Ser Ser Tyr
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Gly Ile Val Ser Asp Thr Thr Thr Thr Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Lys Asp Asn Ala Lys Asn Thr Leu Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Thr Tyr Tyr Cys Ala
85 90 95
Ala Ser His Phe Leu Leu Cys Ala Arg Lys Pro Arg Trp Asp Asp Leu
100 105 110
Ile Lys Tyr Glu Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 237
<211> 119
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65115 sdAb
<400> 237
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ile Tyr Gly Cys Met
20 25 30
Gly Trp Phe Arg Arg Ala Pro Gly Lys Ala Arg Glu Glu Val Ala Thr
35 40 45
Ile Tyr Arg Asp Gly Thr Ala Tyr Tyr Ala Asn Ser Val Glu Gly Arg
50 55 60
Phe Thr Ala Ser Arg Asn Asn Ala Glu Asn Thr Leu Ser Leu Glu Met
65 70 75 80
Asn Ser Leu Asn Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Arg
85 90 95
Thr Thr Gly Cys Asn Trp Asp Ile Ser Gly Val Tyr Trp Gly Gln Gly
100 105 110
Thr Gln Val Thr Val Ser Ser
115
<210> 238
<211> 126
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65271 sdAb
<400> 238
Gln Met Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Lys Thr Tyr Gly Arg Cys
20 25 30
Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Leu Val Ala
35 40 45
Ala Thr Tyr Ile Ser Gly Gly Arg Pro Tyr Val Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Ser Thr Met Ser Leu
65 70 75 80
Gln Met Asn Ser Leu Arg Pro Asp Asp Ser Ala Met Tyr Tyr Cys Ala
85 90 95
Ala Gly Ser Ala Gly Arg Gly Pro Cys Asp Arg Phe Asp Gln Asn Gln
100 105 110
Tyr Thr Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 239
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65166 sdAb
<400> 239
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Ser Glu Asp Leu Ser Ile Tyr Gly
20 25 30
Tyr Asn Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu
35 40 45
Ala Val Ala Ala Ile Tyr Thr Gly Arg Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr
65 70 75 80
Val Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr
85 90 95
Tyr Cys Ala Ser Lys Tyr Cys Ala Val Val Ala Asp Phe Gly Asn Ser
100 105 110
Arg Leu Val Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 240
<211> 126
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65450 sdAb
<400> 240
Gln Val Arg Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asp Met Asn Gly Tyr Lys
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ala Val
35 40 45
Ala Gly Ile Tyr Thr Gly Arg Gly Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Lys Tyr Cys Ala Val Val Ala Glu Phe Gly Gly Pro Arg Leu
100 105 110
Val Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 241
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65454 sdAb
<400> 241
Gln Val Arg Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asp Met Asn Gly Tyr Lys
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ala Val
35 40 45
Ala Gly Ile Tyr Thr Gly Arg Asn Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Asp Leu Phe Thr Ile Ser Gln Asp Asn Ala Gln Asn Thr Val Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ser Tyr Cys Ala Val Val Ala Glu Phe Arg Gly Pro Arg Leu Asp
100 105 110
Arg Tyr Trp Gly Tyr Gly Thr Gln Val Thr Val Thr Ser
115 120 125
<210> 242
<211> 123
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65131 sdAb
<400> 242
Glu Val Gln Leu Ala Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Thr Leu Ser Cys Thr Ala Ser Glu Tyr Val Thr His Leu Gly
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val Ala Ile Glu
35 40 45
Ser Phe Arg Ile Gly Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg
50 55 60
Phe Thr Ile Ser His Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met
65 70 75 80
Asn Ser Leu Lys Pro Glu Asp Thr Ala Ile Tyr Tyr Cys Ala Ala Arg
85 90 95
Gln Asp Arg Ser Gly Ala Ser Met Val Asn Arg Asp Ser Tyr Asn Tyr
100 105 110
Trp Gly Lys Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 243
<211> 129
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65182 sdAb
<400> 243
Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Tyr Ser Tyr Gly
20 25 30
Tyr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Lys Ile Tyr Asn Gly Asp Gly Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Gln Asp Arg Arg Asn Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Ala Pro Glu Asp Thr Gly Met Tyr Tyr Cys
85 90 95
Ala Thr Asn Arg Leu Pro Asn Ser Asp Val Asp Leu Val Leu Pro Arg
100 105 110
Phe Gly Arg Phe Gly Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser
115 120 125
Ser
<210> 244
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 sdAb
<400> 244
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Val Tyr Asn Asn Met
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr Tyr Asp Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe Cys Ala Pro Ile Val
100 105 110
Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 245
<211> 128
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 sdAb
<400> 245
Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Val Tyr Asn Asn Met
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn Tyr Ala Asp Ser Val
50 55 60
Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe Cys Ala Pro Ile Pro
100 105 110
Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 246
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60705 sdAb
<400> 246
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ser Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ala Tyr Ser Gly Ser
20 25 30
Cys Met Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly
35 40 45
Val Ala Val Ser Val Arg Arg Thr Gly Ser Ala Phe Tyr Ala Asp Ser
50 55 60
Val Lys Ala Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Met Asn Asn Leu Lys Val Glu Asp Thr Ala Met Tyr Tyr
85 90 95
Cys Ala Ala Asp Phe Thr Cys Arg Thr Trp Thr Leu Asn Lys Asn Tyr
100 105 110
Asn His Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 247
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60660 sdAb
<400> 247
Gln Val His Leu Met Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Asp Thr Gly Tyr Gln Pro
20 25 30
Thr Met Arg Trp Tyr Arg Gln Ala Pro Gly Lys Glu Arg Glu Phe Val
35 40 45
Ser Ala Ile Tyr Ser Asp Gln Thr Thr Ser Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Arg Lys Thr Val Tyr Leu
65 70 75 80
Gln Met Ala Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys Lys
85 90 95
Leu Thr Thr Arg Arg Gly Ser Glu Tyr Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 248
<211> 121
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60662 sdAb
<400> 248
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Tyr Arg Asn Cys Arg Ser
20 25 30
Thr Met Arg Trp Tyr Arg Gln Gly Pro Gly Gln Val Arg Asp Trp Val
35 40 45
Ser Ser Ile Tyr Thr Asp Gly Thr Thr Ser Tyr Thr Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ala Gln Asp Lys Gly Lys Asn Thr Val Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Gln Pro Glu Asp Thr Ala Met Tyr Tyr Cys Arg
85 90 95
Ile Asp Leu Val Gly Cys Asn Val Ala Gly Gly Ser Pro Tyr Trp Gly
100 105 110
His Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 249
<211> 126
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60664 sdAb
<400> 249
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Lys Thr Tyr Gly Arg Cys
20 25 30
Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Leu Val Ala
35 40 45
Ala Thr Tyr Ile Ser Gly Gly Arg Pro Tyr Val Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Ser Thr Met Ser Leu
65 70 75 80
Gln Met Asn Ser Leu Arg Pro Asp Asp Ser Ala Met Tyr Tyr Cys Ala
85 90 95
Ala Gly Ser Ala Gly Arg Gly Pro Cys Asp Arg Phe Asp Gln Asn Gln
100 105 110
Tyr Thr Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 250
<211> 126
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60668 sdAb
<400> 250
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asp Met Asn Gly Tyr Lys
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Ala Val
35 40 45
Ala Gly Ile Tyr Thr Gly Arg Asn Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Val Phe
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ser Lys Tyr Cys Ala Val Val Ala Glu Phe Gly Gly Pro Arg Leu
100 105 110
Val Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 251
<211> 120
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 sdAb
<400> 251
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Val Ser Ser Gly
20 25 30
Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Arg Val
35 40 45
Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu Asn Thr Leu Tyr Leu
65 70 75 80
Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Ser Cys Thr
85 90 95
Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly Arg Tyr Trp Gly Gln
100 105 110
Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 252
<211> 124
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60678 sdAb
<400> 252
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Tyr Thr Ser Ser Arg Gly
20 25 30
Cys Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Arg Val
35 40 45
Ala Tyr Ile Asn Met Arg Val Leu Thr Thr Ile Tyr Ala Ala Ser Val
50 55 60
Lys Asp Arg Phe Ala Ile Ser Arg Asp Asn Ala Lys Asn Thr Val Asp
65 70 75 80
Leu Gln Met Asn Asn Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Ala Gly Tyr Asn Gly Gln Trp Cys Glu His Ala Ser Asp Val Thr
100 105 110
Ala Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 253
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60679 sdAb
<400> 253
Gln Val His Leu Met Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Arg Ser Gly Val Thr Tyr Cys Arg Leu
20 25 30
Thr Met Arg Trp Tyr Arg Gln Ala Pro Gly Ser Glu Arg Glu Phe Val
35 40 45
Ser Ala Ile Tyr Ser Asp Gly Ser Thr Ala Tyr Ala Asp Ser Val Lys
50 55 60
Gly Arg Phe Thr Met Ser Gln Asp Asp Ala Lys Asn Thr Val Tyr Leu
65 70 75 80
Gln Met Asn Ser Val Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys Lys
85 90 95
Leu Asn Cys Ala Ser Gly Leu Thr Ala Trp Gly Gln Gly Thr Gln Val
100 105 110
Thr Val Ser Ser
115
<210> 254
<211> 124
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81326 sdAb
<400> 254
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Thr Leu Ser Cys Ala Ala Ser Glu Ser Arg Asp Cys Met Ala
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Ala Arg Glu Gly Val Ala Ser Ile
35 40 45
Tyr Ala Pro Asp Gly Ser Thr Thr Tyr Ala Asp Thr Val Lys Gly Arg
50 55 60
Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met
65 70 75 80
Asn Ser Leu Gln Pro Glu Asp Ala Ala Met Tyr His Cys Ala Ile Gly
85 90 95
Gly Leu Ser Arg Asn Thr Cys Gly Tyr Leu Arg Gly Gly Tyr Phe Ala
100 105 110
Tyr Phe Gly Arg Gly Thr Gln Val Thr Val Ser Ser
115 120
<210> 255
<211> 130
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81187 sdAb
<400> 255
Gln Val Arg Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Tyr Ser Ser Tyr
20 25 30
Ser Ser Asn Cys Leu Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg
35 40 45
Glu Ala Val Ala Arg Ile Tyr Pro Asn Ser Gly Ser Thr Tyr Tyr Ala
50 55 60
Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys Asn
65 70 75 80
Thr Val Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met
85 90 95
Tyr Tyr Cys Ala Val Ala Val Gly Val Gly Asp Asn Trp Cys Ala Ser
100 105 110
Gly Ala Ala Tyr Phe Gly Tyr Trp Gly Gln Gly Thr Gln Val Thr Val
115 120 125
Ser Ser
130
<210> 256
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533 sdAb
<400> 256
Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Thr Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Leu Ser Phe Ser Thr Tyr
20 25 30
Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Asn Met Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn Gly Tyr
100 105 110
Asn Arg Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 257
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444 sdAb
<400> 257
Glu Val Gln Leu Ala Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Asn
20 25 30
Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp Ser Val
50 55 60
Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Asn Met Val Tyr
65 70 75 80
Leu Gln Met Asn Asn Leu Glu Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn Gly Tyr
100 105 110
Asn His Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 258
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81487 sdAb
<400> 258
Gln Val Arg Leu Val Glu Ser Gly Gly Gly Ser Val Gln Ala Gly Gly
1 5 10 15
Ser Leu Arg Val Ser Cys Leu Val Ser Lys Leu Thr Ala Trp Arg Ser
20 25 30
Cys Val Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly Val
35 40 45
Ala Ala Ile Tyr Ser Gly Thr Gly Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ala Gln Asp Tyr Ala Lys Asn Met Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Gly Thr Ser Ile Arg Ser Ser Cys Gly Leu Val Arg Asp Glu Tyr
100 105 110
Ala Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
115 120 125
<210> 259
<211> 735
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126 scFV
<400> 259
caggtgcagc tgaagcagtc tggggctgaa ctggcaaaac ctggggcctc agtggagatg 60
tcctgcaagg cttctggcta cacctttact agctactgga tgcactgggt aaaacagagg 120
cctggacagg gtctggaatg gattggatac attaatccta gtactggtca tactgactac 180
aatcagaagt tcaaggacaa ggccacattg actgcagaca aatcctccag cacagcctac 240
atgcaactga gcagcctgac atctgaggac tctgcagtct attactgtgc aagatccaac 300
tgggcctggt ttccttactg gggccaaggg actctggtca ctgtctcgag cggtggaggc 360
ggttcaggcg gaggtggctc tggcggtggc gggtcggaca ttgtgatgac tcagtctcca 420
tcctccctga ctgtgacagc aggagagaag gtcactatga gctgcaagtc cagtcagagt 480
ctgttaaaca gtggaaatca aaagaactac ttgacctggt accagcagaa accagggaag 540
cctcctaaac tgttgatcta ctgggcatcc actagggaat ctggggtccc tgatcgcttc 600
acaggcagtg gatctggaac agatttcact ctcaccatca gcagtgtgca ggctgaagac 660
ctggcagttt attactgtca gaatgattat agttatccgc tcacgttcgg ttctgggacc 720
agactggaaa taaaa 735
<210> 260
<211> 735
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 scFV
<400> 260
caggtgcagc tggtgcagtc cggagcagag gtgaagaagc caggagccag cgtgaaggtg 60
tcctgcaagg cctctggcta caccttcaca agctattgga tgcactgggt gaagcaggca 120
ccaggacagg gactggagtg gatcggctac atcaatccct ccacaggcca caccgactat 180
aaccagaagt ttaaggatcg ggccaccctg acagccgaca cctctacaag caccgtgtac 240
atggagctga gctccctgag gtccgaggat acagccgtgt actattgcgc ccgctctaat 300
tgggcctggt tcccctattg gggccagggc acactggtga ccgtgtctag cggaggagga 360
ggatccggag gaggaggatc tggcggcggc ggcagcgata tcgtgatgac acagtcccct 420
gactctctgg ccgtgtctct gggagagagg gcaaccatca actgtaagtc ctctcagagc 480
ctgctgaact ccggcaatca gaagaactac ctgacctggt atcagcagaa gcctggccag 540
ccccctaagc tgctgatcta ctgggcatct acaagggaga gcggagtgcc agatagattc 600
tccggctctg gcagcggcac cgactttaca ctgaccatca gctccctgca ggccgaggat 660
gtggccgtgt actattgtca gaatgactac agctatcccc tgacatttgg cggcggcacc 720
aagctggaga tcaag 735
<210> 261
<211> 720
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58116 scFV
<400> 261
caggtgcagc tgaaggagtc tggacctgag ctggtgaagc ctggggcttc agtgaagata 60
tcctgcaaga cttctggata cacattcact gaatacacca tgaactgggt gaggcagagc 120
catggaaaga gccttgagtg gattggaggt attattccta acaatggtga tactagctac 180
aaccagaagt tcaagggcaa ggccacattg actgtagaca agtcctccag cacagcctac 240
atggaactcc gcagcctgac atctgaggat tctgcagtct attactgtgc agggcggttt 300
gcttactggg gccaagggac tctggtcact gtctcgagcg gtggaggcgg ttcaggcgga 360
ggtggctctg gcggtggcgg gtcggatatt gtgatgaccc aggctccact cactttgtcg 420
gttaccattg gacaaccagc ctccatctct tgcaagtcaa gtcagagcct cttagatagt 480
gatggaaaga catatttgaa ttggttctta cagaggccag gccagtctcc aaagcgccta 540
atctatctgg tgtctaaact ggactctgga gtccctgaca ggttcactgg cagtggatca 600
gggacagatt tcacactgaa aatcagcaga gtggaggctg aggatttggg agtttattat 660
tgctggcaag gtacacattt tccattcacg ttcggctcgg gcacaaagtt ggaaataaaa 720
<210> 262
<211> 726
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58117 scFV
<400> 262
caggtccagc tgcagcagtc tggacctgag ctgaagaagc ctggagagac cgtcaagatc 60
tcctgcaagg cttcttttta taccttcaca gcctattcaa tgcactgggt gaagcaggct 120
ccaggaaagg gtttaaagtg gatgggctgg ataaacactg agactggtga gccaacatat 180
gcagatgact tcaagggacg gtttgccttc tctttggaaa cctctgccac cactgcctat 240
ttgcagatca acaacctcaa aaatgaggac acggctacat ttttctgtgc taggggacta 300
cggcggtttg cttactgggg ccaggggact ctggtcactg tctcgagcgg tggaggcggt 360
tcaggcggag gtggctctgg cggtggcggg tcggacattg tgatgacaca gtctccaact 420
tctttggctg tgtctctagg gcagagggcc accatatcct gcagagccag tgaaagtgtt 480
gatagttatg gcaatagttt tatgaattgg taccagcaga aaccaggaca gccacccaaa 540
ctcctcatct atcttgcatc ctacctagaa tctggggtcc ctgccaggtt cagtggcagt 600
gggtctagga cagacttcac cctcaccatt gatcctgtgg aggctgatga tgctgcaacc 660
tattactgtc agcaaaataa tgaggatccg tacacgttcg gaggggggac cagactggaa 720
ataaaa 726
<210> 263
<211> 732
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58127 scFV
<400> 263
caggttcagc tgcagcagtc tggggctgaa ctggtgaggc ctggggcttc agtgacgctg 60
tcctgcaagg cttcgggcta cacatttact gactatgaaa ttcactgggt gaagcagaca 120
cctgtgcatg gcctggaatg gattggaggt attgatcctg aaactggtgg tgctgcctac 180
actcagaagt tcaagggcaa ggccacactg actgcagaca aatcctccag cacagcctac 240
atggagctcc gcagcctgac atctgaggac tctgccgtct attactgtac aacttatggt 300
aactaccccc ttgactcctg gggccaaggc accactctca cagtctcgag cggtggaggc 360
ggttcaggcg gaggtggctc tggcggtggc gggtcgggta ttgtgatgac ccagactcca 420
ctctccctgc ctgtcagtct tggagatcaa gcctccatct cttgcagatc tagtcagagc 480
cttgtacaca gtaatggaaa cacctattta cattggtacc tgcagaagcc aggccagtct 540
ccaaagctcc tgatctacaa agtttccaac cgattttctg gggtcccaga caggttcagt 600
ggcagtggat cagggacaga tttcacactc aagatcagca gagtggaggc tgaggatctg 660
ggagtttatt tctgctctca aagtacacat gttccgctca cgttcggtgc tgggaccaga 720
ctggaaataa aa 732
<210> 264
<211> 732
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58143 scFV
<400> 264
caggtgcaac tgaagcagtc tggggctgaa ctggtgaggc ctggggcttc agtgacgctg 60
tcctgcaagg cttcgggcta cacatttact gactatgaaa tgcactgggt gaagcagaca 120
cctgtgcatg gcctggaatg gatcggaggt attgatcctg aaactggtgg tgctgcctac 180
actcagaagt tcaagggcaa ggccacaccg actgcagaca aatcctccag cacagcctac 240
atggagctcc gcagcctgac atctgaggac tctgccgtct attactgtac aacttatggt 300
aactaccccc ttgactcctg gggccaaggc accacggtca ccgtctcgag cggtggaggc 360
ggttcaggcg gaggtggctc tggcggtggc gggtcggata tccagatgac acagactcca 420
ctctccctgc ctgtcagtct tggagatcaa gcctccatct cttgcagatc tagtcagagc 480
cttgtacaca gtaatggaaa cacctattta cattggtacc tgcagaagcc aggccagtct 540
ccaaagctcc tgatctacaa agtttccaac cgattttctg gggtcccaga caggttcagt 600
ggcagtggat cagggacaga tttcacactc aagatcagcg gagtggaggc tgaggatctg 660
ggagtttatt tctgctctca aagtacacat gttccgctca cgttcggtgc tgggaccaag 720
ctggagctga aa 732
<210> 265
<211> 723
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58159 scFV
<400> 265
caggtgcaac tgaagcagtc tggagctgag ctggtaaggc ctgggacttc agtgaagata 60
tcctgcaagg cttctggcta caccatcact aactactggc taggttgggt aaagcagagg 120
ccaggacatg gacttgagtg gattggagat atttaccctg gaggtggtta tactaactac 180
aatgagaagt tcaagggcaa ggccacactg actgcagaca catcctccat cactgcctac 240
atgcagctca gtagcctgac atctgaggac tctgctgtct atttctgtgc aagaggcggt 300
agtagctact ggtacttcga tgtctggggc gcagggacct cagtcaccgt ctcgagcggt 360
ggaggcggtt caggcggagg tggctctggc ggtggcgggt cggatatcca gatgacacag 420
actacatcct ccctgtctgc ctctctggga gacagagtca ccatcagttg cagtgcaagt 480
caggacatta gcaattattt aaactggtat cagcagaaac cagatggaac tgttaaactc 540
ctgatctatt acacatcaag tttacactca ggagtcccat caaggttcag tggcagtggg 600
tctgggacag attattctct caccatcagc aacctggaac ctgaagatat tgccacttac 660
tattgtcagc agtatagtaa ggttccgtac acgttcggag gggggaccaa gctggagctg 720
aaa 723
<210> 266
<211> 720
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58115 scFV
<400> 266
caggtgcagc tgaagcagtc tggacctgag ctggtgaagc ctggggcttc agtgaagata 60
tcctgcaaga cttctggata cacattcact gaatacacca tgaactgggt gaagcagagc 120
catggaaaga gccttgagtg gattggagga attattccta acaatggtga tactagctac 180
aaacaggagt tcaagggcaa ggccacattg actgtagaca agtcctccag cacagcctac 240
atggagctcc gcagcctgac atctgacgat tctgcagtct attactgtgc agggcggttt 300
gcttactggg gccaagggac tctggtcact gtctcgagcg gtggaggcgg ttcaggcgga 360
ggtggctctg gcggtggcgg gtcggatatt gtgatgaccc agactccact cactttgtcg 420
gttaccattg gacaaccagc ctccatctct tgcaagtcaa gtcagagcct cttagatagt 480
gatggaaaga catatttgaa ttggttctta cagaggccag gccagtctcc aaagcgccta 540
atctatctgg tgtctaaact ggactctgga gtccctgaca ggttcactgg cagtggatca 600
gggacagatt tcacactgaa aatcagcaga gtggaggctg aggatttggg agtttattat 660
tgctggcaag gtacacattt tccattcacg ttcggctcgg gcacaaagtt ggaaataaaa 720
<210> 267
<211> 729
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58123 scFV
<400> 267
gaggtccagc tgcagcagtc aggacctggc ctggtggcac cctcacagag cctgtccatc 60
acatgcactg tctctgggtt ctcattatcc agatatagtg tacactgggt tcgccagcct 120
ccaggaaagg gtctggagtg gctgggaatg atatggggtg gtggaaacac agactataat 180
tcagctctca aatccagact gagcatcagc aaggacaact ccaagagcca agttttctta 240
aaaatgaaca gtctgcaaac tgatgacaca gccatgtact actgtgccag aagcctgggc 300
tggtacttcg atatctgggg cgcagggacc acggtcaccg tctcgagcgg tggaggcggt 360
tcaggcggag gtggctctgg cggtggcggg tcggacattg tgatgacaca gtcgccatca 420
tctctggctg tgtctgcagg agaaaaggtc actatgagct gtaagtccag tcaaagtgtt 480
ttatacagtt caaatcagaa gaactacttg gcctggtacc agcagaaacc agggcagtct 540
cctaaactgc tgatctactg ggcatccact agggaatctg gtgtccctga tcgcttcaca 600
ggcagtggat ctgggacaga ttttactctt accatcagca gtgtacaagc tgaagacctg 660
gcagtttatt actgtcatca atacctctcc tcgtggacgt tcggtggagg cacaaagctg 720
gaaatcaaa 729
<210> 268
<211> 735
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58145 scFV
<400> 268
gaggttcagc tgcaacagtc tggggctgaa ctggcaaaac ctggggcctc agtgaagatg 60
tcctgcaagg cttctggcta cacctttact agctactgga tgcactgggt aaaacagagg 120
cctggacagg gtctggaatg gattggatac attaatccta gcactggtta tactgactac 180
aatcagaagt tcaaggacaa ggccacattg actgcagaca aatcctccag cacagcctac 240
atgcaactga gcagcctgac atctgaggac tctgcagtct attactgtgc aagatccaac 300
tgggcctggt ttccttactg gggccaaggg actctggtca ctgtctcgag cggtggaggc 360
ggttcaggcg gaggtggctc tggcggtggc gggtcggaca tccagatgac acagtctcca 420
tcctccctga ctgtgacagc aggagagaag gtcactatga gctgcaagtc cagtcagagt 480
ctgttaaaca gtggaaatca aaagaactac ttgacctggt accagcagaa accagggcag 540
cctcctaaac tgttgatcta ctgggcatcc actagggaat ctggggtccc tgatcgcttc 600
acaggcagtg gatctggaac agatttcact ctcaccatca gcagtgtgca ggctgaagac 660
ctggcagttt attactgtca gaatgattat agttatccgc tcacgttcgg tgctgggacc 720
aagctggagc tgaaa 735
<210> 269
<211> 723
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 scFV
<400> 269
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacctctat tattattcta tccactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatat atttcttctt cttctagcta tacttattat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgctactac 300
ccgtactacg gtatggacta ctggggtcaa ggcaccctgg ttaccgtgag cagcggtgga 360
ggcggttcag gcggaggtgg ctctggcggt ggcgggtcgg acatccagat gacccagagc 420
ccgagcagcc tgagcgcgag cgttggtgac cgtgttacca ttacctgccg tgcgagccag 480
agcgttagca gcgcggtggc gtggtaccag caaaagccgg gtaaagcgcc gaagctgctg 540
atctatagcg cgagcagcct gtatagcggc gttccgagcc gtttcagcgg tagccgtagc 600
ggcaccgact ttaccctgac cattagcagc ctgcagccgg aagatttcgc aacttattac 660
tgtcagcaag gtttctctta ctacccgatc acgttcggac agggcaccaa agttgagatt 720
aaa 723
<210> 270
<211> 711
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51491 scFV
<400> 270
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacctctat tcttattcta tgcactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatat atttatcctt attctggctc tacttattat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgcggttac 300
ggtatggact actggggtca aggcaccctg gttaccgtga gcagcggtgg aggcggttca 360
ggcggaggtg gctctggcgg tggcgggtcg gacatccaga tgacccagag cccgagcagc 420
ctgagcgcga gcgttggtga ccgtgttacc attacctgcc gtgcgagcca gagcgttagc 480
agcgcggtgg cgtggtacca gcaaaagccg ggtaaagcgc cgaagctgct gatctatagc 540
gcgagcagcc tgtatagcgg cgttccgagc cgtttcagcg gtagccgtag cggcaccgac 600
tttaccctga ccattagcag cctgcagccg gaagatttcg caacttatta ctgtcagcaa 660
tcttactact ggctgttcac gttcggacag ggcaccaaag ttgagattaa a 711
<210> 271
<211> 720
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 scFV
<400> 271
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacatctat tattcttcta tgcactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatat atttatcctt attatagcta tacttattat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgcggttac 300
gctttggact actggggtca aggcaccctg gttaccgtga gcagcggtgg aggcggttca 360
ggcggaggtg gctctggcgg tggcgggtcg gacatccaga tgacccagag cccgagcagc 420
ctgagcgcga gcgttggtga ccgtgttacc attacctgcc gtgcgagcca gagcgttagc 480
agcgcggtgg cgtggtacca gcaaaagccg ggtaaagcgc cgaagctgct gatctatagc 540
gcgagcagcc tgtatagcgg cgttccgagc cgtttcagcg gtagccgtag cggcaccgac 600
tttaccctga ccattagcag cctgcagccg gaagatttcg caacttatta ctgtcagcaa 660
gcttcttctg gttaccatta cctgatcacg ttcggacagg gcaccaaagt tgagattaaa 720
<210> 272
<211> 714
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 scFV
<400> 272
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacatctat tcttcttcta tccactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatct atttcttctt attctagcta tacttcttat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgctactac 300
gctatggact actggggtca aggcaccctg gttaccgtga gcagcggtgg aggcggttca 360
ggcggaggtg gctctggcgg tggcgggtcg gacatccaga tgacccagag cccgagcagc 420
ctgagcgcga gcgttggtga ccgtgttacc attacctgcc gtgcgagcca gagcgttagc 480
agcgcggtgg cgtggtacca gcaaaagccg ggtaaagcgc cgaagctgct gatctatagc 540
gcgagcagcc tgtatagcgg cgttccgagc cgtttcagcg gtagccgtag cggcaccgac 600
tttaccctga ccattagcag cctgcagccg gaagatttcg caacttatta ctgtcagcaa 660
ggtccgtact accatccgat cacgttcgga cagggcacca aagttgagat taaa 714
<210> 273
<211> 714
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 scFV
<400> 273
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacctctct tattcttcta tccactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatct atttattctt attctggctc tacttattat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgctactgg 300
ggtatggact actggggtca aggcaccctg gttaccgtga gcagcggtgg aggcggttca 360
ggcggaggtg gctctggcgg tggcgggtcg gacatccaga tgacccagag cccgagcagc 420
ctgagcgcga gcgttggtga ccgtgttacc attacctgcc gtgcgagcca gagcgttagc 480
agcgcggtgg cgtggtacca gcaaaagccg ggtaaagcgc cgaagctgct gatctatagc 540
gcgagcagcc tgtatagcgg cgttccgagc cgtttcagcg gtagccgtag cggcaccgac 600
tttaccctga ccattagcag cctgcagccg gaagatttcg caacttatta ctgtcagcaa 660
tactactggt actacccgat cacgttcgga cagggcacca aagttgagat taaa 714
<210> 274
<211> 723
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 scFV
<400> 274
gaggttcaac tggtggagag cggtggtggt ctggttcagc cgggtggtag cctgcgtctg 60
agctgcgcag cttctggctt caacctctat tcttattata tgcactgggt gcgtcaggcg 120
ccgggtaaag gcctggaatg ggttgcatct atttattctt attctagcta tacttcttat 180
gccgatagcg tcaagggccg tttcaccatc agcgcggata ccagcaaaaa caccgcatac 240
ctgcaaatga acagcctgcg tgcggaagat accgccgtct attattgtgc tcgcccgttc 300
ggttggggtt acgctggtat ggactactgg ggtcaaggca ccctggttac tgtgagcagc 360
ggtggaggcg gttcaggcgg aggtggctct ggcggtggcg ggtcggacat ccagatgacc 420
cagagcccga gcagcctgag cgcgagcgtt ggtgaccgtg ttaccattac ctgccgtgcg 480
agccagagcg ttagcagcgc ggtggcgtgg taccagcaaa agccgggtaa agcgccgaag 540
ctgctgatct atagcgcgag cagcctgtat agcggcgttc cgagccgttt cagcggtagc 600
cgtagcggca ccgactttac cctgaccatt agcagcctgc agccggaaga tttcgcaact 660
tattactgtc agcaaggtta cgctccgatc acgttcggac agggcaccaa agttgagatt 720
aaa 723
<210> 275
<211> 363
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66073 sdAb
<400> 275
caggttcagc tggtggagtc tgggggagac tcggtgcagg ctggggggtc tctgacactc 60
gcctgtacag ggcgtaaata cagcagtcta tactgcatgg cctggttccg ccaggctcca 120
gggaaggcgc gcgagggggt cgcagttatt agcagtggcg gcttcacaaa ttacgctgac 180
tccgtaaagg gccgattcac catctccaga gacaactcca agaacacgct gtatctggca 240
atgaacggcc tgaaacctga ggacactgcc atgtactact gtgcggcagg cctatcctat 300
tgccattcaa gcacagcaac cgccacgtac cggggccagg ggacccaggt caccgtctcc 360
tca 363
<210> 276
<211> 357
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66439 sdAb
<400> 276
cagatgcagc tggtggagtc tgggggaggc tcggtgcagg ctggggggtc tctgagactc 60
tcctgcacag cccctggatt cacctccagt gactgcgaca tggactggta ccgccaggct 120
gcagggaatc agcgcgaatg ggtctcatct cttcttagta ctgacggtag cacaagctat 180
gcggactccg tgaggggccg attcaccatc tccaaagacc cagccaagga cacggtgtat 240
ctgcaaatga acagcctgaa acctgaggac acggccatgt atttctgtag gtgtgtcgtg 300
gctgagtggg gcggcatgga ctactggggc aaaggaaccc tggtcaccgt ctcctca 357
<210> 277
<211> 381
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65955 sdAb
<400> 277
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggcga ccgcgtcagt actggctgta tgggctggtt ccgccagggt 120
ccaggcgagg agcgcgaggg gctcgcacaa attcacaatt ataatatcgc aaagtacgca 180
gactccgtga agggccgatt caccatctcc aaagacaacg ccaagaacat tctgtatctg 240
caaatgaaca gcctgaaacc tgaggacact ggcttgtaca tctgtacggc tcctgtagat 300
tgtagctgga gcatgtttct gcaagaccca cttgcgttgt ctccacctag gggccagggg 360
acccaggtca ccgtctcctc a 381
<210> 278
<211> 366
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 sdAb
<400> 278
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctgaatt cacgtacagt atgggctggt tccgccaggc tccagggaag 120
gagcgcgagg gcgtcgcaca tatttacact cgtggtggta ccacggtcta tgccgactcc 180
gtgaagggcc gattcgtcct ctcccgatac aacgccaaga gcataatgta tctacaaatg 240
aacagcgtga aacttgagga cactgccatg tattactgtg cggcccggac catattcgaa 300
ggtagctggt cgtccccatc ctcgtttgac ttctggggcc aggggaccca ggtcaccgtc 360
tcctca 366
<210> 279
<211> 393
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65926 sdAb
<400> 279
caggtgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggaaa cctctacaat aacatgtgca tgggctggtt ccggcaggct 120
ccagggaagg agcgcgaggg ggtcgcaagt atttatattg gtggtggtta caccaactat 180
gccgactccg tgaagggccg attcaccatc tcccccatct cccgagacaa cgccaagagc 240
acgctgtatc tgcaaatgaa cagcctgaaa cctgaggaca ctgccatgta ctactgtgcg 300
gcagtctcca tcgcgcttac gagggaattc tgcgccccga tcgtttctcg gtataattac 360
tggggccagg ggacccaggt caccgtctcc tca 393
<210> 280
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66159 sdAb
<400> 280
caggtgaggt tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcatgtgcag cctctggaaa cgtctacaat aacatgtgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcaagt atctatgttg gtggtggtta caccaactat 180
gccgactccg tgaggggccg attcaccatc tcccaagaca acgccaagaa cacgctgtat 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc ggcaattacc 300
gtcgcgctta cgagggcttt ctgcgccccg atcccttctc ggtataccaa ctggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 281
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS66416 sdAb
<400> 281
caggtgcagc tggcggagtc tgggggaggt tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggaaa cctctacaat aacatgtgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcggaagt atttatattg gtggtggtta caccaactat 180
tccgaatccg tgaggggccg attcaccatc tccctagaca acgccaagaa gacgctgaat 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc ggcaatcccc 300
atcgcgctta cgagggcttt ctgcgccccg atcgtttctc ggtatacgta ctggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 282
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65850 sdAb
<400> 282
gaggtgcagc tgatggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggatt ctcctacagt aacatctgta tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcggct atttatagta atggtagcac aatctacgca 180
gactccgtga agggccgatt caccgtctcc aaagaattcg ccaagaacac tcagtatctg 240
caaatgaaca gcctgaaacc tgaggacact gccatgtact actgtgcggc aggccggtgt 300
gggggcccta actactgggg ccaggggacc caggtcaccg tctcctca 348
<210> 283
<211> 396
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65183 sdAb
<400> 283
gaggtgcaac tggcggagtc tgggggaggc tcggcgcagg ctggagggtc tctgagactc 60
tcctgtgcaa gcaatgggta ctacaaccgt cgctattgta tggcctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcgact atgactacta ctagtggtcg cacatactat 180
gccgacgccg tgaagggccg attcaccgtc tcccaagaca acgccaagtc cacgctgtat 240
ctgcaaatga gcagcctgaa acctgaggac actgccatgt actactgtgc ggcgcacctt 300
cccagttctt gggtgacgtc gactgattac tgcgacaact tgcaagccgg cttttataac 360
tcctggggcc aggggaccca ggtcaccgtc tcctca 396
<210> 284
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65062 sdAb
<400> 284
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggagt cagcgtggtt aacttcgcca tgaggtggta ccgccaggct 120
ccagggaacg agcgcgagtt cgtctcagcg atgtaccgtt ctggtagcac gtcttacgct 180
gactccgtga ggggccgatt caccatctcc cgagacagcg ccttgaacac ggtgtttctt 240
caaatgagcg gcctgaaacc tgaggacacg gccacgtatt actgtcaagc gacatcacct 300
atgggcgaca cctactgggg ccaggggacc caggtcaccg tctcctca 348
<210> 285
<211> 363
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65065 sdAb
<400> 285
gaggtgcaac tggcggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggata cagctactgt aggtccacca tgcgctggta ccgccaggct 120
ccagggaacg tgcgcgaatt tgtctcagct atctatagtg atggtaccac aagctacaca 180
gactccgtga agggccgatt caccatctcc caagacaacg ccaagaacac tgtgtatcta 240
caaatgaaca gcctgcaacc tgaagacacg gccatgtatt actgtcggat agatcttgtc 300
ggatgcaacg tagctggtgg cagtccttac tggggccagg ggacccaggt caccgtctcc 360
tca 363
<210> 286
<211> 345
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65556 sdAb
<400> 286
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ttggagggtc tctgagactc 60
tcctgtgcag cctctggata caacgcctct atctgccgca tgagctggta ccgccaggct 120
cccgggactg agcgcgagtt cgtctcatcg tcttacaggg atggtagcca aagctacgca 180
gactccgtga aggggcgatt caccacatcc cgagactccg ccaagaacac ggtgtttctg 240
caaatgaaca gcctgaaacc ttcggacacg gccatgtatt actgtaacgc agcttgcccc 300
tggcgggcct actggggcca ggggacccag gtcaccgtct cctca 345
<210> 287
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65069 sdAb
<400> 287
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgtag cctctggaga caccggctac caacctacga tgaggtggta ccgccaggct 120
ccagggaagg agcgcgagtt cgtctccgct atttatagtg atcagaccac aagctatgca 180
gactccgtga agggccggtt caccatctcc caagacaacg ccagaaaaac ggtgtatctg 240
caaatggcta gcctgaaacc tgaggacacg gccatgtatt actgtaaact cactactcgc 300
agggggtctg agtactgggg ccaggggaca caggtcaccg tctcctca 348
<210> 288
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65691 sdAb
<400> 288
cagatgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtacag tctctggata caccgactat aggctcgtac tgaggtggta ccgccaggct 120
ctagggaagg agcgcgagtt catctcagct atttatagtg atggagtcac aagctactca 180
gactccgtga agggccgatt caccatctcc cgagacaacg ccaagaacac ggcgtatctg 240
caaatgaaca gcctgaaatc tgaggacacg gccatgtatt actgtaaagc aaccgggtcc 300
ggtggcgttg cctactgggg ccagggaacc caggtcaccg tctcctca 348
<210> 289
<211> 402
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65064 sdAb
<400> 289
caggttcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgaaactc 60
tcctgtgcag tctctggaga caccgtccag actaactgta tggcctggtt ccgccaggct 120
ccagggaagg agcgcgaggc ggtcgccagc attttgagtc tttattctag tggaggtaag 180
acagtctatg ccgactccgt gaagggccga ttcaccatct ccccagacaa cgcccagaac 240
acggtgtcgc tgcaaatgaa caatttgaaa cctgaggaca ctgccatgta ctactgtgcg 300
actgtccgcg tgaccgtcac ttgggccgaa aagttgaggc gttgtaccgg attcagcggc 360
atggactact ggggcaaagg aaccctggtc accgtctcct ca 402
<210> 290
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65081 sdAb
<400> 290
caggtgcacc tgatggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggagt ccccgctagt agctactgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcaggt attgtcagtg atactaccac aacctacgca 180
gactccgtga agggccgatt caccatctcc aaagacaacg ccaagaacac tctgtatctg 240
caaatgaaca gcctgaaacc tgaggacact gccacgtact actgtgcggc ctcccatttt 300
ctattgtgcg ccagaaaacc ccgctgggat gacctcatta aatatgagta ctggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 291
<211> 357
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65115 sdAb
<400> 291
caggttcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgcgactc 60
tcctgtgcag cctctggata catttacggc tgcatgggct ggttccgccg ggctccaggg 120
aaggcgcgcg aggaggttgc gactatttac cgcgatggta cagcatacta cgcaaactcc 180
gtagagggcc gattcaccgc ctccagaaac aacgccgaga acactctgtc tctggagatg 240
aacagtctga acgctgagga cactgccatg tactactgtg cggcaagaac aactggttgt 300
aactgggaca tatctggggt ttactggggc caggggaccc aggtcaccgt ctcctca 357
<210> 292
<211> 378
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65271 sdAb
<400> 292
cagatgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgacactc 60
tcctgtgcag cctctggaaa aacctacgga cgctgcatgg cctggttccg ccaggctcca 120
gggaaggagc gcgagttagt cgctgctact tatattagtg gtgggcgacc ctacgttgcc 180
gactccgtga agggccgatt caccatttcc cgggacaacg ccaagagtac gatgtctctg 240
caaatgaaca gcctgagacc tgacgacagc gccatgtact actgtgcggc gggttcggcg 300
ggtcggggac cttgtgatcg cttcgaccaa aatcaatata ccttctgggg ccaggggacc 360
caggtcaccg tctcctca 378
<210> 293
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65166 sdAb
<400> 293
caggtgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtacag cctctgaaga cttatctatt tacggttaca attgcatggg ctggttccgc 120
caggctccag ggaaggagcg cgaggcggtc gcagctattt atactggccg tggtaccaca 180
tactatgccg actccgtgaa gggccgattc accatctccc aagacaacgc caagaacact 240
gtgtatctgc aaatgaacag cctgaaacct gaggacactg ccatgtacta ctgtgcgtca 300
aaatactgtg cggtggtagc tgatttcggg aattctcgac tcgttcgtta ctggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 294
<211> 378
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65450 sdAb
<400> 294
caggtgaggt tagtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggaga catgaacggt tacaagtgca tggggtggtt ccgccaggct 120
ccagggaagg agcgcgaggc ggtcgcaggt atttatactg gccgtgggac cacatactat 180
gccgactccg tgaaggaccg attcaccatc tcccaagaca acgccaagaa cactgtgtat 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc agcaaaatac 300
tgtgcggtgg tagctgaatt cgggggtcct cgactcgttc gttactgggg ccaggggacc 360
caggtcaccg tctcctca 378
<210> 295
<211> 378
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65454 sdAb
<400> 295
caggtgaggt tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactg 60
tcctgtgcag cctctggaga catgaacggt tacaagtgca tggggtggtt ccgccaggct 120
ccagggaagg agcgagaggc ggtcgcaggt atttatactg gccgtaatac tacatactat 180
gccgactccg tgaaggacct attcaccatc tcccaagaca acgcctagaa cactgtgttt 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc gtcataatac 300
tgtgcggtgg tagctgaatt ccggggtcct cgactcgatc gttactgggg ctatgggacc 360
caggtcaccg tcacctca 378
<210> 296
<211> 369
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65131 sdAb
<400> 296
gaggtgcagc tggcggagtc tgggggaggc tcggtgcagg ctggagggtc tctgacactc 60
tcctgtacag cctctgaata cgtcacacac ttgggctggt tccgccaggc tccagggaag 120
gagcgcgagg gggtcgcaat cgaaagtttt cgtattggtt atacatacta tgccgactcc 180
gtgaagggtc gattcaccat ctcccacgac aacgccaaga acacgctgta tctgcaaatg 240
aacagcctga aacctgagga cactgccata tactactgtg cggctcggca ggaccgatcg 300
ggggcttcca tggtaaatcg agattcatat aattactggg gcaaggggac ccaggtcacc 360
gtctcctca 369
<210> 297
<211> 387
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65182 sdAb
<400> 297
caggtgaagt tagtggagtc agggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cgtctggata cacgtacagt tacggctaca tgggctggtt ccggcaggct 120
ccagggaagg agcgcgaggg ggtcgcaaag atttataatg gtgacggtag tacatactat 180
gccgactccg tgaagggccg attcaccatc tcccaagacc gccgcaacaa cacgctgtat 240
ctgcaaatga acagtctggc acctgaggac actggcatgt actactgtgc gacaaaccga 300
ctcccaaata gcgacgttga cttggtcctt ccccggttcg gccgttttgg ttactggggc 360
caggggaccc aggtcaccgt ctcctca 387
<210> 298
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 sdAb
<400> 298
caggtgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggtaa tgtctacaat aacatgtgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcaagt atgtatgttg gtggtggtta cacctactat 180
gacgactccg tgaagggccg attcaccatc tcccgagaca acgccaagaa cacgctgtat 240
ctgcaaatga acagcctgaa acctgaagac actgccatgt actactgtgc ggcaatctcc 300
atcgcgctta cgagggaatt ctgcgccccg atcgtttctc ggtataatta ttggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 299
<211> 384
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 sdAb
<400> 299
caggtgaagt tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcatgtgcag cctctggaaa cgtctacaat aacatgtgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcaagt atctatgttg gtggtggtta caccaactat 180
gccgactccg tgaggggccg attcaccatc tcccaagaca acgccaagaa cacgctgtat 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc ggcaattacc 300
gtcgcgctta cgagggcttt ctgcgccccg atcccttctc ggtataccaa ctggggccag 360
gggacccagg tcaccgtctc ctca 384
<210> 300
<211> 375
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60705 sdAb
<400> 300
caggtgcagc tggtggagtc tgggggaggc tcggtgcagt ctggagggtc tctgagactc 60
tcctgtgcag cctctggata cgcctacagt gggtcttgca tgatggcctg gttccgccag 120
gctccaggga aggagcgcga gggggtcgca gttagcgttc gtcgtacggg aagcgcattc 180
tatgccgact ccgtgaaggc ccgattcacc atctcccgcg acaatgccaa gaacacgctg 240
tatctgcaaa tgaataacct gaaagttgag gacactgcca tgtactactg tgcggcagat 300
tttacttgtc gtacgtggac tctcaataaa aattacaacc actggggcca ggggacccag 360
gtcaccgtct cctca 375
<210> 301
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60660 sdAb
<400> 301
caggtgcacc tgatggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgtag cctctggaga caccggctac caacctacga tgaggtggta ccgccaggct 120
ccagggaagg agcgcgagtt cgtctccgct atttatagtg atcagaccac aagctatgca 180
gactccgtga agggccggtt caccatctcc caagacaacg ccagaaaaac ggtgtatctg 240
caaatggcta gcctgaaacc tgaggacacg gccatgtatt actgtaaact cactactcgc 300
agggggtctg agtactgggg ccaggggaca caggtcaccg tctcctca 348
<210> 302
<211> 363
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60662 sdAb
<400> 302
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgtag cctctggata caggaactgt aggtccacca tgcgctggta ccgccagggt 120
ccaggacagg tgcgagactg ggtctcaagt atctatactg atggtaccac aagctacaca 180
gactccgtga agggccgatt caccatcgcc caagacaaag gcaagaacac ggtgtatcta 240
caaatgaaca gcctgcaacc tgaagacacg gccatgtatt actgtcggat agatcttgtc 300
ggatgcaatg tagctggtgg cagtccttac tggggccatg ggacccaggt caccgtctcc 360
tca 363
<210> 303
<211> 378
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60664 sdAb
<400> 303
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgacactc 60
tcctgtgcag cctctggaaa aacctacgga cgctgcatgg cctggttccg ccaggctcca 120
gggaaggagc gcgagttagt cgctgctact tatattagtg gtgggcgacc ctacgttgcc 180
gactccgtga agggccgatt caccatttcc cgggacaacg ccaagagtac gatgtctctg 240
caaatgaaca gcctgagacc tgacgacagc gccatgtact actgtgcggc gggttcggcg 300
ggtcggggac cttgtgatcg cttcgaccaa aatcaatata ccttctgggg ccaggggacc 360
caggtcaccg tctcctca 378
<210> 304
<211> 378
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60668 sdAb
<400> 304
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactg 60
tcctgtgcag cctctggaga catgaacggt tacaagtgca tggggtggtt ccgccaggct 120
ccagggaagg agcgcgaggc ggtcgcaggt atttatactg gccgtaatac tacatactat 180
gccgactccg tgaaggaccg attcaccatc tcccaagaca acgccaagaa cactgtgttt 240
ctgcaaatga acagcctgaa acctgaggac actgccatgt actactgtgc gtcaaaatac 300
tgtgcggtgg tagctgaatt cgggggtcct cgactcgttc gttactgggg ccaggggacc 360
caggtcaccg tctcctca 378
<210> 305
<211> 360
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 sdAb
<400> 305
caggtgcagc tggtggagtc tgggggaggg tcggtgcagg ctggagggtc tctgagactc 60
tcctgcgcag cctctggata caccgtcagt agcggctgca tgggctggtt ccgccaggct 120
ccagggaagg agcgcgagcg ggtcgcacag attggtcgtg atgctaccac gacctacgca 180
gactccgtga agggccgatt caccatcgcc agagacgacg ccgagaacac tctgtatctg 240
caaatgaaca gcctgaaacc tgaagacact gccatgtaca gctgtacggc ctattggggt 300
gtatactgtt tatctccagg acgctactgg ggccagggga cccaggtcac cgtctcctca 360
<210> 306
<211> 372
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60678 sdAb
<400> 306
caggtgcacc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag tctctggata cacctccagt cgcggttgca tgagctggtt ccgccaggct 120
ccagggaagg agcgcgagag ggtcgcatac attaatatgc gtgtcctaac cacaatctat 180
gccgcctccg tgaaggaccg attcgccatc tccagagaca acgccaagaa cacggtggat 240
ctgcaaatga acaacctgaa acctgaggac actgccatgt actactgcgc ggcggggtac 300
aatggacaat ggtgcgaaca tgctagtgac gttactgcct ggggtcaggg gacccaggtc 360
accgtctcct ca 372
<210> 307
<211> 348
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60679 sdAb
<400> 307
caggtgcacc tgatggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcac gctctggagt cacctattgt aggttgacca tgaggtggta ccgccaggct 120
ccagggagcg agcgcgagtt cgtctccgct atttatagtg atggtagcac agcctacgca 180
gactccgtga agggtcgatt caccatgtcc caagacgacg ccaagaacac ggtgtatctg 240
caaatgaaca gcgtgaaacc tgaggacacg gccatgtatt attgtaaatt gaattgtgcg 300
tccggcttga ctgcctgggg ccaggggacc caggtcaccg tctcctca 348
<210> 308
<211> 372
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81326 sdAb
<400> 308
gaggtgcagc tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgacactc 60
tcctgtgcag cctccgagag tagggattgt atggcctggt tccgccaggc tccagggaag 120
gcgcgcgagg gggtcgcatc tatttatgct ccggatggta gcacaaccta tgccgacacc 180
gtgaagggcc gattcaccat ctcccaagac aacgccaaga acacgctgta tctgcaaatg 240
aacagcctgc aacctgagga cgctgccatg taccactgtg cgatcggggg gctgtcacgc 300
aatacttgtg gttacctcag aggcggatac tttgcttact ttggccgggg gacccaggtc 360
accgtctcct ca 372
<210> 309
<211> 390
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81187 sdAb
<400> 309
caggtgaggt tggtggagtc tgggggcggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggata cacctacagc agctacagta gcaactgcct gggctggttc 120
cgccaggctc cagggaagga gcgcgaggca gtcgcacgta tctatcctaa cagtggtagc 180
acatactatg ccgactccgt gaagggccgc ttcaccatct cccaagacaa cgccaagaac 240
acggtgtatc tacaaatgaa cagcctgaaa cctgaggaca ctgccatgta ctactgtgcg 300
gtagcagtgg gagtcggtga taattggtgt gcgtcagggg ccgcatactt tggttactgg 360
ggccagggga cccaggtcac cgtctcctca 390
<210> 310
<211> 375
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533 sdAb
<400> 310
caggtgcacc tggtggagtc tgggggaggc tcggtgcaga ctggagggtc tctaagactc 60
tcctgtacag cctctggact cagcttcagt acctacacgg tggcctggtt ccgccaggct 120
ccaggaaagg agcgcgaggg ggtcgcggct attccatata ctagtcaaca catggtctat 180
accgactccg tgaagggccg attcaccatc tcccgagaca acacaaagaa catggtgtat 240
ctgcaaatga acagcctgaa accggaggac accgccatgt actactgtgc gacagatcgg 300
cgccctggaa cgagtatgtt ggctataaat gggtataacc gctggggcca ggggacccag 360
gtcaccgtct cctca 375
<210> 311
<211> 375
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444 sdAb
<400> 311
gaggtgcagc tggcggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagactc 60
tcctgtgcag cctctggatt caccttcagt cgcaacacga tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcggct attccatata ctagtactgg catagtctat 180
tccgactccg tgggcggccg attcaccatc tcccgagaca acacaaagaa catggtgtat 240
ctgcaaatga acaacctgga accggaggac actgccatgt actactgtgc gacagatcgg 300
cgccctggaa cgactatgtt ggcggtaaat gggtataacc actggggcca ggggacccag 360
gtcaccgtct cctca 375
<210> 312
<211> 375
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> AS81487 sdAb
<400> 312
caggtgaggt tggtggagtc tgggggaggc tcggtgcagg ctggagggtc tctgagagtc 60
tcctgtttag tctctaaact caccgcatgg cgcagctgcg tgggctggtt ccgccaggct 120
ccagggaagg agcgcgaggg ggtcgcagct atatattctg gtactggtag tacatactat 180
gccgactccg tgaagggccg attcaccatc gcccaagact acgccaagaa catggtgtac 240
ttgcaaatga acagcctgaa acctgaagac actgccatgt actactgtgc gggcacgtcg 300
atacgcagca gttgtggctt agtgcgcgat gaatacgcct actggggcca ggggacccag 360
gtcaccgtct cctca 375
<210> 313
<211> 239
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> SS1 scFv
<400> 313
Gln Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Glu Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Gly Tyr
20 25 30
Thr Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile
35 40 45
Gly Leu Ile Thr Pro Tyr Asn Gly Ala Ser Ser Tyr Asn Gln Lys Phe
50 55 60
Arg Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Asp Leu Leu Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Gly Tyr Asp Gly Arg Gly Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Glu Leu Thr Gln Ser Pro Ala Ile
130 135 140
Met Ser Ala Ser Pro Gly Glu Lys Val Thr Met Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met His Trp Tyr Gln Gln Lys Ser Gly Thr Ser
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Gly Arg Phe Ser Gly Ser Gly Ser Gly Asn Ser Tyr Ser Leu Thr Ile
195 200 205
Ser Ser Val Glu Ala Glu Asp Asp Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Gly Tyr Pro Leu Thr Phe Gly Ala Gly Thr Lys Leu Glu Ile
225 230 235
<210> 314
<211> 241
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> M5 scFv
<400> 314
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Glu Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Ser Gly Trp Asp Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
100 105 110
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro Ser
130 135 140
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
145 150 155 160
Ser Gln Ser Ile Arg Tyr Tyr Leu Ser Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Lys Ala Pro Lys Leu Leu Ile Tyr Thr Ala Ser Ile Leu Gln Asn Gly
180 185 190
Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu
195 200 205
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Leu
210 215 220
Gln Thr Tyr Thr Thr Pro Asp Phe Gly Pro Gly Thr Lys Val Glu Ile
225 230 235 240
Lys
<210> 315
<211> 622
<212> PRT
<213> 智人(Homo sapiens)
<400> 315
Met Ala Leu Pro Thr Ala Arg Pro Leu Leu Gly Ser Cys Gly Thr Pro
1 5 10 15
Ala Leu Gly Ser Leu Leu Phe Leu Leu Phe Ser Leu Gly Trp Val Gln
20 25 30
Pro Ser Arg Thr Leu Ala Gly Glu Thr Gly Gln Glu Ala Ala Pro Leu
35 40 45
Asp Gly Val Leu Ala Asn Pro Pro Asn Ile Ser Ser Leu Ser Pro Arg
50 55 60
Gln Leu Leu Gly Phe Pro Cys Ala Glu Val Ser Gly Leu Ser Thr Glu
65 70 75 80
Arg Val Arg Glu Leu Ala Val Ala Leu Ala Gln Lys Asn Val Lys Leu
85 90 95
Ser Thr Glu Gln Leu Arg Cys Leu Ala His Arg Leu Ser Glu Pro Pro
100 105 110
Glu Asp Leu Asp Ala Leu Pro Leu Asp Leu Leu Leu Phe Leu Asn Pro
115 120 125
Asp Ala Phe Ser Gly Pro Gln Ala Cys Thr Arg Phe Phe Ser Arg Ile
130 135 140
Thr Lys Ala Asn Val Asp Leu Leu Pro Arg Gly Ala Pro Glu Arg Gln
145 150 155 160
Arg Leu Leu Pro Ala Ala Leu Ala Cys Trp Gly Val Arg Gly Ser Leu
165 170 175
Leu Ser Glu Ala Asp Val Arg Ala Leu Gly Gly Leu Ala Cys Asp Leu
180 185 190
Pro Gly Arg Phe Val Ala Glu Ser Ala Glu Val Leu Leu Pro Arg Leu
195 200 205
Val Ser Cys Pro Gly Pro Leu Asp Gln Asp Gln Gln Glu Ala Ala Arg
210 215 220
Ala Ala Leu Gln Gly Gly Gly Pro Pro Tyr Gly Pro Pro Ser Thr Trp
225 230 235 240
Ser Val Ser Thr Met Asp Ala Leu Arg Gly Leu Leu Pro Val Leu Gly
245 250 255
Gln Pro Ile Ile Arg Ser Ile Pro Gln Gly Ile Val Ala Ala Trp Arg
260 265 270
Gln Arg Ser Ser Arg Asp Pro Ser Trp Arg Gln Pro Glu Arg Thr Ile
275 280 285
Leu Arg Pro Arg Phe Arg Arg Glu Val Glu Lys Thr Ala Cys Pro Ser
290 295 300
Gly Lys Lys Ala Arg Glu Ile Asp Glu Ser Leu Ile Phe Tyr Lys Lys
305 310 315 320
Trp Glu Leu Glu Ala Cys Val Asp Ala Ala Leu Leu Ala Thr Gln Met
325 330 335
Asp Arg Val Asn Ala Ile Pro Phe Thr Tyr Glu Gln Leu Asp Val Leu
340 345 350
Lys His Lys Leu Asp Glu Leu Tyr Pro Gln Gly Tyr Pro Glu Ser Val
355 360 365
Ile Gln His Leu Gly Tyr Leu Phe Leu Lys Met Ser Pro Glu Asp Ile
370 375 380
Arg Lys Trp Asn Val Thr Ser Leu Glu Thr Leu Lys Ala Leu Leu Glu
385 390 395 400
Val Asn Lys Gly His Glu Met Ser Pro Gln Val Ala Thr Leu Ile Asp
405 410 415
Arg Phe Val Lys Gly Arg Gly Gln Leu Asp Lys Asp Thr Leu Asp Thr
420 425 430
Leu Thr Ala Phe Tyr Pro Gly Tyr Leu Cys Ser Leu Ser Pro Glu Glu
435 440 445
Leu Ser Ser Val Pro Pro Ser Ser Ile Trp Ala Val Arg Pro Gln Asp
450 455 460
Leu Asp Thr Cys Asp Pro Arg Gln Leu Asp Val Leu Tyr Pro Lys Ala
465 470 475 480
Arg Leu Ala Phe Gln Asn Met Asn Gly Ser Glu Tyr Phe Val Lys Ile
485 490 495
Gln Ser Phe Leu Gly Gly Ala Pro Thr Glu Asp Leu Lys Ala Leu Ser
500 505 510
Gln Gln Asn Val Ser Met Asp Leu Ala Thr Phe Met Lys Leu Arg Thr
515 520 525
Asp Ala Val Leu Pro Leu Thr Val Ala Glu Val Gln Lys Leu Leu Gly
530 535 540
Pro His Val Glu Gly Leu Lys Ala Glu Glu Arg His Arg Pro Val Arg
545 550 555 560
Asp Trp Ile Leu Arg Gln Arg Gln Asp Asp Leu Asp Thr Leu Gly Leu
565 570 575
Gly Leu Gln Gly Gly Ile Pro Asn Gly Tyr Leu Val Leu Asp Leu Ser
580 585 590
Met Gln Glu Ala Leu Ser Gly Thr Pro Cys Leu Leu Gly Pro Gly Pro
595 600 605
Val Leu Thr Val Leu Ala Leu Leu Leu Ala Ser Thr Leu Ala
610 615 620
<210> 316
<211> 623
<212> PRT
<213> 食蟹猴(Cynomolgus)
<400> 316
Met Ala Leu Pro Met Ala Arg Pro Leu Ser Gly Ser Cys Gly Thr Pro
1 5 10 15
Ala Leu Gly Ser Leu Leu Phe Leu Leu Phe Ser Leu Gly Trp Val Gln
20 25 30
Pro Ser Arg Val Leu Ala Gly Glu Thr Arg Gln Val Arg Ser Pro Leu
35 40 45
Gly Lys Pro Gly Arg Val Phe Ser Leu Ser Pro Arg Gln Leu Leu Gly
50 55 60
Phe Thr Cys Val Glu Val Ser Gly Leu Ser Thr Glu Leu Val Gln Glu
65 70 75 80
Leu Ala Val Ala Leu Gly Gln Lys Asn Val Lys Leu Ser Ala Glu Gln
85 90 95
Leu Arg Cys Leu Ala His Gln Leu Ser Glu Pro Pro Glu Asp Leu Asp
100 105 110
Ala Leu Pro Leu Asp Leu Leu Leu Phe Leu Asn Pro Asp Ala Phe Ser
115 120 125
Gly Pro Gln Ala Cys Thr His Phe Phe Ser Arg Val Ala Lys Ala Asn
130 135 140
Val Asp Leu Leu Pro Arg Gly Ala Pro Glu Arg Gln Arg Leu Leu Pro
145 150 155 160
Ala Ala Leu Thr Cys Trp Gly Val Arg Gly Ser Leu Leu Ser Glu Ala
165 170 175
Asp Val Arg Ala Leu Gly Gly Leu Ala Cys Asp Leu Pro Gly Arg Phe
180 185 190
Val Ala Glu Ser Ala Glu Val Val Leu Pro Arg Leu Val Arg Cys Leu
195 200 205
Gly Pro Leu Asp Gln Asp Gln Gln Glu Ala Ala Arg Ala Ala Leu Gln
210 215 220
Arg Gly Gly Pro Pro Tyr Gly Pro Pro Ser Thr Trp Ser Ile Ser Thr
225 230 235 240
Leu Asp Asp Leu Gln Ser Leu Leu Pro Val Leu Gly Gln Pro Val Ile
245 250 255
His Ser Ile Pro Gln Gly Ile Leu Ala Ala Trp Arg Gln Arg Ser Ser
260 265 270
Arg Asp Pro Ser Trp Gln Gln Pro Glu Gln Thr Val Leu Arg Pro Arg
275 280 285
Phe Arg Arg Asp Val Glu Arg Thr Thr Cys Pro Pro Glu Lys Glu Val
290 295 300
His Glu Ile Asp Glu Ser Leu Ile Phe Tyr Lys Lys Arg Glu Leu Glu
305 310 315 320
Ala Cys Val Asp Pro Ala Leu Leu Ala Ala Gln Met Asp Arg Val Asp
325 330 335
Ala Ile Pro Phe Thr Tyr Glu Gln Leu Asp Val Leu Lys His Lys Leu
340 345 350
Asp Glu Leu Tyr Pro Gln Gly Tyr Pro Glu Ser Val Ile Arg His Leu
355 360 365
Gly His Leu Phe Leu Lys Met Ser Pro Glu Asp Ile Arg Lys Trp Asn
370 375 380
Val Thr Ser Leu Glu Thr Leu Lys Ala Leu Leu Lys Val Ser Lys Gly
385 390 395 400
His Glu Met Ser Ala Gln Trp Pro Val Pro Gln Val Ala Thr Leu Ile
405 410 415
Asp Arg Val Val Val Gly Arg Gly Gln Leu Asp Lys Asp Thr Val Asp
420 425 430
Thr Leu Thr Ala Phe Cys Pro Gly Cys Leu Cys Ser Leu Ser Pro Glu
435 440 445
Arg Leu Ser Ser Val Pro Pro Ser Val Ile Gly Ala Val Arg Pro Gln
450 455 460
Asp Leu Asp Thr Cys Gly Pro Arg Gln Leu Asp Val Leu Tyr Pro Lys
465 470 475 480
Ala Arg Leu Ala Phe Gln Asn Met Ser Gly Ser Glu Tyr Phe Val Lys
485 490 495
Ile Arg Pro Phe Leu Gly Gly Ala Pro Thr Glu Asp Val Lys Ala Leu
500 505 510
Ser Gln Gln Asn Val Ser Met Asp Leu Ala Thr Phe Met Lys Leu Arg
515 520 525
Arg Glu Ala Val Leu Pro Leu Thr Val Ala Glu Val Gln Lys Leu Leu
530 535 540
Gly Pro His Val Glu Gly Leu Lys Val Glu Glu Gln His Ser Pro Val
545 550 555 560
Arg Asp Trp Ile Leu Lys Gln Arg Gln Asp Asp Leu Asp Thr Leu Gly
565 570 575
Leu Gly Leu Gln Gly Gly Ile Pro Asn Gly Tyr Leu Ile Leu Asp Leu
580 585 590
Ser Val Arg Glu Ala Leu Ser Gly Thr Pro Cys Leu Leu Gly Pro Gly
595 600 605
Pro Val Leu Thr Val Leu Ala Leu Leu Leu Ala Ser Thr Leu Ala
610 615 620
<210> 317
<211> 295
<212> PRT
<213> 智人(Homo sapiens)
<400> 317
Met Ala Leu Pro Thr Ala Arg Pro Leu Leu Gly Ser Cys Gly Thr Pro
1 5 10 15
Ala Leu Gly Ser Leu Leu Phe Leu Leu Phe Ser Leu Gly Trp Val Gln
20 25 30
Pro Ser Arg Thr Leu Ala Gly Glu Thr Gly Gln Glu Ala Ala Pro Leu
35 40 45
Asp Gly Val Leu Ala Asn Pro Pro Asn Ile Ser Ser Leu Ser Pro Arg
50 55 60
Gln Leu Leu Gly Phe Pro Cys Ala Glu Val Ser Gly Leu Ser Thr Glu
65 70 75 80
Arg Val Arg Glu Leu Ala Val Ala Leu Ala Gln Lys Asn Val Lys Leu
85 90 95
Ser Thr Glu Gln Leu Arg Cys Leu Ala His Arg Leu Ser Glu Pro Pro
100 105 110
Glu Asp Leu Asp Ala Leu Pro Leu Asp Leu Leu Leu Phe Leu Asn Pro
115 120 125
Asp Ala Phe Ser Gly Pro Gln Ala Cys Thr Arg Phe Phe Ser Arg Ile
130 135 140
Thr Lys Ala Asn Val Asp Leu Leu Pro Arg Gly Ala Pro Glu Arg Gln
145 150 155 160
Arg Leu Leu Pro Ala Ala Leu Ala Cys Trp Gly Val Arg Gly Ser Leu
165 170 175
Leu Ser Glu Ala Asp Val Arg Ala Leu Gly Gly Leu Ala Cys Asp Leu
180 185 190
Pro Gly Arg Phe Val Ala Glu Ser Ala Glu Val Leu Leu Pro Arg Leu
195 200 205
Val Ser Cys Pro Gly Pro Leu Asp Gln Asp Gln Gln Glu Ala Ala Arg
210 215 220
Ala Ala Leu Gln Gly Gly Gly Pro Pro Tyr Gly Pro Pro Ser Thr Trp
225 230 235 240
Ser Val Ser Thr Met Asp Ala Leu Arg Gly Leu Leu Pro Val Leu Gly
245 250 255
Gln Pro Ile Ile Arg Ser Ile Pro Gln Gly Ile Val Ala Ala Trp Arg
260 265 270
Gln Arg Ser Ser Arg Asp Pro Ser Trp Arg Gln Pro Glu Arg Thr Ile
275 280 285
Leu Arg Pro Arg Phe Arg Arg
290 295
<210> 318
<211> 327
<212> PRT
<213> 智人(Homo sapiens)
<400> 318
Glu Val Glu Lys Thr Ala Cys Pro Ser Gly Lys Lys Ala Arg Glu Ile
1 5 10 15
Asp Glu Ser Leu Ile Phe Tyr Lys Lys Trp Glu Leu Glu Ala Cys Val
20 25 30
Asp Ala Ala Leu Leu Ala Thr Gln Met Asp Arg Val Asn Ala Ile Pro
35 40 45
Phe Thr Tyr Glu Gln Leu Asp Val Leu Lys His Lys Leu Asp Glu Leu
50 55 60
Tyr Pro Gln Gly Tyr Pro Glu Ser Val Ile Gln His Leu Gly Tyr Leu
65 70 75 80
Phe Leu Lys Met Ser Pro Glu Asp Ile Arg Lys Trp Asn Val Thr Ser
85 90 95
Leu Glu Thr Leu Lys Ala Leu Leu Glu Val Asn Lys Gly His Glu Met
100 105 110
Ser Pro Gln Val Ala Thr Leu Ile Asp Arg Phe Val Lys Gly Arg Gly
115 120 125
Gln Leu Asp Lys Asp Thr Leu Asp Thr Leu Thr Ala Phe Tyr Pro Gly
130 135 140
Tyr Leu Cys Ser Leu Ser Pro Glu Glu Leu Ser Ser Val Pro Pro Ser
145 150 155 160
Ser Ile Trp Ala Val Arg Pro Gln Asp Leu Asp Thr Cys Asp Pro Arg
165 170 175
Gln Leu Asp Val Leu Tyr Pro Lys Ala Arg Leu Ala Phe Gln Asn Met
180 185 190
Asn Gly Ser Glu Tyr Phe Val Lys Ile Gln Ser Phe Leu Gly Gly Ala
195 200 205
Pro Thr Glu Asp Leu Lys Ala Leu Ser Gln Gln Asn Val Ser Met Asp
210 215 220
Leu Ala Thr Phe Met Lys Leu Arg Thr Asp Ala Val Leu Pro Leu Thr
225 230 235 240
Val Ala Glu Val Gln Lys Leu Leu Gly Pro His Val Glu Gly Leu Lys
245 250 255
Ala Glu Glu Arg His Arg Pro Val Arg Asp Trp Ile Leu Arg Gln Arg
260 265 270
Gln Asp Asp Leu Asp Thr Leu Gly Leu Gly Leu Gln Gly Gly Ile Pro
275 280 285
Asn Gly Tyr Leu Val Leu Asp Leu Ser Met Gln Glu Ala Leu Ser Gly
290 295 300
Thr Pro Cys Leu Leu Gly Pro Gly Pro Val Leu Thr Val Leu Ala Leu
305 310 315 320
Leu Leu Ala Ser Thr Leu Ala
325
<210> 319
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53
<400> 319
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe
20
<210> 320
<211> 16
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 51-65
<400> 320
Cys Thr Phe Lys Glu Leu Val Tyr Glu Thr Val Arg Val Pro Gly Cys
1 5 10 15
<210> 321
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 81-95
<400> 321
Gln Cys His Cys Gly Lys Cys Asp Ser Asp Ser Thr Asp Cys Thr
1 5 10 15
<210> 322
<211> 26
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 87-94 + FSHβ 25-42
<400> 322
Cys Asp Ser Asp Ser Thr Asp Cys Ile Leu Gln Cys Met Gly Cys Cys
1 5 10 15
Phe Ser Arg Ala Tyr Pro Thr Pro Leu Arg
20 25
<210> 323
<211> 45
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 87-94 + FSHβ 25-42 + FSHβ 27-45
<400> 323
Cys Asp Ser Asp Ser Thr Asp Cys Ile Leu Gln Cys Met Gly Cys Cys
1 5 10 15
Phe Ser Arg Ala Tyr Pro Thr Pro Leu Arg Trp Cys Ala Gly Tyr Cys
20 25 30
Tyr Cys Tyr Thr Arg Asp Val Lys Asp Pro Ala Arg Pro
35 40 45
<210> 324
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR肽 33-53
<400> 324
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys
<210> 325
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR肽51-65
<400> 325
Lys Thr Cys Thr Phe Lys Glu Leu Val Tyr Glu Thr Val Arg Val
1 5 10 15
<210> 326
<211> 19
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR肽81-95
<400> 326
Gly Ser Gln Cys His Cys Gly Lys Cys Asp Ser Asp Ser Thr Asp Cys
1 5 10 15
Thr Ala Ser
<210> 327
<211> 30
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR拮抗剂A
<400> 327
Gly Ser Cys Asp Ser Asp Ser Thr Asp Cys Ile Leu Gln Cys Met Gly
1 5 10 15
Cys Cys Phe Ser Arg Ala Tyr Pro Thr Pro Leu Arg Ala Ser
20 25 30
<210> 328
<211> 30
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR拮抗剂B
<400> 328
Gly Ser Arg Leu Pro Thr Pro Tyr Ala Arg Ser Phe Cys Cys Gly Met
1 5 10 15
Cys Gln Leu Ile Cys Asp Thr Ser Asp Ser Asp Cys Ala Ser
20 25 30
<210> 329
<211> 50
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR激动剂A
<400> 329
Gly Ser Cys Asp Ser Asp Ser Thr Asp Cys Ile Leu Gln Cys Met Gly
1 5 10 15
Cys Cys Phe Ser Arg Ala Tyr Pro Thr Pro Leu Arg Trp Cys Ala Gly
20 25 30
Tyr Cys Tyr Cys Tyr Thr Arg Asp Leu Val Lys Asp Pro Ala Arg Pro
35 40 45
Ala Ser
50
<210> 330
<211> 46
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR激动剂B
<400> 330
Pro Arg Ala Pro Asp Lys Val Leu Asp Arg Thr Tyr Cys Tyr Cys Tyr
1 5 10 15
Gly Ala Cys Trp Arg Leu Pro Thr Pro Tyr Ala Arg Ser Phe Cys Cys
20 25 30
Gly Met Cys Gln Leu Ile Cys Asp Thr Ser Asp Ser Asp Cys
35 40 45
<210> 331
<211> 207
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 抗FSHR肽α+β
<400> 331
Gly Ser Asn Ser Cys Glu Leu Thr Asn Ile Thr Ile Ala Ile Glu Lys
1 5 10 15
Glu Glu Cys Arg Phe Cys Ile Ser Ile Asn Thr Thr Trp Cys Ala Gly
20 25 30
Tyr Cys Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys
35 40 45
Ile Gln Lys Thr Cys Thr Phe Lys Glu Leu Val Tyr Glu Thr Val Arg
50 55 60
Val Pro Gly Cys Ala His His Ala Asp Ser Leu Tyr Thr Tyr Pro Val
65 70 75 80
Ala Thr Gln Cys His Cys Gly Lys Cys Asp Ser Asp Ser Thr Asp Cys
85 90 95
Thr Val Arg Gly Leu Gly Pro Ser Tyr Cys Ser Phe Gly Glu Met Lys
100 105 110
Glu Ala Pro Asp Val Gln Asp Cys Pro Glu Cys Thr Leu Gln Glu Asn
115 120 125
Pro Phe Phe Ser Gln Pro Gly Ala Pro Ile Leu Gln Cys Met Gly Cys
130 135 140
Cys Phe Ser Arg Ala Tyr Pro Thr Pro Leu Arg Ser Lys Lys Thr Met
145 150 155 160
Leu Val Gln Lys Asn Val Thr Ser Glu Ser Thr Cys Cys Val Ala Lys
165 170 175
Ser Tyr Asn Arg Val Thr Val Met Gly Gly Phe Lys Val Glu Asn His
180 185 190
Thr Ala Cys His Cys Ser Thr Cys Tyr Tyr His Lys Ser Ala Ser
195 200 205
<210> 332
<211> 253
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> Fc融合FSHβ 33-53
<400> 332
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys
20 25 30
Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu
35 40 45
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu
50 55 60
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
65 70 75 80
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
85 90 95
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
100 105 110
Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
115 120 125
Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys
130 135 140
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser
145 150 155 160
Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys
165 170 175
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
180 185 190
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
195 200 205
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
210 215 220
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
225 230 235 240
His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
245 250
<210> 333
<211> 759
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> Fc融合FSHβ 33-53
<400> 333
tacacccggg acctggtgta taaggatccc gccagaccta agatccagaa gacctgcaca 60
ttcgagccca agtcctgtga taagacccac acatgccccc cttgtcctgc tccagagctg 120
ctgggcggcc ctagcgtgtt cctgtttcca cccaagccta aggacaccct gatgatctct 180
cggaccccag aggtgacatg cgtggtggtg gacgtgagcc acgaggatcc cgaggtgaag 240
tttaactggt atgtggatgg cgtggaggtg cacaatgcca agaccaagcc cagagaggag 300
cagtacaact ccacctatag ggtggtgtct gtgctgacag tgctgcacca ggactggctc 360
aacggcaagg agtataagtg caaggtgtcc aataaggccc tgcccgcccc tatcgagaag 420
accatctcta aggccaaggg ccagcctcgg gagccacagg tgtacacact gcctccatcc 480
agagacgagc tgaccaagaa ccaggtgtct ctgacatgtc tggtcaaggg cttctatccc 540
tctgatatcg ccgtggagtg ggagagcaat ggccagcctg agaacaatta caagaccaca 600
ccccctgtgc tggactccga tggctctttc tttctgtata gcaagctgac cgtggataag 660
tcccggtggc agcagggcaa cgtgttcagc tgttccgtga tgcacgaggc actgcacaac 720
cattacaccc agaagtcact gtcactgtcc ccaggcaag 759
<210> 334
<211> 5
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 接头
<400> 334
Gly Gly Gly Gly Ser
1 5
<210> 335
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 接头
<400> 335
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
1 5 10
<210> 336
<211> 15
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 接头
<400> 336
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
1 5 10 15
<210> 337
<211> 20
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 接头
<400> 337
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
1 5 10 15
Gly Gly Gly Ser
20
<210> 338
<211> 25
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 接头
<400> 338
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
1 5 10 15
Gly Gly Gly Ser Gly Gly Gly Gly Ser
20 25
<210> 339
<211> 1335
<212> DNA
<213> 人工序列(Artificial Sequence)
<220>
<223> EF1α启动子
<400> 339
gagtaattca tacaaaagga ctcgcccctg ccttggggaa tcccagggac cgtcgttaaa 60
ctcccactaa cgtagaaccc agagatcgct gcgttcccgc cccctcaccc gcccgctctc 120
gtcatcactg aggtggagaa gagcatgcgt gaggctccgg tgcccgtcag tgggcagagc 180
gcacatcgcc cacagtcccc gagaagttgg ggggaggggt cggcaattga accggtgcct 240
agagaaggtg gcgcggggta aactgggaaa gtgatgtcgt gtactggctc cgcctttttc 300
ccgagggtgg gggagaaccg tatataagtg cagtagtcgc cgtgaacgtt ctttttcgca 360
acgggtttgc cgccagaaca caggtaagtg ccgtgtgtgg ttcccgcggg cctggcctct 420
ttacgggtta tggcccttgc gtgccttgaa ttacttccac gcccctggct gcagtacgtg 480
attcttgatc ccgagcttcg ggttggaagt gggtgggaga gttcgaggcc ttgcgcttaa 540
ggagcccctt cgcctcgtgc ttgagttgag gcctggcttg ggcgctgggg ccgccgcgtg 600
cgaatctggt ggcaccttcg cgcctgtctc gctgctttcg ataagtctct agccatttaa 660
aatttttgat gacctgctgc gacgcttttt ttctggcaag atagtcttgt aaatgcgggc 720
caagatctgc acactggtat ttcggttttt ggggccgcgg gcggcgacgg ggcccgtgcg 780
tcccagcgca catgttcggc gaggcggggc ctgcgagcgc ggccaccgag aatcggacgg 840
gggtagtctc aagctggccg gcctgctctg gtgcctggcc tcgcgccgcc gtgtatcgcc 900
ccgccctggg cggcaaggct ggcccggtcg gcaccagttg cgtgagcgga aagatggccg 960
cttcccggcc ctgctgcagg gagctcaaaa tggaggacgc ggcgctcggg agagcgggcg 1020
ggtgagtcac ccacacaaag gaaaagggcc tttccgtcct cagccgtcgc ttcatgtgac 1080
tccacggagt accgggcgcc gtccaggcac ctcgattagt tctcgagctt ttggagtacg 1140
tcgtctttag gttgggggga ggggttttat gcgatggagt ttccccacac tgagtgggtg 1200
gagactgaag ttaggccagc ttggcacttg atgtaattct ccttggaatt tgcccttttt 1260
gagtttggat cttggttcat tctcaagcct cagacagtgg ttcaaagttt ttttcttcca 1320
tttcaggtgt cgtga 1335
<210> 340
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD8α信号肽
<400> 340
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro
20
<210> 341
<211> 45
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD8α铰链结构域
<400> 341
Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala
1 5 10 15
Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly
20 25 30
Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
35 40 45
<210> 342
<211> 24
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD8α跨膜结构域
<400> 342
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
1 5 10 15
Ser Leu Val Ile Thr Leu Tyr Cys
20
<210> 343
<211> 42
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD137胞内结构域
<400> 343
Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met
1 5 10 15
Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe
20 25 30
Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu
35 40
<210> 344
<211> 41
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD28胞内结构域
<400> 344
Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr
1 5 10 15
Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro
20 25 30
Pro Arg Asp Phe Ala Ala Tyr Arg Ser
35 40
<210> 345
<211> 112
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3α胞内结构域
<400> 345
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
1 5 10 15
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
20 25 30
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
35 40 45
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
50 55 60
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
65 70 75 80
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
85 90 95
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
100 105 110
<210> 346
<211> 22
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> P2A元件
<400> 346
Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val
1 5 10 15
Glu Glu Asn Pro Gly Pro
20
<210> 347
<211> 199
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> dnTGFβRII
<400> 347
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser
195
<210> 348
<211> 281
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AD58126VH3VL1 scFV串联
<400> 348
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys
35 40 45
Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr
50 55 60
Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Ala Pro Gly Gln Gly
65 70 75 80
Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp Tyr
85 90 95
Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser Thr
100 105 110
Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp Gly
130 135 140
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly
145 150 155 160
Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser Pro
165 170 175
Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys Lys
180 185 190
Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu Thr
195 200 205
Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr Trp
210 215 220
Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly
225 230 235 240
Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu Asp
245 250 255
Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr Phe
260 265 270
Gly Gly Gly Thr Lys Leu Glu Ile Lys
275 280
<210> 349
<211> 277
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51489 scFV串联
<400> 349
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val
35 40 45
Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn
50 55 60
Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly
65 70 75 80
Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr Tyr
85 90 95
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys
100 105 110
Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr Trp
130 135 140
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
145 150 155 160
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
165 170 175
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
180 185 190
Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys
195 200 205
Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr
210 215 220
Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe
225 230 235 240
Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr
245 250 255
Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr
260 265 270
Lys Val Glu Ile Lys
275
<210> 350
<211> 276
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AD92110 scFV串联
<400> 350
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val
35 40 45
Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn
50 55 60
Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly
65 70 75 80
Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr Tyr
85 90 95
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys
100 105 110
Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln Gly
130 135 140
Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
145 150 155 160
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
165 170 175
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser
180 185 190
Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys
195 200 205
Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val
210 215 220
Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr
225 230 235 240
Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln
245 250 255
Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr Lys
260 265 270
Val Glu Ile Lys
275
<210> 351
<211> 274
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91156 scFV串联
<400> 351
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val
35 40 45
Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn
50 55 60
Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly
65 70 75 80
Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser Tyr
85 90 95
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys
100 105 110
Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln Gly
130 135 140
Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
145 150 155 160
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
165 170 175
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser
180 185 190
Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys
195 200 205
Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val
210 215 220
Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr
225 230 235 240
Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln
245 250 255
Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu
260 265 270
Ile Lys
<210> 352
<211> 274
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91189 scFV串联
<400> 352
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val
35 40 45
Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn
50 55 60
Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly
65 70 75 80
Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr Tyr
85 90 95
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys
100 105 110
Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln Gly
130 135 140
Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
145 150 155 160
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
165 170 175
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser
180 185 190
Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys
195 200 205
Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val
210 215 220
Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr
225 230 235 240
Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln
245 250 255
Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val Glu
260 265 270
Ile Lys
<210> 353
<211> 277
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51674 scFV串联
<400> 353
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val
35 40 45
Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn
50 55 60
Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly
65 70 75 80
Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser Tyr
85 90 95
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys
100 105 110
Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala
115 120 125
Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met Asp
130 135 140
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
145 150 155 160
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
165 170 175
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
180 185 190
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
195 200 205
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
210 215 220
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
225 230 235 240
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
245 250 255
Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly Thr
260 265 270
Lys Val Glu Ile Lys
275
<210> 354
<211> 158
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS65233 sdAb串联
<400> 354
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Gln Val His Leu Val Glu Ser Gly Gly Gly Ser Val
35 40 45
Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr
50 55 60
Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Gly
65 70 75 80
Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser
85 90 95
Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile Met
100 105 110
Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr Tyr
115 120 125
Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser
130 135 140
Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
145 150 155
<210> 355
<211> 164
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60685 sdAb串联
<400> 355
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val
35 40 45
Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Val
50 55 60
Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu
65 70 75 80
Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr Tyr
85 90 95
Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys
100 105 110
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
115 120 125
Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe Cys
130 135 140
Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln Val
145 150 155 160
Thr Val Ser Ser
<210> 356
<211> 164
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60702 sdAb串联
<400> 356
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser Val
35 40 45
Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn Val
50 55 60
Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu
65 70 75 80
Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn Tyr
85 90 95
Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala Lys
100 105 110
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
115 120 125
Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe Cys
130 135 140
Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln Val
145 150 155 160
Thr Val Ser Ser
<210> 357
<211> 156
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60676 sdAb串联
<400> 357
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
1 5 10 15
Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
20 25 30
Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser Val
35 40 45
Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr
50 55 60
Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu
65 70 75 80
Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr Ala
85 90 95
Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu Asn
100 105 110
Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Met
115 120 125
Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly Arg
130 135 140
Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser
145 150 155
<210> 358
<211> 489
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 CAR
<400> 358
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val
20 25 30
Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Ala Pro Gly Gln
50 55 60
Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp
65 70 75 80
Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser
85 90 95
Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp
115 120 125
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
130 135 140
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser
145 150 155 160
Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys
165 170 175
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
180 185 190
Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr
195 200 205
Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu
225 230 235 240
Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
245 250 255
Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr Thr Pro Ala Pro
260 265 270
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
275 280 285
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
290 295 300
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
305 310 315 320
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
325 330 335
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
340 345 350
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
355 360 365
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
370 375 380
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
385 390 395 400
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
405 410 415
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
420 425 430
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
435 440 445
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
450 455 460
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
465 470 475 480
Leu His Met Gln Ala Leu Pro Pro Arg
485
<210> 359
<211> 485
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 CAR
<400> 359
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr
115 120 125
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln
145 150 155 160
Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr
165 170 175
Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln
180 185 190
Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu
195 200 205
Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp
210 215 220
Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr
225 230 235 240
Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg
485
<210> 360
<211> 484
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 CAR
<400> 360
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr
245 250 255
Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
260 265 270
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
275 280 285
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
290 295 300
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
305 310 315 320
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
325 330 335
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
340 345 350
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
355 360 365
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
370 375 380
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
385 390 395 400
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
405 410 415
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
420 425 430
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
435 440 445
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
450 455 460
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
465 470 475 480
Leu Pro Pro Arg
<210> 361
<211> 482
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 CAR
<400> 361
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg
<210> 362
<211> 482
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 CAR
<400> 362
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg
<210> 363
<211> 485
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 CAR
<400> 363
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met
115 120 125
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
145 150 155 160
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
165 170 175
Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr
180 185 190
Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser
195 200 205
Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly
210 215 220
Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala
225 230 235 240
Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg
485
<210> 364
<211> 366
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 CAR
<400> 364
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val His Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile
85 90 95
Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
355 360 365
<210> 365
<211> 372
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 CAR
<400> 365
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr
65 70 75 80
Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe
115 120 125
Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg
370
<210> 366
<211> 372
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 CAR
<400> 366
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn
65 70 75 80
Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe
115 120 125
Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg
370
<210> 367
<211> 364
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 CAR
<400> 367
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr
35 40 45
Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr
65 70 75 80
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu
85 90 95
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
100 105 110
Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly
115 120 125
Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr
130 135 140
Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro
145 150 155 160
Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val
165 170 175
His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro
180 185 190
Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu
195 200 205
Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro
210 215 220
Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys
225 230 235 240
Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe
245 250 255
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
260 265 270
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
275 280 285
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
290 295 300
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
305 310 315 320
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
325 330 335
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
340 345 350
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
355 360
<210> 368
<211> 483
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> SS1 CAR
<400> 368
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Gln Gln Ser Gly Pro Glu Leu
20 25 30
Glu Lys Pro Gly Ala Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Ser Phe Thr Gly Tyr Thr Met Asn Trp Val Lys Gln Ser His Gly Lys
50 55 60
Ser Leu Glu Trp Ile Gly Leu Ile Thr Pro Tyr Asn Gly Ala Ser Ser
65 70 75 80
Tyr Asn Gln Lys Phe Arg Gly Lys Ala Thr Leu Thr Val Asp Lys Ser
85 90 95
Ser Ser Thr Ala Tyr Met Asp Leu Leu Ser Leu Thr Ser Glu Asp Ser
100 105 110
Ala Val Tyr Phe Cys Ala Arg Gly Gly Tyr Asp Gly Arg Gly Phe Asp
115 120 125
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly
130 135 140
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Glu Leu Thr
145 150 155 160
Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly Glu Lys Val Thr Met
165 170 175
Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met His Trp Tyr Gln Gln
180 185 190
Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu
195 200 205
Ala Ser Gly Val Pro Gly Arg Phe Ser Gly Ser Gly Ser Gly Asn Ser
210 215 220
Tyr Ser Leu Thr Ile Ser Ser Val Glu Ala Glu Asp Asp Ala Thr Tyr
225 230 235 240
Tyr Cys Gln Gln Trp Ser Gly Tyr Pro Leu Thr Phe Gly Ala Gly Thr
245 250 255
Lys Leu Glu Ile Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
260 265 270
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
275 280 285
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
290 295 300
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
305 310 315 320
Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu
325 330 335
Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln
340 345 350
Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly
355 360 365
Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr
370 375 380
Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg
385 390 395 400
Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met
405 410 415
Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu
420 425 430
Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys
435 440 445
Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu
450 455 460
Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu
465 470 475 480
Pro Pro Arg
<210> 369
<211> 485
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> M5 CAR
<400> 369
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val
20 25 30
Glu Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Thr Phe Thr Asp Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln
50 55 60
Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn
65 70 75 80
Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser
85 90 95
Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Ser Gly Trp Asp Phe Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met
145 150 155 160
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
165 170 175
Ile Thr Cys Arg Ala Ser Gln Ser Ile Arg Tyr Tyr Leu Ser Trp Tyr
180 185 190
Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Thr Ala Ser
195 200 205
Ile Leu Gln Asn Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly
210 215 220
Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala
225 230 235 240
Thr Tyr Tyr Cys Leu Gln Thr Tyr Thr Thr Pro Asp Phe Gly Pro Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg
485
<210> 370
<211> 525
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AD58126VH3VL1串联CAR
<400> 370
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser
50 55 60
Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys
65 70 75 80
Ala Ser Gly Tyr Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln
85 90 95
Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr
100 105 110
Gly His Thr Asp Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr
115 120 125
Ala Asp Thr Ser Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg
130 135 140
Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp
145 150 155 160
Phe Pro Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly
165 170 175
Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val
180 185 190
Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala
195 200 205
Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln
210 215 220
Lys Asn Tyr Leu Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys
225 230 235 240
Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg
245 250 255
Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser
260 265 270
Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser
275 280 285
Tyr Pro Leu Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr
290 295 300
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
305 310 315 320
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
325 330 335
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
340 345 350
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
355 360 365
Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln
370 375 380
Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser
385 390 395 400
Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys
405 410 415
Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln
420 425 430
Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu
435 440 445
Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg
450 455 460
Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met
465 470 475 480
Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly
485 490 495
Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp
500 505 510
Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
515 520 525
<210> 371
<211> 521
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51489串联CAR
<400> 371
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser
100 105 110
Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr
145 150 155 160
Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly
165 170 175
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile
180 185 190
Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg
195 200 205
Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
210 215 220
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser
225 230 235 240
Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg
245 250 255
Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp
260 265 270
Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr
275 280 285
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro
290 295 300
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
305 310 315 320
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
325 330 335
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
340 345 350
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
355 360 365
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
370 375 380
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
385 390 395 400
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
405 410 415
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
420 425 430
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
435 440 445
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
450 455 460
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
465 470 475 480
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
485 490 495
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
500 505 510
Leu His Met Gln Ala Leu Pro Pro Arg
515 520
<210> 372
<211> 520
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS92110串联CAR
<400> 372
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr
100 105 110
Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe
275 280 285
Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg
290 295 300
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
305 310 315 320
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
325 330 335
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
340 345 350
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
355 360 365
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
370 375 380
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
385 390 395 400
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
405 410 415
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
420 425 430
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
435 440 445
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
450 455 460
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
465 470 475 480
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
485 490 495
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
500 505 510
His Met Gln Ala Leu Pro Pro Arg
515 520
<210> 373
<211> 518
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91156串联CAR
<400> 373
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser
100 105 110
Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln
275 280 285
Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro
290 295 300
Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu
305 310 315 320
Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp
325 330 335
Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly
340 345 350
Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg
355 360 365
Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln
370 375 380
Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu
385 390 395 400
Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala
405 410 415
Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu
420 425 430
Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp
435 440 445
Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu
450 455 460
Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile
465 470 475 480
Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr
485 490 495
Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met
500 505 510
Gln Ala Leu Pro Pro Arg
515
<210> 374
<211> 518
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91189串联CAR
<400> 374
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser
100 105 110
Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln
275 280 285
Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro
290 295 300
Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu
305 310 315 320
Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp
325 330 335
Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly
340 345 350
Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg
355 360 365
Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln
370 375 380
Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu
385 390 395 400
Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala
405 410 415
Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu
420 425 430
Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp
435 440 445
Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu
450 455 460
Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile
465 470 475 480
Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr
485 490 495
Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met
500 505 510
Gln Ala Leu Pro Pro Arg
515
<210> 375
<211> 521
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51674串联CAR
<400> 375
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser
100 105 110
Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly
145 150 155 160
Tyr Ala Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
180 185 190
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
195 200 205
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala
210 215 220
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
225 230 235 240
Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
245 250 255
Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
260 265 270
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr
275 280 285
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro
290 295 300
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
305 310 315 320
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
325 330 335
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
340 345 350
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
355 360 365
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
370 375 380
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
385 390 395 400
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
405 410 415
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
420 425 430
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
435 440 445
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
450 455 460
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
465 470 475 480
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
485 490 495
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
500 505 510
Leu His Met Gln Ala Leu Pro Pro Arg
515 520
<210> 376
<211> 402
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS65233串联CAR
<400> 376
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val His Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Glu Phe Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly
85 90 95
Lys Glu Arg Glu Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr
100 105 110
Val Tyr Ala Asp Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn
115 120 125
Ala Lys Ser Ile Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp
130 135 140
Thr Ala Met Tyr Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp
145 150 155 160
Ser Ser Pro Ser Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr
165 170 175
Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
180 185 190
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
195 200 205
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
210 215 220
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
225 230 235 240
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
245 250 255
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
260 265 270
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
275 280 285
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
290 295 300
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
305 310 315 320
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
325 330 335
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
340 345 350
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
355 360 365
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
370 375 380
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
385 390 395 400
Pro Arg
<210> 377
<211> 408
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60685串联CAR
<400> 377
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Asn Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly
100 105 110
Gly Tyr Thr Tyr Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Arg Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys
130 135 140
Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu
145 150 155 160
Thr Arg Glu Phe Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly
165 170 175
Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg
180 185 190
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
195 200 205
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
210 215 220
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
225 230 235 240
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
245 250 255
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
260 265 270
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
275 280 285
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
290 295 300
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
305 310 315 320
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
325 330 335
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
340 345 350
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
355 360 365
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
370 375 380
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
385 390 395 400
His Met Gln Ala Leu Pro Pro Arg
405
<210> 378
<211> 408
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60702串联CAR
<400> 378
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Lys Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Asn Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly
100 105 110
Gly Tyr Thr Asn Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser
115 120 125
Gln Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys
130 135 140
Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu
145 150 155 160
Thr Arg Ala Phe Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly
165 170 175
Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg
180 185 190
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
195 200 205
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
210 215 220
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
225 230 235 240
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
245 250 255
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
260 265 270
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
275 280 285
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
290 295 300
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
305 310 315 320
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
325 330 335
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
340 345 350
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
355 360 365
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
370 375 380
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
385 390 395 400
His Met Gln Ala Leu Pro Pro Arg
405
<210> 379
<211> 400
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60676串联CAR
<400> 379
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Tyr Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala
100 105 110
Thr Thr Thr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg
115 120 125
Asp Asp Ala Glu Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro
130 135 140
Glu Asp Thr Ala Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys
145 150 155 160
Leu Ser Pro Gly Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser
165 170 175
Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile
180 185 190
Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala
195 200 205
Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr
210 215 220
Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu
225 230 235 240
Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile
245 250 255
Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp
260 265 270
Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu
275 280 285
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
290 295 300
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
305 310 315 320
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
325 330 335
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
340 345 350
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
355 360 365
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
370 375 380
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
385 390 395 400
<210> 380
<211> 775
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 + FSHβ 33-53双重CAR
<400> 380
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val
20 25 30
Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Ala Pro Gly Gln
50 55 60
Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp
65 70 75 80
Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser
85 90 95
Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp
115 120 125
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
130 135 140
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser
145 150 155 160
Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys
165 170 175
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
180 185 190
Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr
195 200 205
Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu
225 230 235 240
Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
245 250 255
Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr Thr Pro Ala Pro
260 265 270
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
275 280 285
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
290 295 300
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
305 310 315 320
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
325 330 335
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
340 345 350
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
355 360 365
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
370 375 380
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
385 390 395 400
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
405 410 415
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
420 425 430
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
435 440 445
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
450 455 460
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
465 470 475 480
Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe
485 490 495
Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met
500 505 510
Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His
515 520 525
Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg
530 535 540
Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg
545 550 555 560
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
565 570 575
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
580 585 590
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
595 600 605
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser
610 615 620
Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg
625 630 635 640
Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg
645 650 655
Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp
660 665 670
Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn
675 680 685
Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg
690 695 700
Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly
705 710 715 720
Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu
725 730 735
Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu
740 745 750
Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His
755 760 765
Met Gln Ala Leu Pro Pro Arg
770 775
<210> 381
<211> 771
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 + FSHβ 33-53双重CAR
<400> 381
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr
115 120 125
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln
145 150 155 160
Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr
165 170 175
Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln
180 185 190
Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu
195 200 205
Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp
210 215 220
Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr
225 230 235 240
Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val
500 505 510
Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro
515 520 525
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
530 535 540
Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
545 550 555 560
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
565 570 575
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
580 585 590
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
595 600 605
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg
610 615 620
Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro
625 630 635 640
Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala
645 650 655
Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr
660 665 670
Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg
675 680 685
Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met
690 695 700
Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu
705 710 715 720
Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys
725 730 735
Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu
740 745 750
Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu
755 760 765
Pro Pro Arg
770
<210> 382
<211> 770
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 + FSHβ 33-53双重CAR
<400> 382
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr
245 250 255
Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
260 265 270
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
275 280 285
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
290 295 300
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
305 310 315 320
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
325 330 335
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
340 345 350
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
355 360 365
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
370 375 380
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
385 390 395 400
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
405 410 415
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
420 425 430
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
435 440 445
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
450 455 460
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
465 470 475 480
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
485 490 495
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
500 505 510
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
515 520 525
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
530 535 540
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
545 550 555 560
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
565 570 575
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
580 585 590
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
595 600 605
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
610 615 620
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
625 630 635 640
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
645 650 655
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
660 665 670
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
675 680 685
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
690 695 700
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
705 710 715 720
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
725 730 735
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
740 745 750
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
755 760 765
Pro Arg
770
<210> 383
<211> 768
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 + FSHβ 33-53双重CAR
<400> 383
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu
500 505 510
Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg
515 520 525
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
530 535 540
Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
545 550 555 560
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
565 570 575
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
580 585 590
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
595 600 605
Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His
610 615 620
Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys
625 630 635 640
His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser
645 650 655
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
660 665 670
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
675 680 685
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
690 695 700
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
705 710 715 720
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
725 730 735
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
740 745 750
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
755 760 765
<210> 384
<211> 768
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 + FSHβ 33-53双重CAR
<400> 384
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu
500 505 510
Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg
515 520 525
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
530 535 540
Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
545 550 555 560
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
565 570 575
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
580 585 590
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
595 600 605
Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His
610 615 620
Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys
625 630 635 640
His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser
645 650 655
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
660 665 670
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
675 680 685
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
690 695 700
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
705 710 715 720
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
725 730 735
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
740 745 750
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
755 760 765
<210> 385
<211> 771
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 + FSHβ 33-53双重CAR
<400> 385
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met
115 120 125
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
145 150 155 160
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
165 170 175
Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr
180 185 190
Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser
195 200 205
Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly
210 215 220
Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala
225 230 235 240
Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val
500 505 510
Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro
515 520 525
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
530 535 540
Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
545 550 555 560
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
565 570 575
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
580 585 590
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
595 600 605
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg
610 615 620
Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro
625 630 635 640
Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala
645 650 655
Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr
660 665 670
Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg
675 680 685
Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met
690 695 700
Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu
705 710 715 720
Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys
725 730 735
Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu
740 745 750
Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu
755 760 765
Pro Pro Arg
770
<210> 386
<211> 652
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 + FSHβ 33-53双重CAR
<400> 386
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val His Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile
85 90 95
Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
355 360 365
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
370 375 380
Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu
385 390 395 400
Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr
405 410 415
Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr
420 425 430
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
435 440 445
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
450 455 460
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
465 470 475 480
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
485 490 495
Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met
500 505 510
Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro
515 520 525
Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe
530 535 540
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
545 550 555 560
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
565 570 575
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
580 585 590
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
595 600 605
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
610 615 620
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
625 630 635 640
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
645 650
<210> 387
<211> 658
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 + FSHβ 33-53双重CAR
<400> 387
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr
65 70 75 80
Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe
115 120 125
Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
385 390 395 400
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
405 410 415
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
420 425 430
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
435 440 445
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
450 455 460
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
465 470 475 480
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
485 490 495
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
500 505 510
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
515 520 525
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
530 535 540
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
545 550 555 560
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
565 570 575
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
580 585 590
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
595 600 605
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
610 615 620
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
625 630 635 640
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
645 650 655
Pro Arg
<210> 388
<211> 658
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 + FSHβ 33-53双重CAR
<400> 388
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn
65 70 75 80
Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe
115 120 125
Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
385 390 395 400
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
405 410 415
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
420 425 430
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
435 440 445
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
450 455 460
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
465 470 475 480
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
485 490 495
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
500 505 510
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
515 520 525
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
530 535 540
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
545 550 555 560
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
565 570 575
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
580 585 590
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
595 600 605
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
610 615 620
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
625 630 635 640
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
645 650 655
Pro Arg
<210> 389
<211> 650
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 + FSHβ 33-53双重CAR
<400> 389
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr
35 40 45
Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr
65 70 75 80
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu
85 90 95
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
100 105 110
Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly
115 120 125
Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr
130 135 140
Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro
145 150 155 160
Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val
165 170 175
His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro
180 185 190
Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu
195 200 205
Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro
210 215 220
Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys
225 230 235 240
Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe
245 250 255
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
260 265 270
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
275 280 285
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
290 295 300
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
305 310 315 320
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
325 330 335
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
340 345 350
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala
355 360 365
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
370 375 380
Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu
385 390 395 400
Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp
405 410 415
Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr Thr Pro
420 425 430
Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu
435 440 445
Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His
450 455 460
Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu
465 470 475 480
Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr
485 490 495
Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met
500 505 510
Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala
515 520 525
Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg
530 535 540
Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn
545 550 555 560
Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg
565 570 575
Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro
580 585 590
Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala
595 600 605
Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His
610 615 620
Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp
625 630 635 640
Ala Leu His Met Gln Ala Leu Pro Pro Arg
645 650
<210> 390
<211> 710
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 CAR,具有dnTGFβRII
<400> 390
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val
20 25 30
Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Ala Pro Gly Gln
50 55 60
Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp
65 70 75 80
Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser
85 90 95
Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp
115 120 125
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
130 135 140
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser
145 150 155 160
Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys
165 170 175
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
180 185 190
Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr
195 200 205
Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu
225 230 235 240
Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
245 250 255
Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr Thr Pro Ala Pro
260 265 270
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
275 280 285
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
290 295 300
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
305 310 315 320
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
325 330 335
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
340 345 350
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
355 360 365
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
370 375 380
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
385 390 395 400
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
405 410 415
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
420 425 430
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
435 440 445
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
450 455 460
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
465 470 475 480
Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe
485 490 495
Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met
500 505 510
Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp
515 520 525
Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn
530 535 540
Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln
545 550 555 560
Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys
565 570 575
Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln
580 585 590
Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu
595 600 605
Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu
610 615 620
Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro
625 630 635 640
Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp
645 650 655
Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu
660 665 670
Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly
675 680 685
Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg
690 695 700
Gln Gln Lys Leu Ser Ser
705 710
<210> 391
<211> 706
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 CAR,具有dnTGFβRII
<400> 391
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr
115 120 125
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln
145 150 155 160
Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr
165 170 175
Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln
180 185 190
Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu
195 200 205
Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp
210 215 220
Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr
225 230 235 240
Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu
500 505 510
Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala
515 520 525
Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile
530 535 540
Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe
545 550 555 560
Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser
565 570 575
Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val
580 585 590
Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys
595 600 605
His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala
610 615 620
Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe
625 630 635 640
Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe
645 650 655
Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe
660 665 670
Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser
675 680 685
Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu
690 695 700
Ser Ser
705
<210> 392
<211> 705
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 CAR,具有dnTGFβRII
<400> 392
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr
245 250 255
Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
260 265 270
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
275 280 285
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
290 295 300
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
305 310 315 320
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
325 330 335
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
340 345 350
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
355 360 365
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
370 375 380
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
385 390 395 400
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
405 410 415
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
420 425 430
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
435 440 445
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
450 455 460
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
465 470 475 480
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
485 490 495
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu
500 505 510
Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser
515 520 525
Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val
530 535 540
Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys
545 550 555 560
Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn
565 570 575
Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala
580 585 590
Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His
595 600 605
Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser
610 615 620
Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe
625 630 635 640
Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser
645 650 655
Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln
660 665 670
Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val
675 680 685
Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser
690 695 700
Ser
705
<210> 393
<211> 703
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 CAR,具有dnTGFβRII
<400> 393
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
500 505 510
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
515 520 525
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
530 535 540
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
545 550 555 560
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
565 570 575
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
580 585 590
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
595 600 605
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
610 615 620
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
625 630 635 640
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
645 650 655
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
660 665 670
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
675 680 685
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
690 695 700
<210> 394
<211> 703
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 CAR,具有dnTGFβRII
<400> 394
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
500 505 510
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
515 520 525
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
530 535 540
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
545 550 555 560
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
565 570 575
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
580 585 590
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
595 600 605
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
610 615 620
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
625 630 635 640
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
645 650 655
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
660 665 670
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
675 680 685
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
690 695 700
<210> 395
<211> 706
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 CAR,具有dnTGFβRII
<400> 395
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met
115 120 125
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
145 150 155 160
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
165 170 175
Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr
180 185 190
Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser
195 200 205
Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly
210 215 220
Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala
225 230 235 240
Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu
500 505 510
Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala
515 520 525
Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile
530 535 540
Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe
545 550 555 560
Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser
565 570 575
Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val
580 585 590
Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys
595 600 605
His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala
610 615 620
Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe
625 630 635 640
Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe
645 650 655
Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe
660 665 670
Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser
675 680 685
Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu
690 695 700
Ser Ser
705
<210> 396
<211> 587
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 CAR,具有dnTGFβRII
<400> 396
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val His Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile
85 90 95
Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
355 360 365
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
370 375 380
Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu
385 390 395 400
His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val
405 410 415
Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala
420 425 430
Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr
435 440 445
Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile
450 455 460
Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp
465 470 475 480
Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr
485 490 495
His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys
500 505 510
Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser
515 520 525
Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser
530 535 540
Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu
545 550 555 560
Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys
565 570 575
Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
580 585
<210> 397
<211> 593
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 CAR,具有dnTGFβRII
<400> 397
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr
65 70 75 80
Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe
115 120 125
Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu
385 390 395 400
Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser
405 410 415
Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val
420 425 430
Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys
435 440 445
Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn
450 455 460
Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala
465 470 475 480
Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His
485 490 495
Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser
500 505 510
Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe
515 520 525
Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser
530 535 540
Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln
545 550 555 560
Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val
565 570 575
Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser
580 585 590
Ser
<210> 398
<211> 593
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 CAR,具有dnTGFβRII
<400> 398
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn
65 70 75 80
Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe
115 120 125
Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu
385 390 395 400
Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser
405 410 415
Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val
420 425 430
Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys
435 440 445
Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn
450 455 460
Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala
465 470 475 480
Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His
485 490 495
Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser
500 505 510
Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe
515 520 525
Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser
530 535 540
Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln
545 550 555 560
Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val
565 570 575
Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser
580 585 590
Ser
<210> 399
<211> 585
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 CAR,具有dnTGFβRII
<400> 399
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr
35 40 45
Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr
65 70 75 80
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu
85 90 95
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
100 105 110
Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly
115 120 125
Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr
130 135 140
Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro
145 150 155 160
Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val
165 170 175
His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro
180 185 190
Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu
195 200 205
Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro
210 215 220
Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys
225 230 235 240
Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe
245 250 255
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
260 265 270
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
275 280 285
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
290 295 300
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
305 310 315 320
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
325 330 335
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
340 345 350
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala
355 360 365
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
370 375 380
Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile
385 390 395 400
Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys
405 410 415
Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys
420 425 430
Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp
435 440 445
Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu
450 455 460
Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn
465 470 475 480
Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp
485 490 495
Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys
500 505 510
Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu
515 520 525
Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro
530 535 540
Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro
545 550 555 560
Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg
565 570 575
Val Asn Arg Gln Gln Lys Leu Ser Ser
580 585
<210> 400
<211> 746
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AD58126VH3VL1串联CAR,具有dnTGFβRII
<400> 400
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser
50 55 60
Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys
65 70 75 80
Ala Ser Gly Tyr Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln
85 90 95
Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr
100 105 110
Gly His Thr Asp Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr
115 120 125
Ala Asp Thr Ser Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg
130 135 140
Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp
145 150 155 160
Phe Pro Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly
165 170 175
Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val
180 185 190
Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala
195 200 205
Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln
210 215 220
Lys Asn Tyr Leu Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys
225 230 235 240
Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg
245 250 255
Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser
260 265 270
Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser
275 280 285
Tyr Pro Leu Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr
290 295 300
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
305 310 315 320
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
325 330 335
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
340 345 350
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
355 360 365
Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln
370 375 380
Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser
385 390 395 400
Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys
405 410 415
Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln
420 425 430
Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu
435 440 445
Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg
450 455 460
Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met
465 470 475 480
Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly
485 490 495
Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp
500 505 510
Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly
515 520 525
Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn
530 535 540
Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His
545 550 555 560
Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln
565 570 575
Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val
580 585 590
Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys
595 600 605
Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys
610 615 620
Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu
625 630 635 640
Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His
645 650 655
Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu
660 665 670
Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp
675 680 685
Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn
690 695 700
Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu
705 710 715 720
Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr
725 730 735
Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
740 745
<210> 401
<211> 742
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51489串联CAR,具有dnTGFβRII
<400> 401
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser
100 105 110
Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr
145 150 155 160
Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly
165 170 175
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile
180 185 190
Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg
195 200 205
Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala
210 215 220
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser
225 230 235 240
Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg
245 250 255
Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp
260 265 270
Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr
275 280 285
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro
290 295 300
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
305 310 315 320
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
325 330 335
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
340 345 350
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
355 360 365
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
370 375 380
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
385 390 395 400
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
405 410 415
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
420 425 430
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
435 440 445
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
450 455 460
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
465 470 475 480
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
485 490 495
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
500 505 510
Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe
515 520 525
Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met
530 535 540
Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp
545 550 555 560
Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn
565 570 575
Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln
580 585 590
Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys
595 600 605
Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln
610 615 620
Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu
625 630 635 640
Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu
645 650 655
Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro
660 665 670
Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp
675 680 685
Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu
690 695 700
Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly
705 710 715 720
Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg
725 730 735
Gln Gln Lys Leu Ser Ser
740
<210> 402
<211> 741
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS92110串联CAR,具有dnTGFβRII
<400> 402
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr
100 105 110
Ser Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe
275 280 285
Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg
290 295 300
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
305 310 315 320
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
325 330 335
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
340 345 350
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
355 360 365
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
370 375 380
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
385 390 395 400
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
405 410 415
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
420 425 430
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
435 440 445
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
450 455 460
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
465 470 475 480
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
485 490 495
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
500 505 510
His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser
515 520 525
Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly
530 535 540
Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr
545 550 555 560
Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn
565 570 575
Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu
580 585 590
Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser
595 600 605
Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu
610 615 620
Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu
625 630 635 640
Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu
645 650 655
Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly
660 665 670
Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn
675 680 685
Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu
690 695 700
Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val
705 710 715 720
Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln
725 730 735
Gln Lys Leu Ser Ser
740
<210> 403
<211> 739
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91156串联CAR,具有dnTGFβRII
<400> 403
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser
100 105 110
Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln
275 280 285
Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro
290 295 300
Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu
305 310 315 320
Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp
325 330 335
Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly
340 345 350
Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg
355 360 365
Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln
370 375 380
Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu
385 390 395 400
Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala
405 410 415
Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu
420 425 430
Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp
435 440 445
Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu
450 455 460
Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile
465 470 475 480
Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr
485 490 495
Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met
500 505 510
Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu
515 520 525
Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly
530 535 540
Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile
545 550 555 560
Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met
565 570 575
Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys
580 585 590
Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met
595 600 605
Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys
610 615 620
Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val
625 630 635 640
Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala
645 650 655
Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr
660 665 670
Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile
675 680 685
Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile
690 695 700
Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile
705 710 715 720
Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys
725 730 735
Leu Ser Ser
<210> 404
<211> 739
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS91189串联CAR,具有dnTGFβRII
<400> 404
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser
100 105 110
Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp
145 150 155 160
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
180 185 190
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
195 200 205
Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln
210 215 220
Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser
225 230 235 240
Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr
245 250 255
Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
260 265 270
Tyr Tyr Cys Gln Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln
275 280 285
Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro
290 295 300
Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu
305 310 315 320
Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp
325 330 335
Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly
340 345 350
Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg
355 360 365
Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln
370 375 380
Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu
385 390 395 400
Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala
405 410 415
Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu
420 425 430
Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp
435 440 445
Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu
450 455 460
Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile
465 470 475 480
Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr
485 490 495
Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met
500 505 510
Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu
515 520 525
Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly
530 535 540
Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile
545 550 555 560
Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met
565 570 575
Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys
580 585 590
Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met
595 600 605
Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys
610 615 620
Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val
625 630 635 640
Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala
645 650 655
Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr
660 665 670
Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile
675 680 685
Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile
690 695 700
Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile
705 710 715 720
Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys
725 730 735
Leu Ser Ser
<210> 405
<211> 742
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS51674串联CAR,具有dnTGFβRII
<400> 405
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser
100 105 110
Ser Tyr Thr Ser Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly
145 150 155 160
Tyr Ala Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
165 170 175
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
180 185 190
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
195 200 205
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala
210 215 220
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
225 230 235 240
Tyr Ser Ala Ser Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
245 250 255
Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
260 265 270
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr
275 280 285
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro
290 295 300
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
305 310 315 320
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
325 330 335
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
340 345 350
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
355 360 365
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
370 375 380
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
385 390 395 400
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
405 410 415
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
420 425 430
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
435 440 445
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
450 455 460
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
465 470 475 480
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
485 490 495
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
500 505 510
Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe
515 520 525
Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met
530 535 540
Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp
545 550 555 560
Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn
565 570 575
Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln
580 585 590
Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys
595 600 605
Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln
610 615 620
Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu
625 630 635 640
Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu
645 650 655
Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro
660 665 670
Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp
675 680 685
Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu
690 695 700
Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly
705 710 715 720
Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg
725 730 735
Gln Gln Lys Leu Ser Ser
740
<210> 406
<211> 623
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS65233串联CAR,具有dnTGFβRII
<400> 406
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val His Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Glu Phe Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly
85 90 95
Lys Glu Arg Glu Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr
100 105 110
Val Tyr Ala Asp Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn
115 120 125
Ala Lys Ser Ile Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp
130 135 140
Thr Ala Met Tyr Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp
145 150 155 160
Ser Ser Pro Ser Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr
165 170 175
Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
180 185 190
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
195 200 205
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
210 215 220
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
225 230 235 240
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
245 250 255
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
260 265 270
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
275 280 285
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
290 295 300
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
305 310 315 320
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
325 330 335
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
340 345 350
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
355 360 365
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
370 375 380
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
385 390 395 400
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
405 410 415
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
420 425 430
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
435 440 445
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
450 455 460
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
465 470 475 480
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
485 490 495
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
500 505 510
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
515 520 525
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
530 535 540
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
545 550 555 560
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
565 570 575
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
580 585 590
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
595 600 605
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
610 615 620
<210> 407
<211> 629
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60685串联CAR,具有dnTGFβRII
<400> 407
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Asn Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly
100 105 110
Gly Tyr Thr Tyr Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Arg Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys
130 135 140
Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu
145 150 155 160
Thr Arg Glu Phe Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly
165 170 175
Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg
180 185 190
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
195 200 205
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
210 215 220
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
225 230 235 240
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
245 250 255
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
260 265 270
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
275 280 285
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
290 295 300
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
305 310 315 320
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
325 330 335
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
340 345 350
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
355 360 365
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
370 375 380
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
385 390 395 400
His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser
405 410 415
Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly
420 425 430
Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr
435 440 445
Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn
450 455 460
Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu
465 470 475 480
Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser
485 490 495
Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu
500 505 510
Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu
515 520 525
Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu
530 535 540
Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly
545 550 555 560
Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn
565 570 575
Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu
580 585 590
Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val
595 600 605
Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln
610 615 620
Gln Lys Leu Ser Ser
625
<210> 408
<211> 629
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60702串联CAR,具有dnTGFβRII
<400> 408
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Lys Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Asn Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly
100 105 110
Gly Tyr Thr Asn Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser
115 120 125
Gln Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys
130 135 140
Pro Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu
145 150 155 160
Thr Arg Ala Phe Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly
165 170 175
Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg
180 185 190
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
195 200 205
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
210 215 220
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
225 230 235 240
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg
245 250 255
Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro
260 265 270
Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu
275 280 285
Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala
290 295 300
Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu
305 310 315 320
Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly
325 330 335
Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu
340 345 350
Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser
355 360 365
Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly
370 375 380
Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu
385 390 395 400
His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser
405 410 415
Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly
420 425 430
Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr
435 440 445
Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn
450 455 460
Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu
465 470 475 480
Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser
485 490 495
Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu
500 505 510
Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu
515 520 525
Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu
530 535 540
Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly
545 550 555 560
Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn
565 570 575
Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu
580 585 590
Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val
595 600 605
Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln
610 615 620
Gln Lys Leu Ser Ser
625
<210> 409
<211> 621
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS60676串联CAR,具有dnTGFβRII
<400> 409
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Tyr Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala
100 105 110
Thr Thr Thr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg
115 120 125
Asp Asp Ala Glu Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro
130 135 140
Glu Asp Thr Ala Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys
145 150 155 160
Leu Ser Pro Gly Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser
165 170 175
Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile
180 185 190
Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala
195 200 205
Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr
210 215 220
Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu
225 230 235 240
Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile
245 250 255
Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp
260 265 270
Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu
275 280 285
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
290 295 300
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
305 310 315 320
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
325 330 335
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
340 345 350
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
355 360 365
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
370 375 380
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
385 390 395 400
Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val
405 410 415
Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp
420 425 430
Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro
435 440 445
His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn
450 455 460
Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe
465 470 475 480
Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr
485 490 495
Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys
500 505 510
Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu
515 520 525
Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile
530 535 540
Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys
545 550 555 560
Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn
565 570 575
Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile
580 585 590
Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe
595 600 605
Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
610 615 620
<210> 410
<211> 996
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AD58126VH3VL1 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 410
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val
20 25 30
Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
35 40 45
Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Ala Pro Gly Gln
50 55 60
Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Thr Gly His Thr Asp
65 70 75 80
Tyr Asn Gln Lys Phe Lys Asp Arg Ala Thr Leu Thr Ala Asp Thr Ser
85 90 95
Thr Ser Thr Val Tyr Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Ser Asn Trp Ala Trp Phe Pro Tyr Trp
115 120 125
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
130 135 140
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser
145 150 155 160
Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys
165 170 175
Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Asn Gln Lys Asn Tyr Leu
180 185 190
Thr Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr
195 200 205
Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu
225 230 235 240
Asp Val Ala Val Tyr Tyr Cys Gln Asn Asp Tyr Ser Tyr Pro Leu Thr
245 250 255
Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Thr Thr Thr Pro Ala Pro
260 265 270
Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu
275 280 285
Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg
290 295 300
Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly
305 310 315 320
Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys
325 330 335
Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg
340 345 350
Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro
355 360 365
Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser
370 375 380
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
385 390 395 400
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
405 410 415
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
420 425 430
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
435 440 445
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
450 455 460
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
465 470 475 480
Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe
485 490 495
Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met
500 505 510
Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His
515 520 525
Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg
530 535 540
Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg
545 550 555 560
Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg
565 570 575
Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly
580 585 590
Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr
595 600 605
Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser
610 615 620
Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg
625 630 635 640
Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg
645 650 655
Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp
660 665 670
Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn
675 680 685
Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg
690 695 700
Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly
705 710 715 720
Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu
725 730 735
Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu
740 745 750
Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His
755 760 765
Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu
770 775 780
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg
785 790 795 800
Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg
805 810 815
Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp
820 825 830
Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys
835 840 845
Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys
850 855 860
Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val
865 870 875 880
Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr
885 890 895
Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp
900 905 910
Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu
915 920 925
Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile
930 935 940
Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val
945 950 955 960
Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala
965 970 975
Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln
980 985 990
Lys Leu Ser Ser
995
<210> 411
<211> 992
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51489 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 411
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Tyr Tyr Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Ser Ser Ser Ser Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Pro Tyr Tyr Gly Met Asp Tyr
115 120 125
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln
145 150 155 160
Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr
165 170 175
Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln
180 185 190
Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu
195 200 205
Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp
210 215 220
Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr
225 230 235 240
Tyr Cys Gln Gln Gly Phe Ser Tyr Tyr Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val
500 505 510
Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro
515 520 525
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
530 535 540
Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
545 550 555 560
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
565 570 575
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
580 585 590
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
595 600 605
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg
610 615 620
Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro
625 630 635 640
Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala
645 650 655
Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr
660 665 670
Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg
675 680 685
Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met
690 695 700
Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu
705 710 715 720
Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys
725 730 735
Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu
740 745 750
Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu
755 760 765
Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala
770 775 780
Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg
785 790 795 800
Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr
805 810 815
Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr
820 825 830
Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp
835 840 845
Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys
850 855 860
Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val
865 870 875 880
Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp
885 890 895
Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro
900 905 910
Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met
915 920 925
Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu
930 935 940
Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val
945 950 955 960
Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile
965 970 975
Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
980 985 990
<210> 412
<211> 991
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS92110 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 412
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Tyr Ser Ser Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Tyr Ile Tyr Pro Tyr Tyr Ser Tyr Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Gly Tyr Ala Leu Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Ala Ser Ser Gly Tyr His Tyr Leu Ile Thr Phe Gly Gln Gly Thr
245 250 255
Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
260 265 270
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
275 280 285
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
290 295 300
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
305 310 315 320
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
325 330 335
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
340 345 350
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
355 360 365
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
370 375 380
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
385 390 395 400
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
405 410 415
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
420 425 430
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
435 440 445
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
450 455 460
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
465 470 475 480
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
485 490 495
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
500 505 510
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
515 520 525
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
530 535 540
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
545 550 555 560
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
565 570 575
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
580 585 590
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
595 600 605
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
610 615 620
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
625 630 635 640
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
645 650 655
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
660 665 670
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
675 680 685
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
690 695 700
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
705 710 715 720
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
725 730 735
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
740 745 750
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
755 760 765
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
770 775 780
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
785 790 795 800
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
805 810 815
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
820 825 830
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
835 840 845
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
850 855 860
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
865 870 875 880
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
885 890 895
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
900 905 910
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
915 920 925
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
930 935 940
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
945 950 955 960
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
965 970 975
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
980 985 990
<210> 413
<211> 989
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91156 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 413
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Ile Tyr Ser Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Ser Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Tyr Ala Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Gly Pro Tyr Tyr His Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu
500 505 510
Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg
515 520 525
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
530 535 540
Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
545 550 555 560
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
565 570 575
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
580 585 590
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
595 600 605
Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His
610 615 620
Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys
625 630 635 640
His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser
645 650 655
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
660 665 670
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
675 680 685
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
690 695 700
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
705 710 715 720
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
725 730 735
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
740 745 750
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
755 760 765
Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val
770 775 780
Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp
785 790 795 800
Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro
805 810 815
His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn
820 825 830
Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe
835 840 845
Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr
850 855 860
Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys
865 870 875 880
Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu
885 890 895
Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile
900 905 910
Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys
915 920 925
Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn
930 935 940
Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile
945 950 955 960
Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe
965 970 975
Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
980 985
<210> 414
<211> 989
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS91189 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 414
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Ser Tyr Ser Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Gly Ser Thr Tyr
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Tyr Trp Gly Met Asp Tyr Trp Gly Gln
115 120 125
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
145 150 155 160
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
165 170 175
Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
180 185 190
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Ser Leu Tyr Ser Gly
195 200 205
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu
210 215 220
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
225 230 235 240
Gln Tyr Tyr Trp Tyr Tyr Pro Ile Thr Phe Gly Gln Gly Thr Lys Val
245 250 255
Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
260 265 270
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
275 280 285
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
290 295 300
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
305 310 315 320
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
325 330 335
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
340 345 350
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
355 360 365
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
370 375 380
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
385 390 395 400
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
405 410 415
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
420 425 430
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
435 440 445
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
450 455 460
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
465 470 475 480
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
485 490 495
Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu
500 505 510
Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg
515 520 525
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
530 535 540
Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
545 550 555 560
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
565 570 575
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
580 585 590
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
595 600 605
Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His
610 615 620
Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys
625 630 635 640
His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser
645 650 655
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly
660 665 670
Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr
675 680 685
Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys
690 695 700
Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys
705 710 715 720
Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg
725 730 735
Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala
740 745 750
Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
755 760 765
Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val
770 775 780
Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp
785 790 795 800
Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro
805 810 815
His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn
820 825 830
Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe
835 840 845
Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr
850 855 860
Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys
865 870 875 880
Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu
885 890 895
Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile
900 905 910
Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys
915 920 925
Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn
930 935 940
Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile
945 950 955 960
Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe
965 970 975
Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
980 985
<210> 415
<211> 992
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS51674 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 415
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Asn Leu Tyr Ser Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Trp Val Ala Ser Ile Tyr Ser Tyr Ser Ser Tyr Thr Ser
65 70 75 80
Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser
85 90 95
Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Arg Pro Phe Gly Trp Gly Tyr Ala Gly Met
115 120 125
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly
130 135 140
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
145 150 155 160
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
165 170 175
Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Ala Val Ala Trp Tyr
180 185 190
Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser
195 200 205
Ser Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly
210 215 220
Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala
225 230 235 240
Thr Tyr Tyr Cys Gln Gln Gly Tyr Ala Pro Ile Thr Phe Gly Gln Gly
245 250 255
Thr Lys Val Glu Ile Lys Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
260 265 270
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
275 280 285
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
290 295 300
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
305 310 315 320
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
325 330 335
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
340 345 350
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
355 360 365
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
370 375 380
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
385 390 395 400
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
405 410 415
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
420 425 430
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
435 440 445
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
450 455 460
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
465 470 475 480
Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys
485 490 495
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val
500 505 510
Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro
515 520 525
Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln
530 535 540
Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
545 550 555 560
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
565 570 575
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
580 585 590
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
595 600 605
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg
610 615 620
Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro
625 630 635 640
Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala
645 650 655
Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr
660 665 670
Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg
675 680 685
Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met
690 695 700
Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu
705 710 715 720
Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys
725 730 735
Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu
740 745 750
Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu
755 760 765
Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala
770 775 780
Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg
785 790 795 800
Gly Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr
805 810 815
Ile Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr
820 825 830
Asp Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp
835 840 845
Val Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys
850 855 860
Ser Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val
865 870 875 880
Trp Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp
885 890 895
Pro Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro
900 905 910
Lys Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met
915 920 925
Cys Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu
930 935 940
Glu Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val
945 950 955 960
Thr Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile
965 970 975
Ile Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
980 985 990
<210> 416
<211> 873
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 416
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val His Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Tyr Asn Ala Lys Ser Ile
85 90 95
Met Tyr Leu Gln Met Asn Ser Val Lys Leu Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
355 360 365
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
370 375 380
Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu
385 390 395 400
Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr
405 410 415
Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr
420 425 430
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
435 440 445
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
450 455 460
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
465 470 475 480
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
485 490 495
Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met
500 505 510
Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro
515 520 525
Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe
530 535 540
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
545 550 555 560
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
565 570 575
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
580 585 590
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
595 600 605
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
610 615 620
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
625 630 635 640
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala
645 650 655
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
660 665 670
Gly Pro Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile
675 680 685
Val Leu Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys
690 695 700
Ser Val Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys
705 710 715 720
Phe Pro Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp
725 730 735
Asn Gln Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu
740 745 750
Lys Pro Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn
755 760 765
Ile Thr Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp
770 775 780
Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys
785 790 795 800
Lys Lys Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu
805 810 815
Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro
820 825 830
Asp Leu Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro
835 840 845
Pro Leu Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg
850 855 860
Val Asn Arg Gln Gln Lys Leu Ser Ser
865 870
<210> 417
<211> 879
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60685 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 417
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Met Tyr Val Gly Gly Gly Tyr Thr Tyr
65 70 75 80
Tyr Asp Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Ser Ile Ala Leu Thr Arg Glu Phe
115 120 125
Cys Ala Pro Ile Val Ser Arg Tyr Asn Tyr Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
385 390 395 400
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
405 410 415
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
420 425 430
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
435 440 445
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
450 455 460
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
465 470 475 480
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
485 490 495
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
500 505 510
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
515 520 525
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
530 535 540
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
545 550 555 560
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
565 570 575
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
580 585 590
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
595 600 605
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
610 615 620
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
625 630 635 640
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
645 650 655
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
660 665 670
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
675 680 685
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
690 695 700
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
705 710 715 720
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
725 730 735
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
740 745 750
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
755 760 765
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
770 775 780
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
785 790 795 800
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
805 810 815
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
820 825 830
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
835 840 845
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
850 855 860
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
865 870 875
<210> 418
<211> 879
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60702 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 418
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Lys Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Asn
35 40 45
Val Tyr Asn Asn Met Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Gly Val Ala Ser Ile Tyr Val Gly Gly Gly Tyr Thr Asn
65 70 75 80
Tyr Ala Asp Ser Val Arg Gly Arg Phe Thr Ile Ser Gln Asp Asn Ala
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Ala Ile Thr Val Ala Leu Thr Arg Ala Phe
115 120 125
Cys Ala Pro Ile Pro Ser Arg Tyr Thr Asn Trp Gly Gln Gly Thr Gln
130 135 140
Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro
145 150 155 160
Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys
165 170 175
Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala
180 185 190
Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu
195 200 205
Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys
210 215 220
Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr
225 230 235 240
Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly
245 250 255
Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala
260 265 270
Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg
275 280 285
Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu
290 295 300
Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn
305 310 315 320
Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met
325 330 335
Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly
340 345 350
Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala
355 360 365
Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln
370 375 380
Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr
385 390 395 400
Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr
405 410 415
Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys
420 425 430
Thr Cys Thr Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala
435 440 445
Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg
450 455 460
Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys
465 470 475 480
Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu
485 490 495
Leu Ser Leu Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu
500 505 510
Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr
515 520 525
Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr
530 535 540
Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
545 550 555 560
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
565 570 575
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
580 585 590
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
595 600 605
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
610 615 620
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
625 630 635 640
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
645 650 655
Pro Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly
660 665 670
Asp Val Glu Glu Asn Pro Gly Pro Met Gly Arg Gly Leu Leu Arg Gly
675 680 685
Leu Trp Pro Leu His Ile Val Leu Trp Thr Arg Ile Ala Ser Thr Ile
690 695 700
Pro Pro His Val Gln Lys Ser Val Asn Asn Asp Met Ile Val Thr Asp
705 710 715 720
Asn Asn Gly Ala Val Lys Phe Pro Gln Leu Cys Lys Phe Cys Asp Val
725 730 735
Arg Phe Ser Thr Cys Asp Asn Gln Lys Ser Cys Met Ser Asn Cys Ser
740 745 750
Ile Thr Ser Ile Cys Glu Lys Pro Gln Glu Val Cys Val Ala Val Trp
755 760 765
Arg Lys Asn Asp Glu Asn Ile Thr Leu Glu Thr Val Cys His Asp Pro
770 775 780
Lys Leu Pro Tyr His Asp Phe Ile Leu Glu Asp Ala Ala Ser Pro Lys
785 790 795 800
Cys Ile Met Lys Glu Lys Lys Lys Pro Gly Glu Thr Phe Phe Met Cys
805 810 815
Ser Cys Ser Ser Asp Glu Cys Asn Asp Asn Ile Ile Phe Ser Glu Glu
820 825 830
Tyr Asn Thr Ser Asn Pro Asp Leu Leu Leu Val Ile Phe Gln Val Thr
835 840 845
Gly Ile Ser Leu Leu Pro Pro Leu Gly Val Ala Ile Ser Val Ile Ile
850 855 860
Ile Phe Tyr Cys Tyr Arg Val Asn Arg Gln Gln Lys Leu Ser Ser
865 870 875
<210> 419
<211> 871
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS60676 + FSHβ 33-53双重CAR,具有dnTGFβRII
<400> 419
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Ser
20 25 30
Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr
35 40 45
Thr Val Ser Ser Gly Cys Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Glu Arg Glu Arg Val Ala Gln Ile Gly Arg Asp Ala Thr Thr Thr Tyr
65 70 75 80
Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ala Arg Asp Asp Ala Glu
85 90 95
Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala
100 105 110
Met Tyr Ser Cys Thr Ala Tyr Trp Gly Val Tyr Cys Leu Ser Pro Gly
115 120 125
Arg Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Thr Thr Thr
130 135 140
Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro
145 150 155 160
Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val
165 170 175
His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro
180 185 190
Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu
195 200 205
Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro
210 215 220
Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys
225 230 235 240
Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe
245 250 255
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
260 265 270
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
275 280 285
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
290 295 300
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
305 310 315 320
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
325 330 335
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
340 345 350
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala
355 360 365
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
370 375 380
Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu
385 390 395 400
Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp
405 410 415
Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr Thr Pro
420 425 430
Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu
435 440 445
Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His
450 455 460
Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu
465 470 475 480
Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr
485 490 495
Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met
500 505 510
Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala
515 520 525
Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg
530 535 540
Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn
545 550 555 560
Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg
565 570 575
Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro
580 585 590
Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala
595 600 605
Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His
610 615 620
Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp
625 630 635 640
Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr Asn
645 650 655
Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro
660 665 670
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
675 680 685
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
690 695 700
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
705 710 715 720
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
725 730 735
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
740 745 750
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
755 760 765
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
770 775 780
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
785 790 795 800
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
805 810 815
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
820 825 830
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
835 840 845
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
850 855 860
Arg Gln Gln Lys Leu Ser Ser
865 870
<210> 420
<211> 122
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH4
<400> 420
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser Met Gly
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val Ser His Ile
35 40 45
Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys Gly Arg
50 55 60
Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln Met
65 70 75 80
Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Ala Arg
85 90 95
Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp Phe Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 421
<211> 122
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5
<400> 421
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser Met Gly
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val Ala His Ile
35 40 45
Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys Gly Arg
50 55 60
Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Met Tyr Leu Gln Met
65 70 75 80
Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Arg
85 90 95
Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp Phe Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 422
<211> 122
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH6
<400> 422
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser Met Gly
20 25 30
Trp Phe Arg Gln Ala Pro Gly Lys Gly Arg Glu Gly Val Ala His Ile
35 40 45
Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys Gly Arg
50 55 60
Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Met Tyr Leu Gln Met
65 70 75 80
Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala Ala Arg
85 90 95
Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp Phe Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 423
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH4
<400> 423
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Asn
20 25 30
Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val
35 40 45
Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp Ser Val
50 55 60
Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn Gly Tyr
100 105 110
Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210> 424
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5
<400> 424
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Asn
20 25 30
Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val
35 40 45
Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp Ser Val
50 55 60
Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn Gly Tyr
100 105 110
Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210> 425
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH6
<400> 425
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Asn
20 25 30
Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Arg Glu Gly Val
35 40 45
Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp Ser Val
50 55 60
Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn Gly Tyr
100 105 110
Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120 125
<210> 426
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4
<400> 426
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser Thr Tyr
20 25 30
Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val
35 40 45
Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn Gly Tyr
100 105 110
Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
115 120 125
<210> 427
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH5
<400> 427
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser Thr Tyr
20 25 30
Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val
35 40 45
Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn Gly Tyr
100 105 110
Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
115 120 125
<210> 428
<211> 125
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH6
<400> 428
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser Thr Tyr
20 25 30
Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Arg Glu Gly Val
35 40 45
Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn Gly Tyr
100 105 110
Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
115 120 125
<210> 429
<211> 333
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> TC-210
<400> 429
Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu Cys Leu Leu Ser
1 5 10 15
Val Gly Val Trp Gly Gln Glu Val Gln Leu Val Glu Ser Gly Gly Gly
20 25 30
Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly
35 40 45
Gly Asp Trp Ser Ala Asn Phe Met Tyr Trp Tyr Arg Gln Ala Pro Gly
50 55 60
Lys Gln Arg Glu Leu Val Ala Arg Ile Ser Gly Arg Gly Val Val Asp
65 70 75 80
Tyr Val Glu Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Val Ala Ser Tyr Trp Gly Gln Gly Thr Leu
115 120 125
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
130 135 140
Gly Gly Gly Ser Asp Gly Asn Glu Glu Met Gly Gly Ile Thr Gln Thr
145 150 155 160
Pro Tyr Lys Val Ser Ile Ser Gly Thr Thr Val Ile Leu Thr Cys Pro
165 170 175
Gln Tyr Pro Gly Ser Glu Ile Leu Trp Gln His Asn Asp Lys Asn Ile
180 185 190
Gly Gly Asp Glu Asp Asp Lys Asn Ile Gly Ser Asp Glu Asp His Leu
195 200 205
Ser Leu Lys Glu Phe Ser Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys
210 215 220
Tyr Pro Arg Gly Ser Lys Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu
225 230 235 240
Arg Ala Arg Val Cys Glu Asn Cys Met Glu Met Asp Val Met Ser Val
245 250 255
Ala Thr Ile Val Ile Val Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu
260 265 270
Leu Val Tyr Tyr Trp Ser Lys Asn Arg Lys Ala Lys Ala Lys Pro Val
275 280 285
Thr Arg Gly Ala Gly Ala Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu
290 295 300
Arg Pro Pro Pro Val Pro Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly
305 310 315 320
Gln Arg Asp Leu Tyr Ser Gly Leu Asn Gln Arg Arg Ile
325 330
<210> 430
<211> 22
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3ε信号肽
<400> 430
Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu Cys Leu Leu Ser
1 5 10 15
Val Gly Val Trp Gly Gln
20
<210> 431
<211> 22
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3γ信号肽
<400> 431
Met Glu Gln Gly Lys Gly Leu Ala Val Leu Ile Leu Ala Ile Ile Leu
1 5 10 15
Leu Gln Gly Thr Leu Ala
20
<210> 432
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3δ信号肽
<400> 432
Met Glu His Ser Thr Phe Leu Ser Gly Leu Val Leu Ala Thr Leu Leu
1 5 10 15
Ser Gln Val Ser Pro
20
<210> 433
<211> 104
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3ε胞外结构域
<400> 433
Asp Gly Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val
1 5 10 15
Ser Ile Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly
20 25 30
Ser Glu Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp Glu
35 40 45
Asp Asp Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys Glu
50 55 60
Phe Ser Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly
65 70 75 80
Ser Lys Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val
85 90 95
Cys Glu Asn Cys Met Glu Met Asp
100
<210> 434
<211> 94
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3γ胞外结构域
<400> 434
Gln Ser Ile Lys Gly Asn His Leu Val Lys Val Tyr Asp Tyr Gln Glu
1 5 10 15
Asp Gly Ser Val Leu Leu Thr Cys Asp Ala Glu Ala Lys Asn Ile Thr
20 25 30
Trp Phe Lys Asp Gly Lys Met Ile Gly Phe Leu Thr Glu Asp Lys Lys
35 40 45
Lys Trp Asn Leu Gly Ser Asn Ala Lys Asp Pro Arg Gly Met Tyr Gln
50 55 60
Cys Lys Gly Ser Gln Asn Lys Ser Lys Pro Leu Gln Val Tyr Tyr Arg
65 70 75 80
Met Cys Gln Asn Cys Ile Glu Leu Asn Ala Ala Thr Ile Ser
85 90
<210> 435
<211> 84
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3δ胞外结构域
<400> 435
Phe Lys Ile Pro Ile Glu Glu Leu Glu Asp Arg Val Phe Val Asn Cys
1 5 10 15
Asn Thr Ser Ile Thr Trp Val Glu Gly Thr Val Gly Thr Leu Leu Ser
20 25 30
Asp Ile Thr Arg Leu Asp Leu Gly Lys Arg Ile Leu Asp Pro Arg Gly
35 40 45
Ile Tyr Arg Cys Asn Gly Thr Asp Ile Tyr Lys Asp Lys Glu Ser Thr
50 55 60
Val Gln Val His Tyr Arg Met Cys Gln Ser Cys Val Glu Leu Asp Pro
65 70 75 80
Ala Thr Val Ala
<210> 436
<211> 26
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3ε跨膜结构域
<400> 436
Val Met Ser Val Ala Thr Ile Val Ile Val Asp Ile Cys Ile Thr Gly
1 5 10 15
Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser
20 25
<210> 437
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3γ跨膜结构域
<400> 437
Gly Phe Leu Phe Ala Glu Ile Val Ser Ile Phe Val Leu Ala Val Gly
1 5 10 15
Val Tyr Phe Ile Ala
20
<210> 438
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3δ跨膜结构域
<400> 438
Gly Ile Ile Val Thr Asp Val Ile Ala Thr Leu Leu Leu Ala Leu Gly
1 5 10 15
Val Phe Cys Phe Ala
20
<210> 439
<211> 55
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3ε胞内结构域
<400> 439
Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala
1 5 10 15
Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro
20 25 30
Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser
35 40 45
Gly Leu Asn Gln Arg Arg Ile
50 55
<210> 440
<211> 45
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3γ胞内结构域
<400> 440
Gly Gln Asp Gly Val Arg Gln Ser Arg Ala Ser Asp Lys Gln Thr Leu
1 5 10 15
Leu Pro Asn Asp Gln Leu Tyr Gln Pro Leu Lys Asp Arg Glu Asp Asp
20 25 30
Gln Tyr Ser His Leu Gln Gly Asn Gln Leu Arg Arg Asn
35 40 45
<210> 441
<211> 45
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> CD3δ胞内结构域
<400> 441
Gly His Glu Thr Gly Arg Leu Ser Gly Ala Ala Asp Thr Gln Ala Leu
1 5 10 15
Leu Arg Asn Asp Gln Val Tyr Gln Pro Leu Arg Asp Arg Asp Asp Ala
20 25 30
Gln Tyr Ser His Leu Gly Gly Asn Trp Ala Arg Asn Lys
35 40 45
<210> 442
<211> 243
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 εTCR
<400> 442
Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu Cys Leu Leu Ser
1 5 10 15
Val Gly Val Trp Gly Gln Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro
20 25 30
Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser
35 40 45
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Gly Asn Glu Glu Met
50 55 60
Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val Ser Ile Ser Gly Thr Thr
65 70 75 80
Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly Ser Glu Ile Leu Trp Gln
85 90 95
His Asn Asp Lys Asn Ile Gly Gly Asp Glu Asp Asp Lys Asn Ile Gly
100 105 110
Ser Asp Glu Asp His Leu Ser Leu Lys Glu Phe Ser Glu Leu Glu Gln
115 120 125
Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly Ser Lys Pro Glu Asp Ala
130 135 140
Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val Cys Glu Asn Cys Met Glu
145 150 155 160
Met Asp Val Met Ser Val Ala Thr Ile Val Ile Val Asp Ile Cys Ile
165 170 175
Thr Gly Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser Lys Asn Arg Lys
180 185 190
Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala Gly Gly Arg Gln
195 200 205
Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro Asn Pro Asp Tyr
210 215 220
Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser Gly Leu Asn Gln
225 230 235 240
Arg Arg Ile
<210> 443
<211> 218
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 γTCR
<400> 443
Met Glu Gln Gly Lys Gly Leu Ala Val Leu Ile Leu Ala Ile Ile Leu
1 5 10 15
Leu Gln Gly Thr Leu Ala Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro
20 25 30
Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser
35 40 45
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ser Ile Lys Gly Asn
50 55 60
His Leu Val Lys Val Tyr Asp Tyr Gln Glu Asp Gly Ser Val Leu Leu
65 70 75 80
Thr Cys Asp Ala Glu Ala Lys Asn Ile Thr Trp Phe Lys Asp Gly Lys
85 90 95
Met Ile Gly Phe Leu Thr Glu Asp Lys Lys Lys Trp Asn Leu Gly Ser
100 105 110
Asn Ala Lys Asp Pro Arg Gly Met Tyr Gln Cys Lys Gly Ser Gln Asn
115 120 125
Lys Ser Lys Pro Leu Gln Val Tyr Tyr Arg Met Cys Gln Asn Cys Ile
130 135 140
Glu Leu Asn Ala Ala Thr Ile Ser Gly Phe Leu Phe Ala Glu Ile Val
145 150 155 160
Ser Ile Phe Val Leu Ala Val Gly Val Tyr Phe Ile Ala Gly Gln Asp
165 170 175
Gly Val Arg Gln Ser Arg Ala Ser Asp Lys Gln Thr Leu Leu Pro Asn
180 185 190
Asp Gln Leu Tyr Gln Pro Leu Lys Asp Arg Glu Asp Asp Gln Tyr Ser
195 200 205
His Leu Gln Gly Asn Gln Leu Arg Arg Asn
210 215
<210> 444
<211> 207
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 δTCR
<400> 444
Met Glu His Ser Thr Phe Leu Ser Gly Leu Val Leu Ala Thr Leu Leu
1 5 10 15
Ser Gln Val Ser Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Phe Lys Ile Pro Ile Glu Glu
50 55 60
Leu Glu Asp Arg Val Phe Val Asn Cys Asn Thr Ser Ile Thr Trp Val
65 70 75 80
Glu Gly Thr Val Gly Thr Leu Leu Ser Asp Ile Thr Arg Leu Asp Leu
85 90 95
Gly Lys Arg Ile Leu Asp Pro Arg Gly Ile Tyr Arg Cys Asn Gly Thr
100 105 110
Asp Ile Tyr Lys Asp Lys Glu Ser Thr Val Gln Val His Tyr Arg Met
115 120 125
Cys Gln Ser Cys Val Glu Leu Asp Pro Ala Thr Val Ala Gly Ile Ile
130 135 140
Val Thr Asp Val Ile Ala Thr Leu Leu Leu Ala Leu Gly Val Phe Cys
145 150 155 160
Phe Ala Gly His Glu Thr Gly Arg Leu Ser Gly Ala Ala Asp Thr Gln
165 170 175
Ala Leu Leu Arg Asn Asp Gln Val Tyr Gln Pro Leu Arg Asp Arg Asp
180 185 190
Asp Ala Gln Tyr Ser His Leu Gly Gly Asn Trp Ala Arg Asn Lys
195 200 205
<210> 445
<211> 366
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 CAR
<400> 445
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr
85 90 95
Met Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
355 360 365
<210> 446
<211> 369
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 CAR
<400> 446
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Thr Phe Ser Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val
65 70 75 80
Tyr Ser Asp Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu
115 120 125
Ala Val Asn Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg
<210> 447
<211> 369
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 CAR
<400> 447
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu
35 40 45
Ser Phe Ser Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val
65 70 75 80
Tyr Thr Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu
115 120 125
Ala Ile Asn Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg
<210> 448
<211> 402
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS65233VH5串联CAR
<400> 448
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Glu Phe Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly
85 90 95
Lys Gly Leu Glu Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr
100 105 110
Val Tyr Ala Asp Ser Val Lys Gly Arg Phe Val Leu Ser Arg Asp Asn
115 120 125
Ser Lys Asn Thr Met Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp
130 135 140
Thr Ala Met Tyr Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp
145 150 155 160
Ser Ser Pro Ser Ser Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr
165 170 175
Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
180 185 190
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
195 200 205
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
210 215 220
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
225 230 235 240
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
245 250 255
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
260 265 270
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
275 280 285
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
290 295 300
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
305 310 315 320
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
325 330 335
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
340 345 350
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
355 360 365
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
370 375 380
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
385 390 395 400
Pro Arg
<210> 449
<211> 405
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS80444VH5串联CAR
<400> 449
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Phe Thr Phe Ser Arg Asn Thr Met Gly Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Gly Val Ser Ala Ile Pro Tyr Thr Ser
100 105 110
Thr Gly Ile Val Tyr Ser Asp Ser Val Gly Gly Arg Phe Thr Ile Ser
115 120 125
Arg Asp Asn Ser Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly
145 150 155 160
Thr Thr Met Leu Ala Val Asn Gly Tyr Asn His Trp Gly Gln Gly Thr
165 170 175
Leu Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
180 185 190
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
195 200 205
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
210 215 220
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
225 230 235 240
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
245 250 255
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
260 265 270
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
275 280 285
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
290 295 300
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
305 310 315 320
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
325 330 335
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
340 345 350
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
355 360 365
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
370 375 380
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
385 390 395 400
Ala Leu Pro Pro Arg
405
<210> 450
<211> 405
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS80533VH4串联CAR
<400> 450
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala
20 25 30
Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly
35 40 45
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser
50 55 60
Gly Gly Gly Val Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala
65 70 75 80
Ala Ser Gly Leu Ser Phe Ser Thr Tyr Thr Val Ala Trp Phe Arg Gln
85 90 95
Ala Pro Gly Lys Gly Leu Glu Gly Val Ala Ala Ile Pro Tyr Thr Ser
100 105 110
Gln His Met Val Tyr Thr Asp Ser Val Lys Gly Arg Phe Thr Ile Ser
115 120 125
Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg
130 135 140
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly
145 150 155 160
Thr Ser Met Leu Ala Ile Asn Gly Tyr Asn Arg Trp Gly Gln Gly Thr
165 170 175
Thr Val Thr Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr
180 185 190
Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala
195 200 205
Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe
210 215 220
Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val
225 230 235 240
Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys
245 250 255
Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr
260 265 270
Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu
275 280 285
Gly Gly Cys Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro
290 295 300
Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly
305 310 315 320
Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro
325 330 335
Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr
340 345 350
Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly
355 360 365
Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln
370 375 380
Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln
385 390 395 400
Ala Leu Pro Pro Arg
405
<210> 451
<211> 652
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 + FSHβ 33-53双重CAR
<400> 451
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr
85 90 95
Met Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
355 360 365
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
370 375 380
Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu
385 390 395 400
Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr
405 410 415
Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr
420 425 430
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
435 440 445
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
450 455 460
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
465 470 475 480
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
485 490 495
Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met
500 505 510
Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro
515 520 525
Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe
530 535 540
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
545 550 555 560
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
565 570 575
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
580 585 590
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
595 600 605
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
610 615 620
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
625 630 635 640
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
645 650
<210> 452
<211> 655
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 + FSHβ 33-53双重CAR
<400> 452
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Thr Phe Ser Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val
65 70 75 80
Tyr Ser Asp Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu
115 120 125
Ala Val Asn Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp
370 375 380
Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu
385 390 395 400
Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp
405 410 415
Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr
420 425 430
Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile
435 440 445
Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala
450 455 460
Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr
465 470 475 480
Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu
485 490 495
Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser
500 505 510
Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His
515 520 525
Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg
530 535 540
Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln
545 550 555 560
Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp
565 570 575
Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro
580 585 590
Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp
595 600 605
Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg
610 615 620
Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr
625 630 635 640
Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
645 650 655
<210> 453
<211> 655
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 FSHβ 33-53双重CAR
<400> 453
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu
35 40 45
Ser Phe Ser Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val
65 70 75 80
Tyr Thr Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu
115 120 125
Ala Ile Asn Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp
370 375 380
Val Glu Glu Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu
385 390 395 400
Leu Pro Leu Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp
405 410 415
Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr
420 425 430
Phe Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile
435 440 445
Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala
450 455 460
Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr
465 470 475 480
Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu
485 490 495
Val Ile Thr Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser
500 505 510
Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His
515 520 525
Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg
530 535 540
Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln
545 550 555 560
Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp
565 570 575
Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro
580 585 590
Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp
595 600 605
Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg
610 615 620
Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr
625 630 635 640
Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
645 650 655
<210> 454
<211> 631
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 CAR + FSHβ 33-53 εTCR
<400> 454
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe
35 40 45
Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
50 55 60
Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp
65 70 75 80
Ser Val Lys Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr
85 90 95
Met Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
100 105 110
Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser
115 120 125
Ser Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
130 135 140
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
145 150 155 160
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
165 170 175
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
180 185 190
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
195 200 205
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
210 215 220
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
225 230 235 240
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
245 250 255
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
260 265 270
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
275 280 285
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
290 295 300
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
305 310 315 320
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
325 330 335
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
340 345 350
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
355 360 365
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
370 375 380
Asn Pro Gly Pro Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu
385 390 395 400
Cys Leu Leu Ser Val Gly Val Trp Gly Gln Tyr Thr Arg Asp Leu Val
405 410 415
Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly
420 425 430
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Gly
435 440 445
Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val Ser Ile
450 455 460
Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly Ser Glu
465 470 475 480
Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp Glu Asp Asp
485 490 495
Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys Glu Phe Ser
500 505 510
Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly Ser Lys
515 520 525
Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val Cys Glu
530 535 540
Asn Cys Met Glu Met Asp Val Met Ser Val Ala Thr Ile Val Ile Val
545 550 555 560
Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser
565 570 575
Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala
580 585 590
Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro
595 600 605
Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser
610 615 620
Gly Leu Asn Gln Arg Arg Ile
625 630
<210> 455
<211> 634
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 CAR + FSHβ 33-53 εTCR
<400> 455
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe
35 40 45
Thr Phe Ser Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val
65 70 75 80
Tyr Ser Asp Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Met Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu
115 120 125
Ala Val Asn Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp
370 375 380
Val Glu Glu Asn Pro Gly Pro Met Gln Ser Gly Thr His Trp Arg Val
385 390 395 400
Leu Gly Leu Cys Leu Leu Ser Val Gly Val Trp Gly Gln Tyr Thr Arg
405 410 415
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
420 425 430
Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
435 440 445
Ser Asp Gly Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys
450 455 460
Val Ser Ile Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro
465 470 475 480
Gly Ser Glu Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp
485 490 495
Glu Asp Asp Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys
500 505 510
Glu Phe Ser Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg
515 520 525
Gly Ser Lys Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg
530 535 540
Val Cys Glu Asn Cys Met Glu Met Asp Val Met Ser Val Ala Thr Ile
545 550 555 560
Val Ile Val Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr
565 570 575
Tyr Trp Ser Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly
580 585 590
Ala Gly Ala Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro
595 600 605
Pro Val Pro Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp
610 615 620
Leu Tyr Ser Gly Leu Asn Gln Arg Arg Ile
625 630
<210> 456
<211> 634
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 CAR + FSHβ 33-53 εTCR
<400> 456
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
1 5 10 15
His Ala Ala Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val
20 25 30
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu
35 40 45
Ser Phe Ser Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys
50 55 60
Gly Leu Glu Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val
65 70 75 80
Tyr Thr Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
85 90 95
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
100 105 110
Ala Val Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu
115 120 125
Ala Ile Asn Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val
130 135 140
Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr
145 150 155 160
Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala
165 170 175
Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile
180 185 190
Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser
195 200 205
Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr
210 215 220
Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu
225 230 235 240
Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu
245 250 255
Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln
260 265 270
Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu
275 280 285
Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly
290 295 300
Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln
305 310 315 320
Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu
325 330 335
Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr
340 345 350
Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro
355 360 365
Arg Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp
370 375 380
Val Glu Glu Asn Pro Gly Pro Met Gln Ser Gly Thr His Trp Arg Val
385 390 395 400
Leu Gly Leu Cys Leu Leu Ser Val Gly Val Trp Gly Gln Tyr Thr Arg
405 410 415
Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys
420 425 430
Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
435 440 445
Ser Asp Gly Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys
450 455 460
Val Ser Ile Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro
465 470 475 480
Gly Ser Glu Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp
485 490 495
Glu Asp Asp Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys
500 505 510
Glu Phe Ser Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg
515 520 525
Gly Ser Lys Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg
530 535 540
Val Cys Glu Asn Cys Met Glu Met Asp Val Met Ser Val Ala Thr Ile
545 550 555 560
Val Ile Val Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr
565 570 575
Tyr Trp Ser Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly
580 585 590
Ala Gly Ala Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro
595 600 605
Pro Val Pro Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp
610 615 620
Leu Tyr Ser Gly Leu Asn Gln Arg Arg Ile
625 630
<210> 457
<211> 464
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 εTCR,具有dnTGF RII
<400> 457
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gln Ser
210 215 220
Gly Thr His Trp Arg Val Leu Gly Leu Cys Leu Leu Ser Val Gly Val
225 230 235 240
Trp Gly Gln Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro
245 250 255
Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly
260 265 270
Gly Ser Gly Gly Gly Gly Ser Asp Gly Asn Glu Glu Met Gly Gly Ile
275 280 285
Thr Gln Thr Pro Tyr Lys Val Ser Ile Ser Gly Thr Thr Val Ile Leu
290 295 300
Thr Cys Pro Gln Tyr Pro Gly Ser Glu Ile Leu Trp Gln His Asn Asp
305 310 315 320
Lys Asn Ile Gly Gly Asp Glu Asp Asp Lys Asn Ile Gly Ser Asp Glu
325 330 335
Asp His Leu Ser Leu Lys Glu Phe Ser Glu Leu Glu Gln Ser Gly Tyr
340 345 350
Tyr Val Cys Tyr Pro Arg Gly Ser Lys Pro Glu Asp Ala Asn Phe Tyr
355 360 365
Leu Tyr Leu Arg Ala Arg Val Cys Glu Asn Cys Met Glu Met Asp Val
370 375 380
Met Ser Val Ala Thr Ile Val Ile Val Asp Ile Cys Ile Thr Gly Gly
385 390 395 400
Leu Leu Leu Leu Val Tyr Tyr Trp Ser Lys Asn Arg Lys Ala Lys Ala
405 410 415
Lys Pro Val Thr Arg Gly Ala Gly Ala Gly Gly Arg Gln Arg Gly Gln
420 425 430
Asn Lys Glu Arg Pro Pro Pro Val Pro Asn Pro Asp Tyr Glu Pro Ile
435 440 445
Arg Lys Gly Gln Arg Asp Leu Tyr Ser Gly Leu Asn Gln Arg Arg Ile
450 455 460
<210> 458
<211> 439
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 γTCR,具有dnTGF RII
<400> 458
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Glu Gln
210 215 220
Gly Lys Gly Leu Ala Val Leu Ile Leu Ala Ile Ile Leu Leu Gln Gly
225 230 235 240
Thr Leu Ala Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro
245 250 255
Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly
260 265 270
Gly Ser Gly Gly Gly Gly Ser Gln Ser Ile Lys Gly Asn His Leu Val
275 280 285
Lys Val Tyr Asp Tyr Gln Glu Asp Gly Ser Val Leu Leu Thr Cys Asp
290 295 300
Ala Glu Ala Lys Asn Ile Thr Trp Phe Lys Asp Gly Lys Met Ile Gly
305 310 315 320
Phe Leu Thr Glu Asp Lys Lys Lys Trp Asn Leu Gly Ser Asn Ala Lys
325 330 335
Asp Pro Arg Gly Met Tyr Gln Cys Lys Gly Ser Gln Asn Lys Ser Lys
340 345 350
Pro Leu Gln Val Tyr Tyr Arg Met Cys Gln Asn Cys Ile Glu Leu Asn
355 360 365
Ala Ala Thr Ile Ser Gly Phe Leu Phe Ala Glu Ile Val Ser Ile Phe
370 375 380
Val Leu Ala Val Gly Val Tyr Phe Ile Ala Gly Gln Asp Gly Val Arg
385 390 395 400
Gln Ser Arg Ala Ser Asp Lys Gln Thr Leu Leu Pro Asn Asp Gln Leu
405 410 415
Tyr Gln Pro Leu Lys Asp Arg Glu Asp Asp Gln Tyr Ser His Leu Gln
420 425 430
Gly Asn Gln Leu Arg Arg Asn
435
<210> 459
<211> 428
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 δTCR,具有dnTGF RII
<400> 459
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Glu His
210 215 220
Ser Thr Phe Leu Ser Gly Leu Val Leu Ala Thr Leu Leu Ser Gln Val
225 230 235 240
Ser Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys
245 250 255
Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly
260 265 270
Ser Gly Gly Gly Gly Ser Phe Lys Ile Pro Ile Glu Glu Leu Glu Asp
275 280 285
Arg Val Phe Val Asn Cys Asn Thr Ser Ile Thr Trp Val Glu Gly Thr
290 295 300
Val Gly Thr Leu Leu Ser Asp Ile Thr Arg Leu Asp Leu Gly Lys Arg
305 310 315 320
Ile Leu Asp Pro Arg Gly Ile Tyr Arg Cys Asn Gly Thr Asp Ile Tyr
325 330 335
Lys Asp Lys Glu Ser Thr Val Gln Val His Tyr Arg Met Cys Gln Ser
340 345 350
Cys Val Glu Leu Asp Pro Ala Thr Val Ala Gly Ile Ile Val Thr Asp
355 360 365
Val Ile Ala Thr Leu Leu Leu Ala Leu Gly Val Phe Cys Phe Ala Gly
370 375 380
His Glu Thr Gly Arg Leu Ser Gly Ala Ala Asp Thr Gln Ala Leu Leu
385 390 395 400
Arg Asn Asp Gln Val Tyr Gln Pro Leu Arg Asp Arg Asp Asp Ala Gln
405 410 415
Tyr Ser His Leu Gly Gly Asn Trp Ala Arg Asn Lys
420 425
<210> 460
<211> 587
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 CAR,具有dnTGF RII
<400> 460
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser
260 265 270
Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val Ala
275 280 285
His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys
290 295 300
Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Met Tyr Leu
305 310 315 320
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala
325 330 335
Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp
340 345 350
Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr Thr Thr Pro
355 360 365
Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu
370 375 380
Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His
385 390 395 400
Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu
405 410 415
Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr
420 425 430
Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe
435 440 445
Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg
450 455 460
Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser
465 470 475 480
Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr
485 490 495
Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys
500 505 510
Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn
515 520 525
Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu
530 535 540
Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly
545 550 555 560
His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr
565 570 575
Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
580 585
<210> 461
<211> 590
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 CAR,具有dnTGF RII
<400> 461
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser
260 265 270
Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp
290 295 300
Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn
340 345 350
Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
580 585 590
<210> 462
<211> 590
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 CAR,具有dnTGF RII
<400> 462
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser
260 265 270
Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp
290 295 300
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn
340 345 350
Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
580 585 590
<210> 463
<211> 623
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS65233VH5串联CAR,具有dnTGF RII
<400> 463
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys
245 250 255
Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly
260 265 270
Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly
275 280 285
Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu
290 295 300
Phe Thr Tyr Ser Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu
305 310 315 320
Glu Gly Val Ala His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala
325 330 335
Asp Ser Val Lys Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn
340 345 350
Thr Met Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met
355 360 365
Tyr Tyr Cys Ala Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro
370 375 380
Ser Ser Phe Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
385 390 395 400
Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala
405 410 415
Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly
420 425 430
Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile
435 440 445
Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val
450 455 460
Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe
465 470 475 480
Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly
485 490 495
Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg
500 505 510
Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln
515 520 525
Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp
530 535 540
Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro
545 550 555 560
Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp
565 570 575
Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg
580 585 590
Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr
595 600 605
Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
610 615 620
<210> 464
<211> 626
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS80444VH5串联CAR,具有dnTGF RII
<400> 464
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys
245 250 255
Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly
260 265 270
Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly
275 280 285
Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly
290 295 300
Phe Thr Phe Ser Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly
305 310 315 320
Lys Gly Leu Glu Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile
325 330 335
Val Tyr Ser Asp Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn
340 345 350
Ser Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp
355 360 365
Thr Ala Met Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met
370 375 380
Leu Ala Val Asn Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr
385 390 395 400
Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
405 410 415
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
420 425 430
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
435 440 445
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
450 455 460
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
465 470 475 480
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
485 490 495
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
500 505 510
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
515 520 525
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
530 535 540
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
545 550 555 560
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
565 570 575
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
580 585 590
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
595 600 605
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
610 615 620
Pro Arg
625
<210> 465
<211> 626
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> FSHβ 33-53 + AS80533VH4串联CAR,具有dnTGF RII
<400> 465
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro Ala Arg Pro Lys
245 250 255
Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly Ser Gly Gly Gly Gly
260 265 270
Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Glu Ser Gly Gly Gly
275 280 285
Val Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly
290 295 300
Leu Ser Phe Ser Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly
305 310 315 320
Lys Gly Leu Glu Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met
325 330 335
Val Tyr Thr Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn
340 345 350
Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp
355 360 365
Thr Ala Val Tyr Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met
370 375 380
Leu Ala Ile Asn Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr
385 390 395 400
Val Ser Ser Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro
405 410 415
Thr Ile Ala Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro
420 425 430
Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp
435 440 445
Ile Tyr Ile Trp Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu
450 455 460
Ser Leu Val Ile Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu
465 470 475 480
Tyr Ile Phe Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu
485 490 495
Glu Asp Gly Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys
500 505 510
Glu Leu Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys
515 520 525
Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu
530 535 540
Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly
545 550 555 560
Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu
565 570 575
Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly
580 585 590
Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser
595 600 605
Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro
610 615 620
Pro Arg
625
<210> 466
<211> 873
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 + FSHβ 33-53双重CAR,具有dnTGF RII
<400> 466
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser
260 265 270
Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val Ala
275 280 285
His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys
290 295 300
Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Met Tyr Leu
305 310 315 320
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala
325 330 335
Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp
340 345 350
Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr Thr Thr Pro
355 360 365
Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu
370 375 380
Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His
385 390 395 400
Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu
405 410 415
Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr
420 425 430
Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe
435 440 445
Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg
450 455 460
Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser
465 470 475 480
Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr
485 490 495
Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys
500 505 510
Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn
515 520 525
Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu
530 535 540
Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly
545 550 555 560
His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr
565 570 575
Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr
580 585 590
Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly
595 600 605
Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu
610 615 620
Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr Lys Asp Pro
625 630 635 640
Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr Thr Pro Ala
645 650 655
Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu Ser
660 665 670
Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr
675 680 685
Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu Ala
690 695 700
Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr Cys
705 710 715 720
Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr
725 730 735
Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro
740 745 750
Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser
755 760 765
Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr Asn Glu
770 775 780
Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg
785 790 795 800
Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln
805 810 815
Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr
820 825 830
Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp
835 840 845
Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala
850 855 860
Leu His Met Gln Ala Leu Pro Pro Arg
865 870
<210> 467
<211> 876
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 + FSHβ 33-53双重CAR,具有dnTGF RII
<400> 467
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser
260 265 270
Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp
290 295 300
Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn
340 345 350
Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
580 585 590
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
595 600 605
Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu
610 615 620
Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr
625 630 635 640
Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr
645 650 655
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
660 665 670
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
675 680 685
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
690 695 700
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
705 710 715 720
Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met
725 730 735
Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro
740 745 750
Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe
755 760 765
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
770 775 780
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
785 790 795 800
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
805 810 815
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
820 825 830
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
835 840 845
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
850 855 860
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
865 870 875
<210> 468
<211> 876
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 + FSHβ 33-53双重CAR,具有dnTGF RII
<400> 468
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser
260 265 270
Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp
290 295 300
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn
340 345 350
Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
580 585 590
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
595 600 605
Asn Pro Gly Pro Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu
610 615 620
Ala Leu Leu Leu His Ala Ala Arg Pro Tyr Thr Arg Asp Leu Val Tyr
625 630 635 640
Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Thr Thr
645 650 655
Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln
660 665 670
Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala
675 680 685
Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala
690 695 700
Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr
705 710 715 720
Leu Tyr Cys Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met
725 730 735
Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro
740 745 750
Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe
755 760 765
Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu
770 775 780
Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp
785 790 795 800
Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys
805 810 815
Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala
820 825 830
Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys
835 840 845
Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr
850 855 860
Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg
865 870 875
<210> 469
<211> 852
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS65233VH5 CAR + FSHβ 33-53 εTCR,具有dnTGF RII
<400> 469
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Phe Thr Tyr Ser
260 265 270
Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Gly Val Ala
275 280 285
His Ile Tyr Thr Arg Gly Gly Thr Thr Val Tyr Ala Asp Ser Val Lys
290 295 300
Gly Arg Phe Val Leu Ser Arg Asp Asn Ser Lys Asn Thr Met Tyr Leu
305 310 315 320
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala
325 330 335
Ala Arg Thr Ile Phe Glu Gly Ser Trp Ser Ser Pro Ser Ser Phe Asp
340 345 350
Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr Thr Thr Pro
355 360 365
Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln Pro Leu
370 375 380
Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala Val His
385 390 395 400
Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp Ala Pro Leu
405 410 415
Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile Thr Leu Tyr
420 425 430
Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys Gln Pro Phe
435 440 445
Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys Ser Cys Arg
450 455 460
Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val Lys Phe Ser
465 470 475 480
Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn Gln Leu Tyr
485 490 495
Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys
500 505 510
Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn
515 520 525
Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu
530 535 540
Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly
545 550 555 560
His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr
565 570 575
Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser Gly Ala Thr
580 585 590
Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly
595 600 605
Pro Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu Cys Leu Leu
610 615 620
Ser Val Gly Val Trp Gly Gln Tyr Thr Arg Asp Leu Val Tyr Lys Asp
625 630 635 640
Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly Gly Gly Gly
645 650 655
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Gly Asn Glu Glu
660 665 670
Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val Ser Ile Ser Gly Thr
675 680 685
Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly Ser Glu Ile Leu Trp
690 695 700
Gln His Asn Asp Lys Asn Ile Gly Gly Asp Glu Asp Asp Lys Asn Ile
705 710 715 720
Gly Ser Asp Glu Asp His Leu Ser Leu Lys Glu Phe Ser Glu Leu Glu
725 730 735
Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly Ser Lys Pro Glu Asp
740 745 750
Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val Cys Glu Asn Cys Met
755 760 765
Glu Met Asp Val Met Ser Val Ala Thr Ile Val Ile Val Asp Ile Cys
770 775 780
Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser Lys Asn Arg
785 790 795 800
Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala Gly Gly Arg
805 810 815
Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro Asn Pro Asp
820 825 830
Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser Gly Leu Asn
835 840 845
Gln Arg Arg Ile
850
<210> 470
<211> 855
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80444VH5 CAR + FSHβ 33-53 εTCR,具有dnTGF RII
<400> 470
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser
260 265 270
Arg Asn Thr Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ser Ala Ile Pro Tyr Thr Ser Thr Gly Ile Val Tyr Ser Asp
290 295 300
Ser Val Gly Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Thr Met Leu Ala Val Asn
340 345 350
Gly Tyr Asn His Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
580 585 590
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
595 600 605
Asn Pro Gly Pro Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu
610 615 620
Cys Leu Leu Ser Val Gly Val Trp Gly Gln Tyr Thr Arg Asp Leu Val
625 630 635 640
Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly
645 650 655
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Gly
660 665 670
Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val Ser Ile
675 680 685
Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly Ser Glu
690 695 700
Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp Glu Asp Asp
705 710 715 720
Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys Glu Phe Ser
725 730 735
Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly Ser Lys
740 745 750
Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val Cys Glu
755 760 765
Asn Cys Met Glu Met Asp Val Met Ser Val Ala Thr Ile Val Ile Val
770 775 780
Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser
785 790 795 800
Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala
805 810 815
Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro
820 825 830
Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser
835 840 845
Gly Leu Asn Gln Arg Arg Ile
850 855
<210> 471
<211> 855
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> AS80533VH4 CAR + FSHβ 33-53 εTCR,具有dnTGF RII
<400> 471
Met Gly Arg Gly Leu Leu Arg Gly Leu Trp Pro Leu His Ile Val Leu
1 5 10 15
Trp Thr Arg Ile Ala Ser Thr Ile Pro Pro His Val Gln Lys Ser Val
20 25 30
Asn Asn Asp Met Ile Val Thr Asp Asn Asn Gly Ala Val Lys Phe Pro
35 40 45
Gln Leu Cys Lys Phe Cys Asp Val Arg Phe Ser Thr Cys Asp Asn Gln
50 55 60
Lys Ser Cys Met Ser Asn Cys Ser Ile Thr Ser Ile Cys Glu Lys Pro
65 70 75 80
Gln Glu Val Cys Val Ala Val Trp Arg Lys Asn Asp Glu Asn Ile Thr
85 90 95
Leu Glu Thr Val Cys His Asp Pro Lys Leu Pro Tyr His Asp Phe Ile
100 105 110
Leu Glu Asp Ala Ala Ser Pro Lys Cys Ile Met Lys Glu Lys Lys Lys
115 120 125
Pro Gly Glu Thr Phe Phe Met Cys Ser Cys Ser Ser Asp Glu Cys Asn
130 135 140
Asp Asn Ile Ile Phe Ser Glu Glu Tyr Asn Thr Ser Asn Pro Asp Leu
145 150 155 160
Leu Leu Val Ile Phe Gln Val Thr Gly Ile Ser Leu Leu Pro Pro Leu
165 170 175
Gly Val Ala Ile Ser Val Ile Ile Ile Phe Tyr Cys Tyr Arg Val Asn
180 185 190
Arg Gln Gln Lys Leu Ser Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu
195 200 205
Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Met Ala Leu
210 215 220
Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu His Ala Ala
225 230 235 240
Arg Pro Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro
245 250 255
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Phe Ser
260 265 270
Thr Tyr Thr Val Ala Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu
275 280 285
Gly Val Ala Ala Ile Pro Tyr Thr Ser Gln His Met Val Tyr Thr Asp
290 295 300
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
305 310 315 320
Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
325 330 335
Tyr Cys Ala Thr Asp Arg Arg Pro Gly Thr Ser Met Leu Ala Ile Asn
340 345 350
Gly Tyr Asn Arg Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Thr
355 360 365
Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser
370 375 380
Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly
385 390 395 400
Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Ile Tyr Ile Trp
405 410 415
Ala Pro Leu Ala Gly Thr Cys Gly Val Leu Leu Leu Ser Leu Val Ile
420 425 430
Thr Leu Tyr Cys Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe Lys
435 440 445
Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly Cys
450 455 460
Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu Arg Val
465 470 475 480
Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Lys Gln Gly Gln Asn
485 490 495
Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp Val
500 505 510
Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro Arg
515 520 525
Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp Lys
530 535 540
Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg Arg
545 550 555 560
Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr Lys
565 570 575
Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg Gly Ser
580 585 590
Gly Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu
595 600 605
Asn Pro Gly Pro Met Gln Ser Gly Thr His Trp Arg Val Leu Gly Leu
610 615 620
Cys Leu Leu Ser Val Gly Val Trp Gly Gln Tyr Thr Arg Asp Leu Val
625 630 635 640
Tyr Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys Thr Cys Thr Phe Gly
645 650 655
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Gly
660 665 670
Asn Glu Glu Met Gly Gly Ile Thr Gln Thr Pro Tyr Lys Val Ser Ile
675 680 685
Ser Gly Thr Thr Val Ile Leu Thr Cys Pro Gln Tyr Pro Gly Ser Glu
690 695 700
Ile Leu Trp Gln His Asn Asp Lys Asn Ile Gly Gly Asp Glu Asp Asp
705 710 715 720
Lys Asn Ile Gly Ser Asp Glu Asp His Leu Ser Leu Lys Glu Phe Ser
725 730 735
Glu Leu Glu Gln Ser Gly Tyr Tyr Val Cys Tyr Pro Arg Gly Ser Lys
740 745 750
Pro Glu Asp Ala Asn Phe Tyr Leu Tyr Leu Arg Ala Arg Val Cys Glu
755 760 765
Asn Cys Met Glu Met Asp Val Met Ser Val Ala Thr Ile Val Ile Val
770 775 780
Asp Ile Cys Ile Thr Gly Gly Leu Leu Leu Leu Val Tyr Tyr Trp Ser
785 790 795 800
Lys Asn Arg Lys Ala Lys Ala Lys Pro Val Thr Arg Gly Ala Gly Ala
805 810 815
Gly Gly Arg Gln Arg Gly Gln Asn Lys Glu Arg Pro Pro Pro Val Pro
820 825 830
Asn Pro Asp Tyr Glu Pro Ile Arg Lys Gly Gln Arg Asp Leu Tyr Ser
835 840 845
Gly Leu Asn Gln Arg Arg Ile
850 855
- 上一篇:一种医用注射器针头装配设备
- 下一篇:利用肽标签的蛋白质可溶性表达